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NANOJARS: VERSATILE PLATFORM FOR PYRAZOLE SYNTHESIS AND CHEMISTRY,
AND SELECTIVE EXTRACTION OF ANIONS

Basil Mohammed Ahmed, Ph.D.
Western Michigan University, 2018

This work is centered around nanojars, a family of nano-sized anion-incarcerating agents.
It addresses various aspects of nanojar chemistry, such as synthesis strategies (including green
methodologies) for pyrazole ligands needed for the preparation of nanojars, characterization and
study of the mechanism of assembly of nanojars, and selective extraction of anions from water
using nanojars.
Nanojars are neutral, supramolecular coordination complexes of the general formula [anion⊂
{Cu(µ-OH)(µ-pz)}n], formed by the reaction of Cu2+, HO‒ and pyrazolate ions (C3H2N2‒, pz‒)
in the presence of oxoanions with large hydration energy (e.g. CO32–, SO42–, PO43–, HPO42–).
Nanojars are comprised of n = 26–36 repeating units of the formula [Cu(OH)(pz)], which are
arranged in stacks of three or four. The stacking of metallamacrocycles creates a hydrophilic
central cavity occupied by the incarcerated anion, surrounded by a hydrophobic periphery, which
provides solubility in numerous organic solvents. Nanojars are robust under neutral to extremely
alkaline (pH > 14) conditions and bind certain anions with high strength. Under acidic conditions,
however, nanojars reversibly break down and release the anion. Consequently, nanojars are
excellent candidates for anion extraction agents.

The main objectives of this work are: (1) Synthesize and characterize various pyrazole
ligands, including tethered multi-pyrazole ligand. In particular, pyrazoles with aliphatic and
oligo(ethylene glycol) chains are targeted, which are expected to further expand the solubility of
nanojars, in aliphatic solvents (such as ISOPARTM, suitable for industrial scale extractions) and
water, respectively. (2) Prepare and characterize nanojars using the synthesized pyrazole ligands.
Characterization techniques include NMR and UV–vis spectroscopy, mass spectrometry, X-ray
crystallography and thermogravimetric analysis. (3) Study the mechanism of formation of nanojars, using pH titration, UV–vis spectroscopy and mass spectrometry. (4) Study the extraction of
sulfate (SO42–) and carbonate (CO32–) ions from aqueous media by nanojars, and develop a method
for selective extraction of these anions.
Besides the anticipated outcomes based on the objectives described above, a number of
unforeseen, yet fundamentally significant results for the broader field of chemistry are also
presented. Unexpected results during the organic synthesis work inspired computational studies,
which resulted in demystification of misunderstood theoretical concepts related to the reactivity of
pyrazole derivatives. Thus, the “adjacent lone pair effect”, and the drastic deprotonation reactivity
difference between 3- and 5-alkylpyrazole isomers, as well as between five- and six-membered
aromatic molecules, was elucidated. The unusual and contrasting reactivity of amino- and
hydroxypyrazole derivatives toward aldehydes and ketones under either neutral or acidic conditions
was also studied, providing not only an understanding of the mechanism of the reactions, but also
a variety of novel bis- and non-scorpionate tris(pyrazolyl)methane ligands. Furthermore, the
selective C-4 deuteration of pyrazole substrates by D2O was studied, and a convenient procedure
for large-scale deuteration was developed.
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CHAPTER 1

1

1.1

INTRODUCTION

Anion binding and extraction
Anion binding and removal from water by synthetic receptors is one of the most extensively

researched topics in the field of supramolecular chemistry, because of the important roles that
anions play in various environmental, biological and chemical processes.1 Among these anions are
sulfate and phosphate, which are known to interfere with the disposal of aqueous nuclear waste by
vitrification, and they can cause eutrophication originating from the continuous discharge of
fertilizers.2,3 In addition, arsenate, chromate and selenate are known for their toxicity and
carcinogenicity.4,5
The removal of anions from water is usually achieved by liquid–liquid extraction, as well as
by other techniques such as solid–phase extraction and selective crystallization. The extraction
processes depend mainly on the binding strength of the anions with water, which is sorted in the
Hofmeister series depending on the hydration energies of the anions (Figure 1.1). Removal of the
anions with large hydration energy from water is very challenging because of their high affinity
for water.6 For instance, carbonate and sulfate, which have very large hydration energies (ΔGºh =
–1315 kJ mol–1, –1090 kJ mol–1, respectively), are much harder to remove from water compared
to anions with smaller hydration energies, such as nitrate and perchlorate (ΔGºh = –306 kJ mol–1,
–214 kJ mol–1, respectively).5,7
Strongly hydrated
CO32⎼

SO42⎼

Weakly hydrated
S2O32⎼

H2PO4⎼

I⎼

Figure 1.1: Hofmeister series.8
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Cl⎼

Br⎼

NO3⎼

I⎼

ClO4⎼

SCN⎼

In addition, selective recognition and extraction of these anions from mixtures is a very
challenging problem, due to their similar properties, such as size and charge. For instance,
phosphate and arsenate anions have the same charge,9 very similar size10 and acidity constant.11
Therefore, the design of novel chemical systems, capable of efficient and selective extraction of
anions from solutions, is gaining increasing attention in recent years.6,12,13,14,15 The most effective
and practical way to bind and extract hydrophilic anions from water is by encapsulating and
isolating them completely from the surrounding environment by using cage-like extracting
agents.16 In order to complete the separation process, the extracting agent needs to be able to
transfer the anions from water into a different, immiscible phase to collect them easily.5 A brief
review of the major classes of currently known anion receptors is present below.
1.1.1 Tripodal anion receptors
Tripodal anion receptors represent a class of acyclic anion binding agents which consist of
three conformationally flexible arms where the ligating groups are attached to coordinate the guest
anion.12 Tripodal anion receptors show relatively high selectivity toward tetrahedral oxoanions,
originating from the shape complimentary between the flexible arms and the tetrahedral oxoanions.
With their hydrogen-bonding functionalized arms, tripodal receptors have been shown to
coordinate with the guest anions by formation of capsules or pseudo-capsules assemblies.17 The
formed molecular capsules are able to isolate the encapsulated anion from the solution. To
encapsulate multi-charged oxoanions and hydrated anions, higher coordination number is
required; therefore, dimeric capsules are created by two tripodal molecules with the guest anion.
Tris(2-aminoethyl)amine based tris(urea/thiourea) ligand (TTU) (Figure 1.2) are well-known types
of tripodal anion receptors, which were reported for the first time in 1995.18

N
NH

X

NH
R

HN

HN

X
HN

X
HN
R

R

Figure 1.2: Chemical structure of tripodal urea/thiourea anion receptor (TTU) (X = O, S).
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Selective binding for anions is achieved by using specific substituents for the receptor.
Bachas and co-workers have studied the effect of scaffold rigidity and cavity size on selectivity of
the receptors to construct ion-selective electrodes, by using tris(urea) receptor of N-butyl-4-oxo4H-chromene-2-carboxamide substituted group based on either a tren scaffold (see Figure 1.2) or
a cis-1,3,5-tris(aminomethyl)cyclohexane scaffold (Figure 1.3).19

NH

NH
O

O

R

R

R=

R
HN

HN
NH

O
HN

O

O

O
nBu

NH

Figure 1.3: Chemical structure of tripodal urea receptor cis-1,3,5-tris(aminomethyl)cyclohexane.
The electrodes based on the ionophore that incorporates the flexible tren scaffold show high
affinity toward hydrophilic anions, with an improved selectivity for sulfate. In contrast, the
ionophore with the rigid cis-1,3,5-tris(aminomethyl)cyclohexane scaffold exhibits a more affinity
toward hydrophobic anions.
Das and co-workers have demonstrated selective binding for sulfate over dihydrogen
phosphate, acetate, nitrate and perchlorate by using a tren-based receptor with 4-nitrophenyl
functionalities.20 Replacing urea with thiourea by the same group led to preferential binding toward
phosphate by two independent dimeric capsule assemblies, as indicated by 1H NMR titration,
compared to other anions such as carbonate, sulfate and fluoride. The higher selectivity toward
phosphate is related to the aromatic π····π stacking and aryl C–H…N interactions between the
receptor side arms.17
Yang, Wu and co-workers studied the host-guest binding behavior by cyclic voltammetry,
using tren-based receptor with 2-ferrocenyl functionalities, and by fluorescence spectroscopy,
using tris(urea) receptor with 3-quinoline functionalities.21 The studies were performed using
sulfate and fluoride anions. In addition, they compared the binding strength between the former
and the later ligand with sulfate anion using 1H NMR, and they indicated higher affinity of the
later receptor to sulfate than the former one. Furthermore, both of these receptors bind sulfate
3

significantly stronger than fluoride. This result points to a better complementarity of the receptor
with tetrahedral anions such as sulfate, than the spherical anions such as fluoride.
Efficient and selective extraction of sulfate anions from water was achieved by the same
group by developing a tripodal hexaurea receptor (Figure 1.4), even in the presence of excess
nitrate and chloride anions.22
(a)

(b)
N
NH

O

HN

O

NH

HN

O

HN
HN

NH

HN
HN

HN

O
HN

O2N

O

O

NH

NO2
NO2

Figure 1.4: Chemical structure of the tripodal hexaurea receptor (a), X-ray structure of the receptor
with the fully encapsulated sulfate anion via hydrogen bonding (b). Figure b is reproduced from
reference 12 with permission from The Royal Society of Chemistry.
Complementarity, chelate effect and hydrophobicity of the receptor led to overcome the
large hydration energy of the sulfate anions.22 All six urea groups in the receptor are involved in
hydrogen bonding with the sulfate anion to form a total of twelve hydrogen bonds, allowing full
encapsulation of the anion inside the receptor in the tetrahedral cavity.
A tren based tris(urea) receptor functionalized with pentafluorophenyl has been prepared
by Ghosh and his co-workers, who studied its binding in solution with various anions and showed
that the receptor favors anions with lage hydration enegries (H2PO4– > SO42– > CO32– > CH3COO–
> F– > Cl– >> Br–), with high selectivity observed for dihydrogen phosphate.12 On the other hand,
this receptor showed higher binding for phosphate and sulfate anions compared to the same
receptor where phenyl is the substituted group.23 Higher selectivity toward sulfate over other
4

anions such as dihydrogen phosphate, acetate, chloride, bromide, iodide, nitrate and perchlorate
was achieved by using the same functional group, pentafluorophenyl-substituted tris(urea)
receptor based on the more rigid cyanuric acid platform (Figure 1.5), in the solid state, solution
and gas phase.24
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Figure 1.5: Chemical structure of a cyanuric acid based pentafluorophenyl urea receptor.
Gale and his co-workers investigated the anion binding affinities of a series of fluorinated
phenyl tren based tris(urea) and tris(thiourea) receptors (see Figure 1.2) (X = O or S; R = Ph, pC6H4F, C6F5, p-C6H4(CF3), 3,5-bis(CF3)C6H3) with different anions in solution such as chloride,
sulfate, dihydrogen phosphate, hydrogen carbonate and nitrate, by using 1H NMR titration.25 The
study revealed that the receptors bind anions according to the trend SO42– > H2PO4– > Cl– > HCO3–
>> NO3–, which shows high selectivity toward sulfate and only limited binding with nitrate anion.
It’s also observed that the more acidic thiourea-based receptors showed lower binding constants
than those of the equivalent urea-based receptors, and the stability constants decrease with
increasing electron-withdrawing ability of the substituents.
2-Aminothiazolium-containing tripodal receptors based on a benzene platform show a
strong affinity towards sulfate when a phenyl group is present at the 4-position of the thiazoline
ring, and affinity toward acetate in the absence of the phenyl group (Figure 1.6).26 The phenyl
group on the thiazoline ring has played an important role in the formation of a cone conformation
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upon sulfate binding through mutual aromatic static interaction. The isothermal titration
calorimetry (ITC) method was used to investigate the affinities of these receptors toward anions.
R
R
S

R=

R

H 2N

H 2N

S
or

N

N
Ph

Figure 1.6: Chemical structures of 2-aminothiazoline based receptors.
Hossain et al. have recently reported the synthesis of p-phenylene-bridged hexafunctional
tripodal receptor consisting of two differently functionalized clefts, a urea-based inner cleft and a
thiourea-based outer cleft (Figure 1.7).27 Experimental studies (1H NMR titration and 2D NOESY)
and theoretical calculations (high-level DFT) demonstrated that the receptor can effectively bind
sulfate anions in a two-step binding process. The 1:2 stoichiometric complex formed is stabilized
through complementary hydrogen-bonding interactions. The enhanced H-bonding ability as well
as the structural complementarity of the thiourea functionalities lead to stronger interactions with
the anion than in the case of the urea analogue. Therefore, the first sulfate anion binds preferentially
at the thiourea-based outer cleft, followed by the second sulfate anion, which binds at the ureabased inner cleft. This binding propagation was further supported by DFT calculations, illustrating
that the thiourea-bound complex is energetically more favorable than the urea-bound complex.
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Figure 1.7: Chemical structure of p-phenylene-bridged hexafunctional mixed urea/thiourea
tripodal receptor.
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The calculated binding constants gathered from the titration of the ligand with other anions
such as hydrogen sulfate, hydrogen phosphate, perchlorate and nitrate revealed the overall binding
trend SO42– > HSO4– > H2PO4– > ClO4– or NO3–.
In general, it is clear that the urea receptors prefer to bind the tetrahedral sulfate anion
selectively,12 compared to a tren based tripodal amide receptor (Figure 1.8), which showed
selectivity toward hydrogen sulfate over chloride, bromide, nitrate and phosphate.28

N
O

NH

HN

HN

O

O

N

N

N

Figure 1.8: Chemical structure of a tren based amide receptor.

1.1.2 Cyclic anion receptors
A variety of synthetic receptors have been developed to tackle the challenging task of
achieving high affinity and selectivity for anions in aqueous media. Cyclic receptors, in which the
binding units are arranged around the closed rings have played a key role. Considering their
preorganized structure and thermodynamic stability (chelate, macrocycle and macrobicycle
effect), cyclic receptors offer advantages over acyclic receptors in binding anions.29 All cyclic
receptors described in this section are functionalized with amine, amide, pyrrole and indole anionbinding groups.
Sessler and co-workers prepared cyclo[8]pyrroles (Figure 1.9) by the oxidative selfcoupling of bipyrroles in the presence of H2SO4, which have been used for liquid-liquid extraction
of sulfate anions from aqueous solution along with Aliquat 336N as a phase-transfer catalyst.30 An
isotopic exchange experiment with sodium sulfate spiked with a radioactive SO42– tracer has shown
that the receptor (R = C11H23) has very high exchange constant, which means that the more
hydrophilic sulfate anion can be usefully extracted into an organic layer from a much higher
concentration of lipophilic anions, such as nitrate.31
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Figure 1.9: Chemical structure of sulfate complex of cyclo[8]pyrrole.
Moyer, Sessler and co-workers have explored the effect of the substituents in macrocycles
on the liquid–liquid anion exchange of sulfate, using two classes of neutral macrocyclic receptors
in chloroform solution containing Aliquat 336N as phase-transfer catalyst (Figure 1.10).32
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Figure 1.10: Chemical structure of different macrocycles based on tetramides, calix[4]pyrroles and
calix[5]pyrroles.
The study revealed that the substituents have a strong influence on the ability of the
receptor to enhance sulfate extraction. For instance, the dansyl substituents on the tetramide
macrocycles appear effective, whereas in the case of calix[4]pyrroles, the fluorine substituents
8

apparently weaken the extraction ability of the receptor, contrary to the expectation that the
electron-withdrawing groups should enhance anion binding by strengthening the hydrogen bonds.
Higher concentration of the fluorinated calix[5]pyrrole receptor is required to push the sulfate
distribution ratio to technologically useful values.
Later, the same group has shown that the use of a methyltrialkylammonium (alkyl = C6–
C10) cation allows simple, unfunctionallized calix[4]pyrrole to work as a selective sulfate anion
extractant.33 The enhancement in the selectivity for sulfate extraction is attributed to the concurrent
binding of the sulfate anion and the methyltrialkylammonium cation to the cone-conformation of
the calix[4]pyrrole, rendering the host an ion-pair receptor.
Based on the calix[4]pyrrole receptor, Sessler and co-workers have designed and
synthesized receptor derivatives with higher affinity to anions (Figure 1.11).34 The observed higher
affinity originates from the additional two acidic hydrogen-bonding donors provided by the
bipyrrole units, as well as to the anion encapsulation.
The calix[4]pyrrole-based anion receptors were found to extract the sulfate anion as
methylalkyl ammonium salts from water into organic media with higher efficiency than the parent
calix[4]pyrrole.
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Figure 1.11: Chemical structure of calix[4]pyrrole receptor (a), calix[4]pyrrole-based receptor
derivatives (b, c), optimized geometry for calix[4]pyrrole·SO42– (d), optimized geometry for
calix[4]pyrrole-based receptors·SO42– (e, f). Figures d, e and f are reprinted with permission from
reference 34. Copyright 2014 American Chemical Society.
Sessler and co-workers have recently reported a receptor derivative based on the
calix[4]pyrrole motif; bis-calix[4]pyrroles are capable of binding two oxoanions (1:2 ratio),
specifically H2PO4– , H2PO73– and SO42– (Figure 1.12).35

10

(a)

(b)

(c)

(d)

Figure 1.12: Chemical structure of bis-calix[4]pyrrole receptor (a), crystal structure of (H2PO4–)2
·(H2O)2Ìbis-calix[4]pyrrole (b), crystal structure of (SO42–)2·(H2O)2Ìbis-calix[4]pyrrole (c),
crystal structure of (H2P2O72–)2·(H2O)2Ìbis-calix[4]pyrrole (d). Reproduced from reference 36,
copyright 2018, with permission from Elsevier.
Anion-templated synthesis of macrocycles with geometry complimentary to the guest
anion is an alternative strategy for anion binding. Beer and co-workers have shown for the first
time the templating role of sulfate anion in the high yield synthesis of a [2]catenane (Scheme 1.1).37
The synthesized catenane did not form in the presence of other anions such as chloride, fluoride
and acetate. The higher selectivity towards sulfate is attributed to the electrostatic attraction and
complementarity between the orthogonal arrangement of four amide groups from two units of the
receptor, and the tetrahedral geometry of the sulfate anion.
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Scheme 1.1: Synthesis of sulfate-templated catenane.
Mani and co-workers reported a class of large macrocycles containing N,Ndi(pyrrolylmethyl)-N-methylamine moieties (Scheme 1.2).38 The observed anion binding of the
two receptors is different regardless of their similar pyrrolic and amine NH donors. This difference
was attributed to the degree of flexibility provided by the linkers (ethylene vs phenylene). 1H NMR
titration experiments revealed that the receptor with a phenylene spacer binds anions in 1:2 ratio
(Scheme 1.2), whereas the other receptor binds the anion in 1:1 ratio. Furthermore, the 1H NMR
titration experiments showed different affinities for anions, and the relative order was SO42– > F–
> Cl– > Br– > PhCOO– for both receptors.
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Scheme 1.2: Schematic representation of the multiple equilibria of the receptor with anions.
Flood and co-workers reported that the cyanostar (CS) macrocycle (Figure 1.13) can
stabilize a dimer of hydrogen sulfate anions in a sandwich-like arrangement by twenty CH……O
hydrogen bonds (ten hydrogen bonds provided by each macrocycle).39 Crystal structure
characterization revealed that the S–O……O–S distance between the dimeric hydrogen sulfates
inside the cavity of the receptor is ~ 2.51 Å, which is shorter than that in the free hydrogen sulfate
dimer (2.62 Å). In addition to the crystallographically confirmed structure with two layers of the
cyanostar hosting a dimer of the hydrogen sulfate (Figure 1.13), ESI-MS analysis revealed the
presence of three stacked cyanostar macrocycles hosting a dimer of hydrogen sulfate anions. The
presence of the complex equivalents 2:2 and 3:2 (host:guest) in solutions is also confirmed by
NMR spectroscopic methods.

(c)

(b)
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H
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H
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H
H

H
H

H

Figure 1.13: Chemical structure of cyanostar (a), top view crystal structure of the complex
(Bu4N)2(CS)2(HSO4)2 (b), side view crystal structure of the complex (Bu4N)2(CS)2(HSO4)2 (c).
Figures b and c are reprinted from reference 39. Copyright Wiley-VCH Verlag GmbH & Co.
KGaA. Reproduced with permission.
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In addition to the two-dimensional macromonocyclic receptors, three-dimensional
macrobicyclic receptors have also been prepared in order to achieve high selectivity and binding
affinity toward anions in aqueous solutions. Nelson and co-workers,40 Bowman-James and coworkers,41 Ghosh and co-workers42 have structurally characterized the encapsulation of sulfate in
the cavity of protonated macrobicyclic receptors with different spacers (furan,40 m-xylyl, 2,6dicarbonypyridyl41 and p-xylyl42, respectively) in aqueous solvent (Figure 1.14). The study of the
crystal structures of sulfate complexes of these receptors revealed that the anion is encapsulated
inside the cavity by eight, five and eight NH……O hydrogen bonds in the case of furan, m-xylyl
and 2,6-dicarbonypyridyl spacers, respectively, whereas four NH……O and six CH……O hydrogen
bonds are present in the case of the receptor with p-xylyl spacer.
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Figure 1.14: Chemical structure of macrobyciclic receptors with furan spacer (a), m-xylyl spacer
(b), 2,6-dicarbonypyridyl spacer (c), p-xylyl spacer (d).
Later, Bowman-James and co-workers reported the design and synthesis of a tricyclic anion
receptor, which consists of two tetraamide monocycles attached together by two ethylene chains
(Figure 1.15).43 Structural and binding studies indicated that this receptor is selective for linear
anions such as FHF– and N3–. The four bridging amines are protonated in the presence of excess
H2SO4. The protonated receptor exists as a complex with two sulfate anions and two water
molecules inside the cage. Crystallographic study of the complex showed that each sulfate is bound
by four NH……O hydrogen bonds with the amide groups and by one OH……O H-bond with a water
molecule.
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(b) (c)

(a)

(b) (c)

Figure 1.15: Chemical structure of the tricyclic anion receptor (a), top view of the crystal structure
of the complex with sulfate (b), side view of the crystal structure of the complex with sulfate (c).
Reproduced from reference 36, copyright 2018, with permission from Elsevier.

1.1.3 Metal-based anion receptors
Metal ions play an important role in anion recognition processes in two ways: (1) they can
work as the active site for anion binding by attractive electrostatic interactions, (2) they can be
used to orient the hydrogen bond donor substituents to a rigid arrangement favoring selective anion
binding. The complex receptors are normally designed so that the hydrogen bond donor groups
(e.g. amine, amide etc.) are covalently linked to the metal ions to form a coordination complex that
provides a suitable orientation of the hydrogen bond donors for binding anions. The coordination
geometry of the metal ions (tetrahedral, square planar or octahedral), in addition to the nature and
length of the spacer connecting ligand and hydrogen bond donors normally dictate the shape and
size of the anion binding site within the receptor.12
Loeb and co-workers have demonstrated a remarkable selectivity for sulfate anion by a
platinum(II) complex (Figure 1.16).44 The square-planar coordination geometry preference Pt(II)
and the free rotation around the Pt(II)–N bonds in the complex give the possibility of three options
(up and down) with respect to the butyl urea substituents: all up (cone conformation) three up/one
down and two up/two down. The crystal structure of the complex showed that the receptor adopted
15

the cone conformation with all eight N–H groups oriented toward the cavity, which provide
complete encapsulation of the sulfate anion.

1

H NMR titration experiments of the complex

[Pt(ligand)4](BF4)2 with different anions such as chloride, bromide, iodide, dihydrogenephosphate,
sulfate, triflate, perrhenate and nitrate, showed a preferential binding toward sulfate and
dihydrogenephosphate.

(a) (b)

(a) (b)

N

H

N

H

O

N

Figure 1.16: Chemical structure of the urea-functionalized iso-quinoline ligand (a) and crystal
structure of the tetrakis Pt(II) complex of the ligand with sulfate anion (b). Figure b reprinted with
permission from reference 44. Copyright 2004 American Chemical Society.
Beer and co-workers have demonstrated the selective binding of sulfate by tetraimidazolium zinc metalloporphyrin anion receptor (Figure 1.17).45 UV–vis spectroscopic studies
indicated that the receptor is capable of strongly complexing sulfate in competitive water-DMSO
solvent mixture. The strong anion binding is attributed to a combination of electrostatic attraction
with Zn(II) and hydrogen bonding with the imidazolium methine groups.
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Figure 1.17: Chemical structure of tetra-imidazolium zinc metalloporphyrin.
Encapsulation of sulfate in a molecular capsule by six urea groups was achieved by the
coordination of six mono-pyridylurea ligands around an octahedral Cu(II) center, which resulted
in the formation of two C3-symmetric clefts at the two ends of the molecule (Figure 1.18).46 X-ray
structure showed that two molecules aligned along the C3-axis to create a cavity that encapsulates
the sulfate anion inside its center. Inside the formed capsule, all six urea groups are involved in
strong hydrogen bonding with the encapsulated sulfate anion.
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(a)

(c)
NH
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NH

Figure 1.18: Chemical structure of mono-pyridylurea ligand (a), X-ray structure of 1D hydrogenbonded copper(II) complex chain linked by sulfate encapsulation (b), and sulfate encapsulation by
multiple hydrogen bonds provided from six urea groups in the complex [SO4(urea)6]2– (c). Figures
b and c reproduced from reference 46 with permission from The Royal Society of Chemistry.
Custelcean, Hay and co-workers have used computer-aided design based on a monourea
ligand coordination with NiSO4 or ZnSO4.47 They successfully obtained a series of hexakis-urea
functionalized M4L6 tetrahedral cages with an anion coordinated in the cavity by twelve hydrogen
bonds, provided from six urea groups arranged along each edge of the tetrahedral cage. The
obtained cage cavities with six urea anion-binding sites have high selective encapsulation
capability for tetrahedral oxoanions such as SO42–, SeO42–, CrO42–, MoO42–, WO42–, and PO43–,
over anions of different shapes and charges such as F–, Cl–, Br–, I–, NO3–, BF4–, ClO4–, ReO4–, PF6,
CH3CO2–, CH3SO3–, CF3SO3–, CO32–, SO32–, and SeO32– (Figure 1.19).
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Figure 1.19: Chemical structure of the monourea ligand (a), crystal structure of the tetrahedral cage
formed by the ligand and NiSO4 (b), and the 12 hydrogen bonds from six urea groups around a
sulfate anion (c). Reprinted with permission from reference 47. Copyright 2012 American
Chemical Society.

1.1.4 Other types of anion receptors
Eventual application of supramolecular chemistry in anion binding requires continued
development of new molecular receptors to achieve the required efficiency and selectivity toward
the targeted anion in the desired media. This goal has led researchers to explore other hydrogen
bond donor and acceptor groups such as carbazole, indole, pyrrole-sulfonamides and
indolecarbazoles, as anion receptors.
Davis, Beer and co-workers have shown by 1H NMR titration that two indolocarbazoles
assemble around a sulfate anion in a 2:1 receptor:anion stoichiometry (Figure 1.20).48 X-ray
structure confirmed the stoichiometry of the complex in the solid state. This assembly process
around the sulfate anion allowed the formation of a pseudo-rotaxane, when a hybrid crown etherisophthalamide macrocycle was combined with a 1:1 mixture of sulfate and the indolocarbazole
ligand (Figure 1.20). This work demonstrated the important role that indolocarbazole may play in
anion assembly processes.
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Figure 1.20: The structure and hydrogen bonding of 2:1 indolocarbazole-sulfate complex (a), and
sulfate-templated pseudo-rotaxane (b).
Schubert and co-workers have used triazolinium-based mono- and bis-tridentate receptors
for selective binding of sulfate (Figure 1.21).49 Furthermore, they have demonstrated that the
controlled degree of methylation can help in the formation of mono- or bis-tridentate complexes.
The anion binding behavior of the receptors shown in (Figure 1.21a and b) toward sulfate, were
estimated by 1H NMR spectroscopy in CD3CN/CD3OD (4:1 v/v); Job’s plots show that the
receptors bind to sulfate in 1:1 and 1:2 stoichiometries, respectively.
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Figure 1.21: Chemical structure of triazolinium based mono-tridentate receptor (a), bis-tridentate
receptor (b), triazolinium based mono-tridentate receptor complex with SO42– in 1:1 stoichiometry
(c), and triazolinium based di-tridentate receptor complex with SO42– in 2:1 stoichiometry (d).
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Huggins and co-workers have used molecular receptors based on pyrrole-sulfonamides for
binding anions (Figure 1.22).50 Anion binding studies of the receptors have been conducted with
different anions by 1H NMR titration experiments, indicating that receptors 6 and 7 (Figure 1.22)
bind to hydrogen sulfate stronger than to other anions such as chloride, bromide, nitrate and
benzoate. Receptors 8 and 9 (Figure 1.22) bind hydrogen sulfate weaker than receptors 6 and 7.
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Figure 1.22: Chemical structure of pyrrole-sulfonamide based receptors (a, b), and chemical
structure showing the hydrogen bonding of receptor 2 with the encapsulated hydrogen sulfate (c).
The computational study they have conducted showed that HSO4– is bound to the receptor (7,
Figure 1.22) by five hydrogen bonds (two from the pyrrolic NH and two from sulfonamide NH),
and the fifth hydrogen bond was donated from the hydrogen sulfate to the carbonyl group of the
ester moiety. The latter hydrogen bond is attributed to be responsible for the observed selectivity
of the receptors (6 and 7 see Figure 1.22) toward hydrogen sulfate.
1.2

Copper(II) pyrazolate chemistry
Multinuclear copper(II) complexes are continuously attracting attention due to their

interesting magnetic properties and potential catalytic activity,51 their relevance to the active
centers of a number of metalloproteins,52 their application in the synthesis of metal-organic
frameworks (MOFs),53,54,55,56,57 and their applications in the anion encapsulation area.58 The
pyrazolate anion (C3H3N2–) can coordinate to copper through both N-atoms, and form copper
pyrazolate complexes ranging from di-, tri-, tetra-, penta-, hexa- to polynuclear structures,
including 1D chains as well as 2D and 3D networks. Copper (II) pyrazolate complexes are prepared
by the direct reaction of pyrazole with Cu(I) or Cu(II) ions in the presence of bases,59 by oxidizing
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Cu(I) pyrazolate complexes,60 by solvothermal reactions of copper salts with pyrazole,61 or by selfassembly reactions from presynthesized copper pyrazolate complexes.59a,60a,62
Monica, Moret and co-workers have prepared an octanuclear copper(II) pyrazolate complex
[Cu(II)8(dmpz)8(OH)8] (Hdmpz = 3,5-dimethylpyrazole), by the reaction of [Cu(I)(dmpz)]n with
O2 in a wet solvent at atmospheric pressure and room temperature.63 The obtained octanuclear
copper(II) complex consists of a cyclic planar system of copper(II) centers connected by hydroxide
and 3,5-dimethylpyrazolate units to form a toroidal shaped molecule. The authors demonstrated
the catalytic activity of the complex by the oxidation of organic substrates such as
triphenylphosphine, aromatic primary amines, dibenzylamine, and carbon monoxide to form
triphenylphosphine oxide, azobenzenes, N-benzylidenebenzylamine and carbon dioxide,
respectively (Scheme 1.3). Each mole of the complex reacted with triphenylphosphine to give 4
moles of the triphenylphosphine oxide, suggesting that the octanuclear complex transformed in
solution to tautomeric species of the general formula [Cu8(dmpz)8(O)x(OH)8–2x(H2O)x] (x = 1 – 4),
which might behave as the catalytically active species.

PPh3
CO
ArNH2

O

O2/Pyridine
[Cu8(dmpz)8(OH)8]

PPh3

CO2
ArN NAr
(C6H5CH2)2N

(C6H5CH2)2NH

CHC6H5

Scheme 1.3: Oxidation reactions catalyzed by an octanuclear Cu(II) complex.
Monari, Pandolfo, Pettinari, Pombeiro and co-workers have reported the formation of a
trinuclear triangular copper complex [Cu3(µ3-OH)(µ-pz)3(EtCOO)2(H2O)]·H2O (Figure 1.23a), by
the addition of pyrazole to a water solution of Cu(EtCOO)2·H2O, and leaving the resulting solution
to crystallize at 12 °C.64 A different compound [Cu3(µ3-OH)(µ-pz)3(EtCOO)2(H2O)] (Figure
1.23b), is produced when the reaction and crystallization are carried out at 18–22 °C. The presence
of the lattice water molecule in the former compound leads to the formation of a very different
assembly than in the latter compound. Propionate ions in both complexes are involved in intraand intermolecular hydrogen bonding to generate complex supramolecular 2D MOFs. The
obtained compounds reveal remarkable activity and selectivity as catalysts or catalyst precursors
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for liquid biphasic (MeCN/H2O) peroxidative oxidation of cyclohexane and cyclopentane to the
corresponding alcohols and ketones.
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Figure 1.23: Chemical structure of [Cu3(µ3-OH)(µ-pz)3(EtCOO)2(H2O)]·H2O (a), and [Cu3(µ3OH)(µ-pz)3(EtCOO)2(H2O)] (b).
Due to the biological activity of the redox-active trinuclear copper clusters as the active
centers of several copper proteins such as ascorbate oxidase, laccase, and ceruloplasmin,65 much
effort has been made to synthesize, characterize and study the properties of trinuclear copper
clusters.
Raptis and co-workers made significant progress in the synthesis, characterization and
study of the structural,52 magnetic,52 electrochemical,66,67 and spectroscopic68 properties of
trinuclear copper(II) pyrazolate complexes. The complexes prepared, including (PPN)[Cu3(µ3OH)(µ-pz)3Cl3], (PPN)2[Cu3(µ3-O)(µ-pz)3Cl3], (PPN/Bu4N)2[Cu3(µ3-Cl)2(µ-pz)3Cl3] and (Et3NH)
[Cu3(µ3-OH)(µ-pz)3Cl3(pzH)] (Scheme 1.4) have been characterized crystallographically and
showed for the first time, planar CuII3(µ3-O) and the CuII3(µ3-Cl)2 motifs. Measurements of the
magnetic susceptibility revealed that the three copper centers of (PPN)2[Cu3(µ3-O)(µ-pz)3Cl3]
show strong antiferromagnetic coupling with JCu–Cu = –500 cm–1.52
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Scheme 1.4: Structure and transformation of the trinuclear Cu(II) complexes.
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In another study, the same group have shown the effect of copper-substitution on the
structure and nuclearity of Cu(II) pyrazolates.69 In this study, they showed that the replacement of
the terminal chloride ligands of [Cu3(µ3-X)(µ-pz)3Cl3]n– (X = O, OH; n = 1, 2) or [Cu3(µ3-Cl)2(µpz)3Cl3]2– complexes for cyanate, acetate or bromide ligands maintains the integrity of the
triangular species and PPN[Cu3(µ3-OH)(µ-pz)3(NCO)3], PPN[Cu3(µ3-OH)(µ-pz)3(O2CCH3)3
(H2O)]·H2O, Bu4N[Cu3(µ3-OH)(µ-pz)3(O2CCH3)3]·3H2O and (Bu4N)2[Cu3(µ3-Br)2(µ-pz)3Br3]
were obtained and characterized spectroscopically and crystallographically. In contrast,
replacement of chloride with benzoate ligands resulted in tetranuclear and hexanuclear complexes
(Bu4N)2[Cu4(µ3-OH)2(µ-4-X-pz)2(µ-O2CPh)2(µ-O2CPh)4] (X = H, Cl, Br, NO2) and (Bu4N)2
[Cu6(µ3-O)(µ3-OH)(µ-4-NO2-pz)6(µ-O2CPh)3(µ-O2CPh)2(H2O)]·(CH2Cl2)0.5. Removing all chloride ions in the absence of appropriate ligands leads to higher nuclearity metallacycles [Cu(µOH)(µ-pz)]n (n = 6, 8, 9, 12, 14) (Scheme 1.5).
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of chloride ligand with cyanate, acetate, benzoate, and without an appropriate ligand, respectively.
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Trinuclear copper(II) pyrazolates have been applied as secondary building units (SBUs) to
obtain multicomponent metal-organic frameworks (MOFs),53,54,55,56,57 in which different metal
ions are organized into specific SBUs through one-pot synthesis.70
Li and co-workers synthesized multicomponent MOFs by combining 4-pyrazolecarboxylic
acid (H2PyC) as the only organic ligand, with Zn(II) and Cu(II) ions (Figure 1.24).57 The obtained
MOF (FDM-3; FDM = Fudan materials) has three geometrically and compositionally different
SBUs: triangular, octahedral and square pyramidal. These SBUs are arranged in a cubic symmetry
to form four different polyhedral cages (Figure 1.24).56 The metals in these SBUs have switchable
redox states (CuI/CuII) while maintaining the SBUs geometry, as monitored by X-ray diffraction
and X-ray photoelectron spectroscopy. Furthermore, the interchangeability of Cu(I) and Cu(II) in
these MOFs was studied by their catalytic performances in the decomposition process of H2O2.
(a)

(e)

(d)

(b)

(c)

Figure 1.24: Structures of SBUs in the MOF FDM-3. Trinuclear Cu(II) pyrazolate SBU Cu3(µ3OH)(PyC)3 (a), octahedral SBUs Zn4O(COO)3R3 (R = COO or NN) (b), square pyramidal SBUs
Zn4O(COO)4R (c), one unit cell of the MOF FDM-3 (d) and the topology of FDM-3 net is ott (e).
Color codes of d and e: triangular Cu(II) pyrazolate SBU is light brown; octahedral SBU is blue;
square-pyramidal SBU is orange. Reprinted with permission from reference 56. Copyright 2015
American Chemical Society.
In the anion-encapsulation field, Raptis, Mezei and co-workers have used copper(II)
pyrazolate motifs to prepare neutral anion-incarcerating agents that consist of three or four stacked
metallamacrocycles of the general formula [{cis-CuII(µ-OH)(µ-pz)}n] (n = 6, 8, 9, 12 and 14)
(Figure 1.25).58 X-ray crystallographic study of the obtained compounds, (PPN)[ClÌ{[Cu(µ25

OH)(µ-pz)]6+12}2] 10, (Bu4N)[ClÌ{[Cu(µ-OH)(µ-pz)]6+12}2] 11, (Bu4N)2[CO3Ì{Cu(µ-OH)(µpz)}6+12+9] 12 and (PPN)2[SO4Ì{Cu(µ-OH)(µ-pz)}8+14+9] 13 (Figure 1.26) showed encapsulated
anions inside the cavity of the supramolecular host. The supramolecular host-guest architectures
10 and 13 were obtained serendipitously in an attempt to remove chlorides from the complex
(PPN)[Cu3(µ3-O)(µ-pz)3Cl3] in a wet solvent. The transformation process of the triangular
trinuclear complex into the polymeric cis-rings occurs through ring-opening, oligomerization and
ring-closing of the Cu–pz backbone. A similar procedure using (Bu4N)[Cu3(µ3-O)(µ-pz)3Cl3]
yielded 12, whereas 11 was prepared by the reaction of Cu(OH)2 and pyrazole in the presence of
Bu4NCl.

Cu8

Cu6

6.6 Å

Cu9

8.8 Å

9.2 Å

Cu14

Cu12

12.7 Å

14.4 Å

Figure 1.25: Metallamacrocyclic rings [{cis-CuII(µ-OH)(µ-pz)}n] (n = 6, 8, 9, 12 and 14)
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The metallamacrocycles consist of distorted square-planar CuII-centers connected by µ-pyrazolate
groupsthat provide hydrophobicity at the outer-surface of the rings, whereas µ-OH groups pointing
to the center of the rings provide hydrophilicity for the cavity.

12

10 and 11

13

Figure 1.26: Ball and stick diagram of the assemblies [ClÌ{[Cu(µ-OH)(µ-pz)]6+12}2] 10 and 11,
[CO3Ì{Cu(µ-OH)(µ-pz)}6+12+9] 12 and [SO4Ì{Cu(µ-OH)(µ-pz)}8+14+9] 13. Reprinted from
reference 58. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
The pyrazolate and hydroxyl groups of the larger rings are either both in-plane with CuII-centers
or out-of-pane; in the former case, the in-plane pyrazolates point their trans-OH groups (in-plane)
to the center of the rings, while out-of-plane pyrazolates alternate in up and down orientation
relative to the mean plane of the copper centers and pointing their respective trans-OH groups to
the opposite sides. The larger rings act as hosts (O donors) for the smaller rings, which in turn
adopt a conical shape where the hydroxyl groups are oriented toward the center and the pyrazolates
are oriented in the opposite direction. Therefore, the hydroxyl groups and pyrazolates are
appropriately oriented to provide better interaction between the larger (12–14 membered) and
smaller (6–9 membered) rings via Cu····O interactions and H-bonding. In the case of 10 and 11,
two [{Cu(µ-OH)(µ-pz)}6+12] units sandwich a chloride anion by twelve H-bonds, six from each
[{Cu(µ-OH)(µ-pz)}6+12] unit, specifically from the 6 membered ring hydroxyl groups. The
aggregate is further supported by an additional 12 H-bonds between the two 12-membered rings
on each side of the sandwich (Scheme 1.6).
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Scheme 1.6: Schematic diagram showing the assembly of [ClÌ{[Cu(µ-OH)(µ-pz)]6+12}2] in 10 and
11. Reprinted from reference 58. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced
with permission.
In the case of 12, the carbonate ion is encapsulated between the [{Cu(µ-OH)(µ-pz)}6+12]
unit and a 9-membered ring, in which all the carbonate oxygens are in H-bonding distance to all
of the hydroxyl groups of the 9- and 6-membered rings. Additional H-bonding and Cu····O
interactions between rings provide robustness to the structure. The same pattern was observed in
the case of 13, in which the rings are connected to each other by H-bonding and Cu····O
interactions and hold the sulfate ion by H-bonding from the 8- and 9-membered rings.
Later, Mezei and co-workers (our group) have prepared the anion-encapsulating agents
“nanojars” directly from their original components by reacting CuSO4, pyrazole and KOH in 1:1:2
ratio, in the presence of (Bu4N)2SO4 to form (Bu4N)2[SO4Ì{Cu(µ-OH)(µ-pz)}6+12+10] and
(Bu4N)2[SO4Ì{Cu(µ-OH)(µ-pz)}8+14+9] nanojars, which have been demonstrated crystallographyically.71 The obtained nanojars revealed unprecedented binding strength toward sulfate anion. The
binding strength was tested by the vigorous stirring of a DCM solution of nanojars with saturated
aqueous Ba(OH)2 solution. After two weeks of stirring, no precipitation of BaSO4 was observed
and the electronic spectrum of the blue nanojars solution remained unchanged. Furthermore, they
have demonstrated the selectivity toward sulfate over nitrate and perchlorate even in the presence
of large excess of nitrate and perchlorate in the reaction mixture.
In another study, one or two phosphate or arsenate ions were incarcerated within nanojars,
capped nanojars and nanohelicages.72 The phosphate- and arsenate-incarcerating nanojars were
obtained by the reaction of Cu(OH)2 with pyrazole, Bu4NOH and H3PO4 or Na2HAsO4,
respectively. Isolation of individual nanojars (Bu4N)2[HXO42–Ì{CuII(µ-OH)(µ-pz)}31] (X = P or
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As), capped nanojar (Bu4N)[PO43–Ì{CuII30(µ-OH)27(µ3-OCH3)(µ-pz)30(CH3OH)2}] 15, and
helicages (Bu4N)2[(XO43–)2Ì{CuII15(µ3-OH)2(µ-OH)6(µ-pz)18}] (16, X=P; 17, X=As) (Figure
1.27), were attained by the selective dissolution and crystallization of the reaction products from
solvents of different polarities.

(a)

(c)

(e)
(b)

(d)

15

16
Cu

P

As

O

N

C

17

Figure 1.27: Schematic assembly of the capped nanojar 15 from the Cu6+12+9 nanojar and a cyclic
trinuclear unit (a), crystal structure of 15 (red: Cu9 ring; violet: Cu12 ring; light-blue: Cu6 ring; dark
grey: trinuclear ring ; light grey: methanol) (b), schematic assembly of helicage 16 from two cyclic
and three linear trinuclear units (only two are shown for clarity) (c), and crystal structure of 16 and
17 (only the left-handed M, L/L enantiomers are shown) (d and e, respectively). Reproduced from
reference 72 with permission from The Royal Society of Chemistry.
The nanojars (Bu4N)2[HPO42–Ì{CuII(µ-OH)(µ-pz)}31] and (Bu4N)2[HAsO42–Ì{CuII(µOH)(µ-pz)}31] were obtaind by diffusion of hexane vapors into toluene extracts of the product
mixtures. The HXO42– ions are incarcerated within the formed nanojars, which are comprised of
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an 8+14+9-membered [Cu(OH)(pz)]n ring combination (n = 8, 9, 14), with pseudo-mirror
symmetry. In both nanojars, the X–OH bonds point toward the 9-membered ring, while the other
three O-atoms point toward the 8-membered ring. The HXO42– anions are bound by a total of
thirteen hydrogen bonds: four hydrogen bonds between each O-atoms of HXO42– and the OH
groups of the 9-membered ring, and one hydrogen bond between the X–OH and the OH groups of
the 8-membered ring. The hydrogen atom of the HXO42– anion is not involved in the hydrogen
bonding, as no hydrogen bond acceptor is available within hydrogen bonding distance from the
X–OH.
In

addition, the capped

nanojar, (Bu4N)[PO43–Ì{CuII30(µ-OH)27(µ3-OCH3)(µ-pz)30

(CH3OH)2}] 15 was obtained when the solvent system used for crystal growing was changed to
more polar methanol/n-butyl acetate. The fully deprotonated PO43– ion was incarcerated within
Cu6+12+9 nanojar with pseudo-three-fold symmetry, similar to the carbonate-nanojars found
earlier,58 albeit with some modifications. The presence of an additional Cu3(µ3-OCH3)(µ-pz)3
trinuclear unit capping the 9-membered ring, which is found rotated at 180º relative to the 6+12
ring-combination found in (Bu4N)2[CO32–Ì{Cu(µ-OH)(µ-pz)}27]58 is the most significant
difference. As the Cu3(µ3-OCH3)(µ-pz)3 trinuclear unit binds, three OH groups of the 9-membered
ring are bent away from the 12-membered ring, creating two pockets that are occupied by two
methanol solvent molecules. Within the nanojar, the incarcerated PO43– ion is bound by a total of
twelve hydrogen bonds: three hydrogen bonds from the 6-membered ring and nine from the 9membered ring, as well as by weak Cu–O bonds (average 2.37(1) Å) formed between one of the
four O-atoms of PO43– and the three Cu-atoms of the trinuclear unit.
Furthermore, the unprecedented helicage structures, (Bu4N)2[(PO43–)2Ì{CuII15(µ3-OH)2(µOH)6(µ-pz)18}] 16 and (Bu4N)2[(AsO43–)2Ì{CuII15(µ3-OH)2(µ-OH)6(µ-pz)18}] 17 were obtained by
the vapor diffusion of hexane to a bromobenzene/nitrobenzene (1:1) solution of the phosphate or
arsenate containing products, respectively. These structures, comprised of three linear trinuclear
Cu3(µ3-OH)2(µ-pz)4 units bridging two cyclic trinuclear Cu3(µ3-OH)(µ-pz)3 units, incarcerate two
unusually closely spaced, head-to-head PO43– or AsO43– ions. These anions are bound by three
relatively short hydrogen bonds (average 2.672(8) Å in 16, 2.68(2) Å in 17) and by three typical
Cu–O bonds (average 1.945(5) Å in 16, 1.95(2) Å in 17) to the linear trinuclear units, and by three
weak Cu–O bonds to the cyclic trinuclear units (average 2.274(7) Å in 16, 2.25(2) Å in 17). As a
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result of binding PO43– or AsO43– ions, the pyrazolate moieties immediately coordinated to the
Cu3(µ3-OH)(µ-pz)3 units are tilted either in a clockwise (Δ) or a counter-clockwise (L) fashion.
When the two essentially parallel, cyclic trinuclear fragments are joined together, a twisted
arrangement of the three bridging linear trinuclear units results, and nanoscale chirality appears.
Within the racemic crystals of 16 and 17, the two axially chiral, p (Δ/ Δ) and M (L/L) enantiomers
are found segregated in alternating layers.
1.3

Synthesis methods of pyrazole derivatives
During the past few decades, pyrazole derivatives have attracted considerable attention, due

to their diverse pharmaceutical applications73 and agricultural use.74 Pyrazole derivatives are
commonly prepared by the two mostly applied pyrazole synthesis methods of Knorr75 and
Pechmann76. In Knorr pyrazole synthesis, a β-ketoaldehyde or the corresponding acetal/ketal,
prepared from ethyl or methyl formate and a ketone, is condensed with hydrazine to produce
pyrazole derivatives (Scheme 1.7a).73b,77 The Pechmann pyrazole synthesis consists of the 1,3dipolar cycloaddition of diazomethane to alkynes (Scheme 1.7b).78,79 3-Diazoalkenes
spontaneously undergo intramolecular 1,3-dipolar cycloaddition to yield 3(5)-alkylpyrazoles
(Scheme 1.7c).80 In addition, there are other common methods of synthesis of 3(5)-alkylpyrazoles,
such as the conversion of a ketone to a β-(dimethylamino)vinyl ketone using N,Ndimethylformamide dimethyl acetal (Scheme 1.7d),79 or by using acetylene (or its bistrimethylsilyl derivative) and an acyl chloride to obtain a β-chlorovinyl ketone (Scheme 1.7e),81
followed in both cases by reaction with hydrazine to afford 3(5)-alkylpyrazoles. 3(5)Alkylpyrazoles can be obtained from aldehydes via α,β-unsaturated tosylhydrazones (Scheme
1.7f).82 3(5)-Alkylpyrazoles can also be prepared via the reaction of hydrazine with iodo-83 or
methoxyenynes84 (Scheme 1.7g). Furthermore, oxidation of 2-pyrazolines, produced by the
reaction of enones or enals with hydrazine,79,85 afford the corresponding pyrazoles (Scheme
1.7h).79,86
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Scheme 1.7: Current procedures of synthesis of 3(5)-alkylpyrazoles.

1.4

Objectives and goals

The long-term goal of this project is to develop selective anion-binding and extraction agents,
capable of recognizing individual anions and of transferring them from aqueous media to an
immiscible organic solvent (preferably long-chain aliphatic solvents). The short-term goal is to
achieve selectivity among anions with comparable hydration energies, such as sulfate (SO42−, ∆Gh°
= –1064 kJ/mol) and carbonate (CO32−, ∆Gh° = –1324 kJ/mol) and to extract one of these anions
selectively in the presence of a large excess of the other anion, using nanojars as anion binding
and extraction agents.
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The specific objectives are:
1) Synthesize and characterize various pyrazole ligands, including tethered multi-pyrazole ligands
(with two, three and four connected pyrazole units). In particular, pyrazoles with aliphatic and
oligo(ethylene glycol) chains are targeted, which are expected to further expand the solubility of
nanojars, in aliphatic solvents (such as ISOPARTM, suitable for industrial scale extractions) and
water, respectively.
2) Prepare and characterize nanojars using the synthesized pyrazole ligands. Characterization
techniques include NMR and UV–vis spectroscopy, mass spectrometry, X-ray crystallography and
thermogravimetric analysis.
3) Study the mechanism of formation of nanojars, using pH titration, UV–vis spectroscopy and
mass spectrometry.
4) Study the extraction of sulfate (SO42–) and carbonate (CO32–) ions from aqueous media by
nanojars, and develop a method for selective extraction of these anions.
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CHAPTER 2

2

2.1

EXPERIMENTAL

General procedures and instrumentation

2.1.1 General procedures
Molecular sieves (3 Å) were dried by heating to 260 °C under a high vacuum for 12 hours.
THF was dried using sodium and benzophenone and distilled under N2 atmosphere. Ethanol was
dried over 3 Å molecular sieves for 5 days and stored under N2 atmosphere. Na2CO3 was dried at
250 °C for 7 days and was left to cool down in a vacuum desiccator over fresh Drierite. Ethyl
acetate was dried over 3 Å molecular sieves for 5 days. All other reagents and solvents are
commercially available and were used as received. Thin layer chromatography (TLC) was
performed on Sigma–Aldrich silica gel plates and viewed under UV light (256 nm and/or 354 nm
wavelengths) or an iodine bath. Column chromatography was performed using flash silica gel from
Dynamic Adsorbents and VWR.
1-aminopyrazole,87 pyrazole-3(5)-carbaldehyde, 88 pyrazole-4-carbaldehyde, 89 4-hydroxypyrazole,90 3-hydroxypyrazole,91 4-fluoropyrazole,92 4-chloropyrazole,93 4-bromopyrazole,93 4-iodopyrazole,94 4-nitropyrazole,95 4-formylpyrazole,89a 3-formylpyrazole,88 pyrazole-4-sulfonic acid,96 3,5-diethylpyrazole,97 3,5-di-tert-butylpyrazole,98 3,5-bis(trifluoromethyl)pyrazole,99 3,5diphenylpyrazole,100 4-phenylpyrazole,101 4-n-butylpyrazole,102 and 4-(3-hydroxypropyl)pyrazole103 were prepared according to published procedures.
Nanojars of the general formula [anion⊂{Cu(OH)(R-pz)}n]2–, where anion = CO32– or
SO42–, R stands for various pyrazole (pz) substituents and n = 26 – 34, were prepared by Dr. Gellert
Mezei.104,105,106,107,108
All of the X-ray crystallographyic characterizations and studies were done by Dr. Gellert Mezei.
Computational chemistry studies were done by Dr. Yirong Mo, Liangyu Guan, and Dr. Joel
Karty,109 and by Dr. Yirong Mo and Huaiyu Zhang.110
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2.1.2 General instrumentation
1

H NMR and 13C NMR spectra were recorded on a Jeol JNM-ECP400 instrument operating

at 400 MHz at temperatures varying from –60 to +150 °C using deuterated solvents. Vacuum was
measured with a McLeod gauge connected to a Schlenk line. Melting points were determined on
a MEL-TEMP II (Laboratory Devices, USA) apparatus. UV–vis spectra were obtained on a
Shimadzu UV-1650PC spectrophotometer. Mass spectra were recorded using a Waters Model
Synapse G1 HDMS instrument using LC–MS grade solvents. X-ray diffraction data were collected
on a Bruker SMART APEX II diffractometer using graphite-monochromated Mo-K𝛼 (𝜆= 0.71073
Å) radiation at 100 K. pH was measured with a Mettler Toledo S20 SevenEasy pH-meter,
calibrated with pH 4.01, 7.00, and 10.01 standard buffer solutions. Thermogravimetric analysis
was performed on a TA Instrument Model Q500 analyzer.
2.2

Synthesis

2.2.1 Synthesis of starting materials and ligands
2.2.1.1

Synthesis of 3(5)-alkylpyrazoles
The synthetic procedures of 3(5)-alkylpyrazoles (Table 2.1) were originally published in

RSC Adv. 2015, 5, 24081–24093,111 and are reproduced by permission of The Royal Society of
Chemistry. http://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra00837a#!divAbstract.
2.2.1.1.1

Synthesis of 1-(tetrahydropyran-2-yl)pyrazole

A heavy-wall glass pressure flask was charged with pyrazole (50.0 g, 73.4 mmol) and 3,4dihydro-2H-pyran (68.2 g, 81.1 mmol). The mixture was homogenized and then heated to 125 C
for 24 hours in an oven. After cooling to room temperature, the product was subjected to vacuum
to remove traces of excess DHP. Pure THP-protected pyrazole (as indicated by 1H and 13C NMR)
is obtained in quantitative yield (111 g) (Scheme 2.1). The product can be distilled at 64–65 °C
(0.08 mmHg), if further purification is desired. 1H NMR (400 MHz, CDCl3): δ 7.60 (d, 1H, 3J =
2.2 Hz, 5-H-pz), 7.55 (s, 1H, 3-H-pz), 6.29 (m, 1H, 4-H-pz), 5.38 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6
Hz, CH–THP), 4.02–4.07 (m, 1H, CH2O–THP), 3.65–3.73 (m, 1H, CH2O–THP), 1.97–2.19 (m,
3H, CH2–THP), 1.55–1.76 (m, 3H, CH2–THP) ppm. 1H NMR (400 MHz, DMSO- d6): δ 7.86 (d,
1H, 3J = 2.2 Hz, 5-H-pz), 7.48 (s, 1H, 3-H-pz), 6.30 (s, 1H, 4-H-pz), 5.39 (dd, 1H, 3J = 9.9 Hz, 3J
= 2.6 Hz, CH–THP), 3.88–3.95 (m, 1H, CH2O–THP), 3.57–3.67 (m, 1H, CH2O–THP), 2.03–2.14
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(m, 1H, CH2–THP), 1.85–1.97 (m, 2H, CH2–THP), 1.58–1.72 (m, 1H, CH2–THP), 1.48–1.58 (m,
2H, CH2–THP) ppm. 13C{1H} NMR (101 MHz, CDCl3): δ 139.7, 127.6, 106.1, 87.6, 67.9, 30.6,
25.0, 22.6 ppm.

DHP, 125 ºC

HN

N

100 %

N

N

O

Scheme 2.1: Green protection of pyrazole (DHP = 3,4-dihydo-2H-pyran).

2.2.1.1.2

General procedure for the preparation of 5-alkyl-1-(tetrahydropyran-2-yl)pyrazoles

Method A: 1-(tetrahydropyran-2-yl)pyrazole (5.000 g, 32.85 mmol) is dissolved in
anhydrous THF (50 mL) in a Schlenk flask under a dry N2 atmosphere. The solution is chilled to
−78 ºC by stirring for 15 minutes in a dry-ice/isopropanol bath. nBuLi (1.6 M in hexane, 21 mL,
32.85 mmol) is added dropwise from an N2-purged syringe. Stirring at −78 ºC is continued for
another 30 minutes, then the 1-iodo- or 1-bromoalkane (36.14 mmol; in the case of 1,6diiodohexane: 10.95 mmol) is added dropwise over 20 minutes. After stirring at −78 ºC for 3 hours,
the solution is left to warm up to room temperature and is quenched with water (1 mL). The
volatiles are removed on a Rotavap, 80 mL water is added to the residue and it is extracted with
ethyl acetate (or diethyl ether) (3 × 80 mL), followed by washing with a 10% aqueous sodium
thiosulfate solution (80 mL; only when 1-iodoalkane is used as starting material), brine (80 mL)
and drying with anhydrous MgSO4. After removing the volatiles on the Rotavap, the residual oil
is heated to ~75 °C (only when alkyl is C1–C6) under high vacuum (~0.15 mmHg) to remove traces
of the unreacted 1-(tetrahydropyran-2-yl)pyrazole and excess 1-haloalkane. Pure 5-alkyl-1(tetrahydropyran-2-yl)pyrazoles (by 1H and 13C NMR) are thus obtained (Scheme 2.2). When alkyl
is C1–C4, the products can be distilled in vacuum, if needed. When alkyl is C5 and longer,
distillation leads to isomerization and/or deprotection. In those cases, purification is accomplished
by column chromatography (see example for C16 below). 1,6-Bis(1-(tetrahydropyran-2-yl)pyrazol-5-yl)hexane is purified by recrystallization from ethyl acetate/hexane. The products are
colorless oils (C1–C9) or colorless crystalline solids (C10, C12, C16, 1,6-bis(1-(tetrahydropyran-236

yl)pyrazol-5-yl)hexane). For conversion calculations, distinct proton signals in the 1H NMR
spectrum are used: 3-H-pyrazole, 4-H-pyrazole or CH–THP signals for Method A, and R–CH2–X
(R = alkyl, X = I or Br) signals for Method B.
Method B: same as method A, except that 1-(tetrahydropyran-2-yl)pyrazole is used in 10%
excess instead of the iodoalkane.
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Scheme 2.2: Synthesis of 5-alkyl-1-(tetrahydropyran-2-yl)pyrazoles (R = primary alkyl group; X
= I or Br).

2.2.1.1.2.1

5-Methyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 71–72 °C (0.08 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.43 (d, 1H, 3J = 1.3 Hz, 3H-pz), 6.03 (d, 1H, 3J = 1.5 Hz, 4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.00–
4.05 (m, 1H, CH2O–THP), 3.61–3.68 (m, 1H, CH2O–THP), 2.42–2.52 (m, 1H, CH2–THP), 2.34
(s, 3H, CH3), 2.06–2.14 (m, 1H, CH2–THP), 1.92–2.00 (m, 1H, CH2– THP), 1.54–1.77 (m, 3H,
CH2–THP) ppm. 13C NMR (101 MHz, CDCl3): δ 139.1, 106.2, 84.5, 67.8, 29.4, 25.1, 22.9, 11.0
ppm. For 3- methyl-1-(tetrahydropyran-2-yl)pyrazole, only the 3-H-pz (7.47 ppm, d, 1H, 3J = 2.2
Hz) and 4-H-pz (6.06 ppm, d, 1H, 3J = 2.2 Hz) protons could be clearly distinguished from the
corresponding protons of the 5-methyl isomer in the 1H NMR spectrum (400 MHz, CDCl3) of the
isomer mixture obtained after heating the pure 5-methyl isomer to 125 °C in a pressure tube.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C9H14N2NaO 189.1004; found 189.0998.
2.2.1.1.2.2

5-Ethyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 90–91 °C (0.12 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.5 Hz, 3H-pz), 6.05 (d, 1H, 3J = 1.5 Hz, 4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.00–
4.05 (m, 1H, CH2O–THP), 3.60–3.66 (m, 1H, CH2O –THP), 2.62–2.78 (m, 2H, CH2CH3), 2.44–
2.54 (m, 1H, CH2–THP), 2.07–2.13 (m, 1H, CH2–THP), 1.91–1.98 (m, 1H, CH2–THP), 1.54–1.77
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(m, 3H, CH2–THP), 1.27 (t, 3H, 3J = 7.5 Hz, CH2CH3) ppm.

13

C NMR (101 MHz, CDCl3): δ

145.4, 139.1, 104.3, 84.3, 67.8, 29.5, 25.1, 23.0, 18.6, 12.8 ppm. HRMS (ESI-TOF) m/z: [M +
Na]+ calcd. for C10H16N2NaO 203.1160; found 203.1158.
2.2.1.1.2.3

5-n-Propyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 95–96 °C (0.20 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.8 Hz, 3H-pz), 6.04 (d, 1H, 3J = 1.6 Hz, 4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.00–
4.06 (m, 1H, CH2O–THP), 3.60–3.67 (m, 1H, CH2O–THP), 2.56–2.71 (m, 2H, CH2CH2CH3),
2.44–2.55 (m, 1H, CH2–THP), 2.07–2.14 (m, 1H, CH2–THP), 1.90– 1.97 (m, 1H, CH2–THP),
1.54–1.77 (m, 5H, CH2–THP and CH2CH2CH3), 1.00 (t, 3H, 3J = 7.3 Hz, (CH2)2CH3) ppm.
13

C NMR (101 MHz, CDCl3): δ 143.8, 139.1, 105.0, 84.2, 67.8, 29.6, 27.3, 25.1, 23.0, 22.0, 14.0

ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C11H18N2NaO 217.1317; found 217.1298.
2.2.1.1.2.4

5-n-Butyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 99–100 °C (0.10 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.4 Hz, 3H-pz), 6.04 (d, 1H, 3J = 1.8 Hz, 4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.00–
4.06 (m, 1H, CH2O–THP), 3.60–3.67 (m, 1H, CH2O–THP), 2.59–2.72 (m, 2H, CH2(CH2)2CH3),
2.44–2.55 (m, 1H, CH2–THP), 2.07–2.14 (m, 1H, CH2–THP), 1.90–1.97 (m, 1H, CH2–THP),
1.54–1.77 (m, 5H, CH2–THP and CH2CH2CH2CH3), 1.41 (m, 2H, (CH2)2CH2CH3), 0.94 (t, 3H, 3J
= 7.3 Hz, (CH2)3CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 144.0, 139.1, 104.9, 84.2, 67.8, 30.8,
29.6, 25.1, 25.0, 23.0, 22.5, 13.9 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C12H20N2NaO
231.1473; found 231.1474.
2.2.1.1.2.5

5-n-Pentyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 104–106 °C (0.10 mmHg) (isomerization occurs). Before distillation (after heating to
75 °C in vacuum, no isomerization): 1H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.5 Hz, 3H-pz), 6.04 (d, 1H, 3J = 0.7 Hz, 4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.00–
4.06 (m, 1H, CH2O–THP), 3.59–3.67 (m, 1H, CH2O–THP), 2.58–2.72 (m, 2H, CH2(CH2)3CH3),
2.44–2.55 (m, 1H, CH2–THP), 2.06–2.14 (m, 1H, CH2–THP), 1.90–1.97 (m, 1H, CH2–THP),
1.54–1.78 (m, 5H, CH2–THP and CH2CH2 (CH2)2CH3), 1.31–1.41 (m, 4H, (CH2)2(CH2)2CH3),
0.90 (t, 3H, 3J = 6.8 Hz, (CH2)4CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 144.1, 139.1, 104.9,
84.2, 67.9, 31.6, 29.6, 28.3, 25.3, 25.1, 23.0, 22.5, 14.1 ppm. For 3-n-pentyl-1-(tetrahydropyran38

2-yl)pyrazole, only the 3-H-pz (7.48 ppm, d, 1H, 3J = 2.2 Hz), 4-H-pz (6.08 ppm, d, 1H, 3J = 2.6
Hz) and CH–THP (5.30 ppm, dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz) protons could be clearly
distinguished from the corresponding protons of the 5-n-pentyl isomer in the 1H NMR spectrum
(400 MHz, CDCl3) of the isomer mixture obtained after distillation. HRMS (ESI-TOF) m/z: [M +
Na]+ calcd. for C13H22N2NaO 245.1630; found 245.1637.
2.2.1.1.2.6

5-i-Pentyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 78–79 °C (~0.005 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.5 Hz,
3-H-pz), 6.03 (d, 1H, 3J = 0.7 Hz, 4-H-pz), 5.24 (dd, 1H, 3J = 10.2 Hz, 3J = 2.6 Hz, CH–THP),
4.03 (m, 1H, CH2O–THP), 3.63 (m, 1H, CH2O –THP), 2.66 (m, 2H, CH2CH2CH(CH3)2), 2.50 (m,
1H, CH2–THP), 2.11 (m, 1H, CH2–THP), 1.94 (m, 1H, CH2–THP), 1.47–1.78 (m, 6H, CH2–THP
and CH2 CH2CH(CH3)2), 0.94 (d, 6H, 3J = 6.6 Hz, (CH2)2CH(CH3)2) ppm. 13C NMR (101 MHz,
CDCl3): δ 144.2, 139.2, 104.8, 84.2, 67.9, 37.7, 29.6, 27.8, 25.1, 23.2, 23.0, 22.5 ppm. HRMS
(ESI-TOF) m/z: [M + Na]+ calcd. for C13H22N2NaO 245.1630; found 245.1609.
2.2.1.1.2.7

5-n-Hexyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 121–123 °C (0.20 mmHg) (isomerization occurs). Before distillation: 1H NMR (400
MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.3 Hz, 3-H-pz), 6.04 (d, 1H, 3J = 1.5 Hz, 4-H-pz), 5.24 (dd, 1H,
3

J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.00–4.06 (m, 1H, CH2O–THP), 3.59–3.67 (m, 1H, CH2O –

THP), 2.58–2.72 (m, 2H, CH2(CH2)4CH3), 2.44–2.55 (m, 1H, CH2–THP), 2.06–2.14 (m, 1H, CH2–
THP), 1.90–1.97 (m, 1H, CH2–THP), 1.54–1.78 (m, 5H, CH2–THP and CH2CH2(CH2)3CH3),
1.26–1.42 (m, 6H, (CH2)2(CH2)3CH3), 0.89 (t, 3H, 3J = 7.2 Hz, (CH2)5CH3) ppm. 13C NMR (101
MHz, CDCl3): δ 144.1, 139.2, 104.9, 84.2, 67.9, 31.7, 29.6, 29.1, 28.6, 25.3, 25.1, 23.0, 22.7, 14.2
ppm. For the 3-n-hexyl-1-(tetrahydropyran-2-yl)- pyrazole, only the 3-H-pz (7.48 ppm, d, 1H, 3J
= 2.2 Hz), 4-H-pz (6.08 ppm, d, 1H, 3J = 2.2 Hz) and CH–THP (5.30 ppm, dd, 1H, 3J = 9.9 Hz, 3J
= 2.6 Hz) protons could be clearly distinguished from the corresponding protons of the 5-n-hexyl
isomer in the 1H NMR spectrum (400 MHz, CDCl3) of the isomer mixture obtained after
distillation. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C14H24N2NaO 259.1786; found 259.1786.
2.2.1.1.2.8

5-n-Heptyl-1-(tetrahydropyran-2-yl)pyrazole

B.p. 128–130 °C (0.15 mmHg) (isomerization occurs). Before distillation: 1H NMR (400
MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.5 Hz, 3-H-pz), 6.04 (d, 1H, 3J = 1.5 Hz, 4-H-pz), 5.24 (dd, 1H,
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3

J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.03 (m, 1H, CH2O–THP), 3.63 (m, 1H, CH2O–THP), 2.58–

2.72 (m, 2H, CH2(CH2)5CH3), 2.44–2.55 (m, 1H, CH2–THP), 2.06–2.14 (m, 1H, CH2–THP), 1.90–
1.97 (m, 1H, CH2–THP), 1.54–1.78 (m, 5H, CH2–THP and CH2CH2(CH2)4CH3), 1.23–1.43 (m,
8H, (CH2)2(CH2)4CH3), 0.88 (t, 3H, 3J = 6.8 Hz, (CH2)6CH3) ppm. 13C NMR (101 MHz, CDCl3):
δ 144.1, 139.1, 104.9, 84.2, 67.8, 31.8, 29.6, 29.4, 29.1, 28.7, 25.3, 25.1, 23.0, 22.7, 14.2 ppm.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C15H26N2NaO 273.1943; found 273.1924.
2.2.1.1.2.9
1

5-n-Octyl-1-(tetrahydropyran-2-yl)pyrazole

H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.8 Hz, 3-H-pz), 6.04 (d, 1H, 3J = 1.7 Hz,

4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.03 (m, 1H, CH2O–THP), 3.63 (m,
1H, CH2O –THP), 2.65 (m, 2H, CH2(CH2)6CH3), 2.50 (m, 1H, CH2–THP), 2.11 (m, 1H, CH2–
THP), 1.93 (m, 1H, CH2–THP), 1.54–1.78 (m, 5H, CH2–THP and CH2CH2(CH2)5CH3), 1.23–1.43
(m, 10H, (CH2)2(CH2)5CH3), 0.87 (t, 3H, 3J = 6.8 Hz, (CH2)7CH3) ppm.

13

C NMR (101 MHz,

CDCl3): δ 144.1, 139.2, 104.9, 84.2, 67.9, 31.9, 29.6, 29.4 (two overlapping peaks), 29.3, 28.7,
25.3, 25.1, 23.0, 22.8, 14.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C16H28N2NaO
287.2099; found 287.2084.
2.2.1.1.2.10
1

5-n-Nonyl-1-(tetrahydropyran-2-yl)pyrazole

H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.5 Hz, 3-H-pz), 6.04 (d, 1H, 3J = 1.8 Hz,

4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.03 (m, 1H, CH2O–THP), 3.63 (m,
1H, CH2O–THP), 2.65 (m, 2H, CH2(CH2)7CH3), 2.50 (m, 1H, CH2–THP), 2.11 (m, 1H, CH2–
THP), 1.93 (m, 1H, CH2–THP), 1.54–1.78 (m, 5H, CH2–THP and CH2CH2(CH2)6CH3), 1.20–1.42
(m, 12H, (CH2)2(CH2)6CH3), 0.87 (t, 3H, 3J = 6.8 Hz, (CH2)8CH3) ppm.

13

C NMR (101 MHz,

CDCl3): δ 144.1, 139.2, 104.9, 84.2, 67.9, 32.0, 29.8, 29.6, 29.47, 29.43, 29.39, 28.7, 25.3, 25.1,
23.0, 22.8, 14.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C17H30N2NaO 301.2256; found
301.2247.
2.2.1.1.2.11
1

5-n-Decyl-1-(tetrahydropyran-2-yl)pyrazole

H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 1.8 Hz, 3-H-pz), 6.04 (d, 1H, 3J = 1.5 Hz,

4-H-pz), 5.24 (dd, 1H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.03 (m, 1H, CH2O–THP), 3.63 (m,
1H, CH2O–THP), 2.65 (m, 2H, CH2(CH2)8CH3), 2.50 (m, 1H, CH2–THP), 2.11 (m, 1H, CH2–
THP), 1.93 (m, 1H, CH2–THP), 1.54–1.78 (m, 5H, CH2–THP and CH2CH2(CH2)7CH3), 1.23–1.43
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(m, 14H, (CH2)2(CH2)7CH3), 0.87 (t, 3H, 3J = 6.8 Hz, (CH2)9CH3) ppm.

13

C NMR (101 MHz,

CDCl3): δ 144.1, 139.2, 104.9, 84.2, 67.9, 32.0, 29.68, 29.63, 29.59, 29.47, 29.43 (two overlapping
peaks), 28.7, 25.3, 25.1, 23.0, 22.8, 14.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C18H32N2NaO 315.2412; found 315.2412.
2.2.1.1.2.12
1

5-n-Dodecyl-1-(tetrahydropyran-2-yl)pyrazole

H NMR (400 MHz, CDCl3): δ 7.45 (s, 1H, 3-H-pz), 6.04 (s, 1H, 4-H-pz), 5.24 (dd, 1H, 3J

= 9.9 Hz, 3J = 2.6 Hz, CH–THP), 4.03 (m, 1H, CH2O–THP), 3.63 (m, 1H, CH2O–THP), 2.65 (m,
2H, CH2(CH2)10CH3), 2.50 (m, 1H, CH2–THP), 2.10 (m, 1H, CH2–THP), 1.93 (m, 1H, CH2–THP),
1.54–1.78 (m, 5H, CH2–THP and CH2CH2(CH2)9CH3), 1.23–1.43 (m, 18H, (CH2)2(CH2)9CH3),
0.87 (t, 3H, 3J = 6.6 Hz, (CH2)11CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 144.1, 139.2, 104.9,
84.2, 67.9, 32.0, 29.4–29.9 (eight overlapping peaks), 28.7, 25.3, 25.1, 23.0, 22.8, 14.2 ppm.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C20H36N2NaO 343.2725; found 343.2724.
2.2.1.1.2.13

5-n-Hexadecyl-1-(tetrahydropyran-2-yl)pyrazole

M.p. 54 °C. Purification of the 5-alkyl isomer was carried out by column chromatography.
15.5 g of crude material was loaded onto 800 g silica gel (Dynamic Adsorbents, 32–63 m;
stationary phase width/height: ~9.5 × 26 cm) and was eluted with ~6 L hexane/ethyl acetate (6:1).
3.8 g 1-iodohexadecane was recovered as the first fraction, followed by 1.1 g of a mixture of 1iodohexadecane and 1-(tetrahydropyran-2-yl)pyrazole, and finally by 9.4 g pure 5-n-hexadecyl-1(tetrahydropyran-2-yl)- pyrazole. Rf = 0.25 (TLC). 1H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J
= 0.8 Hz, 3-H-pz), 6.04 (d, 1H, 3J = 0.8 Hz, 4-H-pz), 5.24 (dd, 1H, 3J = 10.1 Hz, 3J = 2.4 Hz, CH–
THP), 4.00–4.06 (m, 1H, CH2O–THP), 3.59–3.67 (m, 1H, CH2O–THP), 2.58–2.72 (m, 2H,
CH2(CH2)14CH3), 2.44–2.55 (m, 1H, CH2–THP), 2.07–2.14 (m, 1H, CH2–THP), 1.90–1.97 (m,
1H, CH2–THP), 1.54–1.78 (m, 5H, CH2–THP and CH2CH2(CH2)13CH3), 1.18–1.42 (m, 26H,
(CH2)2(CH2)13CH3), 0.87 (t, 3H, 3J = 6.8 Hz, (CH2)15CH3) ppm. 13C NMR (101 MHz, CDCl3): δ
144.1, 139.1, 104.9, 84.2, 67.9, 32.0, 29.8 (seven overlapping peaks), 29.64, 29.59, 29.47 (two
overlapping peaks), 29.43, 28.7, 25.3, 25.1, 23.0, 22.8, 14.2 ppm. HRMS (ESI-TOF) m/z: [M +
Na]+ calcd. for C24H44N2NaO 399.3351; found 399.3350.
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2.2.1.1.2.14

1,6-Bis(1-(tetrahydropyran-2-yl)pyrazol-5-yl)hexane

M.p. 70–71 C. 1H NMR (400 MHz, CDCl3): δ 7.45 (d, 2H, 3J = 1.4 Hz, 3-H-pz), 6.03 (d,
2H, 3J = 1.4 Hz, 4-H-pz), 5.23 (dd, 2H, 3J = 9.9 Hz, 3J = 2.6 Hz, CH–THP), 3.99–4.05 (m, 2H,
CH2O–THP), 3.58–3.66 (m, 2H, CH2O–THP), 2.59–2.73 (m, 4H, CH2(CH2)4CH2), 2.44–2.55 (m,
2H, CH2–THP), 2.06–2.14 (m, 2H, CH2–THP), 1.90–1.97 (m, 2H, CH2–THP), 1.54–1.77 (m, 10H,
CH2–THP and CH2CH2(CH2)2CH2CH2), 1.38–1.47 (m, 4H, (CH2)2(CH2)2(CH2)2) ppm. 13C NMR
(101 MHz, CDCl3): δ 143.8, 139.1, 104.9, 84.2, 67.8, 29.6, 29.1, 28.5, 25.2, 25.1, 23.0 ppm. HRMS
(ESI-TOF) m/z: [M + Na]+ calcd. for C22H34N4NaO2 409.2579; found 409.2579.
2.2.1.1.3

General procedure for the deprotection of 5-alkyl-1-(tetrahydropyran-2-yl)pyrazoles

5-Alkyl-1-(tetrahydropyran-2-yl)pyrazole (20 mmol) is dissolved in ethanol (200 mL) and
conc. HCl (10 mL) is added dropwise under stirring. After stirring at room temperature for 8 hours,
complete deprotection is indicated by the absence of 5-alkyl-1-(tetrahydropyran-2-yl)pyrazole
signals in the 1H NMR spectrum of the reaction mixture. The volatiles are removed on a Rotavap
at 35 ºC and the residual aqueous solution is neutralized with NaHCO3 to pH ~8, followed by
extraction with diethyl ether (3 × 100 mL) and drying of the combined organic layers with
anhydrous MgSO4. After removing the solvent and drying under high vacuum, pure 5alkylpyrazoles (by 1H and 13C NMR) are obtained (Scheme 2.3), that can be further purified by
vacuum distillation or recrystallization (solid products). In the case of 1,6-bis(1-(tetrahydropyran2-yl)pyrazol-5-yl)hexane, neutralization with NaHCO3 provides a white precipitate, which is
filtered, washed with brine, dried, dissolved in hot nitrobenzene, filtered, and, after removal of the
solvent, dried at 100 ºC under high vacuum. The products are colorless oils, with the exception of
the C16 derivative and 1,6-bis(pyrazol-5-yl)hexane, which are colorless crystalline solids.
R

aq. HCl
N

N

100%

R
HN

N

O

Scheme 2.3: Synthesis of 3(5)-alkylpyrazoles via deprotonation of 5-alkyl-1-(tetrahydropyran-2yl)pyrazoles.
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2.2.1.1.3.1

3(5)-Methylpyrazole

B.p. 58–59 ºC (0.16 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.48 (d, 1H, 3J = 1.8 Hz, 3H-pz), 6.07 (s, 1H, 3J = 1.5 Hz, 4-H-pz), 2.34 (s, 3H, CH3) ppm. 13C NMR (101 MHz, CDCl3): δ
143.2, 135.1, 104.5, 12.0 ppm.
2.2.1.1.3.2

3(5)-Ethylpyrazole

B.p. 74–75 ºC (0.70 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.50 (s, 1H, 3-H-pz), 6.09 (s,
1H, 4-H-pz), 2.72 (q, 2H, 3J = 7.7 Hz, CH2CH3), 1.28 (t, 3H, 3J = 7.7 Hz, CH2CH3) ppm. 13C NMR
(101 MHz, CDCl3): δ 149.4, 135.1, 103.0, 20.1, 13.7 ppm.
2.2.1.1.3.3

3(5)-n-Propylpyrazole

B.p. 72–73 ºC (0.12 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.49 (d, 1H, 3J = 2.2 Hz, 3H-pz), 6.08 (d, 1H, 3J = 1.8 Hz, 4-H-pz), 2.65 (t, 2H, 3J = 7.5 Hz, CH2CH2CH3), 1.68 (m, 2H,
CH2CH2CH3), 0.97 (t, 3H, 3J = 7.3 Hz, (CH2)2CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 147.7,
135.2, 103.6, 28.8, 22.8, 13.9 ppm.
2.2.1.1.3.4

3(5)-n-Butylpyrazole

B.p. 84–85 ºC (0.10 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.48 (d, 1H, 3J =1.8 Hz, 3-Hpz), 6.08 (d, 1H, 3J =1.6 Hz, 4-H-pz), 2.67 (t, 2H, 3J =7.9 Hz, CH2(CH2)2CH3), 1.64 (m, 2H,
CH2CH2CH2CH3), 1.38 (m, 2H, (CH2)2CH2CH3), 0.93 (t, 3H, 3J = 7.5 Hz, (CH2)3CH3) ppm. 13C
NMR (101 MHz, CDCl3): δ 147.8, 135.2, 103.4, 31.7, 26.5, 22.5, 13.9 ppm.
2.2.1.1.3.5

3(5)-n-Pentylpyrazole

B.p. 98–99 ºC (0.11 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.49 (d, 1H, 3J = 1.2 Hz, 3H-pz), 6.08 (d, 1H, 3J = 2.2 Hz, 4-H-pz), 2.66 (t, 2H, 3J = 7.7 Hz, CH2(CH2)3CH3), 1.65 (m, 2H,
CH2CH2(CH2)2CH3), 1.29–1.38 (m, 4H, (CH2)2(CH2)2CH3), 0.88 (m, 3H, (CH2)4CH3) ppm.

13

C

NMR (101 MHz, CDCl3): δ 148.2, 135.3, 103.5, 31.6, 29.2, 26.8, 22.5, 14.1 ppm.
2.2.1.1.3.6

3(5)-i-Pentylpyrazole

B.p. 66 ºC (~0.005 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.49 (d, 1H, 3J = 1.8 Hz, 3-Hpz), 6.08 (d, 1H, 3J = 1.8 Hz, 4-H-pz), 2.68 (t, 2H, 3J = 7.9 Hz, CH2CH2CH(CH3)2), 1.52–1.66 (m,
3H, CH2CH2CH(CH3)2), 0.92 (d, 6H, 3J = 6.6 Hz, (CH2)2CH(CH3)2) ppm. 13C NMR (101 MHz,
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CDCl3): δ 148.2, 135.2, 103.4, 38.5, 27.8, 24.7, 22.5 ppm. HRMS (ESI-TOF) m/z: [M – H]– calcd.
for C8H13N2 137.1079; found 137.1084.
2.2.1.1.3.7

3(5)-n-Hexylpyrazole

B.p. 126–127 ºC (0.20 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.48 (d, 1H, 3J = 1.5 Hz,
3-H-pz), 6.08 (d, 1H, 3J = 1.5 Hz, 4-H-pz), 2.66 (t, 2H, 3J = 7.9 Hz, CH2(CH2)4CH3), 1.65 (m, 2H,
CH2CH2(CH2)3CH3), 1.26–1.40 (m, 6H, (CH2)2(CH2)3CH3), 0.88 (t, 3H, 3J = 1.5 7.0 Hz,
(CH2)5CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 148.1, 135.5, 103.5, 31.7, 29.5, 29.1, 26.8, 22.7,
14.2 ppm.
2.2.1.1.3.8

3(5)-n-Heptylpyrazole

B.p. 112–119 ºC (0.10 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.48 (d, 1H, 3J = 1.8 Hz,
3-H-pz), 6.08 (d, 1H, 3J = 1.8 Hz, 4-H-pz), 2.66 (t, 2H, 3J = 7.7 Hz, CH2(CH2)5CH3), 1.65 (m, 2H,
CH2CH2(CH2)4CH3), 1.20–1.39 (m, 8H, (CH2)2(CH2)4CH3), 0.87 (t, 3H, 3J = 7.0 Hz, (CH2)6CH3)
ppm. 13C NMR (101 MHz, CDCl3): δ 148.0, 135.6, 103.4, 31.9, 29.5, 29.4, 29.2, 26.8, 22.7, 14.2
ppm.
2.2.1.1.3.9

3(5)-n-Octylpyrazole

B.p. 126–128 ºC (0.15 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.48 (d, 1H, 3J = 2.0 Hz,
3-H-pz), 6.08 (d, 1H, 3J = 2.0 Hz, 4-H-pz), 2.66 (t, 2H, 3J = 7.7 Hz, CH2(CH2)6CH3), 1.64 (m, 2H,
CH2CH2(CH2)5CH3), 1.20–1.40 (m, 10H, CH2CH2(CH2)5CH3), 0.87 (t, 3H, 3J = 7.0 Hz,
(CH2)7CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 148.0, 135.3, 103.4, 32.0, 29.54, 29.47, 29.43,
29.3, 26.8, 22.8, 14.2 ppm.
2.2.1.1.3.10

3(5)-n-Nonylpyrazole

B.p. 140–142 ºC (0.07 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.48 (d, 1H, 3J = 1.8 Hz,
3-H-pz), 6.08 (d, 1H, 3J = 1.8 Hz, 4-H-pz), 2.66 (t, 2H, 3J = 7.9 Hz, CH2(CH2)7CH3), 1.65 (m, 2H,
CH2CH2(CH2)6CH3), 1.20–1.40 (m, 12H, CH2CH2(CH2)6CH3), 0.87 (t, 3H, 3J = 7.0 Hz,
(CH2)8CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 148.1, 135.3, 103.4, 32.0, 29.6, 29.53, 29.50,
29.42, 29.40, 26.8, 22.8, 14.2 ppm.
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2.2.1.1.3.11

3(5)-n-Decylpyrazole

B.p. 131 ºC (~0.005 mmHg). 1H NMR (400 MHz, CDCl3): δ 7.48 (d, 1H, 3J = 1.8 Hz, 3H-pz), 6.08 (s, 1H, 3J = 1.8 Hz, 4-H-pz), 2.65 (t, 2H, 3J = 7.7 Hz, CH2(CH2)8CH3), 1.64 (m, 2H,
CH2CH2(CH2)7CH3), 1.23–1.37 (m, 14H, (CH2)2(CH2)7CH3), 0.87 (t, 3H, 3J = 6.8 Hz, (CH2)9CH3)
ppm.

13

C NMR (101 MHz, CDCl3): δ 148.1, 135.4, 103.5, 32.0, 29.69, 29.65, 29.5 (two

overlapping peaks), 29.4 (two overlapping peaks), 26.8, 22.8, 14.2 ppm.
2.2.1.1.3.12
1

3(5)-n-Dodecylpyrazole

H NMR (400 MHz, CDCl3): δ 7.49 (d, 1H, 3J = 1.8 Hz, 3-H-pz), 6.07 (s, 1H, 3J = 1.5 Hz,

4-H-pz), 2.68 (t, 2H, 3J = 7.9 Hz, CH2(CH2)10CH3), 1.66 (m, 2H, CH2CH2(CH2)9CH3), 1.18–1.38
(m, 18H, (CH2)2(CH2)13CH3), 0.87 (t, 3H, 3J = 6.8 Hz, (CH2)11CH3) ppm. 13C NMR (101 MHz,
CDCl3): δ 147.9, 135.2, 103.6, 32.0, 29.7–29.8 (three overlapping peaks), 29.6, 29.4–29.5 (four
overlapping peaks), 26.8, 22.8, 14.2 ppm.
2.2.1.1.3.13

3(5)-n-Hexadecylpyrazole

M.p. 46.5–47 ºC. 1H NMR (400 MHz, CDCl3): δ 7.48 (s, 1H, 3-H-pz), 6.08 (s, 1H, 4-Hpz), 2.65 (t, 2H, 3J = 7.7 Hz, CH2(CH2)14CH3), 1.64 (m, 2H, CH2CH2(CH2)13CH3), 1.18–1.38 (m,
26H, (CH2)2(CH2)9CH3), 0.87 (t, 3H, 3J = 6.8 Hz, (CH2)15CH3) ppm. 13C NMR (101 MHz, CDCl3):
δ 148.0, 135.3, 103.5, 32.0, 29.4–30.0 (twelve overlapping peaks), 26.8, 22.8, 14.2 ppm. HRMS
(ESI-TOF) m/z: [M – H]– calcd. for C19H35N2 291.2800; found 291.2780.
2.2.1.1.3.14

1,6-Bis(pyrazol-3(5)-yl)hexane

M.p. 87–88 ºC (for the hydrate: m.p. 68–69 ºC). 1H NMR (400 MHz, DMSO-d6): δ 7.46
(s, 2H, 3-H-pz), 6.02 (s, 2H, 4-H-pz), 2.55 (t, 4H, 3J = 7.7 Hz, CH2(CH2)4CH2), 1.56 (m, 4H,
CH2CH2(CH2)2CH2CH2), 1.30 (m, 4H, (CH2)2(CH2)2(CH2)2) ppm. 13C NMR (101 MHz, DMSOd6): δ 147.2, 134.8, 103.4, 29.5, 29.0, 26.5 ppm. HRMS (ESI-TOF) m/z: [M – H]– calcd. for
C12H17N4 217.1453; found 217.1470.
2.2.1.1.4

One-pot synthesis of 3(5)-alkylpyrazoles

Step 1. Pyrazole (10.000 g, 0.1469 mol) and 3,4-dihydro-2H-pyran (16.75 mL, 15.44 g,
0.1836 mol) are added to a 500 mL round-bottom pressure flask, which is sealed with a PTFE front
seal bushing. The pyrazole dissolves completely in the 3,4-dihydro-2H-pyran and provides a
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homogeneous solution. The flask is placed in an oven and kept at 125 ºC for 24 hours. After cooling
to room temperature, the excess unreacted 3,4-dihydro-2H-pyran is removed under vacuum.
Step 2. The flask containing pure 1-(tetrahydropyran-2-yl)pyrazole is evacuated and
purged with N2. Anhydrous THF (300 mL) is added via N2 purged syringe, and the solution is
chilled to −78 ºC under stirring for 30 minutes. nBuLi (1.6 M in hexanes, 92 mL, 0.15 mol) is
added dropwise over 90 minutes. After stirring for an additional 30 minutes at −78 ºC, 1haloalkane (Method A: 0.1616 mol; Method B: 0.1335 mol) is added via syringe. The solution is
stirred at −78 ºC for 3 hours, then is let to warm up to room temperature overnight. The THF
solvent and the excess haloalkane (method A) or excess 1-THP-pyrazole (Method B) are removed
under vacuum.
Step 3. Deprotection is accomplished by dissolving the 5-alkyl-1-(tetrahydropyran-2yl)pyrazoles in EtOH (300 mL) and stirring with 37% HCl (50 mL) for 4 hours. The solvent is
removed under vacuum at 35 ºC, the residue is neutralized with saturated aqueous NaHCO3
solution (to pH ~8) and is extracted with diethyl ether (5 × 100 mL). The combined organic
fractions are washed with brine (100 mL) and dried over anhydrous MgSO4. If 1-iodoalkane was
used in the second step, additional washing with a dilute aqueous sodium thiosulfate solution is
employed before drying with MgSO4, to remove iodine contamination. After filtration and
evaporation of the solvent, the product is dried in vacuum (for longer alkyl chains the drying is
carried out at 75 ºC, to remove any remaining traces of haloalkane). Pure 3(5)-alkylpyrazoles (by
1

H NMR) are thus obtained, which can be further purified by vacuum distillation. For 3(5)-

hexylpyrazole (obtained by Method A from 1-bromohexane), yield: 20.536 g (92%). For 3(5)decylpyrazole (obtained by method B from 1-bromodecane), yield: 27.675 g (91%).
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Table 2.1: Synthesis of 5-alkyl-1-(tetrahydropyran-2-yl)pyrazoles and 3(5)-alkylpyrazoles by
alkylation of THP-protected pyrazole. Conversion is based on the ratio of integrated 1H NMR
signals of the product and the residual limiting reactant (THP-protected pyrazole for method A;
haloalkane for method B) in the crude reaction mixture (a mixture of 5-alkyl and 3-alkyl isomers).
Reproduced with permission, from reference 111.

Protected pyrazole
Conver Isolated
-sion
yield
(%)
(%)

Pyrazole
Conver Isolated
-sion
yield
(%)
(%)

Entry

Halide reactant
(RX)
(Method)

1

Iodomethane (A)

100

99

100

94

2

Iodoethane (A)

3

Bromoethane (A)

99
96

89
90

100

97

4

1-Iodopropane (A)

95

90

100

99

5

1-Iodobutane (A)

96

95

100

92

6

1-Iodopentane (A)

94

88

100

89

7

1-Iodo-3methylbutane (A)

94

91

100

99

8

1-Iodohexane (A)

96

96

9

1-Bromohexane (A)

96

92

100

95

10

1-Iodoheptane (A)

96

91a

11

1-Iodoheptane (B)

100

98

100

98

12

1-Iodooctane (A)

96

89a

13

1-Iodooctane (B)

100

92

100

99
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Pyrazole

Table 2.1: Continued.

Halide reactant
(RX)
(Method)

Entry

Protected pyrazole
Conver Isolated
-sion
yield
(%)
(%)
95

92a

15

1-Iodononane (A)
1-Iodononane (B)

100

88

16

1-Bromodecane (A)

96

17

1-Iodododecane (A)

95

18

1-Iodododecane (B)
1-Iodohexadecane
(A)
1-Iodohexadecane
(B)

14

19
20
21

1,6-Diiodohexane
(B)

2.2.1.2

Pyrazole

Pyrazole
Conver Isolated
-sion
yield
(%)
(%)
100

99

91

100

94

100

99

100

not
isolated
92

84

76

100

99

82

not
isolated

100

80

100

84

Synthesis of 3,5-dialkylpyrazoles
The synthetic procedures of 3,5-dialkypyrazoles are reprinted with permission, from J.

Org. Chem. 2016, 81, 1718−1722.110 Copyright 2016 American Chemical Society.
2.2.1.2.1

Telescopic synthesis of 3(5)-butyl-5(3)-hexylpyrazole

The following steps are carried out in a 500 mL pressure flask (one pot) (Scheme 2.4). The
contents are protected from atmospheric moisture between steps by using an N2 blanket.
Step 1. Protection of 1H-Pyrazole. THP protection of 1H-pyrazole is accomplished
according to our green method previously described (see section 2.2.1.1.1) by heating 1.200 g
(17.62 mmol) of 1H-pyrazole and 2.00 mL (1.85 g, 22.0 mmol) of 3,4-dihydro-2H-pyran for 24 h
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at 125 °C. After removal of the slight excess of DHP in vacuum, 2.68 g (100%) of pure 1(tetrahydropyran-2-yl)pyrazole is obtained.
Step 2. Synthesis of 5-hexyl-1-(tetrahydropyran-2-yl)pyrazole. The flask containing the
THP-protected pyrazole is evacuated and purged with N2, and then anhydrous THF (40 mL) is
added via an N2-purged syringe. The solution is chilled to −78 °C and stirred for 30 min, and then
the nBuLi solution (1.6 M in hexanes, 11.0 mL, 17.6 mmol) is added dropwise over 10 min. After
the mixture is stirred at −78 °C for 30 min, 1-bromohexane (2.72 mL, 3.20 g, 19.3 mmol) is added,
and the solution is stirred at −78 °C for 90 minutes and then allowed to warm to room temperature
overnight under stirring. The flask is then connected to a vacuum (0.005 mmHg), and both the
excess bromohexane and unreacted 1-THP-pyrazole are removed by gently heating the flask in a
water bath at 55 °C. 1H NMR shows a 96% conversion.
Step 3. Isomerization to 3-hexyl-1-(tetrahydropyran-2-yl)pyrazole. To the 5-hexyl-1-THPpyrazole obtained from 1-bromohexane is added a solution of I2 (7.0 mg, 28 µmol) in DHP (2 mL)
under an N2 atmosphere. The flask is closed and set in an oven at 125 °C for 24 h. After the mixture
is cooled to room temperature, 1H NMR of the product shows an isomeric mixture of 85 mol % 3hexyl-1-THP- pyrazole and 15 mol % 5-hexyl-1-THP-pyrazole. In the absence of I2, it takes 8 days
to reach the 85/15 equilibrium mixture of isomers at 125 °C. If 5-hexyl-1-THP-pyrazole is
prepared using 1-iodohexane instead of 1-bromohexane, traces of residual iodine in the product
have the same catalytic effect.
Step 4. Synthesis of 5-butyl-3-hexyl-1-(tetrahydropyran-2-yl)pyrazole. The flask containing the mixture described above is evacuated and purged with N2. Anhydrous THF (70 mL) is
added, and the mixture is chilled to −78 °C for 30 min. nBuLi (1.6 M in hexanes, 10.0 mL, 16.0
mmol) is added dropwise over 10 min and stirred for 30 min, and then 1-bromobutane (1.90 mL,
2.42 g, 17.6 mmol) is added. After being stirred for 3 h at −78 °C, the solution is allowed to warm
to room temperature overnight under stirring. One milliliter of water is added, and the THF is
removed under vacuum. 1H NMR shows an 89% conversion of 3-hexyl-1-(tetrahydropyran-2yl)pyrazole to 5-butyl-3- hexyl-1-THP-pyrazole along with traces of unreacted 5-hexyl- and 3hexyl-1-THP-pyrazole.
Step 5. Deprotection to 3(5)-butyl-5(3)-hexylpyrazole. To the material obtained above are
added 200 mL of ethanol and 50 mL of HCl (37% in H2O). After the mixture is stirred for 8 h (1H
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NMR shows complete deprotection) the solvent is removed under vacuum. Five milliliters of water
is added to the residue, and the pH is adjusted to 8 with a saturated NaHCO3 solution. The mixture
is extracted with diethyl ether (3 × 80 mL), and the combined organic layers are dried over MgSO4
overnight. The solid material is filtered out, and the solvent is removed under vacuum to give crude
3(5)-butyl-5(3)-hexylpyrazole (3.760 g) as dark red-brown oil. 1H NMR shows a small amount of
3(5)-hexyl-1H-pyrazole impurity. If 1-iodobutane is used instead of 1-bromobutane in the previous
step, 3(5)-butyl-5(3)-hexyl-4-iodopyrazole byproduct is also identified by ESI-MS.
Step 6. Purification of 3(5)-butyl-5(3)-hexylpyrazole. The crude material is purified by
column chromatography using hexane:ethyl acetate (2:1) as eluent. The main product, 3(5)-butyl5(3)-hexylpyrazole, is obtained as a yellow oil (1.941 g, 53% overall yield based on 1H- pyrazole)
with Rf = 45%. If 1-iodobutane is used instead of 1- bromobutane in step 4, the yield of the product
drops to 46% (1.671 g), and 0.649 g of 3(5)-butyl-5(3)-hexyl-4-iodopyrazole is also isolated as a
byproduct.
1) BuLi/THF
DHP
HN

N

4 3
5
1 2

N

125 °C
100%

N

R

-78 °C

N

2) RX

O

R

I2

4 3
5
1 2

N

3 4 5
2 1

N

N

-78 °C

R

3 4 5
2 1

N

N

2) R′X
O

N

O

96%
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N

125 °C

85%

15%

R

3 4 5
2 1

R′
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100%

89%

O

R′

R
HN

N

O

Scheme 2.4: Telescoping synthesis of 3,5-dialkylpyrazoles from pyrazole (DHP = 3,4-dihydro2H-pyran; R = n-hexyl or n-heptyl; R′ = n-butyl), with % conversions (based on 1H NMR).

2.2.1.2.2

General method of preparation of 3,5-dialkyl-1-(tetrahydropyran-2-yl)pyrazoles

1-THP-pyrazole, 5-alkyl-1-THP- pyrazoles, and 3,5-dialkyl-1-THP-pyrazoles are prepared
as described above (steps 1–4). The protected 3,5-dialkylpyrazoles are extracted from the crude
residues obtained after quenching with water and removal of the THF (step 4), using 4 mL of water
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and three portions of 4 mL of diethyl ether (per millimole of substrate). The combined organic
layers are washed with 60 mL of brine and dried over MgSO4. After evaporation of the solvent,
the crude products are purified by column chromatography using dichloromethane:ethyl acetate
(4:1) as eluent and are obtained pure (by 1H NMR, 13C NMR, and ESI-MS) as yellow oils (Rf =
87% for 3(5)-R1-5(3)-R2pyrazole, where R1 = n-butyl and R2 = n-hexyl or n-heptyl).
2.2.1.2.2.1

5-Butyl-3-hexyl-1-(tetrahydropyran-2-yl)pyrazole

Yield: 1.515 g (61% based on 1H-pyrazole). 1H NMR (400 MHz, CDCl3): δ 5.84 (s, 1H,
4-H-pz), 5.14 (dd, 1H, 3J = 10.4 Hz, 3J = 2.4 Hz, CH−THP), 4.02−4.06 (m, 1H, CH2O−THP),
3.57−3.63 (m, 1H, CH2O −THP), 2.53−2.67 (m, 4H, CH2(CH2)4CH3 and CH2(CH2)2CH3),
2.41−2.52 (m, 1H, CH2−THP), 2.05−2.08 (m, 1H, CH2−THP), 1.84−1.91 (m, 1H, CH2−THP),
1.50−1.8 (m, 7H, CH2−THP, CH2CH2(CH2)3CH3 and CH2CH2CH2CH3), 1.20−1.44 (m, 8H,
(CH2)2(CH2)3CH3 and (CH2)2CH2CH3, 0.93 (t, 3H, 2J = 7.32 Hz (CH2)3CH3), 0.86 (t, 3H, 2J = 6.6
Hz (CH2)5CH3). 13C NMR (101 MHz, CDCl3): δ 153.2, 144.5, 103.6, 84.2, 68.1, 31.8, 30.8, 29.9,
29.8, 29.4, 28.6, 25.10, 25.06, 23.3, 22.7, 22.5, 14.2, 14.0. HRMS (ESI-TOF) m/z: [M + Na]+
calcd. for C18H32N2NaO 315.2412; found 315.2415.
2.2.1.2.2.2

5-Butyl-3-heptyl-1-(tetrahydropyran-2-yl)pyrazole

Yield: 3.137 g (62% based on 1H-pyrazole). 1H NMR (400 MHz, CDCl3): δ 5.84 (s, 1H,
4-H-pz), 5.14 (dd, 1H, 3J = 10.4 Hz, 3J = 2.4 Hz, CH−THP), 4.02−4.06 (m, 1H, CH2O−THP),
3.57−3.63 (m, 1H, CH2O−THP), 2.53−2.67 (m, 4H, CH2(CH2)5CH3 and CH2(CH2)2CH3),
2.41−2.51 (m, 1H, CH2−THP), 2.05−2.08 (m, 1H, CH2−THP), 1.85−1.89 (m, 1H, CH2−THP),
1.51−1.77 (m, 7H, CH2−THP, CH2CH2(CH2)4CH3 and CH2CH2CH2CH3), 1.21−1.44 (m, 10H,
(CH2)2(CH2)4CH3 and (CH2)2CH2CH3), 0.93 (t, 3H, 2J = 7.6 Hz (CH2)3CH3), 0.85 (t, 3H, 2J = 6.8
Hz, (CH2)5CH3). 13C NMR (101 MHz, CDCl3): δ 153.2, 144.5, 103.6, 84.2, 68.1, 31.9, 30.8, 29.9,
29.8, 29.7, 29.2, 28.6, 25.09, 25.06, 23.3, 22.7, 22.5, 14.2, 14.0. HRMS (ESI-TOF) m/z: [M + Na]+
calcd. for C19H34N2NaO 329.2568; found 329.2559.
2.2.1.2.3

Alternative general method of preparation of 3,5-dialkylpyrazoles

3,5-Dialkyl-1-(tetrahydropyran-2-yl)pyrazoles are deprotected as described above (step 5),
using 8 mL of ethanol and 2 mL of HCl (37% in H2O) per mmol of substrate for 8 h. After removal
of the solvent, addition of 0.4 mL of H2O, neutralization and extraction with 3 × 6 mL of diethyl
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ether (per millimole of substrate), followed by drying with MgSO4 and removal of the solvent in
high vacuum, pure products are obtained (based on 1H NMR, 13C NMR, and ESI-MS).
2.2.1.2.3.1

3(5)-Butyl-5(3)-hexylpyrazole

Yield: 1.061 g (99% based on 3(5)-butyl-5(3)-hexyl-1-THP-pyrazole). 1H NMR (400
MHz, CDCl3): δ 5.83 (s, 1H, 4-H-pz), 2.56−2.60 (m, 4H, CH2(CH2)4CH3 and CH2(CH2)2CH3),
1.56−1.65 (m, 4H, CH2CH2(CH2)3CH3 and CH2CH2CH2CH3), 1.26−1.41(m, 8H, (CH2)2(CH2)3CH3 and (CH2)2CH2CH3, 0.91 (t, 3H, 2J = 7.60 Hz, (CH2)3CH3, 0.86 (t, 3H, 2J = 6.8 Hz,
(CH2)5CH3. 13C NMR (101 MHz, CDCl3): δ 149.5, 102.1, 31.7, 31.6, 29.4, 29.1, 27.2, 26.8, 22.7,
22.5, 14.1, 13.9. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C13H25N2 209.2017; found 209.2023.
2.2.1.2.3.2

3(5)-Butyl-5(3)-heptylpyrazole

Yield: 2.133 g (94% based on 3(5)-butyl-5(3)-heptyl-1-THP-pyrazole). 1H NMR (400
MHz, CDCl3): δ 5.84 (s, 1H, 4-H-pz), 2.55−2.60 (m, 4H, CH2(CH2)5CH3 and CH2(CH2)2CH3),
1.56−1.65 (m, 4H, CH2CH2(CH2)3CH3

and CH2CH2CH2CH3), 1.26−1.42

(m, 10H,

(CH2)2(CH2)4CH3 and (CH2)2CH2CH3), 0.91 (t, 3H, 2J = 7.20 Hz, (CH2)3CH3), 0.86 (t, 3H, 2J =
6.8 Hz, (CH2)5CH3). 13C NMR (101 MHz, CDCl3): δ 149.4, 102.0, 31.9, 31.6, 29.5, 29.4, 29.2,
27.2, 26.9, 22.7, 22.5, 14.2, 13.9. HRMS (ESI-TOF) m/z: [M + H]+ calcd. for C14H27N2 223.2174;
found 223.2197.
2.2.1.2.4

Alternative method of preparation of 3(5)-hexyl-5(3)-methylpyrazole

The synthetic procedure of 3(5)-hexyl-5(3)-methylpyrazole is reprinted with permission,
from Org. Lett. 2014, 16, 4680−4683.109 Copyright 2014 American Chemical Society.
Step 1. 3(5)-methylpyrazole (14.02 g, 0.171 mole), 3,4-dihydro-2H-pyran (31 mL, 0.340
mole) and trifluoroacetic acid (0.08 mL, 0.001 mole) were mixed and refluxed for 6 hrs., followed
by addition of NaH (0.323 g, 0.013 mol). The protected pyrazole 26.58 g (94%) as a ~2:1 mixture
of 1-THP-3-methylpyrazole and 1-THP-5-methylpyrazole was obtained via distillation under
reduced pressure (Scheme 2.5). 1H NMR (400 MHz, CDCl3): δ 7.47 (d, 1H, 3J = 2.2 Hz), 7.43 (d,
1H, 3J = 1.5 Hz), 6.06 (d, 1H, 3J = 2.2 Hz), 6.03 (d, 1H, 3J = 0.7 Hz), 5.27 (dd, 1H, 3J = 2.2, 3J =
10.2), 5.25 (dd, 1H, 3J = 2.6, 3J = 9.5), 4.10−4.03 (1H, m), 4.06−3.99 (1H, m), 3.71−3.63 (1H, m),
3.68−3.60 (1H, m), 2.52−2.41 (1H, m), 2.34 (3H, s), 2.28 (3H, s), 2.17−1.97 (5H, m), 1.74−1.54
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(6H, m) ppm. 13C NMR (101 MHz, CDCl3): δ 149.2, 139.1, 128.4, 106.2, 105.9, 87.5, 84.5, 68.1,
67.8, 30.5, 29.4, 25.1, 25.0, 22.93, 22.89, 13.7, 11.0 ppm.
Step 2. nBuLi (1.6 M in hexane; 19.0 mL, 0.030 mole) was added dropwise to the protected
pyrazole (5.000 g, 0.030 mole) in dry THF (50 mL) under an N2 atmosphere at −78 ºC. After
stirring for 30 min., 1-iodohexane (5.55 mL, 0.0376 mole) was added dropwise. Stirring was
continued at −78 ºC for 3 hrs., and then at room temperature overnight. After quenching with water
(1 mL) and removal of the solvent, the residue was dissolved in ethyl acetate (160 mL), washed
with water (3 × 80 mL) and brine (3 × 80 mL), and dried with MgSO4. The oily residue obtained
after evaporation of the solvent was dissolved in ethanol (200 mL) and was stirred with conc. HCl
(20 mL) overnight. After neutralization with NaHCO3 to pH ~8, the EtOH was evaporated and the
mixture was extracted with diethyl ether (3 × 100 mL). The combined organic layers were dried
over MgSO4, filtered and evaporated. 3(5)-hexyl-5(3)-methylpyrazole as a colorless oil (3.10 g,
93% yield based on 1-THP- 3-methylpyrazole was obtained via vacuum distillation (0.12 mmHg,
b.p. 112−119 ºC) (Scheme 2.5); 1-THP-5-methylpyrazole is not reactive and was recovered by
distillation, b.p. 70−72 ºC at 0.12 mmHg). 1H NMR (400 MHz, CDCl3): δ 5.83 (s, 1H, 4-H-pz),
2.58 (t, 2H, 3J = 7.7 Hz, CH2), 2.26 (s, 3H, CH3), 1.61 (m, 2H, CH2), 1.38−1.23 (m, 6H, CH2),
0.87 (t, 3H, 3J = 6.7 Hz, CH2CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 149.2, 144.8, 103.1, 31.7,
29.5, 29.1, 27.0, 22.7, 14.2, 12.5 ppm.
CH3
HN

N

CH3

DHP
N

TFA

N

1) BuLi, -78 °C

n-C6H13
N

2) n-C6H13I

O
Step 1

CH3
N

aq. HCl

n-C6H13

CH3
HN

N

O
Step 2

Scheme 2.5: Synthesis of 3(5)-hexyl-5(3)-methylpyrazole (DHP = 3,4-dihydo-2H-pyran; TFA =
trifluoroacetic acid).
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2.2.1.3

Synthesis of 4-n-octylpyrazole, OEG-pyrazoles, 4-ethoxypyrazole and 3,5-dimethyl-4octylpyrazole
The synthetic procedures of 4-n-octylpyrazole, OEG-pyrazoles, 4-ethoxypyrazole and 3,5-

dimethyl-4-octylpyrazole were originally published in Dalton Trans. 2016, 45, 8327−8339,104 and
are reproduced by permission of The Royal Society of Chemistry.
http://pubs.rsc.org/en/content/articlelanding/2016/dt/c6dt00847j#!divAbstract.
2.2.1.3.1

Synthesis of decanal diethyl acetal

Decanal (47.1 mL, 39.1 g, 250 mmol), triethylorthoformate (41.6 mL, 37.1 g, 250 mmol)
and p-toluenesulfonic acid monohydrate (476 mg, 2.50 mmol) are dissolved in 250 mL absolute
ethanol. After standing for 1 hour at room temperature, 1H NMR indicates that the reaction is
practically complete. The solution is left to stand overnight, then it is poured into 500 mL of
saturated sodium bicarbonate solution (∼96 g NaHCO3/L H2O at 20 °C), and is extracted with
ethyl acetate (5 × 100 mL). The combined organic extracts are dried overnight with anhydrous
Na2SO4, followed by evaporation of the solvent and drying under high vacuum to yield 56.4 g
(98%) of decanal diethyl acetal (Scheme 2.6). 1H NMR (400 MHz, CDCl3): δ 4.46 (t,1H, 3J =
6Hz), 3.62 (dq, 2H, 3J = 7Hz), 3.47 (dq, 2H, 3J = 7 Hz), 1.58 (m, 2H), 1.25 (m, 14H), 1.19 (t, 6H,
(t, 3H, 3J = 7 Hz) ppm. 3 J = 7 Hz), 0.86 (t, 3H, 3J = 7 Hz) ppm.
2.2.1.3.2

General method of preparation for 7-ethoxy- 2,5,8-trioxadecane, 10-ethoxy-2,5,8,11tetraoxatridecane and 13-ethoxy-2,5,8,11,14-pentaoxahexadecane

NaH (60% dispersion in mineral oil, 4.000 g, 100 mmol) is placed in a 250 mL three-neck,
round-bottom flask, which is connected to a Schlenk line. A condenser is attached, the third neck
is sealed with a rubber septum, and the system is evacuated and purged with nitrogen three times.
The mineral oil is washed away from the sodium hydride by rinsing with anhydrous hexane. The
hexane (50 mL) is introduced with an N2-purged syringe, and the mixture is stirred for 3 minutes.
After the NaH has settled, the supernatant is removed with a syringe, and the procedure is repeated
three more times. The residue is then dried thoroughly by applying high vacuum. Neat
bromoacetaldehyde diethyl acetal (100 mL, 131 g, 0.664 mol) is added by syringe under stirring,
followed by the dropwise addition of the oligo(ethylene glycol) monomethyl ether,
CH3(OCH2CH2)zOH (50.00 mmole; z = 1, 3.950 mL, 3.8045 g; z = 2, 5.800 mL, 6.007 g; z = 3,
8.000 mL, 8.210 g). The reaction is exothermic and is accompanied by a color change from light
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grey to brown. After heating to 100 °C for 48 hours under stirring, the reaction mixture is left to
cool down to room temperature. Water (20 mL) is added to quench the unreacted NaH, and the
excess bromoacetaldehyde diethyl acetal is distilled off under high vacuum at ∼30 °C. The dark
brown viscous residue is taken up into dichloromethane (200 mL) and is washed with water (40
mL) twice, followed by drying the organic layer with MgSO4 overnight. After filtration, the solvent
is removed under vacuum at ∼30 °C and the product is obtained as red-brown viscous oil in close
to quantitative yield (Scheme 2.6). Although the product is of sufficient purity to be used in the
next step, vacuum distillation can be employed if further purification is needed.
2.2.1.3.2.1

7-Ethoxy-2,5,8-trioxadecane

Obtained as colorless oil after distillation (b.p. 47–49 °C at 0.005 mmHg). 1H NMR (400
MHz, CDCl3): δ 4.63 (t, 1H, 3J = 5 Hz, CH(OCH2CH3)2), 3.65–3.68 (m, 4H, OCH2CH3), 3.52–
3.59 (m, 6H, OCH2CH2 and OCH2CH), 3.36 (s, 3H, OCH3), 1.20 (t, 6H, OCH2CH3) ppm.

13

C

NMR (101 MHz, CDCl3): δ 101.3, 72.03, 70.9, 70.96, 62.4, 59.1 ppm. HRMS (ESI-TOF) m/z: [M
+ Na]+ calcd. for C9H20NaO4 215.1259; found 215.1254.
2.2.1.3.2.2

10-Ethoxy-2,5,8,11-tetraoxatridecane

Obtained as colorless oil after distillation (b.p. 72–73 °C at 0.005 mmHg). 1H NMR (400
MHz, CDCl3): δ 4.67 (t, 1H, CH(OCH2CH3)2), 3.50–3.79 (m, 14H, OCH2 and OCH2CH3), 3.35
(s, 3H, OCH3), 1.19 (t, 3H, CH2CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 101.4, 72.0, 71.7, 70.9,
70.7, 70.6, 65.7, 62.5, 59.2, 15.4 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C11H24NaO5
259.1521; found 259.1514.
2.2.1.3.2.3

13-Ethoxy-2,5,8,11,14-pentaoxahexadecane

Obtained as brown viscous oil. 1H NMR (400 MHz, CDCl3): δ 4.62 (t, 1H, 3J = 6 Hz,
CH(OCH2CH3)2), 3.62–3.66 (m, 12H, CH2CH3 and OCH2CH2), 3.51–3.59 (m, 6H, OCH2CH2),
3.36 (s, 3H, OCH3), 1.20 (t, 6H, CH2CH3) ppm. 13C NMR (101 MHz, CDCl3): δ 101.3, 72.012,
71.967, 70.965, 70.705, 70.667, 70.664, 70.613, 62.4, 59.1 ppm.
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2.2.1.3.3

General method of preparation for 3-R-2-octyl-prop-2-enal, 3-R-2-(2-methoxyethoxy)-prop-2-enal, 3-R-2-(2-(2-methoxyethoxy)ethoxy)-prop-2-enal and 3-R-2(2(2-(2-methoxyethoxy)ethoxy)ethoxy)-prop-2-enal (R = NMe2 and OEt)

POCl3 (6.38 ml, 10.5 g, 68.4 mmol) is added to a 100 mL Schlenk-flask equipped with a
pressure-equalizing addition funnel, sealed with a rubber septum. The system is evacuated and
purged with nitrogen a few times while cooling in an ice bath. DMF (5.86 ml, 5.53 g, 75.7 mmol)
is injected into the addition funnel via N2-purged syringe, and is added dropwise to POCl3 under
stirring. Decanal diethyl acetal (7.26 g, 31.5 mmol) or CH3(OCH2CH2)zOCH2CH(OEt)2 (31.5
mmol; z = 1, 6.05 g; z = 2, 7.43 g; z = 3, 8.82 g) is added via syringe to the colorless crystalline
Vilsmeier reagent obtained. The ice bath is replaced with a water bath and the reaction mixture is
allowed to warm up to room temperature. The color of the reaction slowly turns yellow. The
temperature of the water bath is raised to 70 – 75 °C, causing the color to quickly turn dark orange
and then dark red. A vigorous reaction ensues, accompanied by a large increase in pressure
(relieved through the Schlenk line’s oil bubbler). The reaction mixture is kept at the same
temperature for 2 hours, then the dark brown-red, viscous solution is poured into 50 g crushed ice
and is left to stand overnight. Next day, the mixture is extracted with CH2Cl2 (2 × 25 mL), followed
by Et2O (25 mL). The aqueous phase is neutralized with solid K2CO3 (20 g), which is added in
small portions, under stirring, until pH ≈ 8. The orange-red solution is extracted again with CH2Cl2
(5 × 25 mL) and Et2O (2 × 20 mL). The combined organic extracts are dried overnight with
anhydrous MgSO4. After filtration, the solvent is evaporated under vacuum and DMF is distilled
off in vacuum on a water bath at 80 °C. The resulting dark red-brown oil consists of a mixture of
3-(dimethylamino)-2-n-octyl-prop-2-enal and 3-ethoxy-2-n-octyl-prop-2-enal in the case of
CH3(CH2)8CH(OEt)2, and OEG-substituted dimethylamino and ethoxy-propenal, as well as
smaller amounts of EtO-substituted dimethylamino- and ethoxy-propenal in the case of
CH3(OCH2CH2)zOCH2CH(OEt)2 (Scheme 2.6). These mixtures are used without separation in the
next step.
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2.2.1.3.4

General method of preparation for 4-octylpyrazole, 4-(2-methoxyethoxy)pyrazole,
4-(2-(2-methoxyethoxy)ethoxy)pyrazole and 4-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)pyrazole

The mixtures obtained above are dissolved in methanol (60 mL), hydrazine monohydrate
(1.95 ml, 1.98 g, 39.5 mmol) is added and the mixture is refluxed for 2 hours. After cooling to
room temperature, the solvent is removed under vacuum. The dark red-brown oil is subjected to
purification by vacuum distillation or column chromatography (Scheme 2.6).
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Scheme 2.6: Synthesis of 4-n-octylpyrazole and OEG-pyrazole ligands.

2.2.1.3.4.1

4-Octylpyrazole

Vacuum distillation using a Vigreux column provides pure 4-octylpyrazole as a colorless
liquid (b.p. 143 °C at ~0.1 mmHg), which solidifies on cooling. Yield: 4.21 g (75% based on
decanal). 1H NMR (400 MHz, CDCl3): δ 12.07 (s, br, 1H), 7.40 (s, 2H), 2.49 (t, 2H, 3J = 8 Hz),
1.56 (m, 2H), 1.30 (m, 10H), 0.90 (t, 3H, 3J = 7 Hz) ppm. 13C NMR (101 MHz, CDCl3): δ 132.5,
121.2, 32.0, 31.2, 29.6, 29.4, 24.2, 22.8, 14.2 ppm.
2.2.1.3.4.2

4-(2-Methoxyethoxy)pyrazole

Purified by column chromatography on silica gel (300 g) using neat ethyl acetate as eluent
(Rf = 0.49). The product (1.52 g) is obtained as an orange oil in 34% overall yield (based on
ethylene glycol monomethyl ether). 1H NMR (400 MHz, CDCl3): δ 7.29 (s, 2H, 3,5-H-pz), 4.01–
4.03 (m, 2H, OCH2), 3.67–3.70 (m, 2H, OCH2), 3.42 (s, 3H, OCH3) ppm. 13C NMR (101 MHz,
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CDCl3): δ 145.5, 121.1, 71.1, 59.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C6H10N2NaO2 165.0640; found 165.0643.
2.2.1.3.4.3

4-(2-(2-Methoxyethoxy)ethoxy)pyrazole

Purified by column chromatography on silica gel (300 g) using neat ethyl acetate as eluent
(Rf = 0.35). The product (1.50 g) is obtained as an orange-red oil in 26% overall yield (based on
diethylene glycol monomethyl ether). 1H NMR (400 MHz, CDCl3): δ 7.28 (s, 2H, 3,5-H-pz), 4.02
(t, 2H, OCH2, 3J = 4 Hz), 3.78 (t, 2H, OCH2, 3J = 4 Hz), 3.68 (t, 2H, OCH2, 3J = 4 Hz), 3.56 (t,
2H, OCH2, 3J = 4 Hz), 3.37 (s, 3H, OCH3) ppm. 13C NMR (101 MHz, CDCl3): δ 145.5, 120.9,
71.9, 71.2, 70.7, 69.9, 59.1 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C8H14N2NaO3
209.09021; found 209.0902.
2.2.1.3.4.4

4-(2-(2-(2-Methoxyethoxy)ethoxy)ethoxy)pyrazole

Purified by column chromatography on silica gel (300 g) using an eluent gradient as
follows: 95:5 EtOAc:hexanes first, neat EtOAc second, 95:5 EtOAc:MeOH third, and 90:10
EtOAc:MeOH last. The product (1.44 g) is obtained as an orange- yellow oil in 20% overall yield
(based on triethylene glycol monomethyl ether). 1H NMR (400 MHz, CDCl3): δ 7.28 (s, 2H, 3(5)H-pz), 4.00–4.02 (m, 2H, OCH2), 3.76–3.79 (m, 2H, OCH2), 3.62–3.71 (m, 6H, CH2OCH2CH2),
3.53–3.55 (m, 2H, OCH2), 3.36 (s, 3H, OCH3). 13C NMR (100 MHz, CDCl3): δ 145.5, 121.0, 71.9,
71.3, 70.7, 70.6, 70.5, 69.9, 59.1 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H18N2NaO4
253.1164; found 253.1173.
2.2.1.3.4.5

4-Ethoxypyrazole

Obtained as a side-product during the column chromatography of the mono-, di- and
triethyleneglycol methyl ether substituted pyrazoles described above, in 5:8, 5:10 and 5:7 molar
ratios, respectively (4-EtOpyrazole:4-OEGpyrazole). 1H NMR (400 MHz, CDCl3): δ 7.28 (s, 2H,
3,5-H-pz), 3.94 (q, 2H, 3J = 7 Hz, CH2CH3), 1.37 (t, 3H, 3J = 7 Hz, CH2CH3). 13C NMR NMR
(101 MHz, CDCl3): δ 145.6, 120.8, 67.5, 15.0 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C5H9N2O 113.0715; found 113.0695.

58

2.2.1.3.5

Synthesis of 3,5-dimethyl-4-octylpyrazole

Step 1. Synthesis of 3-(n-octyl)pentane-2,4-dione. A mixture of acetylacetone (30.0 ml,
29.2 g, 0.292 mol) and 1-iodooctane (53.0 ml, 70.5 g, 0.293 mol) is added dropwise to a stirred
suspension of anhydrous K2CO3 (50.0 g, 0.362 mol) in 50 mL acetonitrile. The reaction mixture
is refluxed overnight with stirring. After cooling to room temperature, the solid is filtered off and
washed with acetone. The organic solvents are evaporated on a rotavap, water is added to the
residue and it is extracted with diethyl ether. After evaporation of the ether, the residue (60.7 g) is
fractionally distilled under vacuum (0.15–0.20 mmHg) using a Vigreux column, and the fraction
distilling at 104 °C (43.5 g) is redistilled. The fraction distilling at 117 °C (41.0 g, yield: ~66%) is
found to be a mixture of the keto and enol forms of 3-(n-octyl)-pentane-2,4-dione, with a small
amount of O-alkylated enol. This mixture is used in the next step without further purification.
Step 2. Hydrazine hydrate (N2H4 50–60% in H2O, 12.414 g) is added dropwise to a solution
of 3-(n-octyl)pentane-2,4-dione (38.851 g) in 150 mL EtOH with stirring. The mixture is refluxed
for 14 hours and the solvent is evaporated on a rotavap. The residue (38.664 g) is fractionally
distilled under vacuum, using a vigreux column. The fraction distilling at 155–160 °C (32.721 g)
is redistilled, yielding 32.125 g (56% based on acetylacetone) of pure 3,5-dimethyl-4-noctylpyrazole boiling at 160 °C (Scheme 2.7). 1H NMR (400 MHz, CDCl3): 2.31 (t, 2H, 3J = 8
Hz), 2.19 (s, 6H), 1.41 (m, 2H), 1.27 (m, 10H), 0.87 (t, 3H, 3J = 7 Hz) ppm. 13C NMR (101 MHz,
CDCl3): 142.0, 115.8, 32.0, 30.8, 29.6, 29.5, 29.4, 23.1, 22.8, 14.2, 11.0.
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Scheme 2.7: Synthesis of 3,5-dimethyl-4-octylpyrazole
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2.2.1.4

Synthesis of 1,2-bis(1H-pyrazole-3-yl)ethane
The synthetic procedures of 1,2-bis(1H-pyrazole-3-yl)ethane were originally published in

Chem. Commun. 2017, 53, 1029−1032,108 and are reproduced by permission of The Royal Society
of Chemistry. http://pubs.rsc.org/en/content/articlelanding/2017/cc/c6cc09197k#!divAbstract.
Method A: Step 1. Synthesis of diethyl 2,4,7,9-tetraoxodecanedione. Sodium metal (small
pieces, 11.500 g, 500 mmol) is placed into a 1000 ml three-necked round bottom flask equipped
with a stir-bar, condenser and addition funnel, and connected to a Schlenk line. After evacuation
and purging with N2, the flask is placed into an ice bath and anhydrous diethyl ether (500 ml) is
added by syringe. A mixture of diethyl oxalate (73.000 g, 500 mmol) and 2,5-hexanedione (28.500
g, 250 mmol) is slowly added under stirring, and the dark brown suspension is further stirred for
2 hours at 0 ºC. After warming up to room temperature overnight under an N2 atmosphere, the
reaction mixture is refluxed for 1 hour. The brown suspension is filtered out, washed with diethyl
ether, and dried under high vacuum. The solid is then dissolved in deionized water (2 L) and
acidified to pH ~ 3 with a 10% aqueous solution of H2SO4 (200 mL). A light yellowish-brown
precipitate forms, which is filtered out and dried under high vacuum (22.310 g). Recrystallization
from hot ethanol affords 14.593 g (19%) of diethyl 2,4,7,9-tetraoxodecanedione, as shiny,
brownish plates (Scheme 2.8). NMR in CDCl3 shows the pure enolic form. 1H NMR (400 MHz,
CDCl3): δ 6.43 (s, 2H, COCHCOH), 4.34 (q, 4H, 3J = 7.2 Hz, CH3CH2), 2.91 (s, 4H,
COCH2CH2CO), 1.36 (t, 6H, 3J = 7.1 Hz, CH3CH2) ppm. 13C NMR (101 MHz, CDCl3): δ 202.5,
163.4, 162.0, 102.5, 62.7, 35.3, 14.1 ppm.
Step 2. Synthesis of 1,2-bis(5-carboethoxy-1H-pyrazole-3-yl)ethane. To a hot solution of
diethyl 2,4,7,9-tetraoxodecanedione (14.000 g, 44.5 mmol) in 100 ml ethanol is gradually added
hydrazine hydrate (5.05 g, 4.90 mL, 100 mmol). A crystalline solid forms, which is stirred for 30
minutes, filtered, recrystallized from hot ethanol and dried under vacuum to give 1,2-bis(5carboethoxy-1H-pyrazole-3-yl)ethane (10.215 g, 75%) as a light brown microcrystalline powder
(Scheme 2.8). 1H NMR (400 MHz, DMSO-d6): δ 6.52 (s, 2H, pz-H), 4.24 (q, 4H, 3J = 7.1 Hz,
CH3CH2), 2.97 (s, 4H, CH2CH2), 1.27 (t, 6H, 3J = 7.2 Hz, CH3CH2) ppm. 13C NMR (101 MHz,
DMSO-d6): δ 162.0, 145.6, 142.0, 106.7, 60.6, 25.4, 14.8 ppm.
Step 3. Synthesis of 1,2-bis(5-carboxy-1H-pyrazol-3-yl)ethane. 1,2-bis(5-carboethoxy1H-pyrazole-3-yl)ethane (10.000 g, 32.6 mmole) is dissolved in a 10% aqueous NaOH solution
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(100 mL) and is boiled for 1 hour. After cooling, a 20% aqueous H2SO4 solution (40 mL) is added
gradually, under stirring, to pH~3. The brown precipitate is filtered out, suspended in 37% HCl
(250 mL) and boiled for 30 minutes. Filtration and drying in high vacuum affords 6.528 g (80%)
of 1,2-bis(5-carboxy-1H-pyrazol-3-yl)ethane as a beige powder (Scheme 2.8). 1H NMR (400
MHz, DMSO-d6): δ 6.48 (s, 2H, pz-H), 2.95 (s, 4H, CH2CH2) ppm. 13C NMR (101 MHz, DMSOd6): δ 163.0, 146.9, 141.1, 106.8, 25.8 ppm.
Step 4. Synthesis of 1,2-bis(1H-pyrazol-3-yl)ethane (LH2). 1,2-bis(5-carboxy-1H-pyrazol3-yl)ethane (4.66 g, 18.62 mmole) is added to a vial preheated to 330 °C in a sand bath covered
with a watch glass. As the material starts melting, a white smoke is evolved which condenses onto
the watch glass. After all the material has melted, the vial is taken out of the sand bath and left to
cool to room temperature. The white solid condensed onto the watch glass (~ 50 mg) is pure 1,2bis(1H-pyrazol-3-yl)ethane. The dark brown molten residue is extracted with boiling ethanol under
stirring. After filtration, the ethanolic extract is heated and stirred for 2 hours with activated carbon,
then filtered and evaporated to give a yellowish-brown oil (1.5 g). Upon trituration with diethyl
ether, pure 1,2-bis(1H-pyrazol-3-yl)ethane is obtained as a pale yellow powder (900 mg; overall
yield: 32%) (Scheme 2.8). 1H NMR (400 MHz, DMSO-d6): δ 12.48 (s, 2H, NH), 7.45 (s, 2H, 5H-pz), 6.03 (s, 2H, 4-H-pz), 2.88 (s, 4H, CH2CH2) ppm. 13C NMR (101 MHz, DMSO-d6): δ 147.1,
134.0, 103.4, 26.9 ppm. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for C8H10N4Na+ 185.0803; found
185.0808. Slow evaporation of an EtOH/H2O solution of 1,2-bis(1H-pyrazol-3-yl)ethane produces
single-crystals suitable for X-ray diffraction.
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Scheme 2.8: Synthesis of 1,2-bis(1H-pyrazol-3-yl)ethane in method A.
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Method B: Step 1. Synthesis of (1E, 7E)-1,8-bis(dimethylamino)octa-1,7-diene-3,6-dione.
A solution of 2,5-hexanedione (10.00 g, 0.0876 mol) and dimethylformamide dimethylacetal
(81.45 mL, 73.07 g, 0.613 mol) in dimethylformamide (100 mL) is refluxed in a 250 mL roundbottom flask at 115 °C for 24 hours. The color of the solution gradually turns yellow and finally
dark red. The excess DMF-DMA and the DMF solvent are distilled out under high-vacuum with
heating on a water bath (at ~60 °C). The viscous, dark-red oily residue (20.129 g) is purified by
column chromatography on silica gel (1.5 kg) using EtOAc/MeOH gradient elution (first 9:1, then
8:2, 7:3, 2:1 and 1:1). Rf is 30% with EtOAc:MeOH (2:1) and 7% with EtOAc:MeOH (9:1). (1E,
7E)-1,8-bis(dimethylamino)octa-1,7-diene-3,6-dione is obtained as a brown solid (yield: 4.183 g,
21%) (Scheme 2.9). Further purification can be carried out by recrystallization from an ethyl
acetate solution by hexane vapor diffusion, which affords single crystals suitable for X-ray
diffraction. 1H NMR (400 MHz, CDCl3): δ 7.49 (d, 2H, 3J = 13 Hz, =CH), 5.05 (d, 2H, 3J = 13
Hz, =CH), 2.79–3.00 (m, 12H, N(CH3)2), 2.64 (s, 4H, CH2CH2) ppm.

13

C NMR (101 MHz,

CDCl3): δ 197.2, 152.5, 96.1, 44.8, 37.0, 36.2 ppm. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for
C12H10N2NaO2+ 247.1422; found 247.1427.
Step 2. Synthesis of 1,2-bis(1H-pyrazole-3-yl)ethane (LH2). (1E, 7E)-1,8-bis(dimethylamino)octa-1,7-diene-3,6-dione (1.000 g, 4.45 mmole) is dissolved in ethanol (50 mL) and
hydrazine monohydrate (0.54 mL, 0.56 g, 11 mmole) is added. After refluxing for 6 hours, a brown
precipitate is filtered out. The dark brown filtrate is stirred with activated carbon for 30 minutes
with heating, and then is filtered while hot. The solvent is removed under vacuum and 1,2-bis(1Hpyrazole-3-yl)ethane is obtained as a light yellow solid (yield: 0.656 g, 91%) (Scheme 2.9).
O
+ 2
O
2,5-hexanedione

N

O
O
N
O
DMF-DMA

DMF

NH

N2H4.H2O

N
N

115 °C, 24 hr

EtOH

O
(1E, 7E)-1,8-bis(dimethylamino)octa-1,7-diene-3,6-dione

Scheme 2.9: Synthesis of 1,2-bis(1H-pyrazol-3-yl)ethane in method B.
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1,2-bis(1H-pyrazol-3-yl)ethane

2.2.1.5

Synthesis of N,1-bis(pyrazol-3(5)-yl)methanimine 18
The synthetic procedures of this section through section 2.2.1.12 are reprinted with

permission, from J. Org. Chem. 2017, 82, 10549−10562.112 Copyright 2017 American Chemical
Society.
Pyrazole-3(5)-carbaldehyde (2.024 g, 21.06 mmol) was dissolved in anhydrous ethanol (600 mL)
by gently warming (∼50 °C) under an N2-atmosphere. After cooling to room temperature, the
solution was added by cannula to a flask containing 3(5)-aminopyrazole (1.750 g, 21.06 mmol)
and 3 Å molecular sieves (200 mL). The reaction mixture was allowed to stand at room
temperature and was swirled occasionally (stirring is to be avoided as it leads to the breakup of the
molecular sieve particles, forming a paste). Periodical monitoring showed that the reaction was
complete after 9 days at 25 °C. After most of the solvent was removed under vacuum, the product
(white solid) was precipitated by the addition of excess diethyl ether and then was filtered out and
quickly rinsed with a small amount of ethanol. Yield: 2.809 g, 17.43 mmol (83%) (Scheme 2.10).
M.p. 188−189 °C. 1H NMR (400 MHz, DMSO-d6): δ 13.40 (s, br, 1H, NH-pz), 12.78 (s, br, 1H,
NH-pz), 8.81 (s, 1H, CH=N), 7.81 (s, br, 1H, CH-pz), 7.67 (s, br, 1H, CH-pz), 6.77 (d, 1H, 3J =
1.6 Hz, CH-pz), 6.42 (d, 1H, 3J = 1.6 Hz, CH-pz) ppm. 13C NMR (101 MHz, DMSO-d6): δ 158.1,
153.3, 149.2, 132.6, 104.7, 96.1 ppm. HRMS (ESI-TOF) m/z: [M − H]– calcd. for C7H6N5–,
160.0628; found, 160.0642.
CH
HN

N

O

+

N

H 2N
HN
N

N

NH

N

NH

Scheme 2.10: Synthesis of N,1-bis(pyrazol-3(5)-yl)methanimine 18.

2.2.1.6

Synthesis of N-(4-((1H-pyrazol-3-yl)methylene)-4H-pyrazol-3-yl)-1-(1H-pyrazol-3-yl)
methanimine 19
Pyrazole-3(5)-carbaldehyde (1.057 g, 11.00 mmol) was dissolved in 60 mL ethanol

acidified with HCl (37% in H2O, 0.90 mL, 11 mmol) with slight heating. 3(5)-Aminopyrazole
(0.914 g, 11.0 mmol) was added, and the solution was stirred at room temperature for 12 h,
followed by refluxing for 30 min. After cooling, the reaction mixture was stirred overnight with
sodium bicarbonate. The solution was filtered, and the solvent was removed under vacuum. The
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crude product (2.023 g) was purified by column chromatography on silica gel using 1,2dichloroethane/methanol gradient elution (8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:4, followed by neat
methanol). Rf was 37% with 1,2-dichloroethane/methanol (4:1). The pale yellow solid (425 mg)
contained small amounts (1.8%) of pyrazole-3(5)-carbaldehyde. Further purification was achieved
by column chromatography on neutral aluminum oxide using ethyl acetate/methanol gradient
elution (9:1, 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, followed by neat methanol). Rf was 40% with ethyl
acetate/methanol (9:1). Pure compound 19 was isolated as a white solid. Yield: 393 mg, 1.64 mmol
(30%), based on pyrazole-3(5)-carbaldehyde (Scheme 2.11). M.p. 142−143 °C. 1H NMR (400
MHz, ethanol-d6): δ 8.21 (s, 1H, CH=N), 7.79 (s, 1H, CH-pz), 7.53 (s, 1H, CH-pz), 7.36 (s, 1H,
CH-pz), 6.98 (s, 1H, CH), 6.82 (s, 1H, CH-pz), 5.70 (s, 1H, CH) ppm. 1H NMR (400 MHz, DMSOd6): δ 12.95 (s, br, 2H, NH-pz), 8.25 (s, 1H, CH=N), 7.81 (s, 1H, CH-pz), 7.59 (s, 1H, CH-pz),
7.50 (s, 1H, CH-pz), 6.99 (s, 1H, CH), 6.86 (s, 1H, CH-pz), 5.73 (s, 1H, CH) ppm. 13C NMR (101
MHz, DMSO-d6): δ 151.3, 145.9, 139.5, 138.2, 130.6, 113.8, 109.1, 102.0, 57.0 ppm. HRMS (ESITOF) m/z: [M − H]– calcd. for C11H8N7–, 238.0846; found, 238.0864.
N
1) 12 hr room temp.
2) 30 min. reflux

CH O H2N
HN

N

+

N

NH

N
N
N

EtOH/HCl
HN

NH

N

Scheme 2.11: Synthesis of N-(4-((1H-pyrazol-3-yl)methylene)-4H-pyrazol-3-yl)-1-(1H-pyrazol3-yl)methanimine 19.

2.2.1.7 Synthesis of N-(pyrazol-1-yl)-1-(pyrazol-3(5)-yl)methanimine 20
1-Aminopyrazole (279 mg, 3.35 mmol) and pyrazole-3(5)-carbaldehyde (161 mg, 1.67
mmol) were dissolved in ethanol (20 mL). Hydrochloric acid (37% in H2O, 137 µL, 1.67 mmol)
was added, and the mixture was refluxed overnight. The solvent was removed under vacuum. The
residue was dissolved in chloroform, and the product precipitated by addition of diethyl ether. The
white solid was quickly rinsed with a small amount of chloroform to remove any remaining
unreacted 1-aminopyrazole and was dried under a high vacuum. Yield: 208 mg, 1.29 mmol (77%)
(Scheme 2.12). M.p. 131−132 °C. 1H NMR (400 MHz, CDCl3): δ 9.23 (s, 1H, CH=N), 7.70 (d,
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1H, 3J = 1.4 Hz, 5-H-pz), 7.67 (d, 1H, J = 2.2 Hz, 5-H-pz), 7.55 (s, 1H, 3-H-pz), 6.80 (d, 1H, 3J =
1.8 Hz, 4-H-pz), 6.37 (t, 1H, 3J = 1.8 Hz, 4-H-pz). 13C NMR (101 MHz, CDCl3): δ 144.1, 142.2,
138.0, 133.3, 129.1, 106.5, 106.2. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C7H7N5Na+,
184.0593; found, 184.0569.
CH O
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EtOH/HCl

+
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Scheme 2.12: Synthesis of N-(pyrazol-1-yl)-1-(pyrazol-3(5)-yl)methanimine 20.

2.2.1.8

General procedure for the preparation of bis- and tris(pyrazolyl)methane ligands
The aldehyde or ketone was dissolved in ethanol (10−150 mL) together with 3(5)-

aminopyrazole or 3(5)-hydroxy-1H-pyrazole in a 1:2 molar ratio (of carbonyl/amino groups). The
mixture was acidified with 37% HCl (1 mol %), then sonicated for 15 min, and refluxed for 30
min. After most of the ethanol was removed under vacuum, the reaction mixture was poured into
excess diethyl ether. The solid product was filtered, rinsed with diethyl ether, and dried under a
high vacuum. Pure compounds were obtained from aldehydes, whereas the products derived from
ketones were purified by column chromatography (Scheme 2.13). Reaction conversions are shown
in (Table 2.2), and isolated yields are provided below.
H
N

CH
HN

N

NH2

O
+ 2
HN

N

N
NH2

EtOH/HCl
30 min. reflux
HN

N

NH
H 2N

N

Scheme 2.13: General procedure for the preparation of bis- and tris(pyrazolyl)methane ligands
(exemplified on compound 21).
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Table 2.2: Reaction products of various aldehydes and ketones with 3(5)-aminopyrazole and 3(5)hydroxypyrazole leading to bis- and tris(pyrazolyl)methane ligands, with the corresponding
conversions (by 1H NMR). Reproduced with permission, from reference 112.

21, R = NH2
22, R = OH

37

24, R = NH2
25, R = OH

38

39
26, R = NH2 27, R = OH

28, R = NH2
29, R = OH

40

30, R = NH2
31, R = OH

41

32, R = H
33, R = OH
34, R = CN

42

35

43

44

36
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2.2.1.8.1

Bis(3(5)-aminopyrazol-4-yl)-pyrazol-3(5)-yl-methane 21

White solid, m.p. 205−206 °C. Yield: 84% (426 mg, 1.74 mmol, from 200 mg of pyrazole3-carbaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.48 (s, 1H, 5-H-pz), 7.11 (s, 2H, 5-H-pz),
6.06 (s, 1H, 4-H-pz), 4.98 (s, 1H, CH) ppm.

13

C NMR (101 MHz, DMSO-d6): δ 151.1, 129.8,

107.8, 103.5, 28.5 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H12N8Na+, 267.1077;
found, 267.1077.
2.2.1.8.2

Bis(3(5)-hydroxypyrazol-4-yl)-pyrazol-3(5)-yl-methane 22

Yellow solid, m.p. 179 °C. Yield: 63% (1.612 g, 6.55 mmol, from 1.000 g of pyrazole-3carbaldehyde). 1H NMR (400 MHz, D2O): δ 7.78 (s, 1H, 5-H-pz), 7.52 (s, 2H, 5-H-pz), 6.29 (s,
1H, 4-H-pz), 5.23 (s, 1H, CH) ppm.

13

C NMR (101 MHz, D2O): δ 159.5, 150.5, 133.6, 133.5,

105.4, 27.3 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H10N6O2Na+, 269.0757; found,
269.0750.
2.2.1.8.3

Bis(3(5)-amino-5(3)-methylpyrazol-4-yl)-pyrazol-3(5)-yl-methane 23

White solid, m.p. 219−220 °C. Yield: 98% (560 mg, 2.06 mmol, from 202 mg of pyrazole3-carbaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 8.38 (s, br, 4H, NH2), 7.60 (d, 1H, 3J = 1.8
Hz, 5-H-pz), 5.98 (d, 1H, 3J = 2.4 Hz, 5-H-pz), 5.25 (s, 1H, CH), 1.94 (s, 6H, CH3) ppm. 13C NMR
(101 MHz, DMSO-d6): δ 150.0, 149.7, 140.8, 131.9, 104.4, 103.7, 27.9, 10.6 ppm. HRMS (ESITOF) m/z: [M + Na]+ calcd. for C12H16N8Na+, 295.1390; found, 295.1375.
2.2.1.8.4

Bis(3(5)-aminopyrazol-4-yl)-pyrazol-4-yl-methane 24

White solid, m.p. 164−165 °C. Yield: 71% (771 mg, 3.16 mmol, from 428 mg of pyrazole4-carbaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.43 (s, 2H, 5-H-pz), 7.36 (s, 2H, 3,5-H-pz),
5.15 (s, 1H, CH) ppm. 13C NMR (101 MHz, D2O): δ 149.8, 133.3, 131.2, 122.2, 109.3, 24.9 ppm.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H12N8Na+, 267.1077; found, 267.1086.
2.2.1.8.5

Bis(3(5)-hydroxypyrazol-4-yl)-pyrazol-4-yl-methane 25

Light-yellow solid, m.p. 198 °C. Yield: 84% (313 mg, 1.28 mmol, from 150 mg of
pyrazole-4-carbaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.30 (s, 4H, 3,5-H-pz), 4.90 (s, 1H,
CH) ppm. 13C NMR (101 MHz, DMSO-d6): δ 158.7, 132.3, 129.7, 124.7, 108.7, 24.6 ppm. HRMS
(ESI-TOF) m/z: [M + Na]+ calcd. for C10H10N6O2Na+, 269.0757; found, 269.0757.
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2.2.1.8.6

3,5-Bis(bis(3(5)-aminopyrazol-4-yl)methyl)pyrazole 26

White solid, m.p. 162−163 °C. Yield: 91% (309 mg, 0.735 mmol, from 100 mg of pyrazole3,5-dicarbaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.44 (s, 4H, 4-H-pz), 5.83 (s, 1H, 4-Hpz), 5.21 (s, 2H, CH) ppm. 13C NMR (101 MHz, D2O): δ 149.7, 147.9, 131.5, 108.7, 102.5, 27.4
ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C17H20N14Na+, 443.1887; found, 443.1887.
2.2.1.8.7

3,5-Bis(bis(3(5)-hydroxypyrazol-4-yl)methyl)pyrazole 27

Light-yellow solid, which decomposes at 220 °C. Yield: 70% (177 mg, 0.417 mmol, from
100 mg pyrazole-3,5-dicarbaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.60 (s, 4H, 4-H-pz),
5.90 (s, 1H, 4-H-pz), 5.16 (s, 2H, CH) ppm. 13C NMR (101 MHz, D2O): δ 158.1, 132.3, 131.5,
106.2, 102.8, 27.4 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C17H16N10NaO4+, 447.1248;
found, 447.1225.
2.2.1.8.8

Bis(3(5)-aminopyrazol-4-yl)-imidazol-4-yl-methane 28

White solid, m.p. 210−211 °C. Yield: 98% (498 mg, 2.04 mmol, from 200 mg of imidazole4-carbaldehyde). 1H NMR (400 MHz, D2O): δ 8.59 (s, 1H, 2-H-imidazole), 7.19 (s, 2H, 5-H-pz),
7.05 (s, 1H, 5-H-imidazole), 5.19 (s, 1H, CH) ppm. 13C NMR (101 MHz, D2O): δ 150.8, 134.7,
134.3, 131.2, 116.6, 105.7, 26.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H12N8Na+,
267.1077; found, 267.1083.
2.2.1.8.9

Bis(3(5)-hydroxypyrazol-4-yl)-imidazol-4-yl-methane 29

Yellow solid, m.p. 131−132 °C. Yield: 94% (1.169 g, 4.75 mmol, from 500 mg of
imidazole-4-carbaldehyde). 1H NMR (400 MHz, D2O): δ 7.97 (s, 1H, 2-H-imidazole), 7.11 (s,
2H, 5-H-pz), 6.67 (s, 1H, 5-H-imidazole), 4.83 (s, 1H, CH) ppm. 13C NMR (101 MHz, D2O): δ
160.6, 136.9, 134.2, 133.7, 115.8, 104.8, 26.5 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C10H10N6NaO2+, 269.0757; found, 269.0757.
2.2.1.8.10

Bis(3(5)-aminopyrazol-4-yl)-imidazol-2-yl-methane 30

White solid, m.p. 240−241 °C. Yield: 99% (254 mg, 1.04 mmol, from 100 mg of imidazole2-carbaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.47 (s, 1H, 4/5-H-imidazole), 7.46 (s, 1H,
4/5-H-imidazole), 7.31 (s, 2H, 5-H-pz), 5.59 (s, 1H, CH) ppm. 13C NMR (101 MHz, D2O): δ 150.9,
147.6, 131.5, 119.3, 103.2, 27.9 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H12N8Na+,
267.1077; found, 267.1087.
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2.2.1.8.11

Bis(3(5)-hydroxypyrazol-4-yl)-imidazol-2-yl-methane 31

Light-yellow solid, m.p. 176 °C. Yield: 75% (478 mg, 1.94 mmol, from 250 mg of
imidazole-2-carbaldehyde). 1H NMR (400 MHz, D2O): δ 7.32 (s, 2H, 4,5-H-Im), 7.1 (s, 2H, 5-Hpz), 5.2 (s, 1H, CH) ppm. 13C NMR (101 MHz, D2O): δ 160.5, 148.3, 133.9, 119.0, 101.4, 27.7
ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H10N6NaO2+, 269.0757; found, 269.0773.
2.2.1.8.12

Bis(3(5)-aminopyrazol-4-yl)-phenyl-methane 32

Off-white solid, m.p. 103 °C. Yield: 97% (718 mg, 2.82 mmol, from 310 mg of
benzaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.26−7.25 (m, 4H, 5-H-pz, CH-phenyl),
7.18−7.14 (m, 3H, CH-phenyl), 5.08 (s, 1H, CH) ppm. 13C NMR (101 MHz, DMSO-d6): δ 149.9,
145.1, 130.6, 128.7, 128.3, 126.3, 108.9, 34.4 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C13H14N6Na+, 277.1172; found, 277.1180.
2.2.1.8.13

Bis(3(5)-aminopyrazol-4-yl)-4-hydroxyphenyl-methane 33

Off-white solid, m.p. 156−157 °C. Yield: 94% (210 mg, 0.777 mmol, from 101 mg of 4hydroxybenzaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 8.66 (s, br, 5H, NH2, OH), 7.59 (s, 2H,
5-H-pz), 7.05 (d, 2H, 3J = 7.9 Hz, CH-phenyl), 6.68 (d, 2H, 3J = 8.6 Hz, CH- phenyl), 5.43 (s, 1H,
CH) ppm. 13C NMR (101 MHz, DMSO-d6): δ 156.4, 146.0, 133.4, 132.2, 129.2, 115.6, 110.9, 32.4
ppm. HRMS (ESI-TOF) m/z: [M + Na] + calcd. for C13H14N6NaO+, 293.1121; found, 293.1121.
2.2.1.8.14

Bis(3(5)-aminopyrazol-4-yl)-4-cyanophenyl-methane 34

Pale-yellow solid, m.p. 292−293 °C. Yield: 83% (177 mg, 0.634 mmol, from 102 mg of 4cyanobenzaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.77 (d, 2H, 3J = 8.6 Hz, CH-phenyl),
7.66 (s, 2H, 5-H-pz), 7.47 (d, 2H, 3J = 8.0 Hz, CH-phenyl), 5.71 (s, 1H, CH). 13C NMR (101 MHz,
DMSO-d6): δ 149.4, 146.4, 132.9, 132.2, 129.3, 119.5, 109.6, 109.4, 33.5. HRMS (ESI-TOF) m/z:
[M + Na]+ calcd. for C14H13N7Na+, 302.1124; found, 302.1139.
2.2.1.8.15

Bis(3(5)-aminopyrazol-4-yl)-4-(N,N-diphenylamino)phenylmethane 35

Scarlet-red solid, m.p. 216−217 °C. Yield: 90% (285 mg, 0.676 mmol, from 205 mg of 4(N,N-diphenylamino)benzaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 9.01 (br s, 4H, NH2), 7.50
(s, 2H, 5-H-pz), 7.26 (t, 4H, 3J = 7.3 Hz, CH-phenyl), 7.19 (d, 2H, 3J = 7.3 Hz, CH-phenyl), 6.96
(m, 8H, CH-phenyl), 5.30 (s, 1H, CH) ppm.

13

C NMR (101 MHz, DMSO-d6): δ 147.8, 147.4,
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145.8, 138.7, 131.7, 130.0, 129.3, 124.4, 124.0, 123.2, 110.0, 33.0 ppm. HRMS (ESI-TOF) m/z:
[M + Na]+ calcd. for C25H23N7Na+, 444.1907; found, 444.1891.
2.2.1.8.16

N,N-Bis(bis(3(5)-aminopyrazol-4-yl)methylphenyl)aniline 36

Maroon-red solid, m.p. 225−226 °C. Yield: 48% (132 mg, 0.221 mmol, from 139 mg of
bis(4-formylphenyl)phenylamine). A small amount of a brown precipitate was filtered out before
the product was precipitated out from the solution with diethyl ether. 1H NMR (400 MHz, DMSOd6): δ 9.65 (br s, 4H, NH2), 7.61 (s, 4H, 5-H-pz), 7.22 (m, 6H, CH-phenyl), 7.94 (m, 7H, CHphenyl), 5.44 (s, 1H, CH). 13C NMR (101 MHz, DMSO-d6): δ 147.8, 146.5, 145.9, 138.2, 132.0,
129.9, 129.3, 124.3, 123.5, 122.9, 110.4, 32.7. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C32H31N13Na+, 620.2717; found, 620.2727.
2.2.1.8.17

Bis(3(5)-aminopyrazol-4-yl)methane 37

Off-white solid, m.p. 157−158 °C. Yield: 71% (423 mg, 2.37 mmol, from 101 mg of
formaldehyde). 1H NMR (400 MHz, DMSO-d6): δ 7.07 (s, 2H, 5-H-pz), 3.22 (s, 2H, CH2) ppm.
13

C NMR (101 MHz, DMSO-d6): δ 151.7, 129.6, 104.7, 16.5 ppm. HRMS (ESI-TOF) m/z: [M +

Na]+ calcd. for C7H10N6Na+, 201.0859; found, 201.0842.
2.2.1.8.18

1,1-Bis(3(5)-aminopyrazol-4-yl)decane 38

White solid, m.p. 158−159 °C. Yield: 51% (1.004 g, 3.30 mmol, from 1.011 g of 1decanal). 1H NMR (400 MHz, DMSO-d6): δ 7.12 (s, 2H, 5-H-pz), 3.42 (t, 1H, 3J = 7.3 Hz, CH),
1.70 (q, 2H, 3J = 7.0 Hz, CH2), 1.21 (s, 14H, CH2), 0.84 (t, 3H, 3J = 7.0 Hz, CH3) ppm. 13C NMR
(101 MHz, DMSO-d6): δ 151.2, 128.5, 109.6, 36.3, 31.8, 29.7, 29.6, 29.2, 28.5, 28.0, 22.6, 14.5
ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C16H28N6Na+, 327.2267; found, 327.2248.
2.2.1.8.19

2,2-Bis(3(5)-aminopyrazol-4-yl)butane 39
Purified by column chromatography on silica gel using CHCl3/CH3OH gradient elution

(3:1, 2:1, 1:1, 1:2, 1:3, 1:4, followed by neat CH3OH). Rf was 0.49 with CHCl3/CH3OH (3:1) and
0.57 with CHCl3/CH3OH (2:1). The pure product was isolated as a light-yellow solid, m.p.
176−177 °C. Yield: 19% (130 mg, 0.590 mmol, from 225 mg of 2-butanone). 1H NMR (400 MHz,
DMSO-d6): δ 7.23 (s, 2H, 5-H-pz), 1.86 (q, 2H, 3J = 7.3 Hz, CH2), 1.32 (s, 3H, CH3), 0.66 (t, 3H,
3

J = 7.0 Hz, CH3) ppm. 13C NMR (101 MHz, DMSO-d6): δ 150.9, 128.4, 110.7, 33.9, 31.3, 25.0,

9.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H16N6Na+, 243.1328; found, 243.1325.
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2.2.1.8.20

2,2-Bis(3(5)-aminopyrazol-4-yl)pentane 40

Purified by column chromatography on silica gel using ClCH2CH2Cl/CHCl3/CH3OH
gradient elution (3:1:1 followed by 2:1:1) and then ClCH2CH2Cl/CH3OH gradient elution (2:1,
1:1, 1:2, 1:4, followed by neat CH3OH). Rf was 0.27 with ClCH2CH2Cl /CHCl3/CH3OH (2:1:1).
The pure product was isolated as a very light-yellow solid, m.p. 179− 180 °C. Yield: 18% (511
mg, 2.18 mmol, from 1.035 g of 2-pentanone). 1H NMR (400 MHz, DMSO-d6): δ 11.3 (s, br, NH),
7.22 (s, 2H, 5-H-pz), 3.67 (s, br, NH2), 1.80 (m, 2H, CH2), 1.35 (s, 3H, CH3), 1.08 (m, 2H, CH2),
0.83 (t, 3H, 3J = 6.2 Hz, CH3) ppm. 13C NMR (101 MHz, DMSO-d6): δ 151.3, 127.9, 111.1, 41.6,
33.7, 25.8, 17.7, 15.1 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C11H18N6Na+, 257.1485;
found, 257.1489.
2.2.1.8.21

3,3-Bis(3(5)-aminopyrazol-4-yl)pentane 41

Purified by column chromatography on silica gel using ClCH2CH2Cl/CH3OH gradient
elution (4:1, 3:1, 2:1, 1:1). Rf was 0.31 with ClCH2CH2Cl/CH3OH (3:1). The product was rinsed
with a minimum amount of ClCH2CH2Cl to remove traces of 3-aminopyrazole. The pure product
was isolated as a light-yellow solid, m.p. 181−182 °C. Yield: 8% (215 mg, 0.915 mmol, from 997
mg of 3-pentanone). 1H NMR (400 MHz, DMSO-d6): δ 7.28 (s, 2H, 5-H-pz), 1.80 (q, 2H, 3J = 7.3
Hz, CH2), 0.55 (t, 3H, 3J = 7.2 Hz, CH3) ppm. 13C NMR (101 MHz, DMSO-d6): δ 151.0, 129.1,
109.2, 37.4, 25.7, 8.4 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C11H18N6Na+, 257.1485;
found, 257.1490.
2.2.1.8.22

1,1-Bis(3(5)-aminopyrazol-4-yl)cyclopentane 42

Purified by column chromatography on silica gel using CHCl3/CH3OH gradient elution
(10:1, 8:2, 7:3, 2:1, 1:1, 1:2, 1:4, followed by neat CH3OH). Rf was 0.25 with CHCl3/CH3OH (2:1).
The product was further purified by dissolving in 15 mL of ethanol, precipitating with excess
diethyl ether, and sonicating the filtered product with water, followed by filtration and drying. The
pure product was obtained as a light-gray solid, m.p. 146−147 °C. Yield: 13% (464 mg, 2.00 mg,
from 2.497 g of cyclopentanone). 1H NMR (400 MHz, DMSO-d6): δ 7.26 (s, 2H, 5-H-pz), 3.80 (s,
br, 4H, NH2), 1.98 (s, 4H, CH2), 1.58 (s, 4H, CH2) ppm. 13C NMR (101 MHz, DMSO-d6): δ 151.1,
127.9, 110.6, 41.3, 37.7, 23.4 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C11H16N6Na+,
255.1328; found, 255.1319.

71

2.2.1.8.23

1,1-Bis(3(5)-aminopyrazol-4-yl)-1-phenyl-ethane 43

Purified by column chromatography on silica gel using CH2Cl2/CH3OH gradient elution
(10:1, 10:1.5, 10:2, 7.5:2.5, 7:3, 2:1, 1:2, 1:4, followed by neat CH3OH). Rf was 0.47 with
CH2Cl2/CH3OH (10:1) and 0.18 with CH2Cl2/CH3OH (10:2). The pure product was isolated as a
brownish-yellow solid, m.p. 181−182 °C. Yield: 12% (345 mg, 1.29 mmol, from 1.298 g of
acetophenone). 1H NMR (400 MHz, DMSO-d6): δ 7.18−7.31 (m, 5H, CH-phenyl), 6.97 (s, 2H, 5H-pz), 1.85 (s, 3H, CH3) ppm.

13

C NMR (101 MHz, DMSO-d6): δ 150.9, 147.7, 129.8, 128.5,

127.6, 126.4, 111.9, 29.4 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C14H16N6Na+,
291.1328; found, 291.1307.
2.2.1.9

General procedure for deamination
To a 25 mL round bottom flask containing the substrate (21, 24, 26, 28, or 30) in H2O

(5−20 mL) was added hypophosphorous acid (50% aqueous solution) in a 1:10 molar ratio (amino
group/H3PO2). The solution was acidified with 37% HCl (1:4 molar ratio, substrate/HCl) and was
cooled to 0 °C in an ice bath. A solution of NaNO2 (1.5% in H2O; 1:2.2 molar ratio of amino
group/NaNO2) was added dropwise, under stirring. The resulting mixture was stirred at 0 °C for
15 min and then allowed to warm to room temperature followed by stirring for 30 min at 35 °C.
The solution was then allowed to cool to room temperature and was basified with 20% aqueous
NaOH to pH ∼12. The solvent was removed under vacuum, and the solid residue was sonicated
and refluxed with ethyl acetate (3 × 25−60 mL). Pure products were obtained after filtering out the
inorganic solids and evaporating the solvent (Scheme 2.14).
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Scheme 2.14: Deamination procedure (exemplified on 24) by diazotation followed by reduction
with H3PO2.

72

2.2.1.9.1

Bis(pyrazol-4-yl)-pyrazol-3(5)-yl-methane 45

White solid, m.p. 195 °C. Yield: 57% (50 mg, 0.23 mmol, from 100 mg of 21). 1H NMR
(400 MHz, DMSO-d6): δ 7.48 (s, 1H, 5-H-pz), 7.40 (s, 4H, 3,5-H-pz), 6.06 (s, 1H, 4-H-pz), 5.30
(s, 1H, CH) ppm. 13C NMR (101 MHz, DMSO-d6): δ 137.9, 129.6, 127.7, 124.0, 103.2, 30.9 ppm.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H10N6Na+, 237.0859; found, 237.0835.
2.2.1.9.2

Tris(pyrazol-4-yl)methane 46

Purified by sonication and refluxing in ethyl acetate and acetonitrile (3 × 25 mL each). The
pure product was obtained as a white solid, m.p. 239−240 °C. Yield: 40% (35 mg, 0.16 mmol,
from 100 mg of 24). 1H NMR (400 MHz, DMSO-d6): δ 12.58 (s, 3H, NH), 7.36 (s, 6H, 3,5-H-pz),
5.17 (s, 1H, CH) ppm. 13C NMR (101 MHz, DMSO-d6): δ 140.2, 129.0, 127.9, 30.1 ppm. HRMS
(ESI-TOF) m/z: [M − H]– calcd. for C10H9N6–, 213.0894; found, 213.0868.
2.2.1.9.3

3,5-Bis(bis(pyrazol-4-yl)methyl)pyrazole 47

Purified by sonication in dimethyl sulfoxide, followed by column chromatography on silica
gel using CHCl3/CH3OH (2:1). The pure product (Rf = 0.66) was isolated as a white solid, m.p.
234−235 °C. Yield: 40% (30 mg, 0.083 mmol, from 103 mg of 26). 1H NMR (400 MHz, DMSOd6): δ 12.58 (s, 4H, NH-pz), 12.21 (s, 1H, NH-pz), 7.44 (s, 4H, 3,5-H-pz), 7.30 (s, 4H, 3,5-H-pz),
5.83 (s, 1H, 4-H-pz), 5.26 (s, 1H, CH), 5.16 (s, 1H, CH) ppm. 13C NMR (101 MHz, DMSO-d6): δ
155.7, 147.3, 138.3, 126.8, 124.5, 123.2, 101.5, 32.0, 29.5 ppm. HRMS (ESI-TOF) m/z: [M − H]–
calcd. for C17H15N10–, 359.1486; found, 359.1475.
2.2.1.9.4

Imidazol-4-yl-bis(pyrazol-4-yl)methane 48

Yellow solid, m.p. 131−132 °C. Yield: 63% (165 mg, 0.77 mmol, from 300 mg of 28). 1H
NMR (400 MHz, D2O): δ 7.59 (s, 1H, 2-H-imidazole), 7.40 (s, 4H, 3,5-H-pz), 6.7 (s, 1H, 5-Himidazole), 5.27 (s, 1H, CH) ppm. 13C NMR (101 MHz, D2O): δ 141.6, 136.2, 133.1, 123.8, 115.6,
29.9 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C10H10N6Na+, 237.0859; found, 237.0876.
2.2.1.9.5

Imidazol-2-yl-bis(pyrazol-4-yl)methane 49

Yellow solid, m.p. 269−270 °C. Yield: 21% (65 mg, 0.30 mmol, from 300 mg of 30). 1H
NMR (400 MHz, DMSO-d6): δ 12.64 (s, 2H, NH-pz), 11.68 (s, 1H, NH-imidazole), 7.42 (s, 4H,
3,5-H-pz), 6.96 (s, 1H, 4-H-imidazole), 6.76 (s, 1H, 5-H-imidazole), 5.33 (s, 1H, CH) ppm. 13C
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NMR (101 MHz, DMSO-d6): δ 150.4, 127.4, 122.6, 116.3, 32.2 ppm. HRMS (ESI-TOF) m/z: [M
+ Na]+ calcd. for C10H10N6Na+, 237.0859; found, 237.0860.
2.2.1.10 One-pot, telescoping synthesis of bis(pyrazol-4-yl)-pyrazol-3(5)-yl-methane 45
Pyrazole-3-carbaldehyde (200 mg, 2.082 mmol) and 3(5)-aminopyrazole (346 mg, 4.164
mmol) were dissolved in ethyl alcohol (20 mL). To the solution was added 37% HCl (40 µL), and
the mixture was sonicated for 15 min, followed by refluxing for 30 min. Then the solvent was
removed under vacuum, and hypophosphorous acid (50% in H2O; 2.748 g, 20.82 mmol) and water
(10 mL) were added. After the mixture cooled to 0 °C in an ice bath, a solution of NaNO2 (308
mg, 4.46 mmol) in water (10 mL) was added dropwise, under stirring. The resulting mixture was
stirred at 0 °C for 15 min and then at 35 °C for 30 min. After cooling to room temperature, the
solution was basified with NaOH (20% in H2O) to pH ~ 12. The solvent was removed under
vacuum, and the solid residue was sonicated and refluxed with ethyl acetate (3 × 60 mL). The pure
product (pale-yellow solid) was obtained after filtering out the insoluble inorganic solids and
evaporating the solvent under a vacuum (376 mg, 1.76 mmol, 85%) (Scheme 2.15).
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Scheme 2.15: One-pot, telescoping synthesis of compound 45.

2.2.1.11 Reaction of bis(3(5)-aminopyrazol-4-yl)-pyrazol-3(5)-yl-methane 21 with pyrazole3(5)-carbaldehyde.
The reactions were carried out similarly to the preparation of 18, using 21 (50.0 mg, 0.204
mmol) and pyrazole-3(5)-carbaldehyde (19.6 mg, 0.204 mmol in the case of the 1:1 reaction, and
39.3 mg, 0.409 mmol in the case of the 1:2 reaction). Both reactions led to an equilibrium mixture
after 10 days of sitting in the presence of molecular sieves (3 Å) in ethanol (none of the two went
to completion). In the case of the 1:1 reaction, 21, 50, and 51 were identified by 1H NMR (400
MHz, DMSO-d6), and no pyrazole-3(5)-carbaldehyde was present (see section 3.1.6.1.5). 21: δ
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∼7.50, 7.10, 6.06, 4.97 ppm. 50: δ 8.88, 7.82, 7.60, 7.08, 6.792, 6.787, 6.18, 5.31 ppm. 51: δ 8.84,
7.78, 7.58, 7.22, 6.75, 6.16, 5.71 ppm.
In the case of the 1:2 reaction, 50, 51, and pyrazole-3(5)-carbaldehyde were identified by
1

H NMR (400 MHz, DMSO-d6), and no 21 was present. 50: δ 8.88, 7.75, 7.58, 7.10, 6.79, 6.79,

6.17, 5.35 ppm. 51: δ 8.85, 7.73, 7.56, 7.22, 6.76, 6.14, 5.75 ppm. Pyrazole-3(5)-carbaldehyde: δ
9.92, 7.86, 6.77 ppm. If the final solutions were acidified with HCl (37% in H2O, 10 µL), both 50
and 51 broke down leading to 21 and pyrazole-3(5)-carbaldehyde.
2.2.1.12 Attempted reaction of pyrazole-3(5)-carbaldehyde with pyrazole, 3-methylpyrazole and
3-aminopyridazine
Pyrazole-3(5)-carbaldehyde was dissolved in ethanol acidified with HCl (1:1 molar ratio),
and pyrazole, 3-methylpyrazole or 3-aminopyridazine, was added (1:2 molar ratio). After 12 h of
reflux, 1H NMR and ESI-MS indicated the presence of starting materials (the aldehyde was
converted to acetal) and the absence of products analogous to 21 in the resulting solutions.
2.2.1.13 Green protection methodology of different functional groups
The general procedure for green protection was originally published in Green. Chem. 2016,
18, 6209−6214,113 and is reproduced by permission of The Royal Society of Chemistry.
http://pubs.rsc.org/en/content/articlelanding/2016/gc/c6gc02562e#!divAbstract.
General procedure: The substrate to be protected (100 mg) and 3,4-dihydro-2H-pyran (1.1−16.0
equivalents) are added to a 4 mL heavy-wall borosilicate glass pressure tube (pressure rating: 150
psi), which is closed with a threaded plug. The contents are homogenized by sonication and the
tube is placed in a preheated oven at 125 °C for 24 hours (Scheme 2.16). After cooling to room
temperature, the tube is connected to vacuum through a flask cooled with dry ice, in which the
excess DHP is recovered. In many cases, the protected product can be employed directly in
subsequent synthetic steps in the same flask. If high purity products are desired, the substrate and
DHP must be anhydrous (especially if excess DHP is employed). Alternatively, the products can
be purified by silica gel chromatography.
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Scheme 2.16: Solvent- and catalyst-free, quantitative protection of NH, OH and SH functional
groups with a THP group. Reproduced with permission, from reference 113.

2.2.1.13.1
1

Tetrahydro-2H-pyran-2-yl benzoate

H NMR (400 MHz, CDCl3): δ 8.08 (dd, 2H, 3J = 7.0 Hz, 3J = 1.4 Hz, CH-phenyl), 7.56

(t, 1H, 3J = 7.3 Hz, CH-phenyl), 7.44 (t, 2H, 3J = 8.0 Hz, CH-phenyl), 6.25 (m, 1H, CH-THP),
3.96−4.02 (m, 1H, CH2O-THP), 3.73–3.77 (m, 1H, CH2O-THP), 1.53−1.92 (m, 6H, CH2-THP)
ppm.

13

C NMR (100 MHz, CDCl3): δ 165.2, 133.2, 130.4, 129.8, 128.5, 93.2, 63.3, 29.4, 25.1,

18.7 ppm.
2.2.1.13.2
1

Tetrahydro-2H-pyran-2-yl stearate

H NMR (400 MHz, CDCl3): δ 5.95 (s, 1H, CH-THP), 3.85−3.91 (m, 1H, CH2O-THP),

3.64−3.68 (m, 1H, CH2O-THP), 2.33 (t, 2H, 3J = 7.6 Hz, C(O)CH2), 1.75–1.85 (m, 2H,
C(O)CH2CH2), 1.50–1.70 (m, 6H, CH2-THP), 1.21–1.28 (m, 28H, C(O)CH2CH2(CH2)14CH3),
0.86 (t, 3H, 3 J = 7.0 Hz, C(O)CH2CH2(CH2)14CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 172.7,
92.5, 63.4, 34.6, 32.0, 29.7, 29.6, 29.5, 29.4, 29.35, 29.31, 29.21, 25.0, 24.9, 22.7, 18.8, 14.2 ppm.
HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C23H44NaO3+ 391.3182; found 391.3176.
2.2.1.13.3
1

2-(Phenylthio)tetrahydro-2H-pyran

H NMR (400 MHz, CDCl3): δ 7.48 (d, 2H, 3J = 7.2 Hz, CH-phenyl), 7.20−7.30 (m, 3H,

CH-phenyl), 5.21 (t, 1H, 3J = 5.2 Hz, CH-THP), 4.16−4.20 (m, 1H, CH2O-THP), 3.57−3.60 (m,
1H, CH2O-THP), 2.00−2.05 (m, 1H, CH2-THP), 1.81−1.86 (m, 2H, CH2-THP), 1.62 (m, 3H, CH2THP) ppm. 13C NMR (100 MHz, CDCl3): δ 135.5, 130.8, 128.8, 126.7, 85.2, 64.5, 31.6, 25.6, 21.7
ppm.
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2.2.1.13.4
1

1(2)-(Tetrahydro-2H-pyran-2-yl)-1(2)H-1,2,3-benzotriazole

H NMR (400 MHz, CDCl3): δ 8.05 (d, 1H, 3J = 8.4 Hz, CH-phenyl), 7.87−7.90 (m, 2H,

CH-phenyl), 7.73 (d, 1H, 3J = 8.8 Hz, CH- phenyl), 7.47 (t, 1H, 3J = 6.8 Hz, CH-phenyl), 7.34−7.44
(m, 2H, CH-phenyl), 6.02 (dd, 1H, 3J = 8.4 Hz, 3J = 3.2 Hz, CH-THP), 3.90−3.95 (m, 1H, CH2OTHP), 3.74−3.82 (m, 1H, CH2O-THP), 2.56−2.65 (m, 1H, CH2-THP), 2.16−2.24 (m, 2H, CH2THP), 1.71−1.88 (m, 3H, CH2-THP) ppm. 13C NMR (100 MHz, CDCl3): δ 146.3, 144.2, 132.5,
127.6, 127.0, 124.4, 119.8, 118.6, 111.2, 90.8, 85.8, 67.6, 67.0, 30.0, 29.4, 24.9, 24.8, 21.7, 21.5
ppm.
2.2.1.13.5
1

1(2)-(Tetrahydro-2H-pyran-2-yl)-1(2)H-1,2,3-triazole

H NMR (400 MHz, CDCl3): δ 7.69 (s, 1H, 4-H-triazole), 7.62 (s, 1H, 5-H-triazole), 7.58

(s, 2H, 4-H-triazole and 5-H-triazole),5.62−5.66 (m, 1H, CH-THP), 3.88−3.94 (m, 1H, CH2OTHP), 3.61−3.67 (m, 1H, CH2O-THP), 2.28−2.40 (m, 1H, CH2-THP), 1.92−2.10 (m, 2H, CH2THP), 1.53−1.68 (m, 3H, CH2-THP) ppm.
2.2.1.13.6
1

4-Nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole

H NMR (400 MHz, CDCl3): δ 8.35 (s, 1H, 5-H-pz), 8.08 (s, 1H, 3-H-pz), 5.39 (dd, 1H, 3J

= 9.2 Hz, 3J = 2.6 Hz, CH-THP), 4.05−4.09 (m, 1H, CH2O-THP), 3.69−3.75 (m, 1H, CH2O-THP),
2.11−2.17 (m, 1H, CH2-THP), 1.64−2.04 (m, 5H, CH2-THP) ppm. 13C NMR (100 MHz, CDCl3):
δ 135.6, 127.1, 88.5, 67.9, 30.7, 24.8, 21.8 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C8H11N3NaO3+ 220.0692; found 220.0711.
2.2.1.13.7
1

2-Phenoxytetrahydro-2H-pyran

H NMR (400 MHz, CDCl3): δ 7.27–7.31 (m, 2H, CH-phenyl), 7.06–7.08 (m, 2H, CH-

phenyl), 5.44 (t, 1H, 3J = 3.3 Hz, CH-THP), 3.91–3.94 (m, 1H, CH2O-THP), 3.60–3.63 (m, 1H,
CH2O-THP), 1.99–2.03 (m, 1H, CH2-THP), 1.80–1.90 (m, 2H, CH2-THP), 1.50–1.78 (m, 3H,
CH2-THP) ppm. 13C NMR (100 MHz, CDCl3): 157.1, 129.2, 121.4, 116.4, 96.2, 61.8, 30.4, 25.3,
18.8 ppm.
2.2.1.13.8
1

1(2)-(Tetrahydro-2H-pyran-2-yl)-1(2)H-1,2,4-triazole

H NMR (400 MHz, CDCl3): δ 8.21 (s, 1H, 5-H-triazole), 8.08 (s, 2H, 3-H-triazole and 5-

H-triazole), 7.87 (s, 1H, 3-H-triazole), 5.38(dd, 1H, 3J = 8.8 Hz, 3J = 4.4 Hz, CH-THP), 3.95−3.99
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(m, 1H, CH2O-THP), 3.58−3.65 (m, 1H, CH2O-THP), 1.88−2.05 (m, 3H, CH2-THP), 1.52−1.64
(m, 3H, CH2-THP) ppm.
2.2.1.13.9
1

2-(Decylthio)tetrahydro-2H-pyran

H NMR (400 MHz, CDCl3): δ 4.80–4.83 (m, 1H, CH-THP), 4.04–4.09 (m, 1H, CH2O-

THP), 3.45–3.51(m, 1H, CH2O-THP), 2.43–2.7 (m, 2H, SCH2), 1.52–1.95 (m, 6H, CH2-THP),
1.20–1.40 (m, 16H, CH2(CH2)14CH2), 0.85 (t, 3H, 3J = 6.6, CH3) ppm.

13

C NMR (100 MHz,

CDCl3): δ 94.7, 64.7, 31.9, 31.5, 30.4, 30.0, 29.64, 29.61, 29.40, 29.3, 29, 25.7, 22.7, 21.9, 14.2
ppm.
2.2.1.13.10 4-Chloro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole
1

H NMR (400 MHz, CDCl3): δ 7.59 (s, 1H, 5-H-pz), 7.46 (s, 1H, 3-H-pz), 5.29–5.33(m,

1H, CH-THP), 4.01−4.04 (m, 1H, CH2O-THP), 3.64−3.71 (m, 1H, CH2O-THP ), 2.00−2.09 (m,
3H, CH2-THP ), 1.58−1.69 (m, 3H, CH2-THP) ppm. 13C NMR (100 MHz, CDCl3): δ 137.9, 125.8,
110.7, 88.0, 67.7, 30.3, 24.7, 22.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for
C8H11ClN2NaO+ 209.0452; found 209.0454.
2.2.1.13.11 4-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole
1

H NMR (400 MHz, CDCl3): δ 7.61 (s, 1H, 3-H-pz), 7.48 (s, 1H, 5-H-pz), 5.31−5.33 (m,

1H, CH-THP), 3.99−4.02 (m, 1H, CH2O-THP), 3.64−3.69 (m, 1H, CH2O-THP), 1.99−2.09 (m,
3H, CH2-THP), 1.59−1.65 (m, 3H, CH2-THP) ppm.
2.2.1.13.12 1-(Tetrahydro-2H-pyran-2-yl)-1H-benzimidazole
1

H NMR (400 MHz, CDCl3): δ 8.06 (s, 1H, CH-imidazole), 7.77−7.79 (m, 1H, CH-

phenyl), 7.50−7.52 (m, 1H, CH-phenyl), 7.26−7.31 (m, 2H, CH-phenyl), 5.48 (dd, 1H, 3J = 9.6
Hz, 3J = 2.0 Hz, CH-THP), 4.10−4.12 (m, 1H, CH2O-THP), 3.71−3.77 (m, 1H, CH2O-THP),
2.08−2.21 (m, 3H, CH2-THP), 1.68−1.81 (m, 3H, CH2-THP) ppm.
2.2.1.13.13 3,5-Diphenyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole
1

H NMR (400 MHz, CDCl3): δ 7.88 (d, 2H, 3J = 8.4 Hz, CH-phenyl), 7.58 (d, 2H, 3J = 8.0

Hz, CH-phenyl), 7.27−7.5 (m, 6H, CH-phenyl), 6.64 (s, 1H, 4-H-pz), 5.22 (dd, 1H, 3J = 10.2 Hz,
3

J = 2.2 Hz, CH-THP), 4.16−4.18 (m, 1H, CH2O-THP), 3.62 (t, 1H, 3J = 11.7 Hz, CH2O-THP),

2.65−2.74 (m, 1H, CH2-THP), 2.07−2.10 (m, 1H, CH2-THP), 1.54−1.88 (m, 4H, CH2-THP) ppm.
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C NMR (100 MHz, CDCl3): δ 151.2, 145.6, 133.5, 130.6, 129.1, 128.8, 127.8, 126.0, 103.9, 84.5,

67.8, 29.8, 24.9, 23.1 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C20H20N2NaO+ 327.1467;
found 327.1478.
2.2.1.13.14 1(2)-(Tetrahydro-2H-pyran-2-yl)-1(2)H-indazole
1

H NMR (400 MHz, CDCl3): δ 8.15 (s, 1H,5-H-pz), 8.03 (s, 1H, 3-H-pz), 7.71−7.73 (m,

1H, CH-phenyl), 7.58−7.6 (m, 1H, CH-phenyl), 7.37−7.41 (m, 1H, CH-phenyl), 5.72 (dd, 1H, 3J
= 9.6 Hz, 3J = 2.4 Hz, CH-THP), 4.01−4.05 (m,1H, CH2O-THP), 3.72−3.78 (m, 1H, CH2O-THP),
2.54−2.63 (m, 1H, CH2-THP), 2.06−2.18 (m, 2H, CH2-THP), 1.50−1.82 (m, 3H, CH2-THP) ppm.
2.2.1.13.15 1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazole
1

H NMR (400 MHz, CDCl3): 7.57 (d, 1H, 3J = 2.4 Hz, 5-H-pz), 7.52 (d, 1H, 3J = 1.6 Hz,

3-H-pz), 6.26 (t, 1H, 3J = 2 Hz, 4-H-pz), 5.36 (dd, 1H, 3J = 9.6 Hz, 3J = 2.4 Hz, CH-THP),
4.00−4.04 (m, 1H, CH2O-THP), 3.63−3.69 (m, 1H, CH2O-THP), 1.97−2.13 (m, 3H, CH2-THP),
1.48−1.69 (m, 3H, CH2-THP) ppm.
2.2.1.13.16 1-(Tetrahydro-2H-pyran-2-yl)-1H-imidazole
1

H NMR (400 MHz, CDCl3): δ 7.58 (s, 1H, 2-H-imidazole), 6.96−7.00 (m, 2H, 4-H-

imidazole, 5-H-imidazole), 5.12 (dd, 1H, 3J = 2.4 Hz, 3J = 9.6 Hz, CH-THP), 3.94−3.97 (m, 1H,
CH2O-THP), 3.54−3.60 (m, 1H, CH2O-THP), 1.75−1.93 (m, 3H, CH2-THP), 1.48−1.66 (m, 3H,
CH2-THP) ppm. 13C NMR (100 MHz, CDCl3): δ 135.6, 129.1, 117.0, 100.8, 67.9, 31.5, 24.8, 22.5
ppm.
2.2.1.13.17 3(5)-Methyl-1-(tetrahydro-2H-pyran-2 -yl)-1H-pyrazole
1

H NMR (400 MHz, CDCl3): δ 7.45 (d, 1H, 3J = 2.2 Hz, 5 -H-pz), 7.42 (s, 1H, 3-H-pz),

6.05 (d, 1H, 3J = 2.2 Hz, 4-H-pz), 6.02 (d, 1H, 3J = 0.8 Hz, 4-H-pz), 5.25 (td, 1H, 3J = 7.7 Hz, 3J
= 2.2 Hz, CH-THP) 4.00–4.07 (m, 1H, CH2O-THP), 3.63–3.69 (m, 1H, CH2O-THP), 2.41–2.50
(m, 1H, CH2-THP), 2.32 (s, 3H, CH3), 2.27 (s, 3H, CH3), 2.05–2.12 (m, 1H, CH2-THP), 1.92–2.03
(m, 2H, CH2-THP), 1.51–1.71 (m, 3H, CH2-THP) ppm.

13

C NMR (100 MHz, CDCl3): δ 149.2,

139.1, 139.0, 128.4, 106.2, 105.8, 87.5, 84.4, 68.1, 67.8, 30.5, 29.4, 25.1, 25.0, 22.88, 22.82, 13.7,
10.98 ppm.
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2.2.1.13.18 4-Octyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole
1

H NMR (400 MHz, CDCl3): δ 7.36 (s, 2H, 3-H-pz and 5-H-pz), 5.30 (dd, 1H, 3J = 10.0

Hz, 3J = 2.4 Hz, CH-THP), 4.02−4.06 (m, 1H, CH2O-THP), 3.63−3.70 (m, 1H, CH2O-THP), 2.42
(t, 2H, 3J = 11.6 Hz, CH2(CH2)6CH3), 2.00−2.12 (m, 3H, CH2-THP), 1.49−1.72 (m, 5H, CH2-THP,
CH2CH2(CH2)5CH3), 1.24−1.30 (m, 10H, CH2CH2(CH2)5CH3), 0.86 (t, 3H, 3J = 6.8 Hz,
(CH2)7CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 139.5, 125.6, 122.6, 87.6, 67.9, 32.0, 30.9, 30.5,
29.4, 25.1, 24.3, 22.8, 14.2 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd. for C16H28N2NaO+
287.2093; found 287.2083.
2.2.1.13.19 3,5-Dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole
1

H NMR (400 MHz, CDCl3): δ 5.79 (s, 1H, 4-H-pz), 5.11 (dd, 1H, 3J = 10.0 Hz, 3J = 2.0

Hz, CH2-THP), 3.99−4.04 (m, 1H, CH2O-THP), 3.56−3.62 (td, 1H, 3J = 11.6 Hz, 3J = 2.8 Hz,
CH2O-THP), 2.36−2.46 (m, 1H, CH2-THP), 2.24 (s, 3H, CH3), 2.18 (s, 3H, CH3), 2.01−2.05 (m,
1H, CH2-THP), 1.84−1.89 (m, 1H, CH2-THP), 1.49−1.72 (m. 3H, CH2-THP) ppm. 13C NMR (100
MHz, CDCl3): δ 148.4, 139.9, 106.3, 84.4, 68.1, 29.7, 25.1, 23.2, 13.7, 10.9 ppm. HRMS (ESITOF) m/z: [M + Na]+ calcd. for C10H16N2NaO+ 203.1154; found 203.1178.
2.2.1.13.20 N-(tetrahydro-2H-pyran-2-yl)benzamide
1

H NMR (400 MHz, CDCl3): δ 7.76–7.81 (m, 2H, CH-phenyl), 7.41–7.53 (m, 3H, CH-

phenyl), 6.60 (br, 1H, 3J = 7.3 Hz, NH), 5.30 (t, 1H, 3J = 8.4 Hz, CH-THP), 4.01 (d, 1H, 3J = 11.0
Hz, CH2O-THP), 3.63–3.69 (m, 1H, CH2O-THP), 1.41−1.95 (m, 6H, CH2-THP) ppm. 13C NMR
(100 MHz, CDCl3): δ 166.8, 131.8, 129.2, 127.2, 127, 78.4, 66.2, 29.9, 22.0 ppm.
2.2.1.13.21 2-Butoxytetrahydro-2H-pyran
1

H NMR (400 MHz, CDCl3): δ 4.52 (m, 1H, CH-THP), 3.80−3.83 (m, 1H, CH2O-THP),

3.65–3.75 (m, 1H, OCH2), 3.45–3.51(m, 1H, CH2O-THP), 3.33–3.40 (m, 1H, OCH2), 1.48–1.90
(m, 8H, CH2-THP, OCH2CH2), 1.30–1.40 (m, 2H, CH2CH2CH3), 0.88 (t, 3H, 3J = 7.7 Hz, CH3)
ppm. 13C NMR (100 MHz, CDCl3): δ 98.9, 67.4, 62.3, 31.9, 30.8, 25.6, 19.7, 19.5, 14.0 ppm.
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2.2.1.14 Selective, ambient-temperature C-4 deuteration of pyrazole derivatives by D2O
The synthetic procedures of C-4 deuteration of pyrazole derivatives by D2O are reprinted
with permission, from J. Org. Chem. 2018, 83, 1649−1653.114 Copyright 2018 American Chemical
Society.
2.2.1.14.1

General procedure for catalyzed deuteration in an NMR tube at 25 °C

The pyrazole substrate (0.156 mmole) is dissolved in D2O (99.97 atom % D; 0.5 mL)
directly in a freshly opened ampule, to which DCl (37.0 wt. % in D2O, 99.5 atom % D) or NaOD
(39.9 wt. % in D2O, 99.8 atom % D) is added; the solution is then transferred to an NMR tube. In
the case of the experiments ran in an NMR tube equipped with coaxial insert, a 16 mM aqueous
solution of sodium 3-(trimethylsilyl)-1-propanesulfonate (DSS sodium salt) in D2O is used as
reference. The first 1H NMR scan is collected within 2‒3 minutes following addition of the
substrate to the solvent; additional scans are collected after 1–30 minutes, depending on the rate
of the deuteration (Scheme 2.17).
2.2.1.14.2

General procedure for non-catalyzed deuteration in an NMR tube at 70 °C

The pyrazole substrate (0.156 mmol) is added to an NMR tube purged with N2, to which
D2O (99.96 atom % D, 0.5 mL) is transferred from a freshly opened ampoule (under a blanket of
N2) via an N2-purged syringe. The clear solution is placed in an oil bath at 70 °C for 48 hours (9
days in the case of 3(5)-aminopyrazole). In the case of 3(5)-amino-5(3)-phenylpyrazole (which is
poorly soluble in water), the deuteration is carried out in CD3OD (99.89 atom % D) at 55 °C. 1H
NMR indicates 99% deuteration of the C-4 position in all cases. The products are isolated in
quantitative yield by evaporation of the solvent under high vacuum (Scheme 2.17).

Scheme 2.17: Selective, ambient-temperature C-4 deuteration of pyrazole derivatives. Reproduced
with permission, from reference 114.
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2.2.1.14.2.1

3(5)-Aminopyrazole-d4 (from 3(5)-aminopyrazole)

Orange-brown oil. 1H NMR (400 MHz, D2O): d 7.41 (s, 1H, 5-H-pz) ppm. 13C NMR (101
MHz, D2O): d 153.9, 132.2, 92.9 ppm. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for C3H4DN3Na+
107.0438; found 107.0462.
2.2.1.14.2.2

3(5)-Hydroxypyrazole-d3 (from 3(5)-hydroxypyrazole)

Light yellow solid (m.p. 147‒148 °C). 1H NMR (400 MHz, D2O): d 7.43 (s, 1H, 5-H-pz)
ppm. 13C NMR (101 MHz, D2O): d 163.0, 134.3, 91.0 ppm. HRMS (ESI-TOF) m/z: [M‒H]‒ calcd.
for C3H2DN2O‒ 84.0313; found 84.0342.
2.2.1.14.2.3

5-Amino-1-methylpyrazole-d3 (from 5-amino-1-methylpyrazole)

White solid (m.p. 71‒72 °C). 1H NMR (400 MHz, D2O): d 7.25 (s, 1H, 3-H-pz), 3.55 (s,
3H, CH3) ppm. 13C NMR (101 MHz, D2O): d 146.3, 139.1, 91.3, 33.6 ppm. HRMS (ESI-TOF)
m/z: [M+H]+ calcd. for C4H7DN3+ 99.0775; found 99.0767.
2.2.1.14.2.4

3(5)-Amino-5(3)-methylpyrazole-d4 (from 3(5)-amino-5(3)-methylpyrazole)

Light yellow solid (m.p. 45‒46 °C). 1H NMR (400 MHz, D2O): d 2.10 (s, 3H, CH3) ppm.
13

C NMR (101 MHz, D2O): d 154.3, 143.8, 92.2, 10.4 ppm. HRMS (ESI-TOF) m/z: [M+Na]+

calcd. for C4H6DN3Na+ 121.0595; found 121.0619.
2.2.1.14.2.5

3(5)-Amino-5(3)-hydroxypyrazole-d5 (from 3(5)-amino-5(3)-hydroxypyrazole)

Light yellow solid (m.p. 207‒208 °C). 13C NMR (101 MHz, D2O): d 173.9, 171.7, 160.8,
159.6, 75.6, 36.3 ppm. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for C3H4DN3NaO+ 123.0387;
found 123.0410.
2.2.1.14.2.6

3(5)-Amino-5(3)-tert-butylpyrazole-d4 (from 3(5)-Amino-5(3)-tert-butylpyrazole)

Light orange-brown solid (m.p. 76‒77 °C). 1H NMR (400 MHz, D2O): d 1.19 (s, 9H, CH3)
ppm.

13

C NMR (101 MHz, D2O): d 157.4, 154.2, 89.3, 30.7, 29.2. HRMS (ESI-TOF) m/z:

[M+Na]+ calcd. for C7H12DN3Na+ 163.1064; found 163.1088.
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2.2.1.14.2.7

3(5)-Amino-5(3)-trifluoromethylpyrazole-d4 (from 3(5)-amino-5(3)-trifluoromethylpyrazole)

White solid (m.p. 92‒93 °C). 13C NMR (101 MHz, D2O): d 148.7, 142.2, 121.1, 88.7 ppm.
HRMS (ESI-TOF) m/z: [M‒H]‒ calcd. for C4H2DF3N3‒ 151.0347; found 151.0342.
2.2.1.14.2.8

3(5)-Amino-5(3)-phenylpyrazole-d4 (from 3(5)-Amino-5(3)-phenylpyrazole)

Brown solid (m.p. 122‒123 °C). 1H NMR (400 MHz, CD3OD): d 7.61 (dd, 2H, 4J = 1.1
Hz, 3J = 7.5 Hz, CH-phenyl), 7.37–7.25 (m, 3H, CH-phenyl) ppm. 13C NMR (101 MHz, CD3OD):
d 155.4, 147.6, 132.6, 130, 129.2, 126.5, 90.4 ppm. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for
C9H8DN3Na+ 183.0751; found 183.0730.
2.2.1.14.3

General procedure for large-scale deuteration

The pyrazole substrate (1.564 mmol) is loaded into a Schlenk flask, which is then purged
with N2 three times. D2O or CD3OD (99.89 atom % D, 5.0 mL) is added via N2-purged syringe
and the solution is acidified with DCl (37.0 wt. % in D2O, 99.5 atom % D; 139 µL, 1.564 mmol).
After standing for 24 hours under an N2 atmosphere, the solution is slightly basified with
anhydrous sodium carbonate (87 mg, 0.82 mmol) and the solvent is removed under vacuum. Dry
ethyl acetate (25 mL) is added via N2-purged syringe and the suspension is sonicated followed by
stirring for 8 hours. After allowing the solid to settle, the clear solution is transferred to an empty
Schlenk flask under an N2 atmosphere. Evaporation of the ethyl acetate solvent under high vacuum
affords pure C-4 deuterated (97‒99 atom % D) pyrazole derivatives in 78‒97% yield.
2.3

pH titration and UV–vis monitoring
Stock solutions of Cu(NO3)2/pyrazole (1:1 molar ratio) and NaOH/Na2CO3 are prepared by

dissolving in water 9.7862 g of Cu(NO3)2.2.5H2O (42.07 mmol) and 2.8644 g (42.07 mmol) of
pyrazole, and 4.5377 g of NaOH (113.4 mmol) and 0.2398 g (1.934 mmol) of Na2CO3.H2O,
respectively, in 1000.0±0.3 mL volumetric flasks. The concentration of NaOH is verified by
titration with potassium hydrogen phthalate (0.1122±0.0003 M) and the solution is protected from
atmospheric CO2. Samples for pH and UV–vis measurements are prepared in 25.00±0.06 mL
volumetric flasks, by using 10.00 mL of a Cu(NO3)2/pyrazole (1:1 molar ratio) stock solution and
increasing amounts of the NaOH/Na2CO3 stock solution (up to a Cu:Hpz:NaOH molar ratio of
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1:1:3) or HNO3 (up to a Cu:Hpz:HNO3 molar ratio of 3:3:18), completed to 25.00 mL with water
followed by filtration.
2.4

Mass spectrometric measurements
Mass spectrometric analysis of the organic compounds and nanojars are performed by using

an electrospray ionization source. Sample solutions 10–4−10–5 M are prepared in CH3CN for
fluorinated compounds and nanojars, except for the nanojars with butyl or longer alkyl chain
substituents, in which case a 1:1 (vol.) mixture of CH3CN/THF is used, otherwise MeOH is used
for other organic compounds. Samples are infused by a syringe pump at 5 µL/min and nitrogen is
supplied as nebulizing gas at 500 L/h. The electrospray capillary voltage is set to –2.5 or +3.0 kV,
respectively, with a desolvation temperature of 110 °C. The sampling and extraction cones are
maintained at 40 V (100 V for nanojars with long alkyl chain substituents) and 4.0 V, respectively,
at 80 °C.
2.5
2.5.1

Solution preparation for 1H NMR monitoring
1

H NMR monitoring of the reaction of pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole
The procedures are reprinted with permission, from J. Org. Chem. 2017, 82, 10549−

10562.112 Copyright 2017 American Chemical Society.
Pyrazole-3(5)-carbaldehyde (3.2 mg, 0.033 mmol) is dissolved in ethanol-d6 (0.56 mL) by gently
heating in a firmly closed 1-dram vial. In the case of the acid-catalyzed experiments, DCl (35%
solution in D2O; 3.0 µL, 1.2 mg, 0.033 mmol) is added. After letting the solution cool down to
room temperature, 3(5)-aminopyrazole is added to obtain a 1:1 (2.7 mg, 0.033 mmol) or 1:2 molar
ratio (5.5 mg, 0.066 mmol) of aldehyde:aminopyrazole. The solution is mixed thoroughly and is
loaded immediately into an NMR tube. The 1H NMR monitoring experiment is started 3 minutes
after mixing the aldehyde with the aminopyrazole. Room temperature spectra are collected every
5 minutes for 40 minutes, then every 15 minutes up to a total reaction time of 24 hours. The
temperature of the instrument is then increased to 55 °C and spectra are collected after 5, 10 and
15 minutes, then every 30 minutes up to 24 hours.
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2.5.2

1

H NMR monitoring of deprotonation of 1-(tetrahydropyran-2-yl)pyrazole

1-(tetrahydropyran-2-yl)pyrazole (57 mg, 0.37 mmol) is dissolved in THF-d8 (1 g) and is
loaded into an NMR tube and purged with N2 three times and left under N2 atmosphere. The NMR
tube cooled down to –55 C and substoichiometric amount of nBuLi (1.6 M in hexanes) added to
the 1-(tetrahydropyran-2-yl)pyrazole THF-d8 solution via N2 purged syringe. 1H NMR was done
immediately after the addition of nBuLi, and peaks of both protonated and deprotonated species
were observed. Slight excess of nBuLi (1.6 M in hexanes) added, and variable-temperature 1H
NMR was done (t = 0 is immediately after addition of nBuLi). Variable-temperature 1H NMR
continued until the material decomposition above ~0 °C, and an off-white precipitate falls out of
the solution.
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CHAPTER 3

3

3.1

RESULTS AND DISCUSSION

Organic chemistry results

3.1.1 Solvent- and catalyst-free, quantitative protection of hydroxyl, thiol, carboxylic acid,
amide and heterocyclic amino functional groups
The results discussed in this section were originally published in Green. Chem. 2016, 18,
6209−6214,113 and are reproduced by permission of The Royal Society of Chemistry.
The reaction of neat DHP with various substrates bearing diﬀerent reactive functional groups, such
as hydroxyl, thiol, carboxylic acid, amide and heterocyclic amino groups, proceeds in the absence
of a catalyst at 125 °C to produce the THP-protected substrate, often in quantitative yield (Scheme
2.16, Table 3.1). Protection reactions employing DHP are typically carried out in the presence of
an acidic catalyst, which activates DHP by protonation.115 We find that while the catalyst-free
reaction does not occur at ambient temperature, the acidity of the substrate proton to be replaced
by the THP group increases suﬃciently at higher temperatures to enable reactivity in the absence
of a catalyst. Thus, many substrates are quantitatively protected at 125 °C. The proposed
mechanism of the protection reaction, by electrophilic addition of the substrate to DHP, is
exemplified with benzimidazole in (Scheme 3.1). The clean protection of benzimidazole by
quantitative transformation into 1-(tetrahydropyran-2-yl)benzimidazole is demonstrated in (Figure
3.1). After removing the excess DHP under vacuum, pure protected product is obtained
quantitatively. Further synthetic steps can be carried out on this intermediate in the same flask.
The utility of a same-pot protection step in telescoping syntheses had been illustrated with the onepot synthesis of 3-alkyl- and 3,5-dialkylpyrazoles.111, 110
As the first step in the protection mechanism is a proton transfer, substrates with increased
acidity are expected to be protected more readily by DHP, whereas less acidic substrates are
expected to have reduced reactivity. A series of substrates, with pKa values ranging from 4.2 to
27, have been tested (Table 3.1).
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Although a direct correlation between substrate acidity and reactivity toward DHP is indeed found,
the conversion is aﬀected by several other variables: miscibility of substrate and DHP, amount of
DHP employed, nucleophilicity of the atom to be protected, steric hindrance, reaction time and
reaction temperature. While the optimization of each variable for every substrate is beyond the
scope of this communication, the following guiding principles have been established.
Table 3.1: Protection of diﬀerent functional groups with DHP (at 125 °C in 24 h). pKa values
shown in italics represent predicted values, calculated using Advanced Chemistry Development
Software v11.02 (© 1994–2016 ACD/Labs). Conversions are based on the ratio of integrated 1H
NMR signals of the THP-protected product and the residual substrate, and are verified by 13C NMR
spectroscopy. Reproduced with permission, from reference 113.
Subtrate

DHP
(mole equiv)
16.0
8.0
4.0
4.0
1.1

Conversion
(%)
100
78
66
100
17

6.6

1.1

100

8.2

1.1

100

N

9.3

2.0

100

NO2

9.7

2.0

98

1.1
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1.1
1.5
2.0
3.0
4.0
8.0

50
71
80
83
85
90
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Table 3.1: Continued.
Subtrate

pKa

DHP
(mole equiv)

Conversion
(%)

10.3

2.0

100

SH

10.5

4.0

100

Cl

12.7

1.1

100

Br

12.7

1.1

100

12.8

2.0

100

13.0

8.0

100

3.0

100

1.5

98

1.1

100

2.0

100

1.1

62

14.6

2.0

100

14.9

1.1

100

5.0

100

1.1

50

8.0

0
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Table 3.1: Continued.
Subtrate

Structure

DHP
(mole equiv)
8.0
4.0
1.1
4.0
2.0
1.1

Conversion
(%)
100
90
60
100
97
71

17.0

8.0

0

17.5

8.0

0

27

8.0

0

pKa

O

Benzamide

16.0
NH2

1-Butanol

16.1

OH

Indole
N
H

Pyrrole
Aniline

NH

NH2

Scheme 3.1: Proposed mechanism of protection with 3,4-dihydro-2H-pyran (exemplified on
benzimidazole). Reproduced with permission, from reference 113.

3.1.1.1

Substrate acidity
Increasing acidity of the substrate favors conversion. For instance, pyrazole (pKa 14.2)

requires 24 hours for complete conversion (at 125 °C with 1.1 equiv. of DHP), while 1,2,3-benzotriazole (pKa 8.2) is completely protected in 6 hours. On the other hand, indole (pKa 17) and
aniline (pKa 27) are not protected at all. It is noted that all four substrates mentioned here are
miscible with DHP under the given reaction conditions. Consequently, we can predict that this
methodology should be suitable for the protection of substrates such as 1,2,3,4-tetrazole (pKa 4.9),
89

phthalimide (pKa 8.3), theophylline (pKa 8.8), purine (pKa 8.9) and 5,7-diazaindazole (pKa 9.6),
but not carbazole (pKa 17.1), isoindole (pKa 17.0) or less acidic substrates.

Figure 3.1: 1H NMR spectra documenting the quantitative protection of benzimidazole by 3,4dihydro-2H-pyran to give pure 1-(tetrahydropyran-2-yl) benzimidazole. Reproduced with
permission, from reference 113.

3.1.1.2

Miscibility of the substrate with DHP/Amount of DHP employed
The conversion is aﬀected if the substrate does not mix with the protecting agent (DHP).

In those cases, the conversion can be increased by using larger amounts of DHP. For example,
benzimidazole is more acidic (pKa 12.8) than pyrazole (pKa 14.2), yet under similar conditions
(1.1 equiv., 125 °C, 24 h) the conversion is only 83%. Increasing the amount of DHP to 2
equivalents, however, provides 100% conversion under the same reaction conditions. Similarly,
although indazole does not mix with DHP, 100% conversion can be achieved at 125 °C in 24 h
90

with 3 equiv. of DHP. In the case of 3,5-diphenylpyrazole, 100% conversion can be achieved (at
125 °C at 24 h) if 8 equivalents of DHP are employed.
3.1.1.3

Nucleophilicity of the atom to be protected
Although increasing acidity of the substrate facilitates the protonation of DHP (first step in

Scheme 3.1), decreasing nucleophilicity of the anionic intermediate (N−, O− or S−) is unfavorable
for the nucleophilic attack on the protonated, electrophilic DHP cation (second step in Scheme
3.1). Owing to the larger electronegativity of the O-atom and the delocalization of the negative
charge over three (vs. one) non-bonding electron pairs, O− is a much weaker nucleophile than N−.
Thus, despite a larger acidity compared to heterocyclic amines (such as pyrazole or imidazole),
only 50% conversion is observed for phenol under the same experimental conditions (1.1 equiv.
of DHP, 125 °C, 24 h). The nucleophilicity of carboxylates is further reduced by delocalization of
the negative charge over two O-atoms. Carboxylic acids, ca. one million times more acidic than
phenol, are only sparingly protected under the experimental conditions mentioned above.
Nevertheless, quantitative protection is achieved if DHP is used in excess (Table 3.1). In the case
of aromatic substrates, conjugation provides additional stabilization of the anionic intermediate
(phenoxide, carboxylate) and leads to even further reduction of nucleophilicity. Alcohols are more
easily protected than phenols (despite being ca. one million times less acidic than phenol), due to
the superior nucleophilicity of alkoxides compared to phenoxide. Sulfur, due to its low
electronegativity, larger size and better polarizability, is an excellent nucleophile; hence,
thiophenol is easily protected.
3.1.1.4

Steric hindrance
As expected, steric hindrance does hamper conversion. For example, while pyrazole is

completely protected in 24 hours (at 125 °C with 1.1 equiv. of DHP), 3,5-dimethylpyrazole is
converted only 50% under the same conditions, and 3,5-ditert-butylpyrazole is not protected at all.
These substrates have similar acidities and are all miscible with DHP under the reaction conditions.
3.1.1.5

Reaction time
Longer reaction times do not increase conversion significantly. For example, in the case of

3,5-diphenylpyrazole, extending the reaction time from 24 to 72 hours (at 125 °C with 5.0 equiv.
of DHP) leads to a marginal increase in conversion, from 92 to 96%. Similarly, in the case of
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benzimidazole, tripling the reaction time (at 125 °C with 1.1 equiv. of DHP) leads to an increase
in conversion from 83 to 93%, but completion is not reached.
3.1.1.6

Reaction temperature
Higher temperatures do favor conversion, as the acidity of the substrate increases with

temperature. For instance, pyrazole is protected only 92% after 20 hours at 125 °C; however,
complete protection is achieved if the temperature is raised to 150 °C. Lower temperatures can
also be employed, at the expense of lower conversions. At 100 °C, pyrazole is protected only 68%
(after 24 hours with 1.1 equiv. DHP); nevertheless, increasing the amount of DHP to 2.0 equiv.
provides 100% con-version under the same conditions. The combined influence of reaction
temperature, reaction time and amount of DHP in the case of pyrazole is illustrated in (Table 3.2).
Water is also found to react with DHP under the aforementioned conditions, providing an
equilibrium mixture of 5-hydroxypentanal and 2-hydroxytetrahydropyran, along with their THPprotected products, 5-(2-tetrahydropyranyloxy)pentanal and 2-(2-tetrahydropyranyloxy)tetrahydropyran.116,117,118,119 The reagents used in this study were not anhydrous; therefore, small amounts
of the above-mentioned compounds are observed in those products that are obtained in the
presence of DHP in large excess. These side-products are not observed if the reagents are
anhydrous, or if DHP is used in close to stoichiometric amounts.

Table 3.2: Protection of pyrazole using varying amounts of DHP, at different temperatures and
over varying periods of time. Conversions are based on the ratio of integrated 1H NMR signals of
THP-protected product and residual pyrazole. Reproduced with permission, from reference 113.
DHP (mole equiv)
1.1
1.1
8.0
8.0
1.1
2.0
1.1
1.1
2.0
2.0

Temp (°C )
125
125
125
125
100
100
150
150
150
150
92

Time (h)
24
20
4
8
24
24
14
9
14
9

Conversion (%)
100
92
22
42
68
100
94
89
100
91

3.1.2 Lithiation/alkylation of THP-pyrazole
The results discussed in this section were originally published in RSC Adv. 2015, 5, 24081–
24093,111 and are reproduced by permission of The Royal Society of Chemistry.
Lithiation of THP-protected pyrazole with nBuLi at −78 °C, followed by the addition of a primary
haloalkane, leads to 5-alkyl-1-(tetrahydropyran-2-yl)pyrazoles with excellent conversions, as
shown by 1H NMR (Table 2.1). As expected for SN2 nucleophilic substitutions in general, this
alkylation works best with least hindered, primary alkyl halides. Indeed, close to quantitative
conversions (89−99%) are obtained with 1-iodo- and even with 1-bromoalkanes (except for C16).
Under identical experimental conditions, secondary alkyl and vinyl iodides provide low
conversions (cyclohexyl: 16%; isopropyl: 7%; sec-butyl: <1%; vinyl: 7%), and no reaction is
observed with tert-butyl iodide and iodobenzene. Refluxing the reaction mixture under nitrogen
does not provide a significant improvement. Allyl- and benzyl bromides give conversions of 7%
and 36%, respectively. Isobutyl iodide (1-iodo-2-methylpropane), although a primary alkyl iodide,
also provides a poor conversion (7%), further evidencing that steric crowding around the
electrophilic reaction center is a critical limiting factor. Isopentyl iodide (1-iodo-3-methylbutane),
in which the branching is one carbon atom further from the reaction center, reacts efficiently, with
conversion similar to the n-butyl and n-pentyl analogs.
Lithiation/alkylation of THP-pyrazole were performed by two methods:
Method A. Initially, the alkylations were carried out with excess (10 mole %) iodoalkane,
to maximize the conversion of pyrazole to alkylpyrazole. Excellent conversions were obtained
indeed (94−100%, Table 2.1), and the small amounts (less than 6%) of unreacted 1(tetrahydropyran-2-yl)pyrazole left behind in the reaction mixture can easily be removed by gentle
heating under reduced pressure. The excess 1-iodoalkane (up to C7) can also be removed under
similar conditions, at temperatures that do not affect the product. The removal of the higher
iodoalkanes, however, becomes increasingly more difficult as their boiling point increases, and the
higher temperatures needed for the distillation (under reduced pressure) of C8 and longer
iodoalkanes lead to isomerization of the product and even loss of the protecting group. While this
is not a problem if the target is the preparation of unprotected 3(5)- alkylpyrazoles, the isolation
of pure THP-protected alkylpyrazoles (C8 and up) has to be performed by column chromatography.
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Pure 5-hexadecyl-1-(tetrahydropyran-2-yl)pyrazole is obtained, for example, by elution with
hexane/ethyl acetate (6:1) on a silica gel column.
Method B. To simplify the purification of THP-protected alkylpyrazoles (C8 and up) and
eliminate the need for chromatography, we next carried out alkylations with excess (10 mole %)
1-(tetrahydropyran-2-yl)pyrazole, instead of excess iodoalkane. In this case, the iodoalkane is
completely consumed during the reaction (except for C16), and the excess unreacted 1(tetrahydropyran-2-yl)pyrazole is readily removed by heating to 55−60 °C under reduced pressure
(0.1−0.2 mmHg) (Table 2.1: entries 11, 13, 15, 18, 20, 21).
3.1.3

1

H NMR confirmation of deprotonation site in THP-pyrazole

In order to confirm that the deprotonation/lithiation site in THP-pyrazole is the same site
of alkylation, we have monitored the deprotonation of 1-(tetrahydropyran-2-yl)pyrazole by nBuLi
in an NMR tube under an N2 atmosphere, using THF-d8 as solvent. The NMR tube containing the
1-(tetrahydropyran-2-yl)pyrazole solution was cooled down to –55 °C and a substoichiometric
amount of nBuLi (1.6 M in hexanes) was added. 1H NMR spectrum was recorded immediately
after the addition of nBuLi, and peaks of both protonated and deprotonated species were observed
(Figure 3.2). The spectrum is stable over time (1 hour). Next, a slight excess of nBuLi was added,
and variable-temperature 1H NMR spectra were recorded (t = 0 is immediately after addition of
n

BuLi) (Figure 3.3). No shifts are observed as time passes or as the temperature increases; however,

decomposition occurs above ~0 °C, and an off-white precipitate falls out of the solution.
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Figure 3.2: 1H NMR spectrum of 1-(tetrahydropyran-2-yl)pyrazole in THF-d8 at –55 ºC, immediately after a substoichiometric amount of nBuLi was added. Peaks of both the protonated (red)
and deprotonated (blue) species are observed. Reproduced with permission, from reference 110.

Figure 3.3: Variable-temperature 1H NMR spectra of 1-(tetrahydropyran-2-yl)pyrazole in THF-d8,
with a slight excess of nBuLi added. Reproduced with permission, from reference 110.
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3.1.4 I2-catalyzed thermal isomerization of 5-alkyl- to 3-alkyl-1-THP-pyrazoles
The results discussed in this section are reprinted with permission, from J. Org. Chem.
2016, 81, 1718−1722.110 Copyright 2016 American Chemical Society.
Isomerization of the unreactive 5-alkyl-1-THP-pyrazole isomer to the reactive 3-alkyl-1-THPpyrazole isomer, is crucial for the synthesis of 3,5-dialkyl-1-THP-pyrazole by further
lithiation/alkylation of monoalkyl-1-THP-pyrazole. Such protective group switching is usually
accomplished by an acid-catalyzed, sequential120 or direct121 deprotection-reprotection route.
Thermal isomerization of 5-alkyl- to 3-alkyl-1-THP-pyrazoles, presented herein, offers a new
green alternative, which eliminates the need for solvents, additional reagents and work-up. In
addition, presence of a catalytic amount of iodine (I2) greatly reduces the reaction time needed to
reach equilibrium. This discovery is rooted in our observation that when 5-hexyl-1-THP-pyrazole
is prepared from 1-iodohexane, it undergoes isomerization much faster than when it is prepared
from 1-bromohexane, under the same conditions. Indeed, addition of 0.08 mol% I2 to 5-hexyl-1THP-pyrazole prepared from 1-bromohexane reduces the isomerization time at 125 °C from 8 days
to 24 hours, confirming our hypothesis that trace amounts of iodine originating from 1-iodohexane
catalyze the isomerization. The mechanism of isomerization is likely similar to the one proposed
for the 2-(trimethylsilyl)ethoxymethyl chloride (SEM-Cl) catalyzed SEM group transposition in
SEM-protected pyrazoles,122 as well as the N,N-dimethylaminosulfonyl (DMAS), benzyl (Bn),
methoxymethyl (MOM) and SEM protecting group switching in N-protected imidazoles catalyzed
by DMAS-Cl, BnBr, MOM-Cl or SEM-Cl, respectively.123 The protecting agents listed above are
alkylating agents which, upon alkylation of the free N2-atom of the N1-protected diazole, induce
the elimination of the protecting group and render the N1-atom free. The liberated protecting group
alkylates the next substrate and propagates the reaction. In our case (Scheme 3.2), the alkylating
agent is presumed to be 2-iodotetrahydropyran,124 which initially forms from the reaction of 3,4dihydro-2H-pyran (formed in trace amounts as a result of partial deprotection of the substrate upon
heating111) with HI (formed from the reaction of I2 with the pyrazole ring, leading to 4iodopyrazole125). Alternatively, I2 can react directly with 3,4-dihydro-2H-pyran to produce 2,3diiodotetrahydropyran, which can react similarly to 2-iodotetrahydropyran as the initial alkylating
agent.
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Scheme 3.2: Proposed mechanism of the I2-catalyzed thermal isomerization of 5-alkyl- to 3-alkyl1-THP-pyrazoles (R = alkyl). Reproduced with permission, from reference 110.

3.1.5 One-pot telescoping synthesis of 3,5-dialkylpyrazoles
Aiming at greener preparative methods, we developed a telescopic synthesis of 3,5dialkylpyrazoles (53% overall yield based on 1H-pyrazole) by combining five synthetic steps into
a one-pot method (Scheme 2.4). The solvent- and catalyst-free quantitative step of pyrazole
protection and the solvent-free isomerization step of the unreactive 5-alkyl-1-THP-pyrazole to the
reactive 3-alkyl-1-THP-pyrazole isomer are both crucial to the value of this method. Our method
significantly reduces the consumption of organic solvents and additional reagents and eliminates
the use of highly toxic or explosive starting materials and reagents (such as hydrazine,
diazomethane, and derivatives, often employed for the synthesis of pyrazole derivatives). Because
the one-pot method requires no purification of the intermediates, losses are eliminated, and waste
production is greatly diminished.
Improved overall yields of 3,5-dialkylpyrazoles (60% based on 1H-pyrazole) are obtained if the
THP-protected 3,5-dialkylpyrazoles are purified before deprotection, as column chromatographic
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separation on the protected pyrazoles is more eﬃcient than on the deprotected products. Pure 3,5dialkylpyrazoles are obtained after deprotection with HCl and removal of the solvent in vacuum.
This new methodology could also be applied to the synthesis of various other 3,5-disubstituted
pyrazoles (e.g., alkyl, halogen, hydroxyl, amino, azido, carbonyl, organo-element substituents),
both symmetrical and unsymmetrical, by employing the appropriate electrophiles.
3.1.6 Reaction of amines with aldehydes and ketones
The results discussed in this section are reprinted with permission, from J. Org. Chem.
2017, 82, 10549−10562.112 Copyright 2017 American Chemical Society.
While it is well-known that the formation of Schiff bases from aromatic aldehydes and aromatic
amines is facilitated under acidic conditions,126 no Schiff base product (N,1-bis(pyrazol-3(5)yl)methanimine, 18 (Scheme 3.3)) is obtained from the reaction of pyrazole-3(5)-carbaldehyde
with 3(5)-aminopyrazole (1:1 molar ratio) in the presence of HCl in refluxing ethanol. Instead, a
complex mixture forms, from which bis(3(5)-aminopyrazol-4-yl)-pyrazol-3(5)-yl-methane 21
(Scheme 3.3) was isolated by crystallization and structurally characterized by single-crystal X-ray
diffraction (see section 3.2.4.4.3). When the same reaction is run at room temperature in the
absence of acid, however, an equilibrium mixture of Schiff base 18 and starting materials is
obtained (Scheme 3.3). In order to get insight into the reaction mechanism and to understand the
different outcomes described above, we monitored the reaction of pyrazole-3(5)-carbaldehyde
with 3(5)-aminopyrazole continuously by 1H NMR in ethanol-d6 (in NMR tube) under four
different conditions. Also, we ran the same reactions on a larger scale in ethanol and periodically
analyzed samples withdrawn from the reaction mixture by electrospray ionization mass
spectrometry (ESI-MS in CH3OH or CH3CN) in addition to 1H NMR (in DMSO-d6).
Complementing the 1H NMR spectroscopic study, the ESI-MS analysis provides crucial
information about the identities of the reaction intermediates and final products.
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Scheme 3.3: Diﬀerent outcomes of the reaction of pyrazole-3-carbaldehyde with 3(5)aminopyrazole in the absence or presence of HCl. Reproduced with permission, from reference
112.

3.1.6.1

Reaction monitoring by 1H NMR/ESI-MS and mechanistic details
Two observations need to be pointed out about the pyrazole-3(5)-carbaldehyde and 3(5)-

aminopyrazole starting materials, before considering their reaction. First, the as-prepared pyrazole3(5)-carbaldehyde is a dimer in the solid state,88,127 whereas in solution it has been reported to exist
as either the pure monomer (in pyridine-d6) or together with its dimeric forms (2:1 mixture of
monomer and dimers in DMSO-d6) (Scheme 3.4).127b

Scheme 3.4: Monomeric and dimeric forms of pyrazole-3(5)-carbaldehyde. Reproduced with
permission, from reference 112.
In our hands, the monomeric form was observed exclusively in both DMSO-d6 (δ 9.93,
7.93, 6.77 ppm) and ethanol-d6 (δ 9.91, 7.68, 6.77 ppm), implying dissociation of the insoluble
dimer upon dissolution (heating to ∼50 °C is required to speed up dissolution). In the presence of
HCl (1:1 molar ratio), the signal of the proton adjacent to the pyrazole N-atom is slightly shifted
in DMSO-d6 (δ 9.90, 7.89, 6.77 ppm), whereas in ethanol-d6 all three signals are drastically shifted
as the aldehyde is transformed into diethyl acetal (δ 8.30, 6.75, 5.84 ppm), with only small amounts
(1−2%) of aldehyde present (Figure 3.4). The formation of the acetal is also documented by ESIMS, which shows its Na+ adduct at m/z 193.1.
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Figure 3.4: DCl-catalyzed reaction of pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole (in 1:1
and 1:2 molar ratios) monitored over time by 1H NMR in ethanol-d6. Reproduced with permission,
from reference 112.
When 3(5)-aminopyrazole is added to the latter solution, the peak in the 1H NMR spectrum
corresponding to the free aldehyde (δ 9.90 ppm) is absent. Consequently, we conclude that the
reactive form is the monomeric aldehyde and that the equilibrium is continuously driven toward
the aldehyde, which is then immediately consumed.
Second, during the acid-catalyzed reactions in ethanol-d6, selective deuteration of 3(5)aminopyrazole at the C-4 position was observed.128 Thus, in the reaction with pyrazole-3(5)carbaldehyde, the signal of the 3(5)-aminopyrazole proton at the C-4 position disappears much
more rapidly than the one of the proton at the C-3 position (as seen in Figure 3.4).
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The following NMR studies, assisted by ESI-MS measurements, oﬀer important insights into the
mechanism of the reaction of 3(5)-aminopyrazole with pyrazole-3(5)-carbaldehyde.
3.1.6.1.1

Aldehyde/amine in 1:1 molar ratio in the absence of acid

The reaction of pyrazole-3(5)-carbaldehyde with 3(5)-aminopyrazole in ethanol-d6 in the
absence of an acid catalyst is slow at 25 °C and yields an equilibrium mixture of the Schiﬀ base
product 18 and starting materials (Figure 3.5). A maximum conversion of 90% is observed after
24 h. ESI-MS confirms the Schiﬀ base (18 + H+: m/z 162.1; 18 + Na+: m/z 184.1) as the only major
species observed besides the starting materials. If the reaction is run in anhydrous ethanol in the
presence of molecular sieves (3 Å), the equilibrium reaction is forced to completion by removing
the water byproduct from the reaction mixture. Thus, Schiﬀ base 18 is obtained with 100%
conversion.
3.1.6.1.2

Aldehyde/amine in 1:2 molar ratio in the absence of acid

The presence of a second equivalent (100% excess) of 3(5)-aminopyrazole forces the Schiﬀ
base-forming equilibrium reaction to completion (Figure 3.5). Thus, 100% conversion is obtained
after 24 h at 25 °C. The same outcome is obtained when excess pyrazole-3-carbaldehyde is
employed (Figure 3.6). The excess 3(5)-aminopyrazole can be separated from the Schiﬀ base
product by washing the solid residue (obtained after solvent evaporation) with dichloromethane.
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Figure 3.5: Reaction of pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole (1:1 and 1:2 molar
ratios) monitored over time by 1H NMR in ethanol-d6 (in the absence of acid, at 25 °C).
Reproduced with permission, from reference 112.
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Figure 3.6: Reaction of pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole (1.1:1 then 1.5:1
molar ratio) monitored over time by 1H NMR in ethanol-d6 (in the absence of acid). 10% excess
aldehyde is insufficient for driving the equilibrium reaction to completion; with a 50% excess, the
reaction is practically complete. Reproduced with permission, from reference 112.
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3.1.6.1.3

Aldehyde:amine in 1:1 molar ratio in the presence of acid

In contrast to the case without an acid catalyst, the reaction of pyrazole-3(5)-carbaldehyde with
3(5)-aminopyrazole in ethanol-d6 in the presence of DCl (1 equiv) at 25 °C yields no Schiff base.
Instead, a complex mixture is obtained slowly (Figure 3.4), which contains significant amounts of
unreacted starting materials along with compounds 19, 21, 50, 51, and 52 (Scheme 3.5) after 24 h.
Subsequent heating of the reaction mixture at 55 °C for 24 h leads to complete consumption of the
starting materials; also, 21 becomes more prominent in the final reaction mixture. Identification of
compounds 19, 21, 50, 51, and 52 in this complex mixture was facilitated by ESI-MS analysis,
which shows them as their H+ and/or Na+ adducts: 19 + H+ (m/z 240.1), 19 + Na+ (m/z 262.1), 21
+ H+ (m/z 245.1), 21 + Na+ (m/z 267.1), 50 + H+ (m/z 323.1), 50 + Na+ (m/z 345.1), 51 + H+ (m/z
401.2), 51 + Na+ (m/z 423.2), 52 + H+ (m/z 162.1), 52 + Na+ (m/z 184.1) (Figure 3.7).
3.1.6.1.4

Aldehyde:amine in 1:2 molar ratio in the presence of acid

If pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole are reacted in a 1:2 molar ratio in
the presence of DCl (1 equiv), the reaction is faster, and almost complete conversion to 21 is
observed after 22 h at 25 °C (Figure 3.4); heating the reaction mixture for 3 additional hours at 55
°C leads to 100% conversion. On a large scale, the reaction is complete after 30 min when refluxed
in ethanol at 78 °C. Using smaller amounts of DCl (0.01 equiv) or a weak acid (CH3COOH, 1
equiv) as a catalyst leads to the same product, although the reaction proceeds slightly slower.
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Scheme 3.5: Contrasted reaction mechanisms of the non-catalyzed (a) and acid-catalyzed (b)
reaction of pyrazole-3(5)-carbaldehyde with 3(5)-aminopyrazole. HB represents either water or
3(5)-aminopyrazole. Reproduced with permission, from reference 112.
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52+H+

19+H+

21+Na+

52+MeOH+Na+

50+Na+

52+Na+
52+MeOH+H+

19+Na+

Figure 3.7: ESI-MS spectrum (in CH3OH) of the DCl-catalyzed reaction mixture of pyrazole-3(5)carbaldehyde and 3(5)-aminopyrazole (1:1 molar ratio) in ethanol-d6. Deuterated analogues are
also observed. Reproduced with permission, from reference 112.
On the basis of the results presented above, two different reaction mechanisms are
proposed, depending on whether acid is absent or present (Scheme 3.5). The final outcome also
depends on the relative amounts of pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole. In the
absence of acid, only Schiff base 18 is obtained in equilibrium with the starting materials. The
equilibrium reaction is pushed to completion either by using excess amine or aldehyde reagent or
by removing the water byproduct from the reaction mixture. In the presence of acid, a completely
different outcome is observed. Although the dehydration of the carbinolamine addition product is
acid- catalyzed and would be greatly facilitated under acidic conditions, at the same time the rate
of the amine attack is reduced due to protonation. It has been shown that in Schiff base-forming
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reactions in general, the rate-determining step at neutral pH is the dehydration of the carbinolamine
intermediate, whereas under acidic conditions amine attack becomes the rate-determining step.126
In the special case of 3(5)-aminopyrazole, however, a different type of reactivity is promoted under
acidic catalysis: The C-4 position becomes highly reactive and leads to the preferential formation
of compound 52, which can further react with both the amine and the aldehyde reagents. Thus,
two different pathways ensue next, when the aldehyde/amine ratio is 1:1 (or anything less than
1:2). First, the nonequilibrium reaction of 52 with 3(5)-aminopyrazole leads to 21, which is stable
to both HCl and NaOH (in equimolar amounts) in refluxing ethanol solution. This irreversible
pathway leaves behind unreacted pyrazole-3(5)-carbaldehyde, which can react either with 21 or
with 52. Second, the reversible reaction of 52 with pyrazole-3(5)-carbaldehyde leads to Schiff base
19. At the same time, however, 21 can also react with pyrazole-3(5)-carbaldehyde, leading
reversibly to Schiff bases 50 and 51. Compound 19 was isolated in pure form from the reaction
mixture by column chromatography, along with pure 21; both are characterized by 1H and
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NMR spectroscopy (see Appendix A).
3.1.6.1.5

Reaction of bis(3(5)-aminopyrazol-4-yl)-pyrazol-3(5)-yl-methane 21 with 1 or 2
equivalents of pyrazole-3(5)-carbaldehyde

Pure bis(3(5)-aminopyrazol-4-yl)-pyrazol-3(5)-yl-methane 21 was reacted with either 1 or
2 equivalents of pyrazole-3(5)-carbaldehyde in anhydrous ethanol, in the presence of 3 Å
molecular sieves (25 °C, 10 days). In the case of the 1:1 reaction, all of the aldehyde is consumed
and an approximately equimolar mixture of 21, 50, and 51 is obtained, demonstrating that although
the Schiff-base forming reaction between 21 and pyrazole-3(5)-carbaldehyde is complete, the
resulting compound 50 disproportionates to 21 and 51 in an equilibrium reaction (Figure 3.8). In
contrast, in the case of the 1:2 reaction all of 21 is consumed, and the major product is 51; smaller
amounts of the aldehyde and 50 are still present after 10 days. Although 50 and 51 have not been
isolated in pure form, their 1H NMR signals could be distinguished in both mixtures by tracking
their time-dependent relative concentrations (Figure 3.8).
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Figure 3.8: Reaction of 21 with pyrazole-3(5)-carbaldehyde (1:1 and 1:2 molar ratio) in ethanol
(in the absence of acid) monitored periodically by 1H NMR (in DMSO-d6). Reproduced with
permission, from reference 112.
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When pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole are reacted in a 1:2 molar ratio
(or higher) in the presence of acid, 100% conversion to 21 is observed, which is easily obtained
pure, in high yield, by precipitation from the ethanolic reaction mixture with diethyl ether. In this
case, the intermediate 52 preferentially reacts with 3(5)-aminopyrazole to irreversibly form 21, as
documented by the absence in the 1H NMR spectrum of significant signals corresponding to
compounds 19, 50, 51, or 52. Even if small amounts of 52 would initially react with pyrazole-3(5)carbaldehyde to reversibly form 19, the latter compound equilibrates with 52, which in turn is
irreversibly and ultimately completely consumed by reacting with the remaining 3(5)aminopyrazole. Similarly, any amounts of 50 or 51 would eventually be completely consumed, as
the whole reaction mixture cleanly converges to 21.
The reaction pathways presented in (Scheme 3.5) were further tested by reacting Schiff
bases 18 and 19 with 3(5)-aminopyrazole (in 1:1 and 1:3 molar ratios, respectively) in refluxing
ethanol in the presence of HCl. Both reactions lead to the formation of 21, although slower than in
the case of the direct reaction of pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole in a 1:2
molar ratio. This observation is attributed to the fact that the Schiff bases first need to dissociate
into their aldehyde and amine constituents, before those can react via the pathway leading to 21.
Similarly, the complex mixture obtained from pyrazole-3(5)-carbaldehyde and 3(5)aminopyrazole in a 1:1 molar ratio in the presence of acid can be converted to 21 by adding
additional 3(5)-aminopyrazole to the reaction mixture.
It has become apparent that the unexpected reactivity of 3(5)-aminopyrazole at its C-4
position with an aldehyde reagent under acidic conditions, leading not to the expected Schiff base
18 but to 21 (as opposed to common amines), originates in the electron-donating ability of the
amino group attached to the pyrazole nucleus. Indeed, the reaction of 3(5)-hydroxypyrazole,
bearing a different electron-rich moiety, leads to an analogous product bis(3(5)-hydroxypyrazol4-yl)-pyrazol-3(5)-yl-methane (22) (see Table 2.2). Related products were also reported to result
from the reaction of aldehydes with various substituted hydroxypyrazoles. 129 The need for an
electron-donating substituent to activate the pyrazole nucleus toward the observed reactivity is
further demonstrated by the inability of the parent, unsubstituted pyrazole or 3(5)-methylpyrazole
to form a product analogous to 21 and 22 (see section 2.2.1.12). This reactivity is reminiscent of
the reaction of formaldehyde with phenol130 and aniline.131
109

3.1.6.1.6

Reaction of pyrazole-3(5)-carbaldehyde with 1-aminopyrazole

In order to observe the reactivity leading to the tris(pyrazolyl)methane product, the
activating amino group must be attached to the C-3(5) position of the pyrazole nucleus. Obviously,
if the amino group is at the C-4 position, such reactivity is precluded, and only the Schiff base is
expected as product. Under identical conditions as with 3(5)-aminopyrazole (1:2 molar ratio of
aldehyde/amine, reflux in ethanol with HCl), pyrazole-3(5)-carbaldehyde reacts with 1-aminopyrazole to yield exclusively the Schiff base N-(pyrazol-1-yl)-1-(pyrazol-3(5)-yl)methanimine 20
(Scheme 3.6). 3(5)-Amino-5(3)-methylpyrazole produces the expected tris(pyrazolyl)methane
product 23 (see section 2.2.1.8.3).
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Scheme 3.6: Reactivity difference between 3(5)-aminopyrazole and 1-aminopyrazole. Reproduced
with permission, from reference 112.

3.1.6.1.7

Unreactivity of 3-aminopyridazine with pyrazole-3(5)-carbaldehyde

Similar reactivity to 3-aminopyrazole has been observed with a related heterocycle, 2aminoindole,132 but not with 3-aminopyridazine (Scheme 3.7), the six-membered analogue of 3(5)aminopyrazole (see section 2.2.1.12). These results evoke a similar, drastic deprotonation reactivity difference, between five- and six-membered, methyl-substituted aromatic heterocycles.109
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Scheme 3.7: Reactivity difference between 3-amino derivatives of five- and six-membered
aromatic heterocycles. Reproduced with permission, from reference 112.

3.1.6.2

Factors affecting the acid-catalyzed reaction of 3(5)-amino- and 3(5)-hydroxypyrazole
with aldehydes or ketones
We carried out a comprehensive study of the reaction of 3(5)-aminopyrazole and 3(5)-

hydroxypyrazole with a variety of aldehydes and ketones (2:1 molar ratio, in the presence of HCl).
Thus, we compared the reactivity of aldehydes vs. ketones, and explored the effect on conversion
of aliphatic vs. aromatic substituents (with or without electron withdrawing/donating groups), as
well as steric bulk of the substituent. The obtained series of novel tris- and bis(pyrazolyl)methane
ligands and the corresponding conversions are shown in Table 2.2.
3.1.6.2.1

Aldehyde vs ketone and the effect of steric bulk

Although both aldehydes and ketones react to produce tris- or bis(pyrazolyl)methane
products, the conversion is considerably lower in the case of ketones due to steric hindrance
introduced by the second substituent on the carbonyl group. The effect of steric hindrance is clearly
evidenced in the pentanone isomer series (Table 2.2): a lower conversion is observed with 3pentanone (41, 36%) than with 2-pentanone (40, 40%), whereas cyclopentanone offers a higher
conversion (42, 45%). The conversion drops drastically in the case of ketones with phenyl
substituents: only 15% conversion is observed with acetophenone 43, and no reaction occurs at all
with benzophenone 44.
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3.1.6.2.2

Aliphatic vs aromatic substituents

Quantitative conversion is observed with all aromatic (non-enolizable) aldehydes,
regardless of the substituent (electron-withdrawing CN or electron-donating OH, 32–34). In
contrast, lower conversions are obtained in the case of formaldehyde 37 and aliphatic (enolizable)
aldehydes even in the absence of steric hindrance 38, due to competing side-reactions (such as
aldol condensation in the latter case) (Table 2.2).
3.1.6.3

Deamination of bis(3(5)-aminopyrazol-4-yl)methane derivatives
Deamination133 of 21, 24, 26, 28, and 30 was accomplished by conversion to the

corresponding diazonium salts followed by reduction with hypophosphorous acid (Scheme 2.14).
The reaction was carried out in a one-pot setup, where the diazonium salt is instantaneously
reduced upon its formation.134 Although quantitative conversions were observed, the yields of pure
deaminated products are lower due to difficulties in separating the products from the inorganic salt
byproducts, which are soluble in the same solvents as the products (see section 2.2.1.9).
3.1.6.4

One-pot, telescoping synthesis of bis(pyrazol-4-yl)-pyrazol-3(5)-yl-methane
The quantitative conversion of pyrazole-3(5)-carbaldehyde and 3(5)-aminopyrazole (1:2

molar ratio) to 21 in the presence of HCl allows for the telescoping synthesis of bis(pyrazol-4-yl)pyrazol-3(5)-yl-methane 45, without the need to isolate and purify compound 21 (Scheme 2.15).
Thus, the one-pot reaction offers a significantly improved yield of 45 (85% vs. 48%).
3.1.7 Deuteration of pyrazole derivatives at C-4 position by D2O
The results discussed in this section are reprinted with permission, from J. Org. Chem.
2018, 83, 1649 – 1653.114 Copyright 2018 American Chemical Society.
Here we present a preparative and kinetic study of selective C-4 deuteration of the 3(5)aminopyrazole 53 or 3(5)-hydroxypyrazole 54 nucleus in D2O in the presence or absence of DCl
or NaOD (Scheme 3.8), along with derivatives 55−60 (Figure 3.9). H/D exchange of 98−99% was
achieved in a single run in the case of substrates 53−59 dissolved in a 1.1% (0.30 M) solution of
DCl in D2O. Because of its poor solubility in water, 60 was deuterated in CD3OD (DCl 1.1%, 0.25
M) instead of D2O, which led to 95% H/D exchange for the C-4 position in a single run. The
maximum value of product D atom % attainable in one run depends on the isotopic purity of the
solvent and the catalyst and the ratio between substrate and deuterated solvent. If desired, higher
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D atom % values can be obtained by evaporating the solvent after the first run and repeating the
procedure with fresh solvent.

Scheme 3.8: Deuteration of 3(5)-amino/hydroxypyrazole substrates with D2O. Reproduced with
permission, from reference 114.
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Figure 3.9: Variously substituted 3(5)-amino/hydroxy-pyrazole substrates used in the deuteration
study.

3.1.7.1

Selectivity of deuteration at the pyrazole C-4 position
The selectivity of deuteration at the pyrazole C-4 position (following the fast deuteration

of the much more acidic NH groups) was demonstrated by conducting a reaction in an NMR tube
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equipped with a coaxial insert containing a solution of sodium 3-(trimethylsilyl)-1-propanesulfonate (DSS sodium salt) in D2O as reference. Monitoring the ratio of the proton signals of the
pyrazole C-3(5) position in 53 and of the reference proves that no deuteration occurs at the C-3(5)
position (Figure 3.10). Selective deuteration of the C-4 position is also corroborated by 13C NMR
spectroscopy, which shows a 1:1:1 triplet signal only for the C-4 pyrazole carbon atom (see
Appendix A); the splitting is due to coupling to deuterium (nuclear spin = 1). The deuteration is
further confirmed by high-resolution mass spectrometry (see section 2.2.1.14). Consequently, the
proton at the pyrazole C-3(5) position can also be used as an internal reference in kinetic
experiments, as described in the following section.

Figure 3.10: 1H NMR monitoring of the selective deuteration of 3(5)-aminopyrazole 53 in D2O
with 100 mol % DCl (1:1 molar ratio relative to the substrate) at 25 °C, using sodium 3(trimethylsilyl)-1-propanesulfonate in D2O as reference in a coaxial insert. Reproduced with
permission, from reference 114.
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3.1.7.2

Study the kinetics of H/D exchange
To study the H/D exchange kinetics, we monitored the progress of the deuteration reaction

of 53−60 over time using 1H NMR spectroscopy. At varying intervals of time, the fraction of the
deuterium-exchanged substrate was determined by integrating the peak corresponding to the
exchanging proton (pyrazole C-4 position) against an internal reference proton peak from the
substrate (pyrazole C-3(5) position for 53 and 54, CH3 protons for 55, 56 and 58, phenyl protons
for 60) or an external reference (CH3 protons of DSS sodium salt in coaxial tube in the case of 59).
The reactions were monitored until no further deuteration occurred (Figure 3.10 and Appendix A),
and the maximum D atom % obtained was determined. Plotting the natural logarithm of the
substrate molar concentration against time produces a straight line in all cases, indicating a firstorder reaction with respect to the pyrazole substrate (Figure 3.11). Overall, the deuteration reaction
is pseudo-first-order, as the deuterating agent (solvent) is in large excess. The corresponding rate
constants and half-lives are collected in Table 3.3. In the case of 3(5)-aminopyrazole 53, an
activation energy of 79 kJ/mol is derived from the rate constants obtained at 25 and 70 °C, by
using the Arrhenius equation.

Figure 3.11: Plot on a logarithmic scale of the molar concentration of 3(5)-aminopyrazole 53
during deuteration in D2O with 100 mol % DCl at 25 °C, indicating first-order kinetics.
Reproduced with permission, from reference 114.
115

Table 3.3: Kinetic data for the deuteration of substrates 53‒59 (0.30 M in D2O) and 60 (0.25 M in
CD3OD) at 25 °C, along with the maximum D atom% obtained. Notes: a) reaction was not
monitored until completion; 90% deuteration was observed after 40 days; b) At 70 °C. c) value
could not be determined because complete deuteration was observed before the first NMR scan;
d) values are obtained in CD3OD, as 60 is poorly soluble in D2O. Reproduced with permission,
from reference 114.
Substrate

53

54
55
56
57
58
59
60

3.1.7.2.1

Catalyst
k (h‒1) t1/2 (h)
no catalyst
0.0017 408
b
no catalyst
0.10
6.8
DCl (100 mol %)
0.82
0.85
DCl (10 mol %)
0.79
0.88
DCl (1 mol %)
0.11
6.3
NaOD (100 mol %) 0.11
6.3
DCl (100 mol %)
0.28
2.5
DCl (100 mol %)
4.8
0.14
DCl (100 mol %)
2.1
0.33
DCl (100 mol %)
c
c
no catalyst
0.0084
83
DCl (100 mol %)
2.8
0.25
DCl (100 mol %)
10
0.069
d
DCl (100 mol %)
2.4
0.29d

D (%)
a
99
99
99
98
98
98
99
99
99
98
99
99
95d

Factors influencing the rate of the deuteration reaction

Analysis of (Table 3.3) reveals that both the reaction conditions and the substituents of the
pyrazole substrate influence the rate of the deuteration reaction.
3.1.7.2.1.1

Influence of temperature and acid/base catalyst

In the absence of a catalyst, the deuteration of 3(5)-aminopyrazole 53 by D2O at ambient
temperature is very slow (half-life: 408 h at 25 °C); at a higher temperature, however, a
considerably faster rate is observed (half-life: 6.8 h at 70 °C). Catalysis by DCl (1 mol %) or NaOD
(100 mol %) at 25 °C reduces the half-life from 408 to 6.3 h, whereas larger DCl amounts of 10
and 100 mol % lead to a further reduction in half-life to 53 and 51 min, respectively (Figure 3.12).
These observations are in favor of the reaction mechanism shown in Scheme 3.9. The fact that an
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amount of a strong base (NaOD, 100 mol %) leads to a much smaller rate increase than the same
amount of a strong acid (DCl, 100 mol %) indicates that the second step, of proton abstraction
from the conjugated acid of the pyrazole substrate (catalyzed by a base), is faster than the first step
of formation of the conjugated acid. Therefore, the rate-determining step is the acid-catalyzed D
atom transfer from the electrophilic deuteration agent (D3O+ stronger electrophile than D2O) to the

D atom %

nucleophilic pyrazole substrate.
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70
60
50
40
30
20
10
0

100 mol% DCl, 25 ºC
10 mol% DCl, 25 ºC
1 mol% DCl, 25 ºC

100 mol% NaOD, 25 ºC
no catalyst, 70 ºC
no catalyst, 25 ºC

0

100

200

300

400

time (min)
Figure 3.12: Progress of the deuteration of 3(5)-aminopyrazole 53 in D2O under different
conditions. Reproduced with permission, from reference 114.

Scheme 3.9: Proposed noncatalyzed (a) and acid-catalyzed (b) mechanisms of deuteration (B−D
represents D2O). In the case of the NaOD-catalyzed reaction, B– represents DO–. Reproduced with
permission, from reference 114.
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3.1.7.2.1.2

Influence of the pyrazole substituents

All pyrazole substituents studied, including electron-donating (OH, CH3, tBu) and electronwithdrawing (C6H5, CF3) groups, lead to an increased rate of deuteration (Table 3.3, Figure 3.13).
Electron-donating groups increase the nucleophilicity of the pyrazole substrate, promoting D atom
transfer from the electrophilic deuteration agent, whereas electron-withdrawing groups facilitate
proton elimination from the intermediate by increasing its acidity. In the case of CH3 or tBu
substituents at the pyrazole 3(5)-position, the rate constant increases by a factor of ∼3, whereas an
N−CH3 substituent on the pyrazole nucleus adjacent to the NH2 group leads to an increase by a
factor of ∼6. A CF3 substituent at the pyrazole 3(5)-position leads to an even larger increase of the
rate constant by a factor of ∼12; an OH substituent at the same position increases the rate so
drastically that complete deuteration of the C-4 position is observed in less than 3 min (before the
first NMR scan is obtained).

Figure 3.13: Progress of the deuteration of differently substituted 3(5)-aminopyrazoles at 25 °C in
D2O with 100 mol % DCl. Reproduced with permission, from reference 114.
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3.1.7.3

The role of the amino/hydroxy group in the C-4 deuteration of the pyrazole
To demonstrate the role of the NH2 group in the C-4 deuteration of the pyrazole nucleus,

we carried out analogous reactions with the parent, nonsubstituted pyrazole, as well as with other
electron-donor groups, namely 3(5)-methylpyrazole and 3(5)-hydroxypyrazole. Using 100 mol %
DCl in D2O, 3(5)-aminopyrazole is deuterated 99% at the C-4 position after 8 h at 25 °C. Under
the same conditions, only 7% and 10% deuteration is observed with the parent pyrazole and 3(5)methylpyrazole, respectively. In the case of 3(5)-hydroxypyrazole, however, 96% deuteration is
obtained after 8 h at 25 °C. We conclude that a strong electron-donor group, such as NH2 or OH,
is required to activate the pyrazole nucleus toward facile deuteration of its C-4 position. In
addition, other pyrazoles bearing groups such as NHR, NR2 or OR (R = various substituents) are
also expected to undergo efficient deuteration.
3.1.7.4

The effect of the amino group position and the ring size on the deuteration reaction
In order to obtain the observed deuteration of the pyrazole nucleus, we demonstrated that

the activating amino group must be attached to the C-3(5) position. Under the same experimental
conditions that lead to practically complete deuteration of the C-4 position of 3(5)-amino-pyrazole
(100 mol % DCl, 25 °C, 8 h), virtually no C−H deuteration is observed in the case of 4aminopyrazole (61, Figure 3.14) and 1-aminopyrazole 62. It is also interesting to note that no
deuteration is observed in the case of 3-aminopyridazine 63, the six-membered analogue of 3(5)aminopyrazole. This observation is consistent with other results, which show a similar, drastic
deprotonation reactivity difference between five- and six-membered, methyl-substituted aromatic
heterocycles.109

53

61

62

63

Figure 3.14: Different isomers of aminopyrazole 53, 61, and 62 along with 3-aminopyridazine 63
used in the deuteration study. Reproduced with permission, from reference 114.
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3.1.8 Reactivity differences of five- vs. six-membered aromatic molecules
The results discussed in this section are reprinted with permission, from Org. Lett. 2014,
16, 4680−4683.109 Copyright 2014 American Chemical Society.
Methyl-substituted, six-membered aromatic molecules are deprotonated to benzylic carbanions,
whereas deprotonation of 3(5)-methylpyrazole (NH protected) occurs at an endocylic CH group
(Scheme 3.10).
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Scheme 3.10: Deprotonation of 3(5)-methylpyrazole 64 and 3-methylpyridazine 65 (R =
Protecting group).
The results of quantum mechanical computations at the MP2/6-311+G(d,p) level in the gas
phase concur with the experimental findings, showing that the deprotonated product of 64 (R = H)
on C5 of the aromatic ring 64b is more stable than the one deprotonated on the methyl group 64a
by 13.1 kcal/mol (enthalpy, equivalent to a pKa difference of 9.5). In contrast, 65a is more stable
than 65b by 18.9 kcal/mol (pKa difference of 13.7). The higher stability of 65a compared to 64a
is originating from the much higher conjugation energy in the substituted six-membered rings than
in the five-membered rings. On average, the conjugation effect stabilizes the deprotonated product
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a by 21 kcal/mol more in the six-membered rings than in the five-membered rings. This is due to
the lowering of the LUMO orbitals with the enlargement of the conjugated ring. In terms of VB
theory, there are more resonance structures for six-membered rings than five-membered rings,
leading to higher resonance energies in the former. Obviously, in both 64b and 65b there is
negative hyperconjugation from the in-planar lone pair on the deprotonated carbon (C5 in 64b and
C6 in 65b) to adjacent σ anti-bonds in the form of n → σ*. Both the conjugation and
hyperconjugation effects can be visualized with the electron density difference (EDD) between ΨD
(delocalized ground state of a or b) and ΨL (reference electron-localized resonance state of a or
b), as shown in Figure 3.15.

64a

65a

64b

65b

Figure 3.15: Electron density difference (EDD) maps showing the conjugation in a and the
hyperconjugation in b for deprotonated 3-methylpyrazole 64 and 3-methylpyridazine 65. The blue
and red colors represent loss or gain of electron density, respectively. Reproduced with permission,
from reference 109.
It can be seen that the delocalization of the negative charge from the substituted methylene
group to the ring is more extensive and significant in 65a (pyridazine) than in 64a (pyrazole),
whereas the hyperconjugation effect mainly occurs from the endocyclic carbon (C5 for 64b and
C6 for 65b) to the adjacent σ bonds. The reduction of the conjugative stabilization from 65a to
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64a (23.1 kcal/mol) is significant, but still not enough to explain the change of the energy
difference between the two deprotonated products (32.9 kcal/mol).
After the concept of a hybrid orbital was initially proposed by Pauling,135 it has been well
understood that hybridization is closely related to bond length, bond strength, and bond angle.136
In our case, the hybridization of the carbon atoms in the five-membered rings is different from the
one in the six-membered ring. The computational calculations revealed that the deprotonation
energy decreases with the reduction of the NCC angle. This can be explained by the enhancement
of the s character in the hybrid orbital of the central carbon atom and the subsequent increase of
the C−H bond polarity. With a bond angle (φ) of 108° in 64 and 120° in 65, we can predict that
rehybridization would favor the deprotonation of 64 at C5 over the deprotonation of 65 at C6 by
9−10 kcal/mol. This correlates well with the observed difference of the nondelocalization effect
(ΔXE) between 64 and 65 (9.2 kcal/mol).
3.1.9 Deprotonation reactivity differences between 3-alkyl- and 5-alkyl-1-THP-pyrazole
isomers
The results discussed in this section are reprinted with permission, from J. Org. Chem.
2016, 81, 1718−1722.110 Copyright 2016 American Chemical Society.
N-protected 3-alkylpyrazoles are easily deprotonated by nBuLi at the 5-position of the aromatic
ring, while the 5-alkyl isomers are completely unreactive under the same conditions (Scheme
3.11).
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Scheme 3.11: Deprotonation of 3-methyl-1-R-pyrazole 64 and 5-methyl-1-R-pyrazole 66 isomers.
R = methyl (computations) or tetrahydropyran-2-yl (synthesis). Reproduced with permission, from
reference 110.
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The computational study revealed that the 1,3-dimethylpyrazole 64 and 1,5dimethylpyrazole 66 isomers are essentially isoenergetic at the HF or MP2 theoretical levels.
However, their deprotonated products have very different energies: 64b is much more stable than
66a. The conventional explanation is the ALP effect, which suggests that the repulsion between
the two lone pairs on the adjacent carbon and nitrogen atoms destabilizes 66a.73f,137 The
calculations based on the pairwise Coulomb interaction show that there is indeed a slight decrease
(2.2 kcal/mol) from the repulsion between the two lone pairs in 66a to the repulsion between the
single lone pair with the σCN bond in 64b (Figure 3.16). This amount, however, is small and is
correlated to the structural change, i.e., the CN bond in these two species.

64b

66a

Figure 3.16: Adjacent pair–pair Coulomb interactions in 64b and 66a (a.u.). Reproduced with
permission, from reference 110.
Further investigation into the electron delocalization effect in these systems.138 Table 3.4
compiles the major results, where DE(total) is the energy change between a fully delocalized and
a fully localized Lewis state (the most stable resonance structure) and DE(π) and DE(σ) refer to
the energy change by localizing π- and σ-electrons, respectively. The sum of DE(π) and DE(σ) is
very close to DE(total), suggesting negligible coupling between the delocalizations of σ- and πelectrons. It is interesting that there is little change from 64 and 66 to 64b and 66a for the σelectron delocalization in isomers (64 vs 66 and 64b vs 66a). However, the π-conjugation in 66a
is less stabilizing than in 64b by 13 kcal/mol, which accounts for 60% of the energy gap between
64b and 66a. With all electron pairs localized on either two atoms (bonds) or individual atoms
(lone pairs), 64b is still more stable than 66a by 8 kcal/mol, which most likely is a consequence
of electrostatic interactions: there is an H nucleus and a CH3 group around the negatively charged
carbon in 64b but only a single H nucleus in 66a (Figure 3.16). Therefore, we conclude that it is
not the repulsion between adjacent lone pairs of electrons (ALP effect) that leads to the drastic
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difference between the deprotonation energies of the two isomers, but rather reduced π-resonance
(62% or 13 kcal/ mol) and attractive electrostatic interactions (38% or 8 kcal/ mol).

Table 3.4: Relative energies of 66 vs 64 and 66a vs 64b in addition to their inherent electron
delocalization energies (DEs) for σ- and π-electrons (kcal/mol). Reproduced with permission, from
reference 110.
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Metal–organic/coordination chemistry

3.2.1 Synthesis and fractionation of nanojars
3.2.1.1

Synthesis and study of the properties of carbonate-nanojars
The results discussed in this section were originally published in Dalton Trans. 2016, 45,

8327−8339,104 and are reproduced by permission of The Royal Society of Chemistry.
Nanojars of the general formula [CO32−Ì{Cu(OH)(Rpz)}n] (pz = pyrazolate anion, R = substituent(s), n = 27−31) are synthesized using a one-pot reaction, by stirring copper(II) nitrate, the
pyrazole ligand (or a 1:1 mixture of two different pyrazole ligands) and a base (Cu:Rpz:OH in
1:1:2 molar ratio) in tetrahydrofuran for three days. Various hydroxides, such as MOH (M = Li+,
Na+, K+, Rb+, Cs+, Bu4N+, Et4N+) and M(OH)2 (M = Sr2+, Ba2+) can be employed as bases, along
with the corresponding carbonates, which provide the incarcerated CO32− ion. Alternatively,
copper carbonate Cu2CO3(OH)2 can be used both as copper- and carbonate-source, although it
provides lower yields than the THF-soluble copper(II) nitrate.
Tetrabutylammonium was initially used as counterion in all cases, as it had been shown to
promote crystallization. In the case of highly hydrophobic nanojars based on pyrazoles with butyl
or longer alkyl substituents, however, no ESI-MS signals can be detected when the counterion is
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Bu4N+. The lack of ionization is attributed to extensive ion-pair formation, due to strong
hydrophobic interactions between the long alkyl chains of the nanojars and the large Bu4N+
counterions. Alkali metal counterions (Li+, Na+, K+, Rb+, Cs+) offer partial remedy for the problem,
although in this case the MS signal is weakened by another factor: highly hydrophobic nanojars
are insoluble in neat acetonitrile, therefore less polar tetrahydrofuran has to be added to the MS
solvent in a 1:1 ratio to achieve solubility, which further suppresses the MS signal. Et4N+ behaves
similarly to Bu4N+, although it does induce noteworthy changes in the crystal structure of the
nanojar (see Crystallography section). Besides tetraalkylammonium and alkali or alkaline-earth
metal cations, [KÌ18-crown-6]+ has also been successfully employed as counterion, which forms
in-situ when 18-crown-6 is added to the reaction mixture. The identity of a particular counterion
associated with the nanojar is confirmed by ESI-MS(+) (of the metal cations, only Rb+ and Cs+
have m/z values within the mass spectrometer’s detection window). The size distribution of the
different [CO32−Ì{Cu(OH)(pz)}n] nanojars (n = 27−31) varies slightly with the particular reaction
conditions, such as the copper source, counterion and the base. In contrast, a much more
pronounced variation is produced by the different substituents on the pyrazole ligands.
3.2.1.1.1

Effect of pyrazole substituents on carbonate-nanojar structure

As seen in Figure 3.17, the pyrazole 4-positions point radially away from the nanojar.
Therefore, no steric hindrance is predicted to be caused by substituents in the 4-position.
Substitution at the pyrazole 3- and/or 5-positions, however, is expected to be more critical for
nanojar formation, due to the all-cis configuration of the pyrazole ligands, which places
substituents on the pyrazole units close to the neighboring ligands. The steric hindrance is expected
to be most significant for the two smaller side-rings, with pyrazole units pointing to the same side
of the ring, while the larger, central ring can relieve the hindrance by orienting the pyrazole units
alternately above and below the ring mean-plane (see also sections 3.2.4.4.13 and 3.2.4.4.14 ).
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Figure 3.17: Space-filling models of [CO3Ì{Cu(OH)(4-Rpz)}27]2– nanojars (from left to right:
R = H, Me, nBu, nOct). Reproduced with permission, from reference 104.
All experiments discussed below are carried out in tetrahydrofuran as reaction medium, an
excellent solvent for all nanojars, but not for the NaNO3 by-product, which precipitates out of the
reaction medium. The product mixtures are analyzed by ESI-MS in acetonitrile solutions, or, in
the case of pyrazoles with butyl or longer chains, in a less polar CH3CN/THF (1:1) mixture.
Although the relative intensity of ESI-MS signals is dependent on individual ionization
efficiencies, the various [CO3Ì{Cu(OH)(pz)}n]2− nanojars (n = 27−31) have identical charge and
very similar size and shape, and are expected to have similar ionization efficiencies under identical
ESI-MS conditions. Therefore, the observed ESI-MS signals should provide reliable information
about the relative concentration of different nanojars based on the same ligand in a given solution.
Indeed, this has been confirmed for nanojars based on the parent pyrazole ligand, using 1H NMR
spectroscopy.105 In the case of the mixed-pyrazole nanojars, however, ionization efficiencies drop
drastically as the amount of the hydrophobic ligand component within a nanojar of a given size
increases.
Formic acid is commonly used as an additive for mobile phases in reversed-phase liquid
chromatography separations, as a buffer component, to improve peak shapes, and to promote
ionization by producing [M+H]+ ions. We find that nanojars are extremely sensitive to even traces
of formic acid in the mass spectrometer; consequently, substituted nanojar species
[CO32−Ì{Cun(OH)n(HCOO)y(pz)}n−y] (y = 1−3) are inevitably found in most spectra (at slightly
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lower m/z values than the pure nanojar), unless the instrument is opened up and thoroughly cleaned
prior to injection of nanojar samples. In addition, adduct species are also observed occasionally,
at larger m/z values than the pure nanojar.
3.2.1.1.1.1

Substitution of the pyrazole 4-position

Nanojars [CO3Ì{Cu(OH)(4-Rpz)}n]2– (n = 27−31) based on pyrazoles substituted in the 4position with chains of varying lengths (up to 11 atoms) have been successfully prepared (Table
3.5), indicating that linear chains do not interfere with nanojar formation, regardless of their length
(Figure 3.17). In addition, nanojars with R = F, Cl, Br, I, phenyl and CF3 have been observed
(Table 3.5 entries 2−5, 14, 15), showing that moderately bulky groups in the immediate vicinity
of the pyrazole 4-position are also tolerated. In the case of 4-trifluoromethylpyrazole, a
hexanuclear species [Cu6O2(4-CF3pz)9]- (m/z 1629) is also formed beside the nanojars. Pyrazoles
with potentially coordinating moieties (R = SO3H, COOH, CH=O, OH) in the 4-position do not
form nanojars: only insoluble, presumably polymeric products are obtained in those cases. With
4-nitropyrazole (LH), a soluble mixture of mono- to hexanuclear species (as indicated by the Cuisotope pattern of the ESI-MS signals) is obtained (Figure 3.18). Within this mixture, [CuL2]− (m/z
288), [Cu2L4]− (m/z 575), [NaCu3OL3(NO3)2]− (m/z 690), [Cu3OL5]− (m/z 767), [Cu4O2L6]− (m/z
959), [(Bu4N)Cu3OL6]− (m/z 1122) and [Cu6O2L9]− (m/z 1422) are identified as major components.
The structure of related di-, tri-, tetra- and hexanuclear copper(II)-pyrazolate species has been
established by X-ray diffraction.67,69,94,139,140 Partial reduction of Cu2+ to Cu+ during ESI-MS is
also common.141
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Table 3.5: [Nanojar]2− species with differently substituted pyrazoles detected by ESI-MS(–).
Occasionally, minor amounts of singly-charged [Counterion+(Nanojar2−)]− species are also
observed (not shown). Reproduced with permission, from reference 104.
Entry

Pyrazole (LH)

1

HpzH

2

4-FpzH

3

4-ClpzH

4

4-BrpzH

5

4-IpzH

6

4-EtOpzH

7

4-MepzH

8
9

4-nBupzH
4-nOctpzH

10

4-(HOCH2CH2CH2)pzH

11

4-(CH3OCH2CH2O)pzH

12

4-(CH3(OCH2CH2)2O)pzH

13
14

4-(CH3(OCH2CH2)3O)pzH
4-CF3pzH

15

4-PhpzH

16
17
18
19
20

3-MepzH
3-EtpzH
3-nPrpzH
3-nBupzH
3-nOctpzH
3-CF3pzH/HpzH
(1:1)

21

Nanojar [CO3Ì{Cu(OH)L}n]2–
m/z 2023 (n = 27), 2171 (n = 29), 2244 (n = 30), 2318
(n = 31)
m/z 2266 (n = 27), 2431 (n = 29), 2514 (n = 30), 2597
(n = 31)
m/z 2488 (n = 27), 2670 (n = 29), 2761 (n = 30), 2852
(n = 31)
m/z 3088 (n = 27), 3314 (n = 29), 3428 (n = 30), 3541
(n = 31)
m/z 3723 (n = 27), 3996 (n = 29), 4133 (n = 30), 4270
(n = 31)
m/z 2618 (n = 27), 2809 (n = 29), 3001 (n = 31)
m/z 2212 (n = 27), 2374 (n = 29), 2455 (n = 30), 2536
(n = 31)
m/z 2780 (n = 27), 2984 (n = 29), 3188 (n = 31)
m/z 3538 (n = 27), 3798 (n = 29), 4058 (n = 31)
m/z 2807 (n = 27), 2910 (n = 28), 3013 (n = 29),
3116 (n = 30), 3218 (n = 31)
m/z 3023 (n = 27), 3245 (n = 29), 3466 (n = 31)
m/z 3618 (n = 27), 3751 (n = 28), 3883 (n = 29),
4016 (n = 30), 4149 (n = 31)
m/z 4212 (n = 27), 4522 (n = 29), 4832 (n = 31)
m/z 2941 (n = 27), 3157 (n = 29), 3372 (n = 31)
m/z 3050 (n = 27), 3274 (n = 29), 3386 (n = 30),
3498 (n = 31)
m/z 2455 (n = 30)
m/z 2665 (n = 30)
m/z 2876 (n = 30)
m/z 3086 (n = 30)
m/z 3928 (n = 30)
[CO3Ì{Cun(OH)n(3-CF3pz)y(pz)n−y}]2–
(n = 27, 29, 30; y ≈ 3−17) m/z 2125−2822
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Table 3.5: Continued.
Entry

Nanojar [CO3Ì{Cu(OH)L}n]2–

Pyrazole (LH)
3-PhpzH/HpzH
(1:1)

[CO3Ì{Cun(OH)n(3-Phpz)y(pz)n−y}]2–
(n = 27, 29; y ≈ 5−19) m/z 2251−2893

23

3,5-Me2pzH/HpzH
(1:1)

[CO3Ì{Cun(OH)n(3,5-Me2pz)y(pz)n−y}]2–
(n = 27−31, y ≈ 0−14) m/z 2023−2515

24

3,5-Me2-4-nOctpzH/HpzH
(1:1)

[CO3Ì{Cun(OH)n(3,5-Me2-4-nOctpz)y(pz)n−y}]2–
(n = 29−31, y ≈ 11−17) m/z 3015−3366

25

3,5-Et2pzH/HpzH
(1:1)

[CO3Ì{Cun(OH)n(3,5-Et2pz)y(pz)n−y}]2–
(n = 27−32, y ≈ 0−15) m/z 2023−2813

26

3-nBu-5-nHexpzH/HpzH
(1:1)

27

3-Me-5-CF3pzH/HpzH
(1:1)

[CO3Ì{Cun(OH)n(3-nBu-5-nHexpz)y(pz)n−y}]2–
(n = 27, 29−31, y ≈ 0−6) m/z 2023−2665
[CO3Ì{Cun(OH)n(3-Me-5-CF3pz)y(pz)n−y}]2–
(n = 27, 29, 30, y ≈ 0−11) m/z 2023−2696

22

Figure 3.18: ESI(–) spectrum of the product mixture obtained from Cu(NO3)2, 4-NO2pz, NaOH,
Bu4NOH, and Na2CO3. Reproduced with permission, from reference 104.
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3.2.1.1.1.2

Substitution of the pyrazole 3(5)-position

Alkyl substituents of various lengths (e.g., methyl to n-octyl) are also tolerated at the
pyrazole 3(5)-position (Table 3.5). It is likely that the longer alkyl chains turn away from the
nanojar after the first CH2-unit connected to the pyrazole nucleus, thus avoiding interference from
neighboring pyrazole units of the same Cux-ring. In contrast to 4-alkylpyrazoles, the Cu30-nanojars
[CO3Ì{Cu(OH)(3-Rpz)}30]2– are obtained almost exclusively with 3(5)-alkylpyrazoles. No
nanojars can be observed with bulky phenyl or CF3 substituents at the pyrazole 3(5)-position,
which yield only smaller, Cu1−Cu6 species. However, a 1:1 molar mixture of 3(5)-PhpzH and
HpzH affords an approximately Gaussian distribution of nanojars [CO3Ì{Cun(OH)n(3Phpz)y(pz)n−y}]2– (Figure 3.19; major species: n = 29, y ≈ 5−19). Similarly, a 1:1 mixture of 3(5)F3CpzH and HpzH produces a series of nanojars [CO3Ì{Cun(OH)n(3(5)-F3Cpz)y(pz)n−y}]2–
(Figure 3.20; major species: n = 30, y ≈ 6−17), beside lower nuclearity species [Cu(3-CF3pz)2]−
(m/z 334), [Cu3O(pz)(3-CF3pz)4]− (m/z 814), [Cu3O(3-CF3pz)5]− (m/z 882), [Cu4O(pz)(3CF3pz)2(3-CF3pzH)4]− (m/z 1152), [Cu4O(3-CF3pz)3(3-CF3pzH)4]− (m/z 1220). These latter two
experiments demonstrate that some but not all pyrazole units of a nanojar can tolerate bulkier
substituents in the 3(5)-position. As with 4-substituted pyrazoles, no nanojars are formed by
pyrazoles with COOH, CH=O, NO2, NH2 or OH substituents at their 3(5)-position. In the case of
3-nitropyrazole (HL), a complex, soluble mixture of products (similar to the one obtained with 4nitropyrazole), is characterized by ESI-MS (Figure 3.21): L− (m/z 112), [CuL2]− (m/z 288), [CuL3]−
(m/z 400), [Cu2L3]− (m/z 463), [Cu2OL3]− (m/z 479), [NaCuL4]− (m/z 535), [Cu2(OH)L4]− (m/z
592), [NaCu2OL4]− (m/z 614), [Cu3O(OH)L4]− (m/z 672), [Cu2L5]− (m/z 687), [NaCu2(OH)L5]−
(m/z 727), [Cu3OL5]− (m/z 767), [NaCu2L6]− (m/z 822), [Cu4O2L5]− (m/z 847), [NaCu3OL6]− (m/z
902), [Cu4O2L6]− (m/z 959), [(Bu4N)Cu3OL6]− (m/z 1122), [Cu6OL9]− (m/z 1406), [Cu6L10]− (m/z
1502), [NaCu6O2L10(NO3)]− (m/z 1619).
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Figure 3.19: ESI-MS(–) spectrum of [CO3Ì{Cun(OH)n(3-Phpz)y(pz)n–y}]2– species observed (y:n–
y & m/z shown). Reproduced with permission, from reference 104.

Figure 3.20: ESI-MS(–) spectrum of [CO3Ì{Cun(OH)n(3-CF3pz)y(pz)n–y}]2– species observed
(y:n–y & m/z shown). Reproduced with permission, from reference 104.
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Figure 3.21: ESI(–) spectrum of the product mixture obtained from Cu(NO3)2, 3-NO2pzH, NaOH,
Bu4NOH, and Na2CO3. Reproduced with permission, from reference 104.

3.2.1.1.1.3

Simultaneous substitution of the pyrazole 3- and 5-positions

As expected, no nanojars are obtained with 3,5-disubstituted pyrazoles as sole ligands, not
even with the smallest methyl substituent. When used in a 1:1 molar mixture with HpzH, however,
3,5-dialkylpyrazoles and 3(5)methyl-5(3)trifluoromethylpyrazole do form mixed nanojars. The
ESI-MS(–) spectrum of the nanojars [CO3Ì{Cun(OH)n(3,5-Me2pz)y(pz)n−y}]2–, obtained from a
1:1 molar mixture of 3,5-Me2pzH and HpzH, and Cu2CO3(OH)2 as copper/carbonate source, shows
three major groups of peaks (n = 27, y ≈ 0−9; n = 28, y ≈ 6−13; n = 30, y ≈ 10−14) and small
amounts of nanojars with n = 29, y ≈ 9−14, and n = 31, y ≈ 10−14 (Figure 3.22).
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Figure 3.22: ESI-MS(–) spectrum of [CO3Ì{Cun(OH)n(3,5-Me2pz)y(pz)n–y}]2– (y:n–y & m/z
values shown) obtained from Cu2CO3(OH)2, 3,5-Me2pzH/HpzH (1:1), NaOH and Bu4NOH.
Reproduced with permission, from reference 104.
When Cu(NO3)2 and Na2CO3 are used as copper and carbonate sources, respectively, a
slightly different distribution is observed, with n = 30 as the major group, small amounts of n =
28, 29, and only traces of n = 27, 31 (Figure 3.23). Different ratios of 3,5-Me2pzH and HpzH also
lead to different distributions: a 2:1 molar mixture leads almost exclusively to n = 30, y ≈ 13−20
(most abundant peak: y = 14), with small amounts of n = 28, y ≈ 12−18, while a 5:1 ratio leads to
n = 30, y ≈ 14−20 (most abundant peak: y = 20). Using 3,5-Me2pzH:HpzH ratios higher than 1:1
favors nanojars with larger value of y, but increasing amounts of low-nuclearity species are also
produced at the same time.
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Figure 3.23: ESI-MS(–) spectrum of [CO3Ì{Cun(OH)n(3,5-Me2pz)y(pz)n–y}]2– (y:n–y & m/z
values shown) obtained from Cu(NO3)2, 3,5-Me2pzH/HpzH (1:1), NaOH, Bu4NOH and Na2CO3.
Reproduced with permission, from reference 104.
A

1:1

molar

mixture

of

3,5-Me2-4-nOctpzH

and

HpzH

also

provides

nanojars

[CO3Ì{Cun(OH)n(3,5-Me2-4-nOctpz)y(pz)n−y}]2–, among which the ones with n = 30, y ≈ 10−16
constitute the major group. The ESI-MS(–) of [CO3Ì{Cun(OH)n(3,5-Et2pz)y(pz) n−y}]2– shows
three major groups, n = 27, y ≈ 0−3; n = 29, y ≈ 0−10; n = 30, y ≈ 9−14, and small amounts of n =
31, y ≈ 0−11 and n = 32, y ≈ 12−15 (Figure 3.24). In the case of [CO3Ì{Cun(OH)n(3-nBu-5n

Hexpz)y(pz)n−y}]2–, the major peaks correspond to the parent nanojars (n = 27, 29−31; y = 0), but

smaller amounts of substituted species (y = 1−6) are also observed. In the case of a 3(5)-Me-5(3)CF3pzH:HpzH (1:1) mixture, the major species is [Cu3O(pz)3(3-Me-5-CF3pz)2]− (m/z 706), along
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Figure 3.24: ESI-MS(–) spectrum of [CO3Ì{Cun(OH)n(3,5-Me2pz)y(pz)n–y}]2– (y:n–y & m/z
values shown). Reproduced with permission, from reference 104.
With other low-nuclearity species, and small amounts of nanojars are also observed:
[CO3Ì{Cun(OH)n(3-Me-5-CF3pz)y(pz)n−y}]2– (n = 27, y ≈ 0−2; n = 29, y ≈ 0−2; n = 30, y ≈ 1−11)
(Figure 3.25). In the case of pyrazoles with bulkier substituents, such as bis(trifluoromethyl)-, dit

butyl- and diphenylpyrazole, however, not even mixed nanojars can be obtained. Di-tbutyl- or

diphenylpyrazole mixtures with HpzH (1:1) lead to [CO3Ì{Cu(OH)(pz)}n]2– (n = 27−31) as the
only THF-soluble products.
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Figure 3.25: ESI-MS(–) spectrum of [CO3Ì{Cun(OH)n(3-Me-5-CF3pz)y(pz)n–y}]2– (y:n–y & m/z
shown). Reproduced with permission, from reference 104.
In the case of 3,5-(CF3)2pzH:HpzH (1:1), the main species observed by ESI-MS(–) is the trinuclear
[Cu3O(pz)3{3,5-(CF3)2pz}2]− (m/z 814), along with its adducts [NayCu3O(pz)3{3,5-(CF3)2pz}2+y]−
(y = 1, m/z 1040; y = 2, m/z 1266; y = 3, m/z 1492; y = 4, m/z 1718; y = 5, m/z 1944) and
[(Bu4N)Cu3O(pz)3{(3,5-CF3)2pz}3]− (m/z 1260), as well as [Cu3O(pz)2{(3,5-CF3)2pz}3]− (m/z
950), [Cu3OH(pz)3{(3,5-CF3)2pz}3]− (m/z 1018) and its adduct [Na2Cu3OH(pz)3{(3,5-CF3)2pz}5]−
(m/z

1470).

In

addition,

mononuclear

[Cu{(3,5-CF3)2pz}2]−

(m/z 470),

tetranuclear

[NayCu4O(pz)3{(3,5-CF3)2pz}3+y]− (y = 1, m/z 1307; y = 2, m/z 1533; y = 3, m/z 1759), hexanuclear
[NayCu6O2(pz)6{(3,5-CF3)2pz}3+y]− (y = 1, m/z 1651; y = 2, m/z 1877; y = 3, m/z 2103) as well as
the free ligand and its Na-adducts, [Nay{(3,5-CF3)2pz}1+y]− (y = 0, m/z 203; y = 1, m/z 429; y = 2,
m/z 655), are also observed. Concurrently, the ESI-MS(+) spectrum of the same solution shows,
beside the dominant Bu4N+ ion, mostly trinuclear species [NayCu3O(pz)3{3,5-(CF3)2pz}y]+ (y = 0,
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m/z 408; y = 1, m/z 634; y = 2, m/z 860; y = 3, m/z 1086; y = 4, m/z 1312; y = 5, m/z 1538), and
smaller amounts of hexanuclear species [(Bu4N)yNazCu6O2(pz)6{(3,5-CF3)2pz}1+y+z]+ (y = 0, z =
3, m/z 1697; y = 0, z = 4, m/z 1923; y = 0, z = 5, m/z 2149; y = 2, z = 0, m/z 1910; y = 2, z = 1, m/z
2136; y = 2, z = 2, m/z 2362), [Na3Cu6O(OH)(pz)6{(3,5-CF3)2pz}5]+ (m/z 1901) and [(Bu4N)3
Na2Cu6O2(pz)7{(3,5-CF3)2pz}5]+ (m/z 2672). In general, we observe that the larger the substituents
at the pyrazole 3/5 positions, the less favorable the formation of the corresponding nanojars
becomes, and the more low-nuclearity species are obtained.
3.2.1.1.2

Breakdown of the carbonate-nanojar mixture into Cu27 and Cu29 nanojars upon
treatment with pyridine and into only Cu27 upon treatment with ammonia

The results discussed in this section were originally published in Chem. - Eur. J. 2016, 22,
5499−5503.105 Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
Upon dissolution of the (Bu4N)2[CO3{Cu(OH)(pz)}n] (n=27, 29, 30, 31) nanojar mixture in neat
pyridine, an immediate diminishing of the abundance of the Cu31 nanojar was observed in the ESIMS(–) spectra, accompanied by an increase in the abundance of the Cu29 nanojar. Upon standing,
the Cu31 nanojar (as well as the minor Cu30 nanojar) peak completely disappeared. The relative
abundances of the Cu27 and Cu29 nanojars, compared with the initial abundances, indicate that the
Cu31 nanojar has been converted to the Cu29 nanojar (Figure 3.26).
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Figure 3.26: ESI-MS(–) spectrum of (Bu4N)2[CO3Ì{Cu(OH)(pz)}n] nanojars in CH3CN. Top: assynthesized (n = 27, 29, 30, 31); center: after standing in pyridine solution for 7 days (n = 27, 29);
bottom: after standing in THF solution saturated with NH3 for 7 days (n = 27). Reproduced with
permission, from reference 105.
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The process was monitored continuously by 1H NMR (Figure 3.27), which also confirms
the gradual conversion of the Cu31 nanojar to the Cu8+13+8 nanojar. The bottom spectrum of the
overlaying is shortly after dissolution in pyridine-d5, whereas the top spectrum is after 7 days.
Peaks at 22.36, 26.47, 27.92 and 30.10 ppm are tentatively attributed to the Cu30 (Cu8+14+8) nanojar,
which is present in the original mixture (as shown by ESI-MS), and is a possible intermediate in
the Cu8+14+9 to Cu8+13+8 nanojar transformation.
An even more dramatic outcome was observed when a THF solution of [CO3{Cu
(OH)(pz)}n] was saturated with gaseous ammonia at room temperature. Although no significant
changes could be noticed by ESI-MS immediately after saturation, the Cu31, Cu30, and Cu29
nanojars gradually disappear over time, and only the Cu27 nanojar was left after a few days (Figure
3.26). NH3 likely coordinates to the nanojars’ Cu atoms and produces short-lived intermediates
(undetectable by ESI-MS and 1H NMR techniques) that immediately re-assemble to form the most
stable nanojar, [CO3{Cu(OH)(pz)}27]2–. It is important to note that in the absence of pyridine or
ammonia, nanojars do not interconvert between different Cun sizes, because the distribution of
different Cun nanojars does not change upon dissolution in common solvents. Monodisperse
(Bu4N)2[CO3{Cu(OH)(pz)}27] can thus be obtained by ammonia etching, a process reminiscent of
the preparation of monodisperse Au25 nanorods and nanospheres (ca. 1 nm) by etching
polydisperse Au nanoparticles (1–3.5 nm) with thiols.142
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Figure 3.27: 1H NMR monitoring of the conversion of the (Bu4N)2[CO3Ì{Cu(OH)(pz)}n] (n = 27,
29, 30, 31) nanojar mixture to a mixture of Cu27- and Cu29-nanojars in pyridine-d5. Reproduced
with permission, from reference 105.
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3.2.1.1.3

Solubilizing nanojars in hydrocarbon solvents and water

The results discussed in this section were originally published in Dalton Trans. 2016, 45,
8327−8339,104 and are reproduced by permission of The Royal Society of Chemistry.
For liquid–liquid extraction purposes, solubility of the nanojar in long-chain aliphatic solvents is
desirable. Characteristics of such solvents (typically C9–C18 alkanes/isoalkanes) include low
toxicity, low vapor pressure, low flammability (high flash point), negligible solubility in water,
chemical inertness, no odor or color, and low price. Nanojars comprised of the parent pyrazole
ligand (HpzH), however, are insoluble in aliphatic solvents.71 As illustrated in (Figure 3.17),
attachment of aliphatic chains of increasing lengths to the pyrazole 4-position leads to a gradual
increase of the solubility of the corresponding nanojar in aliphatic solvents, such that nanojars
based on 4-n-octylpyrazole are readily soluble in n-hexadecane (C16, longest straight-chain alkane
that is liquid at room temperature; mp = 18 °C) and even in heavy mineral oil (C15–C50). The same
is true for the 3-n-octylpyrazole derivative, as well as the heteroleptic nanojars based on mixtures
of non-substituted pyrazole and 3,5-dimethyl-4-n-octylpyrazole or 3-n-butyl-5-n-hexylpyrazole.
Although all nanojars prepared so far are soluble in tetrahydrofuran, the solubility of the ones
based on 4-halopyrazoles in toluene is drastically reduced compared to the parent nanojar and the
alkyl- or ether-substituted ones. Thus, only the 4-fluoro-derivative is sparingly soluble in toluene,
while the other halo-derivatives are practically insoluble. It is also noteworthy to mention that the
solubility of the parent nanojar (but not of the ones with alkyl chain substituents) in toluene is
lower when the counterion is a metal cation, compared to the Bu4N+-salt.
Some future applications of nanojars might require solubility in water. Again, nanojars
based on the parent non-substituted pyrazole are insoluble in water.71 Polar, hydrophilic
substituents, such as sulfonate, carboxylate or hydroxyl groups, would be expected to increase the
solubility of the corresponding nanojars in water. However, those groups are also good donors
(especially in their deprotonated forms), and, in the presence of Cu2+, lead to the formation of
polymeric products instead of nanojars.143,144,145 To impart solubility in water while maintaining
nanojar structure, we prepared novel pyrazole ligands with oligo(ethylene glycol) methyl ether
chains attached to the 4-position, 4-CH3(OCH2CH2)ZOpzH (z = 1–3) (Scheme 2.6). While
Na2[CO3⊂{Cu(OH)(4-CH3(OCH2CH2)ZOpz)}n] (n = 27–31) nanojars are negligibly soluble in
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water when z = 1, the corresponding ones with z = 2 have noticeable solubility, and become readily
soluble when z = 3.
3.2.1.1.4

Resistance of carbonate-nanojars to high pH

The results discussed in this section and section 3.2.1.1.5 are reprinted with permission,
from Inorg. Chem. 2016, 55, 7717−7728.106 Copyright 2016 American Chemical Society.
Nanojars (Bu4N)2[CO3⊂{Cu(OH)(pz)}n] are exceptionally stable under alkaline conditions: no
changes are observed in the ESI-MS and UV–vis spectra of a solution of nanojars in CH2Cl2 after
20 weeks of vigorous stirring with an aqueous 1 M NaOH solution (pH 14). Amazingly, nanojars
are resistant even to extreme alkalinities: both a solid sample and a THF solution of the nanojars
are recovered unchanged after stirring for 5 weeks with a 10 M NaOH (30%) solution in water.
3.2.1.1.5

Reactivity of carbonate-nanojars at pH < 7

In contrast to neutral or basic pH, nanojars are unstable under acidic pH, and even mildly
acidic conditions lead to protonation of their OH– (pKa of water, 15.7) and the pz– (pKa of pyrazole,
14.2) moieties (Scheme 3.12). Weak acids, such as hydrated transition metal ions M2+(aq) (M =
Cu, Pb, Ni, Cd, Mn; pKa 7.5, 7.6, 9.9, 10.1 and 10.6, respectively)146 and NH4+(aq) ions (pKa 9.2)
as their nitrate salts in wet THF ([M(H2O)n]x+ + H2O → [M(OH)(H2O)n–1](x–1)+ + H3O+; NH4+ +
H2O → NH3 + H3O+), break down nanojars into trinuclear species, as indicated by the [Cu3O
(pz)3(NO3)2]– (m/z 531.9) and [Cu3O(pz)2(NO3)3]– (m/z 526.8) ions observed by ESI-MS(–), as
well as the [Cu3O(pz)3]+ (m/z 407.9) ion observed by ESI-MS(+). The breakdown occurs even with
extremely weak acids, such as Mg2+(aq) and Ca2+(aq) (pKa 11.2 and 12.7, respectively); however,
nanojars reassemble and precipitate out upon addition of excess water to the corresponding THF
solutions. Stronger acids, such as Fe3+(aq), Hg2+(aq), and Al3+(aq) (pKa 2.2, 3.4 and 5.0,
respectively), lead to complete breakdown of the nanojars to Cu2+ and pyrazole, so that only
mononuclear species, such as [Cu(NO3)3]– (m/z 248.9), [Cu(NO3)2]– (m/z 188) and [CuO(NO3)] –
(m/z 142), are observed in the ESI-MS(–) spectra of the resulting solutions. As shown above
(Scheme 3.12), these reactions are reversible, and addition of sufficient amounts of a strong base
restores the nanojars. Nanojars are not affected by Tl+(aq), Sr2+(aq), Ba2+(aq), Li+(aq), Na+(aq),
K+(aq), and Bu4N+(aq) nitrates (pKa of the hydrated metal cations is 13.2, 13.2, 13.4, 13.6, 13.9,
and 14.0, respectively; Bu4NOH is a strong base similar to NaOH).
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Other weak acids, such as alkylcarboxylic acids (pKa ≈ 5), phenol (pKa 10.0), alkanethiols (pKa
10.4−10.7), and even methanol (pKa 15.5), also lead to breakdown of the nanojars. Indeed, ESIMS of (Bu4N)2[CO3⊂{Cu(OH)(pz)}n] (n = 27, 29, 31) in CH3CN/CH3OH (2:1) shows nanojars in
which an HO– group is substituted by CH3O–, [CO3⊂{Cun(OCH3)(OH)n–1(pz)n}]2– (n = 27, m/z
2029.0; n = 29, m/z 2176.9; n = 31, m/z 2324.4). At higher methanol concentrations
(CH3CN/CH3OH = 1:1), both an HO– and a pz– group are substituted by CH3O– and [CO3⊂{Cun
(OCH3)2(OH)n–1(pz)n–1}]2– species are observed (n = 27, m/z 2011.0; n = 29, m/z 2158.9; n = 31,
m/z 2306.4). Upon further substitution, the nanojars break down to small fragments, so that in a
neat CH3OH solution no nanojar species can be detected, even when freshly prepared. On standing,
the initially blue methanolic solution of nanojars gradually turns colorless and deposits an
insoluble, brown solid. Ethanol (pKa 15.9) and higher alcohols (pKa ≥ 16.0), which have lower
acidity than water (pKa 15.7), dissolve the nanojars without decomposition, as attested by ESI-MS
in ethanol and isopropanol, which show only intact nanojars, [CO3⊂{Cu(OH)(pz)}n]2–.

Scheme 3.12: pH-dependent equilibrium between Cu2+ ions and pyrazole, trinuclear copper
pyrazolate complex, and nanojars (only the one with n = 27 is shown). The stepwise formation of
nanojars with increasing amounts of base is reversible upon lowering the pH. Reproduced with
permission, from reference 106.

3.2.1.2

Synthesis and study of the properties of sulfate-nanojars
The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,

55, 10666−10679.107 Copyright 2016 American Chemical Society.
Upon mixing a solution of copper(II) nitrate and pyrazole in tetrahydrofuran (THF) with a solution
of Bu4NOH and (Bu4N)2SO4 in THF (29:29:58:1 molar ratio), a deep-blue, clear solution is
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instantly obtained, which produces a blue precipitate in quantitative yield upon the addition of
excess water (method A).107 Electrospray ionization mass spectrometry, ESI-MS(–), identifies the
product as a mixture of sulfate-incarcerating nanojars, [SO4⊂{Cu(OH)(pz)}n]2– (CunSO4, n =
27−33; n = 27, m/z 2040.0; n = 28, m/z 2113.4; n = 29, m/z 2187.9; n = 30, m/z 2261.4; n = 31, m/z
2334.9; n = 32, m/z 2409.9; n = 33, m/z 2483.3; m/z values represent the mono-isotopic mass of
the most abundant peak within the isotope pattern; all observed values match calculated values
(Figure 3.28A and Appendix B). If the reaction is carried out using copper(II) sulfate, pyrazole,
NaOH, and Bu4NOH (molar ratio of 29:29:56:2) in THF, a slightly different distribution of
nanojars is obtained (method B),107 with larger amounts of Cu28SO4 and negligible amounts of
Cu30SO4 and Cu33SO4 (Figure 3.28B). The different outcome in the latter case is attributed to the
insolubility of the copper(II) sulfate and NaOH reagents in THF, which also results in a longer
time (three days) being needed to complete the reaction.
Sulfate-incarcerating nanojars of different sizes have different solubility in toluene.
Although a mixture of nanojars is initially completely soluble in toluene, the smaller nanojars
slowly crystallize out of the solution. Thus, when (Bu4NO)2[SO4⊂{Cu(OH)(pz)}n] (obtained using
method B)107 is dissolved in toluene, a clear, deep-blue solution is obtained first. Within minutes,
a dark-blue powder starts settling out, which after filtration and rinsing with toluene is identified
by ESI-MS(–) as Cu28SO4, with small amounts of Cu27SO4 (Figure 3.28C). The filtrate, in turn,
contains the larger Cu29SO4 and Cu31SO4 nanojars, with small amounts of Cu27SO4, Cu28SO4, and
Cu32SO4 (Figure 3.28D). In addition, a sample of Cu31SO4 is also obtained by using Pb(NO3)2 as
an additive (see section 3.2.1.2.2).
3.2.1.2.1

Effect of the amount of Bu4NOH on the size distribution and yield of sulfate-nanojars

As discussed above, replacing most of the Bu4NOH base by NaOH (just enough Bu4NOH
to provide two Bu4N+ counterions per nanojar) leads to a different nanojar distribution. To further
assess whether the amount of available Bu4N+ counterions has an effect on the size distribution of
the resulting nanojars, a pair of experiments was carried out, wherein Bu4NOH was used either in
substoichiometric amount, or in excess. Based on ESI-MS(–) analysis of the nanojar mixtures
obtained under otherwise identical reaction conditions, it becomes evident that, in the latter case,
the Cu27, Cu28, and Cu29 nanojars are considerably more abundant, relative to the Cu31 nanojar,
than in the former case (Figure 3.29).
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Figure 3.28: ESI-MS(–) spectra (in CH3CN) of the sulfate-incarcerating nanojars [SO4Ì
{Cu(OH)(pz)}n]2− (n = 27−33) from Cu(NO3)2, pyrazole, Bu4NOH and (Bu4N)2SO4 (29:29:58:1
molar ratio) in THF (A), from CuSO4, pyrazole, NaOH and Bu4NOH (29:29:56:2 molar ratio) in
THF (B), the fraction crystallized out of toluene (C), and the fraction soluble in toluene (D).
Reproduced with permission, from reference 107.
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Figure 3.29: ESI-MS(–) spectra (in CH3CN) of the reaction product of CuSO4, pyrazole and NaOH
in THF with substoichiometric amount of Bu4NOH (A), and with excess Bu4NOH (B).
Reproduced with permission, from reference 107.
Regardless of their size, all nanojars require two singly charged Bu4N+ counterions.
However, whereas (Bu4N)2[SO4⊂{Cu(OH)(pz)}31] requires 2.0 equivalents of Bu4N+ for 31
equivalents of copper, (Bu4N)2[SO4⊂{Cu(OH)(pz)}27] requires 2.3 equivalents of Bu4N+ for 31
equivalents of copper.
If Bu4NOH is completely left out of the reaction (only NaOH is used as a base), the
resulting sulfate nanojar mixture is impurified with significant amounts of carbonate nanojars,
CunCO3 (see Figure 3.30A), and the yield decreases from ∼81% to ∼21%. Although even highpurity, fresh, commercially available NaOH and Bu4NOH contain small amounts of carbonate (up
to 0.5% in NaOH, unspecified amount in Bu4NOH), the sulfate nanojar mixture is either free of
carbonate nanojars (when obtained via method B)107 or contains negligible amounts of carbonate
nanojars, (when obtained via method A).107 Furthermore, if NaOH is replaced by KOH (which
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contains up to 2% carbonate) in method (B), an approximately equal mixture of the carbonate- and
sulfate-incarcerating nanojars is obtained (Figure 3.31A).
If Bu4NOH is left out (only KOH is used as base), more carbonate nanojars than sulfate
nanojars are obtained (see Figure 3.30B), and the yield decreases to ∼13%. We conclude that the
presence of Bu4N+ is beneficial in forming THF-soluble nanojars, instead of an intractable sideproduct, assumed to be [Cu(µ-OH)(µ-pz)]∞,71 and that the amount of Bu4NOH employed has an
influence on the yield of the reaction, the size distribution of sulfate nanojars, and the amount of
carbonate nanojar impurities.

Figure 3.30: ESI-MS(–) spectra (in CH3CN) of the reaction product of CuSO4, pyrazole and NaOH
(up to 0.5% Na2CO3) in THF (A), and CuSO4, pyrazole and KOH (up to 2% K2CO3) in THF (B).
Reproduced with permission, from reference 107.
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Figure 3.31: ESI-MS(–) spectra (in CH3CN) of the reaction product of CuSO4, pyrazole, KOH
(with K2CO3), and Bu4NOH (28:28:54:2 molar ratio) in THF in the absence of a lead salt (A), in
the presence of PbSO4 (B), and in the presence of Pb(NO3)2 (C). Reproduced with permission,
from reference 107.

3.2.1.2.2

Effect of lead salts on sulfate-nanojar size and purity

Interestingly, if PbSO4 is added to the reaction of CuSO4, pyrazole, KOH (containing
K2CO3), and Bu4NOH (29:29:29:56:2 molar ratio), a pure sulfate nanojar mixture is obtained, with
absolutely no traces of carbonate (Figure 3.31B). Yet, when excess PbSO4 (100-fold) is stirred
with carbonate nanojars, (Bu4N)2[CO3⊂{Cu(µ-OH)(µ-pz)}n] (n = 27, 29 − 31) in wet THF (similar
to the self-assembly reaction conditions), no reaction occurs and the carbonate nanojars are
recovered intact after stirring for 3 days. We conclude that, during the nanojar self-assembly
reaction, PbSO4 (Ksp = 2.53 × 10–8 in H2O at 25 °C)11 sequesters all carbonate before it is
incarcerated by nanojars, and forms almost one million times less-soluble PbCO3 (Ksp = 7.40 ×
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10–14 in H2O at 25 °C).11 In the reaction of CuCO3·Cu(OH)2, PbSO4, pyrazole, NaOH, and
Bu4NOH (29:29:58:54:4 molar ratio), however, PbSO4 is unable to sequester all carbonate, and a
mixture of sulfate- and carbonate-incarcerating nanojars is obtained (see section 3.2.1.3; Anion
exchange studies: carbonate binding vs. sulfate binding by nanojars). This result can be attributed
to the much lower solubility of CuCO3·Cu(OH)2 (Ksp = 7.08 × 10–9) compared to Na2CO3 or
(Bu4N)2CO3, as well as to the intimate proximity of carbonate to copper in the former compound.
A very different result is obtained when Pb(NO3)2 is used instead of PbSO4 during nanojar selfassembly. The reaction of CuSO4, pyrazole, NaOH, Bu4NOH, and Pb(NO3)2 in a 31:31:60:2:31
molar ratio results in only one single nanojar: (Bu4N)2[SO4⊂{Cu(OH)(pz)}31] (Figure 3.31C).
Here, Pb(NO3)2 plays a dual role: first, it acts as a carbonate scavenger, and second, it provides
acidity. Because of hydrolysis, Pb2+(aq) is a weak acid (pKa = 7.6).146 Whereas PbSO4 is very
poorly soluble (4.4 mg/100 mL H2O at 25 °C)147 and its saturated aqueous solution is practically
neutral, Pb(NO3)2 is highly soluble (59.7 g/100 mL H2O at 25 °C)147 and its aqueous solution is
acidic. In a slightly acidic medium, the smaller species of [SO4⊂{Cu(OH)(pz)}n]2– (n = 27−30)
are not stable and transform to Cu31SO4. Isolation of the product by pouring a THF solution in
water leads to the precipitation of Cu31SO4, and small amounts of Cu32SO4. (Bu4N)2
[SO4⊂{Cu(OH)(4-Mepz)}31] was obtained similarly, using 4-methylpyrazole instead of pyrazole.
Note that, as Pb(NO3)2 dissolves during the reaction, the Pb2+ ions react with the excess sulfate
and precipitate as PbSO4, eliminating any free Pb(NO3)2 from the final mixture. When stirred with
Pb(NO3)2 in THF, all nanojars, including Cu31SO4, break down completely to the trinuclear
complex [Cu3(µ-OH)(µ-pz)3(NO3)3]– (as shown by ESI-MS). To prove that the observed effect is
due to Pb2+, the experiment was repeated with Ba(NO3)2 (the pKa of Ba2+(aq) is equal to 13.4)146
instead of Pb(NO3)2: all nanojars were recovered unchanged after 15 days of stirring under
identical conditions. PbSO4, even in large excess (100 equiv per nanojar), is also unable to break
down any of the nanojars, and, despite its solubility (Ksp = 2.53 × 10–8) being over 5 orders of
magnitude higher than that of PbCO3 (Ksp = 7.40 × 10–14), it is unable to exchange carbonate from
CunCO3 to sulfate.
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3.2.1.2.3

Breakdown of the sulfate-nanojar mixture into only Cu31 upon treatment with
ammonia

The results discussed in this section were originally published in Chem. - Eur. J. 2016, 22,
5499−5503.105 Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
Sulfate nanojars (Bu4N)2[SO4{Cu(OH)(pz)}n] (n = 27, 28, 29, 31), in contrast to the analogues
CO3-incarcerating nanojars, were recovered unchanged from a pyridine solution after standing for
six weeks. However, NH3 led to the complete decomposition of the smaller nanojars, and similarly
to the carbonate analogue, gave the most stable nanojar in this case pure (Bu4N)2[SO4
{Cu(OH)(pz)}31] (Figure 3.32).

Figure 3.32: ESI-MS(–) spectrum of the (Bu4N)2[SO4⊂{Cu(OH)(pz)}n] nanojars in CH3CN. Top:
as-synthesized (n = 27, 28, 29, 31); bottom: after standing in THF solution saturated with NH3 for
7 days (n = 31). Reproduced with permission, from reference 105.
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3.2.1.3

Anion exchange studies: carbonate binding vs. sulfate binding by nanojars
The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,

55, 10666−10679.107 Copyright 2016 American Chemical Society.
It has been demonstrated earlier71 that nanojars are selective for anions with large hydration
energies, such as SO42– (ΔGºh = −1064 kJ/mol), and do not form at all with anions with small
hydration energies, such as NO3– (ΔGºh = −289 kJ/ mol) and ClO4– (ΔGºh = −229 kJ/mol).7b,148 It
is then expected that CO32–, with a ca. 25% larger hydration energy (ΔGºh = −1324 kJ/mol) than
sulfate, would be bound significantly stronger by nanojars. We have also shown that sulfate- and
carbonate-incarcerating nanojar mixtures (Cu27−Cu31) are selectively broken down by NH3 to
Cu27CO3 and Cu31SO4, respectively.105 This result was attributed to the better size match between
the smaller carbonate ion and the smallest Cu27 nanojar, and between the larger sulfate ion and the
larger Cu31 nanojar, respectively. The solution-phase thermal stability results, based on the
variable-temperature NMR studies described above, further demonstrate that the Cu8+14+9 nanojar
provides the best fit for the sulfate ion, followed by the Cu8+13+8 nanojar.
To assess the carbonate versus sulfate binding preference of nanojars, we first conducted a
pair of anion competition experiments. In one experiment, sulfate-incarcerating nanojars CunSO4
(n = 27, 28, 29, 31, 32) were stirred in THF with an approximately equimolar amount of
(Bu4N)2CO3 (soluble in THF). A drastic change in the relative amounts of Cu27SO4 and Cu28SO4
nanojars is immediately observed. As indicated by ESI-MS (Figure 3.33), most of the Cu28SO4
nanojars transformed into Cu27SO4 nanojars. At the same time, a peak at m/z 622.2, corresponding
to [(Bu4N)Cu2(pz)2(CO3) 2]–, is also detected. These observations indicate that the Cu10 ring shrinks
to a Cu9 ring as the [SO4⊂{Cu(OH)(pz)}6+12+10]2– nanojar (Cu28SO4) converts to [SO4⊂{Cu
(OH)(pz)}6+12+9]2– (Cu27SO4), while the expelled [Cu(OH)(pz)] unit dimerizes and binds carbonate
to form [Cu2(pz)2(CO3)2]2–. After 45 min, small amounts of [CO3⊂{Cu (OH)(pz)}6+12+9]2– nanojars
are also detected. After 10 days of stirring, the amount of Cu27SO4 and Cu27CO3 nanojars is
approximately equal, while the larger nanojars appear to be unaffected. This mixture remains
virtually unchanged over time, as indicated by ESI-MS after 24 days. Thus, we conclude that
nanojars with n > 27 do not exchange the incarcerated SO42– ion with CO32– ions. The excess
carbonate (not incarcerated by the Cu27CO3 nanojar) precipitates out as (Bu4N)2[Cu2(pz)2(CO3)2]
(purple solid), which is filtered out of the solution (ESI-MS is shown in Figure 3.34A). The
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addition of another equivalent of (Bu4N)2CO3 to the filtrate leads to further conversion of Cu27SO4
to Cu27CO3, and diminishing of Cu28SO4. If excess (Bu4N)2CO3 is used (100 equiv), all nanojars
are converted to (Bu4N)2[Cu2(pz)2(CO3)2], most of which precipitates out as a purple solid.

Figure 3.33: ESI-MS(–) spectra (in CH3CN) of (Bu4N)2[SO4⊂{Cu(OH)(pz)}n] (n = 27, 28, 29,
31): initial spectrum (A), within a few minutes after adding an equimolar amount of (Bu4N)2CO3
(B), after 45 min (C), and after 10 days (D). Inset in panel (B) shows the signal corresponding to
[(Bu4N)Cu2(pz)2(CO3)2]– (m/z 622.2). Reproduced with permission, from reference 107.
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Figure 3.34: ESI-MS(–) spectra (in CH3CN) of a mixture of sulfate- and carbonate-incarcerating
nanojars obtained at ambient temperature with a SO42−:CO32− molar ratio of 1:1: when all reagents
are soluble in the THF reaction medium (A), and after refluxing the THF solution for 24 h (B).
Reproduced with permission, from reference 107.
The ESI-MS of the violet mother liquor shows peaks attributable exclusively to
[(Bu4N)x+1Cu2(pz)2(CO3)2(HCO3)x]− (x = 0−5, m/z 622.2− 2139.6), [(Bu4N)3{Cu2(pz)2(CO3)2}2]−
(m/z 1488.6), and [(Bu4N)x(HCO3)x+1]− clusters (x = 0−11, m/z 61.0−3399.1) (Figure 3.34B). If
the solution obtained after stirring the CunSO4 nanojars with 100 equiv of (Bu4N)2CO3 in THF for
18 h is alternatively poured into excess water, the precipitated product analyzes as approximately
equal amounts of Cu27CO3 and Cu31SO4 nanojars, with a small amount of Cu29CO3. This result
shows that, upon precipitation with water, the dinuclear complex reverts to nanojars, affording the
most stable nanojar with each anion.
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In another experiment, carbonate-incarcerating nanojars CunCO3 (n = 27, 29−31) were
reacted in THF with an approximately equimolar amount of (Bu4N)2SO4 (soluble in THF). Within
minutes, ESI-MS shows that, besides the major set of peaks corresponding to the original nanojars,
a new set of peaks appear, corresponding to nanojars in which one pyrazolate ion is substituted by
an SO42− ion: [(Bu4N)CO3Ì{Cun(OH)n(pz)n−1SO4}]2− (n = 27, m/z 2158.1; n = 29, m/z 2306.0; n
= 30, m/z 2379.5; n = 31, m/z 2453.0) (Figure 3.35). This type of reactivity was not observed in
the previous experiment. As in the previous experiment, a dinuclear species, [(Bu4N)
Cu2(pz)2(SO4)2]− (m/z 694.1), is also detected, along with trace amounts of [SO4Ì{Cu
(OH)(pz)}n]2− (n = 28, m/z 2113.4; n = 31, m/z 2334.9; n = 32, m/z 2409.9). After 1 day, in addition
to the peaks described above, a new nanojar peak is observed at m/z 2471.0, corresponding to
[(Bu4N)SO4Ì{Cu31(OH)31(pz)30SO4}]2−. Also, an increased amount of [SO4Ì{Cu(OH)(pz)}31]2−
is observed, along with dinuclear complexes [(Bu4N)Cu2(pz)2(SO4)(CO3)]− (m/z 658.1) and
[(Bu4N)Cu2(pz)2(CO3)2]− (m/z 622.2). After 6 days, the abundance of Cu31SO4 is slightly larger
than that of Cu31CO3; similarly, the abundance of [(Bu4N)SO4Ì{Cu31(OH)31(pz)30SO4}]2− is larger
than that of [(Bu4N)CO3Ì{Cu31(OH)31(pz)30SO4}]2−. In addition, a new peak is observed at m/z
1566.2, corresponding to [SO4Ì{Cu31(OH)31(pz)30SO4}]3−. After 12 days, the peak at m/z 2453.0
is no longer observed, and Cu31SO4 is much more abundant than Cu31CO3.
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Figure 3.35: ESI-MS(–) spectra (in CH3CN) of (Bu4N)2[CO3⊂{Cu(OH)(pz)}n] (n = 27, 29, 30,
31) (A), within a few minutes after adding an equimolar amount of (Bu4N)2SO4 (B), after 1 day
(C), after 6 days (D), after 12 days (E) and after 18 days (F). Insets show the signals corresponding
to [(Bu4N)Cu2(pz)2(SO4)2]− (m/z 694.1), [(Bu4N)Cu2(pz)2(SO4)(CO3)]− (m/z 658.1) and [(Bu4N)
Cu2(pz)2(CO3)2]− (m/z 622.2), as well as [SO4Ì{Cu31(OH)31(pz)30SO4}]3− (m/z 1566.2).
Reproduced with permission, from reference 107.
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Also, the abundance of the dinuclear species has flipped, favoring [(Bu4N)
Cu2(pz)2(CO3)2]− over [(Bu4N)Cu2(pz)2(SO4)2]−. The trend continues, and after 18 days, only a
small amount of Cu31CO3 is left. Beyond this point, no further changes are observed over time. If
excess (Bu4N)2SO4 is used (100 equiv), no precipitate forms (in contrast to the (Bu4N)2CO3
experiment), and the ESI-MS(–) spectrum of the solution after 5 days is dominated by HSO4− ions
(m/z 97.0) and tetrabutylammonium sulfate clusters, such as [(Bu4N)2x−1(SO4)x]− (x = 2, m/z 918.8;
x = 3, m/z 1499.3; x = 4, m/z 2080.8; x = 5, m/z 2661.3; x = 6, m/z 3241.8). The ESI-MS(+)
spectrum is similarly dominated by peaks corresponding to [(Bu4N)2x+1(SO4)x]+ (x = 0, m/z 242.3;
x = 1, m/z 822.8; x = 2, m/z 1403.3) ions. When the solution is poured into excess water, a blue
precipitate forms, the ESI-MS(–) spectrum of which shows almost exclusively [CO3Ì{Cu
(OH)(pz)}n]2− (n = 27, 29, 30, 31) nanojars, with a small amount of [SO4Ì{Cu(OH)(pz)}31]2−.
Next, we conducted a series of experiments with both sulfate and carbonate ions present in
a 1:1 molar ratio during nanojar self-assembly. Depending on the source of the carbonate and
sulfate ions, varying relative amounts of carbonate- and sulfate-incarcerating nanojars were
observed (Figure 3.36). Using Cu(NO3)2, CuSO4, pyrazole, NaOH, Na2CO3 and Bu4NOH in a
29:1:30:56:1:2 molar ratio in THF, for instance, leads exclusively to sulfate-incarcerating nanojars,
[SO4Ì{Cu(OH)(pz)}31]2−, along with the trinuclear complex [Cu3(µ-OH)(µ-pz)3(NO3)3]−. In
contrast, the reaction of Cu(NO3)2, Na2SO4, pyrazole, NaOH, Na2CO3 and Bu4NOH
(29:29:29:56:29:2 molar ratio) yielded a mixture of carbonate-incarcerating nanojars, [CO3Ì
{Cu(OH)(pz)}n]2− (n = 27, 29, 31), exclusively. A mixture of CuSO4, pyrazole, NaOH, Na2CO3
and Bu4NOH (29:29:56:29:2 molar ratio), or CuCO3·Cu(OH)2, PbSO4, pyrazole, NaOH and
Bu4NOH (29:29:58:54:4 molar ratio) in THF leads to a mixture of carbonate- and sulfateincarcerating nanojars: the carbonate nanojars dominate in the former case, while sulfate nanojars
are more abundant in the latter case. Finally, when all reagents, including the sulfate and carbonate
sources are soluble (Cu(NO3)2, pyrazole, Bu4NOH, (Bu4N)2SO4 and (Bu4N)2CO3 in a
29:29:58:56:1:1 molar ratio in THF), a nanojar mixture overall slightly favoring sulfate over
carbonate is obtained (Figure 3.36). The composition of the mixture also reveals that the Cu28,
Cu31, Cu32, and Cu33 nanojars strongly favor sulfate, whereas the Cu27 nanojar strongly favors
carbonate, and the Cu29 and Cu30 nanojars have a comparable preference for sulfate and carbonate.
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Figure 3.36: ESI-MS(–) spectra (in CH3CN) of the reaction product in THF of Cu(NO3)2, CuSO4,
pyrazole, NaOH, Na2CO3 and Bu4NOH (29:1:30:56:1:2) (A), Cu(NO3)2, Na2SO4, pyrazole,
NaOH, Na2CO3 and Bu4NOH (29:29:29:56:29:2) (B), CuSO4, pyrazole, NaOH, Na2CO3 and
Bu4NOH (29:29:56:29:2) (C), and CuCO3·Cu(OH)2, PbSO4, pyrazole, NaOH and Bu4NOH
(29:29:58:54:4) (D). The SO42–:CO32– molar ratio is 1:1 in all reactions. Reproduced with
permission, from reference 107.
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3.2.1.4

Synthesis of nanojars highly selective for carbonate- vs. sulfate-anions
The results discussed in this section were originally published in Chem. Commun. 2017,

53, 1029−1032,108 and reproduced by permission of The Royal Society of Chemistry.
Nanojars of the formula [{Cu(OH)(pz)}n(anion)]2– (pz = pyrazolate anion; n = 27–33), have been
shown to bind both dinegative CO32– and SO42– anions: carbonate is bound almost exclusively by
odd-membered nanojars (n = 27, 29, 31), whereas sulfate is bound by both even- and oddmembered nanojars (n = 28, 29, 31). Consequently, we sought to use a tethered bis(pyrazole)
ligand to favor the formation of even-membered nanojars (n = 28) and gain selectivity for SO42–
over CO32–. The ligand 1,2-bis(1H-pyrazol-3-yl)ethane (LH2) where prepared by two methods (see
section 2.2.1.4), and used for the synthesis of the even-membered nanojars by two ways; either by
transforming the copper complexes precursors to nanojars, or by the direct synthesis from starting
materials by using LH2.
3.2.1.4.1

Synthesis and characterization of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2 66

Reaction of LH2 (HpzCH2CH2pzH) with Cu(NO3)2 and NaOH (1:2:3 molar ratio) in THF
(Scheme 3.13) produces a dark-blue (λmax = 609 nm, ε = 208 M–1 cm–1 in CH2Cl2; Figure 3.37)
tetranuclear complex Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2 66, isolated as 66(H2O)2(THF).
The ESI-MS spectrum in CH3CN shows peaks at m/z 730.8 and 606.8 in the negative and
positive modes, respectively, corresponding to [Cu4O(OH)(pzCH2CH2pz)2(NO3)2]– and [Cu4O
(OH)(pzCH2CH2pz)2]+ (see Appendix B). Only one set of peaks is observed in the 1H NMR
spectrum in DMSO-d6 at 25 ºC, at 132.39 ppm (OH protons), 52.07 and 46.05 ppm (4- and 5-pz
protons), 0.22 and 2.40 ppm (CH2Cl2 protons)(Figure 3.38). This implies that in solution, the
symmetry of the molecule is determined by two orthogonal mirror planes, and that the two protons
of the CH2 groups are magnetically inequivalent.
Integration of the THF peaks at 1.76 and 3.60 ppm (recorded at 150 ºC, where the H2O
peak does not overlap) indicates the presence of one THF molecule per complex (see Appendix
A). The composition of 66(H2O)2(THF) is also confirmed by elemental analysis108 and
thermogravimetry (see Appendix D). Variable-temperature 1H NMR spectroscopy (see Appendix
C) shows that the pyrazole proton signals shift upfield with increasing temperature (to 43.98 and
39.15 ppm at 150 ºC), whereas the OH and CH2 proton signals shift downfield (to 172.81, 0.64
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and 1.04 ppm, respectively, at 150 ºC). The tertranuclear complex Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2
(NO3)2 66, were characterized as well by X-ray crystallography (see section 3.2.4.4.6).

66

68

67

Scheme 3.13: Synthesis of complexes 66, 67 and 68 from LH2 (Bu4N+ and NO3 counterions not
shown for clarity). Complex 68 (n = 28) forms in mixture with other nanojars, [Cun(OH)n
(pzCH2CH2pz)n/2(CO3)]2– (n = 26, 28, 30). Reproduced with permission, from reference 108.
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Figure 3.37: UV–vis spectra of the tetranuclear complexes 66 (red line) and 67 (violet line) (2.600
× 10−3 M in CH2Cl2), and the mixture of nanojars containing 68 (blue line) (6.500 × 10−4 M in
CH2Cl2). Reproduced with permission, from reference 108.

Figure 3.38: Variable-temperature 1H NMR spectra of 66(H2O)2(THF). Only the regions between
125–175 ppm (OH proton), 35–55 pm (pz protons) and (–3) to 1 ppm (CH2CH2 protons) are shown
for clarity. Reproduced with permission, from reference 108.

160

The novel complex based on the tethered bis(pyrazole) ligand [pzCH2CH2pz]2– (L) stand in stark
contrast with the corresponding complexes obtained with the parent pyrazole (pz) ligand. For
instance, when Hpz is reacted with Cu(NO3)2 and NaOH (2:2:3 molar ratio) in THF, a trinuclear
complex, Cu3(µ3-OH)2(µ-pz)2(NO3)2(H2O),106 is preferentially obtained instead of a tetranuclear
complex analogous to 66 under otherwise identical reaction conditions (Figure 3.39).

Figure 3.39: Contrast between the products of the reaction of Cu(II) and pyrazole (molar ratio 1:1)
with and without an ethylene group tethering pairs of pyrazolate units. Reproduced with
permission, from reference 108.

3.2.1.4.2

Synthesis and characterization of Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4] 67

The tetranuclear complex Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4], prepared by the addition
of LH2, NaOH and Bu4NOH to the THF solution of 66(H2O)2(THF) (2:2:1:1 molar ratio) (Scheme
3.13), produces a new, dark-violet (λmax = 558 nm, ε = 332 M–1 cm–1 in CH2Cl2; Figure 3.37). This
complex can also be obtained directly from Cu(NO3)2, LH2, NaOH and Bu4NOH (4:4:8:1 molar
ratio) in THF. The ESI-MS(–) spectrum of 67 shows one single signal at m/z 911.0, corresponding
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to [Cu4(OH)(pzCH2CH2pz)4]– (see Appendix B). The 1H NMR peaks (DMSO-d6, 400 MHz, 25
ºC) of 67 are very broad (61.71 ppm, w1/2 = 1.4 kHz; 43.51 ppm, w1/2 = 2.0 kHz; 0.92 ppm, w1/2 =
0.25 kHz). The tertranuclear complex Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4] 67, were
characterized by X-ray crystallography as well (see section 3.2.4.4.7).
In the absence of the ethylene tether between pairs of pyrazoles ligands, the hypothetical complex
Bu4N[Cu4(µ4-OH)(µ-pz)8], analogous to 67, is inaccessible by reacting Hpz, Cu(NO3)2, NaOH and
Bu4NOH in 8:4:8:1 molar ratio. Instead, polymeric [Cu(µ-pz)2]∞ is obtained (Figure 3.40).71

Figure 3.40: Contrast between the products of the reaction of Cu(II) and pyrazole (molar ratio 1:2)
with and without an ethylene group tethering pairs of pyrazolate units. Reproduced with
permission, from reference 108.
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Although not observed as a discrete molecule, a [Cu4(µ-pz)8] moiety has no inherent factors (such
as steric hindrance or bonding restrains) preventing its existence. Indeed, this unit has been
observed as part of the extended 3D metal–organic framework of Cu3(BTP)2, with the trivalent
ligand 1,3,5-tris(pyrazol-4-yl)benzene (H3BTP).149 On the other hand, an analysis of the crystal
structure of [Cu(µ-pz)2]∞150 reveals that an ethylene tether between two pz units does prevent the
formation of a linear [Cu(µ3-pzCH2CH2pz)]∞ polymer, due to geometric constrain. Therefore, it
becomes clear that the reason why [Cu4(µ4-OH)(µ3-pzCH2CH2pz)4]– can, whereas [Cu4(µ4-OH)(µpz)8]– cannot be obtained, is that the ethylene tether prevents the system from accessing the
apparently more favorable, polymeric form.
Synthesis and characterization of nanojars [Cun(OH)n(pzCH2CH2pz)n/2(CO3)]2– (n =
26, 28, 30) 68 highly selective for CO32– anions

3.2.1.4.3

Addition of NaOH, Bu4NOH and Na2CO3 to the THF solution of 66(H2O)2(THF) (12:2:1:7
molar ratio) (Scheme 3.13), produces another new, dark-blue product (λmax = 608 nm, ε = ~ 2.5
103 M–1 cm–1 in CH2Cl2; Figure 3.37). Variable-temperature 1H NMR and ESI-MS(–) analysis
reveals

that

this

product

consists

of

a mixture

of

nanojars,

containing

mainly

[Cun(OH)n(pzCH2CH2pz)n/2(CO3)]2– (n = 26, m/z 2117.6; n = 28, m/z 2278.5 [68, Scheme 3.13]; n
= 30, m/z 2439.0) and [Cu28(OH)27(pzCH2CH2pz)14(pzCH2CH2pzH)(CO3)] 2– (m/z 2350.1) (see
Figure 3.41 and Appendices B and Appendix C). A similar mixture of nanojars is obtained directly
from Cu(NO3)2, LH2, Bu4NOH and (Bu4N)2CO3 (28:14:56:1 molar ratio), or from Cu(NO3)2, LH2,
NaOH, Bu4NOH and Na2CO3 (28:14:54:2:1 molar ratio) in THF.

Figure 3.41: ESI-MS(–) spectra (in CH3CN) of the mixture of nanojars [Cun(OH)n
(pzCH2CH2pz)n/2(CO3)]2– (n = 26, 28, 30). Reproduced with permission, from reference 108.
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The smallest nanojar known to date [Cu26(OH)26(pzCH2CH2pz)13(CO3)]2–, becomes
available by using the tethered ligand L, whereas the analogous [{Cu(OH)(pz)}26(CO3)] 2– has
never been observed with the parent pyrazole ligand. The mixture of nanojars obtained with
(pzCH2CH2pz) also contains [Cu28(OH)28(pzCH2CH2pz)14(CO3)]2– and [Cu30(OH)30(pzCH2CH2pz)15(CO3)]2– in large amounts, whereas [{Cu(OH)(pz)}28(CO3)]2– remains elusive and [{Cu(OH)
(pz)}30(CO3)]2– is a very minor component of the nanojar mixture obtained with pyrazole.
Perhaps the most striking result of the conversion of the parent pyrazole ligand to the
tethered ligand pzCH2CH2pz is the selectivity of the corresponding nanojars for the incarceration
of CO32–, not SO42–, contrary to expectations. [Cun(OH)n(pzCH2CH2pz)n/2(CO3)]2– nanojars are
easily obtained from a mixture of Cu(NO3)2, LH2, NaOH, Bu4NOH and Na2CO3 (28:14:54:2:28
molar ratio) in THF. In contrast, no reaction is observed when CuSO4 is used instead of Cu(NO3)2/
Na2CO3, under otherwise identical reaction conditions. In fact, despite the large excess of SO42–
ions, CO3-incarcerating nanojars start forming slowly in the latter mixture after exposure to air, as
CO2 slowly diffuses and converts to CO32–. This result is unexpected, as nanojars based on the
parent pyrazole ligand have comparable propensity to bind the CO32– and SO42– anions,107 and only
the odd-membered ones bind CO32– significantly (Figure 3.42).
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Figure 3.42: Contrast between the Cu28-nanojars formed with SO42– and CO32– with and without
an ethylene group tethering pairs of pyrazolate units. Reproduced with permission, from reference
108.
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3.2.2 Study the self-assembly mechanism of nanojars
The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,
55, 7717−7728.106 Copyright 2016 American Chemical Society.
To study the intermediates and the mechanism of the self-assembly of pyrazole with Cu2+ and OH–
ions into nanojars, we use a set of complementary techniques including mass spectrometry, pH
titration, UV–vis and NMR spectroscopies, chemical synthesis, and single-crystal X-ray
diffraction. The results reveal a pH-dependent equilibrium between Cu2+ ions and pyrazole, a
trinuclear copper pyrazolate complex, and nanojars.
3.2.2.1

Mass spectrometry monitoring of the self-assembly mechanism
The reaction of copper nitrate and pyrazole with NaOH (1:1:2 molar ratio) in the presence

of sodium carbonate in THF was monitored by ESI-MS(–) (Figure 3.43). The reaction mixture
(which does not dissolve the NaOH and Na2CO3 reactants or the NaNO3 byproduct) was sampled
periodically.
Before the addition of any base, the equimolar mixture of Cu(NO3)2 and pyrazole (Hpz)
gives rise to peaks corresponding to mononuclear [Cu(NO3)2]− (m/z 186.9), [Cu(NO3)3]− (m/z
248.9) and [CuO(NO3)]− (m/z 140.9) as major species along with a significant peak at m/z 526.8
corresponding to [Cu3O(pz)2(NO3)3]− (m/z values represent monoisotopic mass of the most
abundant peak within the isotope pattern; all observed values match calculated values). The
presence of the latter complex indicates that pyrazole is partially deprotonated even in the absence
of a base. This suggests that a solution of copper nitrate should become more acidic upon addition
of pyrazole, as some H3O+ ions should form along with the trinuclear complex, which is indeed
the case (see section 3.2.2.2). As soon as NaOH/Na2CO3 is added (not soluble in THF), the
abundance of the mononuclear species decreases whereas the abundance of the trinuclear species
increases. After 25 min of stirring, the mononuclear species are mostly replaced by trinuclear
species, as indicated by peaks corresponding to [Cu3O(pz)2(NO3)3]− (m/z 526.8) and
[Cu3(OH)3(pz)2(NO3)2]− (m/z 499.8) and smaller amounts of [Cu3(OH)3(pz)(NO3)2]− (m/z 432.8),
[Cu3(OH)4(pz)3]− (m/z 459.9), [Cu3(OH)4(pz)2(NO3)(H2O)]− (m/z 472.9), [Cu3(OH)3(pz)3(NO3)]−
(m/z 504.9) and [Cu3O(pz)3(NO3)2]− (m/z 531.8). After 45 min, in addition to the trinuclear species,
tetranuclear [Cu4O2(pz)2(NO3)3]− (m/z 605.7), [NaCu4O2(OH)(pz)3(NO3)2]− (m/z 650.8), and
[Na2Cu4O3(pz)4(NO3)]− (m/z 677.8), as well as hexanuclear [Cu6O2(pz)5(NO3)3(OH)]− (m/z 951.7),
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[Cu6O2(pz)6(NO3)2(H2O)(OH)]− (m/z 974.7), [Cu6O2(pz)5(NO3)4]− (m/z 996.7), [Cu6O2(pz)6
(NO3)3]− (m/z 1001.7), [Cu6(OH)3(pz)6(NO3)3(HCO3)]− (m/z 1081.7) and [Cu6(OH)3(pz)6(NO3)4]−
(m/z 1082.7) species appear. After 85 minutes, the major species identified are
[Cu3(OH)5(pz)2(H2O)2]− (m/z 445.9), [NaCu3(OH)6(pz)2]− (m/z 449.9), [Cu3(OH)4(pz)2(NO3)
(H2O)]− (m/z 472.9), [Cu3(OH)4(pz)3(H2O)]− (m/z 477.9), [Cu3(OH)3(pz)2(NO3)2]− (m/z 499.8),
[Cu3(OH)3(pz)3(NO3)]− (m/z 504.9), [Cu3O(pz)2(NO3)3]− (m/z 526.8), [Cu3O(pz)3(NO3)2]− (m/z
531.8), [Cu4O2(pz)2(NO3)3(H2O)]− (m/z 623.7) and [NaCu4O2(pz)3(NO3)2(OH)]− (m/z 650.8).
Most intriguingly, peaks corresponding to sodium nitrate clusters, [Nax(NO3)x+1]− (x = 0−22; m/z
62.0−1931.5) start appearing

at this point, together with traces of intermediates

[{Cu3(OH)3(pz)3}n/3(NaNO3)yCO3]2− (n = 27, 29, 31; y = 1−13; m/z 2064.5−2869.8) and nanojars
[CO3Ì{Cu(OH)(pz)}n]2− (n = 27, m/z 2022.0; n = 29, m/z 2169.9; n = 31, m/z 2317.4). The
presence of sodium nitrate clusters is unexpected, as NaNO3 is insoluble in both THF and CH3CN,
as indicated by the absence of any sodium nitrate clusters in the ESI-MS spectra of THF or CH3CN
stirred with NaNO3. It is also important to notice that after the peaks of the
[{Cu3(OH)3(pz)3}n/3(NaNO3)yCO3]2− intermediates disappear and the nanojars are fully formed
(after ∼4 h of stirring), the peaks corresponding to NaNO3 clusters can no longer be observed in
the ESI-MS spectra. Therefore, we conclude that the NaNO3 clusters detected by ESI-MS are
formed during sample injection as the [{Cu3(OH)3(pz)3}n/3(NaNO3)yCO3]2− intermediates
eliminate NaNO3 and transform to the final products, [CO3Ì{Cu(OH)(pz)}n]2−.
On the basis of these observations, the following mechanism is proposed (Scheme 3.14).
As the NaOH pellets gradually react with the THF solution of copper nitrate and pyrazole, the
trinuclear complex [Cu3(µ3-OH)(µ-pz)3(NO3)2(H2O)] 69a forms. This complex was isolated and
characterized in detail (see sections 3.2.4.4.8). Further reaction of this complex with NaOH leads
to replacement of the H2O molecule and NO3− ions with HO− ions, forming [Cu3(µ3-OH)(µpz)3(OH)x(NO3)3-x]− (x = 1, m/z 549.9 70; x = 2, m/z 504.9 71; x = 3, m/z 459.9 72) species (species
wherein the OH group is deprotonated or pyrazolate is replaced by nitrate are also observed in the
mass spectra). These species are unstable: unsupported, terminal CuII−OH groups are virtually
absent in copper−pyrazole chemistry. Of the ∼500 crystal structures in the current Cambridge
Structural Database (CSD) containing a [Cu(OH)(pz)] moiety, only three have terminal CuII−OH
groups. In two of these, the terminal CuII−OH group is supported by intramolecular H167

bonding,151,152 whereas in the third one it is supported by steric crowding around the OH group;153
the rest contain far more common bridging µ2-OH and/or µ3-OH groups.

Figure 3.43: Time-dependent ESI-MS(–) spectra of a solution (in CH3CN) sampled periodically
from a mixture of Cu(NO3)2·2.5H2O, pyrazole, NaOH and Na2CO3·H2O (1:1:2:1 molar ratio)
stirred in THF. The spectrum at time zero is of the solution of the first two, THF-soluble reactants,
just before the addition of the insoluble sodium hydroxide and carbonate. Reproduced with
permission, from reference 106.
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74

Scheme 3.14: Proposed mechanism of formation of nanojars. Reproduced with permission, from
reference 106.
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In other copper(II) complexes, terminal Cu−OH groups are similarly stabilized by hydrogen
bonding154,155,156,157 and/ or steric crowding,158,159,160,161,162,163 which prevent bridging/oligomerization.
In the next step, the unstable species 70, 71, and 72 form transient tetranuclear and
hexanuclear species. For example, [Cu6(OH)3(pz)6(NO3)4]− 73, detected at m/z 1082.7, can be
viewed as two trinuclear [Cu3(µ3-OH)(µ-pz)3(NO3)2] units bridged by a µ-OH group. Also, the first
carbonate-incorporating species, [Cu6(OH)2(H2O)(pz)6(NO3)3(CO3)]−, is observed at m/z 1081.7.
As more and more NaOH reacts, increasing numbers of trinuclear units end up bridged together,
forming large intermediates with the formula [{Cu3(OH)3(pz)3}x(NaNO3)y(Na2CO3)z] 74. These
inter- mediates are short lived and will eliminate NaNO3 while transforming into the final products
Na2[CO3Ì{Cu(OH)(pz)}n] (n = 27, 29, 31). It is important to notice that the oligomeric
intermediates [Cu3(OH)3(pz)3]x, based on trinuclear repeating units, have the same composition as
the nanojars, [Cu(OH)(pz)]n (n = 3x) (Scheme 3.15).

Scheme 3.15: Illustration of the relationship between trinuclear [Cu(OH)(pz)]3 units and
[Cu(OH)(pz)]x rings of identical composition found in nanojars (a ring combination with x = 6 and
12 is shown). Reproduced with permission, from reference 106.
Although the exact structure of the intermediates 74 cannot be established, their existence
is unequivocally demonstrated by the following experiment. Mixing an aqueous solution of copper
nitrate and pyrazole with an aqueous solution of NaOH (with small amounts of Na2CO3) in a 1:1:2
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molar ratio under vigorous stirring leads to the immediate, quantitative precipitation of a dark-blue
solid (intermediate 74). If this solid is stirred in its mother liquor for several days, it slowly changes
color to purple, as it transforms into the polymeric [trans-Cu(µ-OH)(µ-pz)]∞.71 This material is
completely insoluble in THF and in other solvents. In contrast, a completely different outcome is
observed if the dark-blue solid (intermediate 74) is immediately filtered out of the solution upon
its precipitation. Although initially completely insoluble (indicating that this material contains
neither the trinuclear intermediate nor the nanojars), when stirred with THF, it slowly dissolves
and yields a mixture of nanojars Na2[CO3Ì{cis-Cu(µ-OH)(µ-pz)}n] (n = 27, 29, 31). It becomes
apparent that in order for the intermediates 74 to convert to nanojars, the reaction medium must
dissolve the final product. Indeed, if a THF solution of Bu4NOH (NaOH is insoluble in THF) is
added at once to a vigorously stirred THF solution of copper nitrate and pyrazole, nanojars
instantly form (as evidenced by ESI-MS). Immediately upon the addition of the Bu4NOH solution,
the reaction is quenched by pouring the deep-blue solution into a large amount of water under
stirring. The blue solid formed is filtered out immediately, rinsed with water, and dried. This
product,

when

added

to

THF,

dissolves

instantly

and

completely,

and

nanojars

(Bu4N)2[CO3Ì{Cu(OH)(pz)}n] (n = 27, 29, 31) are identified in the resulting solution by ESI-MS.
When the reaction with Bu4NOH is carried out in H2O, similar results are obtained as with NaOH:
a dark-blue precipitate forms upon mixing the aqueous solutions of Bu4NOH and copper
nitrate/pyrazole, which after immediate filtration from the solution, followed by rinsing with water
and drying, is at first insoluble in THF. Upon continued stirring, the product slowly dissolves in
THF and fully transforms into nanojars (Bu4N)2[CO3Ì{Cu(OH)(pz)}n] (n = 27, 29, 31), as shown
by ESI-MS. It is conceivable that when the reaction is carried out in THF with soluble Bu4NOH,
the intermediate [Cu3(OH)3(pz)3]x has a size comparable to that of the final nanojars (x = n/3), and
being soluble in THF, it quickly converts to the final product. In contrast, if the reaction is carried
out in H2O, in which neither the intermediate nor the nanojars are soluble, a polymeric intermediate
(large x) is produced, which is also insoluble in THF. This polymeric intermediate will slowly
break down and transform into THF-soluble nanojars upon stirring with THF.
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3.2.2.2

pH titration and UV–vis. monitoring of the self-assembly mechanism
An aqueous solution of Cu(NO3)2 is acidic, due to the hydrolysis of the hydrated Cu2+ ion

(pKa = 7.5).146 Pyrazole is a very weak base (N: pKb 11.43) and a very weak acid (N−H: pKa =
14.21),164 and its aqueous solution is practically neutral. Upon addition of an equimolar amount of
pyrazole to an aqueous Cu(NO3)2 solution (1.72 × 10−2 M), the pH drops from 4.55 to 3.88,
accompanied by a change in the wavelength of the absorbance maximum (λmax) from 800 to 768
nm. These changes indicate not only that pyrazole (Hpz) binds to copper but also that it partially
deprotonates yielding H3O+ ions, along with pyrazolate ion (pz−) in the resulting product(s). The
presence of a trinuclear copper pyrazolate species in this solution is clearly established by ESI-MS
(see section 3.2.2.1). Upon addition of increasing amounts of NaOH (with traces of Na2CO3) to
this solution, the pH gradually increases (Figure 3.44, Table 3.6), while λmax continually shifts
toward lower wavelengths (Figure 3.45, Table 3.6). At a Cu:Hpz:NaOH molar ratio of 3:3:4, the
absorbance reaches a maximum at λmax = 668 nm at a pH of 6.23. At this point, the soluble,
trinuclear complex [Cu3(µ3-OH)(µ-pz)3(NO3)2(H2O)] 69a is fully formed. As more NaOH is added
to the solution, the pH slowly increases, and the absorbance gradually decreases, accompanied by
precipitation of a dark-blue solid (filtered out of the solution prior to the measurements). When a
Cu:Hpz:NaOH molar ratio of 3:3:6 is reached, the absorbance at 668 nm drops to zero and the pH
becomes neutral. At this point, all [Cu3(OH)(pz)3(NO3)2(H2O)] 69a is converted to the insoluble
[{Cu3(OH)3(pz)3}x(NaNO3)y(Na2CO3)z]∞ 74. Addition of further amounts of NaOH to the
colorless solution leads to an abrupt increase in pH, indicating that no other species are left in
solution that would react with NaOH. The two inflection points on the pH titration curve at
Cu:Hpz:NaOH molar ratios of 3:3:4 and 3:3:6, along with the accompanying UV–vis spectral
changes, suggest the reaction sequence shown in Scheme 3.12. As demonstrated below, nanojars
can be transformed back to the trinuclear copper pyrazolate complex and ultimately to Cu2+ ions
and pyrazole upon addition of increasing amounts of acids.
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Figure 3.44: pH titration curve (A) and
accompanying absorbance change at 668 nm
(B) of an aqueous solution of copper nitrate
and pyrazole (1.72 × 10−2 M each) with
increasing amounts of NaOH (containing
Na2CO3) from a Cu:Hpz:NaOH molar ratio of
3:3:0 to 3:3:9. At 4 equivalents of NaOH, the
trinuclear complex Cu3(OH)(pz)3(NO3)2
(H2O) is fully formed, whereas at 6
equivalents of NaOH the trinuclear complex is
fully transformed into insoluble [Cu(OH)
(pz)]∞, which is filtered out of the solution
prior to the measurements. Reproduced with
permission, from reference 106.

Figure 3.45: Electronic absorption spectra
obtained during the titration of an aqueous
solution of copper nitrate and pyrazole (1.72
× 10−2 M each) with NaOH (containing
Na2CO3) from a Cu:Hpz:NaOH molar ratio of
3:3:0 to 3:3:4 (traces a to h in A) and from
3:3:4 to to 3:3:6 (traces h to q in B).
[Cu(OH)(pz)]∞ is insoluble and is filtered out
of the solution. Spectra from the titration of
the copper nitrate/pyrazole solution with
HNO3 to a Cu:Hpz:HNO3 molar ratio of 3:3:1
(trace b¢ in A; pH = 2.34) and 3:3:18 (trace c¢
in A; pH = 1.08) are also shown. Reproduced
with permission, from reference 106.
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Table 3.6: pH and visible absorbance measurements during the titration of Cu(NO3)2/pyrazole (3:3
molar ratio) with NaOH. Reproduced with permission, from reference 106.
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Equivalents of
NaOH
0
0.600
1.200
1.800
2.400
3.000
3.600
3.750
3.840
3.900
4.000
4.200
4.500
4.800
5.100
5.400
5.550
5.700
5.850
5.898
5.949
6.000
6.150
6.300
6.600
7.200
7.800
8.400
9.000

Volume of NaOH
(mL)
0
0.735
1.470
2.205
2.940
3.675
4.410
4.539
4.704
4.777
4.900
5.145
5.512
5.880
6.247
6.615
6.798
6.982
7.166
7.227
7.288
7.350
7.533
7.717
8.085
8.820
9.555
10.290
11.025
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pH

Temp. (ºC)

3.88
4.29
4.43
4.62
4.80
5.05
5.54
5.77
5.93
6.08
6.23
6.26
6.31
6.33
6.50
6.52
6.62
6.74
6.92
7.05
7.19
7.47
9.46
10.20
10.90
11.35
11.57
11.70
11.82

28.0
28.8
28.1
28.4
28.5
28.8
28.1
28.6
28.9
28.4
28.9
28.4
29.5
29.4
30.0
29.2
29.0
29.3
28.9
29.3
29.5
29.5
29.5
29.4
29.0
29.3
29.3
29.3
29.5

Absorbance
(at 668 nm)
0.171
0.268
0.355
0.461
0.558
0.658
0.750
0.779
0.782
0.779
0.776
0.721
0.610
0.453
0.366
0.213
0.152
0.107
0.045
0.024
0.010
0.000
0.013
0.000
0.004
0.000
0.000
0.011
0.000

3.2.2.3

Stepwise synthesis of nanojars
To obtain further proof of the identity of the trinuclear complex intermediate in the

formation of the nanojars, a reaction using Cu(NO3)2, pyrazole, and NaOH in a 3:3:4 molar ratio
is carried out in tetrahydrofuran (THF). After filtering out the insoluble NaNO3 byproduct and
evaporating the solvent, the isolated product (near-quantitative yield) is identified as pure [Cu3(µ3OH)(µ-pz)3(NO3)2(H2O)] 69a with no trace of nanojars, based on single-crystal X-ray diffraction,
ESI-MS, UV–vis, and 1H NMR (see sections 3.2.4.1.3 and 3.2.4.4.8).
Next, we demonstrate that the trinuclear intermediate 69a is fully convertible to nanojars. Upon
stirring 69a with 2 equiv of NaOH (and small amounts of Na2CO3) in THF, the color of the solution
changes from dark green-blue to deep blue and a NaNO3 precipitate is filtered out. After
evaporation of the solvent, the product is identified as pure nanojars Na2[CO3Ì{Cu(OH)(pz)}n] (n
= 27, 29, 31) based on ESI-MS, 1H NMR, and single-crystal X-ray diffraction studies.105 Thus, we
observe a clean transformation of the intermediate to nanojars, as no trinuclear complex nor any
other copper complex is detectable in the final product (Figure 3.46).

Figure 3.46: ESI-MS(–) evidence for the clean synthesis of either trinuclear complex or nanojars
based on the Cu:Hpz:NaOH ratio employed. The lower spectrum corresponds to the product
obtained from the isolated trinuclear complex upon treatment with 2 equivalents of NaOH.
Reproduced with permission, from reference 106.
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3.2.3 Liquid–liquid extraction of anions from water into organic solvents
3.2.3.1

Extraction of carbonate-anions
The results discussed in this section were originally published in Dalton Trans. 2016, 45,

8327−8339,104 and are reproduced by permission of The Royal Society of Chemistry.
The carbonate ion (CO32–) is in a pH-dependent equilibrium with the bicarbonate ion (HCO3–) and
CO2.165 At neutral pH, virtually no CO32– ion is found in aqueous solution, while above pH ∼ 12,
carbonate is found exclusively as CO32–. Given its very large hydration energy (ΔGºh = 1315 kJ
mol–1), the CO32– ion is difficult to extract from water, compared to HCO3– (ΔGºh = 368 kJ
mol–1).7b Herein we show that nanojars are excellent hosts for the solvent extraction of carbonate
at pH 8–14. The industrial solvent Isopar-L is chosen as the organic extraction medium, which is
a relatively harmless, colorless and odorless mixture of C11–C13 isoalkanes, with low vapor
pressure (0.3 mmHg at 20 °C, bp ∼189–209 °C, compared to hexane: 132 mmHg, bp 69 °C).
Carbonate is extracted quantitatively from a 1.0 mM aqueous Na2CO3 solution at pH 8–14 by
stirring with a mixture of 4-R- pyrazole (R = n-butyl or n-octyl), copper nitrate and NaOH (1:1:2
molar ratio) in Isopar-L, whereby nanojars Na2[CO3⊂{Cu(OH)(4-R-pz)}n], identified by ESIMS(–), are separated into the organic phase. As the nanojar forms, it creates a highly hydrophilic
cavity that encloses the carbonate ion, surrounded by a highly hydrophobic outer layer, which fully
isolates the ion and provides solubility in the hydrophobic solvent. The incarcerated anion can be
released as bicarbonate and/or CO2 upon stripping the organic phase with a dilute nitric acid
solution.
3.2.3.2

Extraction of sulfate-anions
The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,

55, 10666−10679.107 Copyright 2016 American Chemical Society.
To demonstrate the extraction of SO42– ions from aqueous media, a sulfate solution was prepared
by mixing aqueous solutions of CuSO4 and KOH/Bu4NOH, which was then stirred with a solution
of pyrazole in CH2Cl2.Cu(OH) 2, which initially precipitates from the aqueous solutions, serves
both as a copper source and base, and it quickly dissolves into the organic phase as it reacts with
pyrazole to form nanojars, while incarcerating the sulfate ion. After separation of the organic phase
and evaporation of the solvent, ESI-MS(–) shows that the product is CunSO4 (n = 27−33), with
small amounts of CunCO3 (n = 27, 29, 31) (Figure 3.47A).
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In another setup, a 1:1 molar mixture of aqueous SO42– and CO32– ions was employed, by
stirring an aqueous solution of (Bu4N)2SO4, (Bu4N)2CO3, and Bu4NOH with a THF solution of
Cu(NO3)2 and pyrazole. The THF phase separated from the aqueous phase after the addition of
NaNO3. Evaporation of the solvent provides a mixture of sulfate- and carbonate-incarcerating
nanojars in comparable amounts (Figure 3.47B). When a large excess of sulfate is used
(Na2SO4/Na2CO3 molar ratio = 125:1 in the aqueous phase), mostly sulfate nanojars (CunSO4, n =
27−33) are obtained, and carbonate is also extracted (exclusively as Cu27CO3) (Figure 3.47C).

Figure 3.47: ESI-MS(–) spectra (in CH3CN) demonstrating extraction of sulfate by nanojars from
water into CH2Cl2, using CuSO4, pyrazole, KOH and Bu4NOH in a 28:28:56:2 molar ratio (A),
into THF, using Cu(NO3)2, pyrazole, Bu4NOH, (Bu4N)2SO4 and (Bu4N)2CO3 in a
29:29:58:1:1molar ratio (B), and into THF, using Cu(NO3)2, pyrazole, NaOH, Bu4NOH, Na2SO4
and Na2CO3 in a 29:29:56:2:125:1 molar ratio (C). Reproduced with permission, from reference
107.
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3.2.4 Characterization of nanojars and other copper complexes
1

3.2.4.1

H NMR spectroscopy and mass spectrometry studies of nanojars and other copper
complexes

3.2.4.1.1

1

H NMR of carbonate-nanojars

The results discussed in this section were originally published in Chem. - Eur. J. 2016, 22,
5499−5503.105 Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
The isolation of pure (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9], as well as of the (Bu4N)2[CO3Ì{Cu
(OH)(pz)}6+12+9] + (Bu4N)2[CO3Ì{Cu(OH)(pz)}7+13+9] + (Bu4N)2[CO3Ì{Cu (OH)(pz)}8+13+8]
mixture, allowed the full interpretation of the intricate 1H NMR spectrum of the as-synthesized
mixture of CO3 nanojars. The spectrum of pure (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9] (Figure 3.48)
showed twelve paramagnetically shifted resonances,166 eight in the δ = 21–38 ppm window
(pyrazolate protons) and four in the (–29)–(–69) ppm window (OH protons; Table 3.7). The four
sets of pyrazole peaks integrate to 9:6:6:6, allowing the assignment of individual Cux ring protons.
Within each pair, the first value corresponds to the pz-4-H proton, and the second one to the pz3,5-H2 protons. Thus, all pyrazolates of the Cu6 ring and Cu9 ring, respectively, are equivalent in
solution (in contrast to the crystal). For the Cu12 ring, two sets of peaks, of equal integrated
intensities, were observed, due to the different magnetic field environments associated with the
Cu6 and Cu9 rings. As can be seen in Figure 3.77, pyrazolato and OH groups of the Cu12 ring in
(Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9] alternate in up and down orientations relative to the mean
plane of the Cu atoms, with six pyrazoles pointing toward the Cu6 ring, and six pyrazoles pointing
toward the Cu9 ring. Assignment of resonances to each set of pyrazoles was confirmed by 1H–1H
COSY NMR data (Figure 3.49). Peak widths at half-heights (w1/2), as well as longitudinal (spin–
lattice, T1), and transverse (spin–spin, T2) relaxation times are summarized in Table 3.7.
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Figure 3.48: 1H NMR spectra (400 MHz, 20 ºC) of Cu27 nanojar (Bu4N)2[CO3Ì{Cu(OH)
(pz)}6+12+9] (top), Cu27/Cu29 nanojar mixture (Bu4N)2[CO3Ì{Cu(OH) (pz)}6+12+9] + (Bu4N)2
[CO3Ì{Cu(OH)(pz)}7+13+9] + (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8] (center), and of the assynthesized nanojar mixture (bottom) in DMSO-d6, showing pyrazole protons (left) and OH
protons (right). Reproduced with permission, from reference 105.
After subtracting the Cu27 peaks from the 1H NMR spectrum of the Cu27 + Cu29 mixture obtained
by pyridine etching (Figure 3.48), Cu29 peaks were assigned as follows: Cu7+13+9 nanojar, 33.93
and 29.84 ppm (Cu9 ring), 30.86 and 27.45 ppm (Cu7 ring), 27.10 and 22.00 ppm (Cu13
ring);Cu8+13+8 nanojar, 28.55 and 25.60 ppm (Cu13 ring), 25.88 and 21.20 ppm (two Cu8 rings).
Finally, by subtracting all Cu27 and Cu29 peaks, Cu31 peaks can be assigned in the spectrum of the
as-synthesized mixture of nanojars. As opposed to the Cu27 and Cu29 nanojars, the Cu31 nanojar
displayed much broader resonances. Thus, only one peak can be distinguished clearly, at 22.65
ppm (Cu14 ring). Broad peaks (overlapped with Cu27 and Cu29 peaks) are evident at 37.6, 33.3,
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31.2, 29.7, 28.4 and 27.3 ppm. Cu30 nanojar peaks could not be assigned, because the abundance
of this species is very low.
Table 3.7: 1H NMR data (400 MHz) for (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9] in DMSO-d6.
Reproduced with permission, from reference 105.
Peak [ppm]
37.92
33.48
31.42
28.32
27.70
26.30
22.40
22.38
−29.56
−32.74
−41.16
−68.65

w1/2 [Hz] T1 (esd) [ms]
31
76.3(0.4)
37
25.1(0.1)
21
55.0(0.1)
36
18.4(0.1)
8.7
167.0(2.1)
8.3
103.1(0.3)
17
55.7(0.7)
18
140
2.89(0.02)
205
2.93(0.01)
206
2.29(0.01)
509
2.45(0.02)

T2 (esd) [ms]
17.6(0.4)
11.6(0.1)
19.5(0.4)
9.6(0.3)
70.4(1.1)
56.6(2.0)
28.9(0.6)
2.65(0.10)
1.82(0.05)
1.76(0.11)
-

Assignment
Cu9 ring, pz-4-H
Cu9 ring, pz-3,5-H2
Cu6 ring, pz-4-H
Cu6 ring, pz-3,5-H2
Cu12 ring, pz-4-H (Cu9)
Cu12 ring, pz-4-H (Cu6)
Cu12 ring, pz-3,5-H2
(Cu129)ring, pz-3,5-H2
Cu
(Cu66ring,
Cu
)
OH
Cu12 ring, OH (Cu6)
Cu12 ring, OH (Cu9)
Cu9 ring, OH

The relatively sharp NMR signals of (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9] suggest strong
antiferromagnetic coupling between the Cu atoms of each Cux ring (average Cu···Cu 3.294(1) Å;
Cu-O-Cu 117.9(2)º). Pyrazolato and O(H) ligands are indeed known to mediate such coupling.52,167
Variable-temperature (VT) NMR indicates that the largest spin density resides on the Cu9 ring,
because its resonances show the largest hyperfine shifts and fastest relaxation, as well as the most
pronounced temperature-dependent shifts (see Figure 3.50 and Appendix C). The localization of
the unpaired electron density on the Cu9 ring becomes even more pronounced at low temperatures,
because the signals of the Cu9 protons shift in opposite direction to the Cu6 and Cu12 protons, and
broaden until they vanish. Variation of the hyperfine shifts in solvents with different donor
numbers is also documented (Table 3.8).
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Figure 3.49: 1H–1H COSY NMR spectrum of (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9]. Reproduced
with permission, from reference 105.

Figure 3.50: Temperature-dependent 1H NMR spectra of (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9] in
toluene-d8. The numbers 6, 9, and 12 correspond to the different Cux rings in [CO3Ì{Cu(OH)
(pz)}6+12+9]2–. Reproduced with permission, from reference 105.
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Table 3.8: 1H NMR data for nanojars (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9], (Bu4N)2[CO3Ì{Cu
(OH)(pz)}7+13+9] and (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8] in different solvents (donor number,168
kcal/mol) at 25 ºC. Reproduced with permission, from reference 105.
Nanojar

Cu9 ring, pz-4-H
Cu9 ring, pz-3,5-H2
Cu6 ring, pz-4-H
Cu6 ring, pz-3,5-H2
Cu12 ring, pz-4-H
(Cu9)
Cu12 ring, pz-4-H
(Cu6)
Cu12 ring, pz-3,5-H2
(Cu9)
Cu12 ring, pz-3,5-H2
(Cu6)
Cu12 ring, OH (Cu6)
Cu12 ring, OH (Cu9)
Cu6 ring, OH
Cu9 ring, OH
Cu9 ring, pz-4-H
Cu9 ring, pz-3,5-H2
Cu7 ring, pz-4-H
Cu7 ring, pz-3,5-H2
Cu13 ring, pz-4-H
Cu13 ring, pz-3,5-H2
Cu8 ring, pz-4-H
Cu8 ring, pz-3,5-H2
Cu13 ring, pz-4-H
Cu13 ring, pz-3,5-H2
Cu13 ring, OH
Cu8 ring, OH

Pyridine-d5 DMSO-d6 Acetonitrile-d3 Chloroform-d
(4)
(33.1)
(29.8)
(14.1)
(Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9]
37.55
37.58
36.80
37.80
33.69
33.18
32.79
34.01
31.46
31.42
31.02
29.04
28.33
28.27
27.44

Toluene-d8
(0.1)
37.75
34.31
29.33
27.58

27.95

27.74

27.84

28.68

28.86

26.54

26.33

26.43

27.14

27.28

23.03

22.42

22.65

23.47

23.84

23.00

22.40

22.61

23.47

23.84

−27.82
−32.80
−42.64
−66.90

−27.37
−33.59
−42.05
−65.73

33.42
30.02
29.97
27.10
28.19
23.20

33.60
30.42
31.26
?
28.44
23.57

27.90
26.76
25.44
22.21
−28.28
−29.96

27.90
26.76
25.44
22.21
−29.53
−32.62

−29.26
−29.57
−30.10
−29.26
−32.93
−31.27
−41.03
−41.16
−41.21
−67.38
−67.94
−64.95
(Bu4N)2[CO3Ì{Cu(OH)(pz)}7+13+9]
34.21
33.86
33.17
30.31
29.77
29.55
30.10
30.95
30.97
27.28
27.51
28.28
26.85
27.11
27.38
22.20
22.01
22.35
(Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8]
28.95
28.55
28.34
26.25
25.94
26.24
25.67
25.60
25.78
21.39
21.23
21.62
−26.03
−26.66
−27.38
−35.50
−33.58
−30.53
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3.2.4.1.2

Variable-temperature 1H NMR and mass-spec characterization of sulfate-nanojars

The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,
55, 10666−10679.107 Copyright 2016 American Chemical Society.
The 1H NMR spectrum of the as-synthesized mixture of sulfate-incarcerating nanojars (method
B)107 in DMSO-d6 is very complex, as it contains six overlapping sets of peaks corresponding to
Cu6+12+9SO4, Cu6+12+10SO4, Cu7+13+9SO4, Cu8+13+8SO4, Cu8+14+9SO4 and Cu8+14+10SO4 nanojars
(Figure 3.51 and Figure 3.52). Within each Cux-ring (x = 6−14, except 11), all pyrazole and OH
groups are magnetically identical, respectively, with the exception of the Cu12-ring, which shows
two sets of signals105 for both the pyrazole and the OH protons in the Cu6+12+9SO4 and Cu6+12+10SO4
nanojars. The pyrazole units have two magnetically distinct set of protons: one at the 4-position
and one at the 3,5-positions (with 1:2 integrated intensities). Thus, the nanojars described above
display 8, 8, 6, 4, 6, and 6 pyrazole proton peaks, respectively, in the 21− 41 ppm window, and 4,
4, 4, 3, 3, and 3 OH proton peaks, respectively, in the window between –25 ppm and −59 ppm. At
room temperature, the assignment of each individual peak in this mixture is impossible, because
of severe (sometimes complete) overlap. The isolation of three different fractions (Cu27/Cu28,
Cu29/Cu31, Cu31/Cu32), combined with variable-temperature measurements over a 25−150 °C range
(see Appendix C), permitted the assignment of all 59 peaks (except the one of the OH proton of
the Cu14-ring of the Cu8+14+10SO4 nanojar, which is likely overlapped with the corresponding peak
of the same size ring of the Cu8+14+9SO4 nanojar).
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Figure 3.51: Variable-temperature 1H NMR spectra of the mixture of six different sulfateincarcerating nanojars in DMSO-d6, showing pyrazole proton signals in the 21−41 ppm window.
Reproduced with permission, from reference 107.
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Figure 3.52: Variable-temperature 1H NMR spectra of the mixture of six different sulfateincarcerating nanojars in DMSO-d6, showing OH proton signals in the (−25)−(−59) ppm window.
Reproduced with permission, from reference 107.
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We have previously shown that (i) because of the paramagnetic Cu(II) atoms, the peaks
corresponding to pyrazole and OH protons are drastically shifted downfield and upfield,
respectively, and (ii) their chemical shift values are temperature-dependent.105 Fortuitously, the
chemical shift of certain peaks displays much larger temperature dependence than those of others.
Monitoring the position of each peak in the 60 variable-temperature 1H NMR spectra collected
allows the observation of individual peaks that are overlapped at a given temperature, but are
clearly separated at a certain different temperature (see Figure 3.53 and Table 3.9).
Comparison of the 1H NMR spectra of the Cu6+12+9SO4 nanojar with the corresponding
ones of the carbonate- encapsulating analogue Cu6+12+9CO3105 indicates that, with the exception of
the Cu12-ring pyrazole protons, which show a difference of <0.3 ppm, all other proton signals have
a significantly different chemical shift (2−3 ppm difference for Cu6- and Cu9-ring pyrazole
protons, and 3−15 ppm difference for OH protons). These differences indicate that the incarcerated
anion (sulfate versus carbonate) has a significant influence on spin density distribution within
nanojars.
The Cu6+12+10SO4 nanojar, which has not been observed before with carbonate,105 displays
signals that are more paramagnetically shifted than those of the Cu6+12+9SO4 nanojar (see Figure
3.51 and Figure 3.52, as well as Appendix C). For instance, the pyrazole signals of the Cu10-ring
are found at 40.27 and 34.50 ppm, compared to 34.83 and 31.03 ppm in the case of the Cu9-ring,
whereas the OH signal of the Cu10-ring is located at −57.75 ppm, compared to −52.95 ppm in the
case of the Cu9-ring.
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Figure 3.53: Temperature-dependent variation of the chemical shift of different Cun-ring protons
in the various sulfate-nanojars in DMSO-d6, illustrating the influence of the size of the ring on
chemical shift, as well as the difference in chemical shift for the same Cun-ring in different
nanojars. Reproduced with permission, from reference 107.
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Table 3.9: Variable-temperature 1H NMR chemical shifts (ppm) of nanojars CunSO4 (n = 27−32)
in DMSO-d6. Reproduced with permission, from reference 107.
25 °C

30 °C

40 °C

50 °C

60 °C

70 °C

80 °C

90 °C

100 °C

110 °C

120 °C

130 °C

140 °C

150 °C

1: Cu27 (6+12+9)
Cu9-ring, pz-4-H

34.83

34.66

34.31

33.93

33.55

33.17

32.77

32.39

32.01

31.64

31.29

30.94

30.63

30.28

Cu9-ring, pz-3,5-H2

31.03

30.89

30.62

30.31

30.01

29.69

29.37

29.05

28.73

28.42

28.11

27.82

27.52

27.24

Cu6-ring, pz-4-H

~33.70

~33.65

33.58

33.50

33.40

33.27

33.15

33.00

32.85

32.69

32.53

32.36

32.18

31.98

Cu6-ring, pz-3,5-H2

30.18

30.18

30.15

30.08

30.01

29.92

29.82

29.70

29.58

29.46

29.32

29.17

29.02

28.86

Cu12-ring, pz-4-H(9)

28.04

28.07

28.13

28.19

28.22

28.25

28.27

28.27

28.27

28.25

28.22

28.19

28.15

28.10

Cu12-ring, pz-4-H(6)

26.44

26.46

26.51

26.56

26.59

26.60

26.60

26.60

26.59

26.56

26.53

26.48

26.44

26.40

Cu12-ring, pz-3,5-H2(9)

22.56

22.57

22.62

22.63

22.65

22.66

22.66

22.65

22.63

22.62

22.59

22.55

22.51

22.45

Cu12-ring, pz-3,5-H2(6)

22.56

22.57

22.62

22.63

22.65

22.63

22.63

22.62

22.60

22.57

22.54

22.50

22.45

22.40

Cu12-ring, OH(6)

−26.18

−26.24

−26.33

−26.47

−26.57

−26.62

−26.68

−26.68

−26.65

−26.66

−26.51

−26.50

−26.50

−26.37

Cu12-ring, OH(9)

−42.02

−42.05

−41.99

−41.93

−41.85

−41.75

−41.72

−41.46

−41.24

−41.08

−40.82

−40.74

−40.34

−40.11

Cu6-ring, OH

−44.39

−44.40

−44.38

−44.28

~−44.2

~−44.0

~−43.8

~−43.7

~−43.6

~−43.4

−42.98

−42.72

−42.45

−42.21

Cu9-ring, OH

−52.95

−52.97

−52.91

−52.63

~−52.3

~−52.0

~−51.8

~−51.2

−50.63

−50.14

−49.64

−49.11

−48.63

−48.11

2: Cu28 (6+12+10)
Cu10-ring, pz-4-H

40.27

39.99

39.46

38.94

38.42

37.92

37.43

36.94

36.47

36.01

35.56

35.12

34.69

34.28

Cu10-ring, pz-3,5-H2

34.50

34.27

33.81

33.37

32.94

32.51

32.08

31.67

31.27

30.89

30.51

30.15

29.81

29.41

Cu6-ring, pz-4-H

33.61

33.63

33.67

33.67

33.64

33.60

33.52

33.41

33.31

33.17

33.03

32.86

32.70

32.54

Cu6-ring, pz-3,5-H2

30.77

30.79

30.80

30.79

30.74

30.68

30.59

30.48

30.37

30.24

30.10

29.92

29.61

29.41

Cu12-ring, pz-4-H(10)

28.97

29.00

29.06

29.09

29.12

29.14

29.14

29.12

29.11

29.08

29.03

28.98

28.92

28.86

Cu12-ring, pz-4-H(6)

27.48

27.50

27.56

27.60

27.61

27.63

27.61

27.60

27.56

27.52

27.47

27.41

27.35

~27.3

Cu12-ring, pz-3,5-H2(10)

23.40

23.41

23.43

23.44

23.46

23.44

23.43

23.40

23.37

23.32

23.27

23.23

23.17

23.09

Cu12-ring, pz-3,5-H2(6)

23.23

23.24

23.27

23.29

23.29

23.29

23.27

23.24

23.23

23.18

23.14

23.09

23.05

22.98

Cu12-ring, OH(6)

−32.98

−32.91

−32.74

−32.57

−32.42

−32.19

−32.01

−31.79

−31.53

−31.32

−31.06

−30.79

−30.53

~−30.2

Cu12-ring, OH(10)

−43.47

−43.56

−43.69

−43.78

−43.81

−43.84

−43.85

−43.76

−43.61

−43.41

~−43.2

~−43.1

~−43.0

~−42.9

Cu6-ring, OH

−51.49

−51.66

−51.95

−52.13

−52.27

−52.16

~−52.0

−52.07

−51.88

−51.66

−51.35

−51.08

−50.69

−50.27

Cu10-ring, OH

−57.75

−57.18

−56.10

−55.05

−53.95

−52.94

~−51.9

~−51.0

−50.02

−49.09

−48.19

−47.29

−46.48

−45.67

3: Cu29 (8+13+8)
Cu8-ring, pz-4-H

28.33

28.31

28.30

28.28

28.25

28.22

28.19

28.14

28.11

28.05

28.01

27.95

27.89

27.82

Cu8-ring, pz-3,5-H2

25.63

25.63

25.61

25.60

25.56

25.55

25.52

25.47

25.43

25.38

25.34

25.27

25.23

25.15

Cu13-ring, pz-4-H

26.59

26.65

26.74

26.82

26.88

26.94

26.98

27.02

27.03

27.05

27.06

27.06

27.05

27.03

Cu13-ring, pz-3,5-H2

21.67

21.70

21.75

21.79

21.84

21.85

21.87

21.89

21.89

21.89

21.87

21.85

21.82

21.81

Cu13-ring, OH

−28.57

−28.65

−28.86

−29.08

−29.18

−29.34

−29.49

−29.60

−29.69

−29.76

−29.89

−29.93

−29.99

−30.07

Cu8-ring, OH

−38.88

−38.57

−38.37

−38.01

−37.76

−37.56

−37.31

−37.11

−36.86

−36.73

−36.52

−36.37

−36.04

−35.11

4: Cu29 (7+13+9)
Cu9-ring, pz-4-H

31.84

31.75

31.56

31.38

31.18

30.98

30.78

30.59

30.40

30.21

~30.00

~29.85

~29.67

29.49

Cu9-ring, pz-3,5-H2

28.63

28.56

28.39

28.21

28.04

27.85

27.67

27.49

27.31

27.13

26.95

26.78

~26.59

~26.45

Cu7-ring, pz-4-H

31.55

31.53

31.50

31.47

31.41

31.35

31.29

31.21

31.12

31.03

~30.94

~30.86

~30.67

~30.48

Cu7-ring, pz-3,5-H2

28.16

28.16

28.13

28.11

~28.08

28.02

~27.97

~27.90

27.82

27.73

27.65

27.56

~27.48

27.35

Cu13-ring, pz-4-H

27.79

27.82

27.87

27.92

27.95

27.96

27.98

27.98

27.96

27.95

27.93

27.90

27.87

~27.81

Nanojar

Cu13-ring, pz-3,5-H2

22.51

22.53

22.54

22.56

22.57

22.57

22.56

22.56

22.53

22.50

22.47

22.44

22.39

22.34

Cu13-ring, OH

−30.24

−30.25

−30.24

−30.24

−30.29

−30.28

−30.27

−30.21

−30.13

~−30.1

~−30.0

~−29.9

~−29.8

~−29.7

Cu7-ring, OH

−42.22

−42.13

−42.05

−41.93

−41.76

−41.61

−41.46

−41.29

−41.11

−40.94

−40.77

~−40.6

~−40.5

~−40.3

Cu9-ring, OH

−45.81

−45.53

−45.04

−44.57

−44.07

−43.60

−43.12

−42.65

−42.20

−41.76

−41.35

~−40.9

~−40.5

~−40.1

5: Cu31 (8+14+9)
Cu9-ring, pz-4-H

32.95

32.79

32.62

32.39

32.19

31.99

31.77

31.60

31.40

31.21

31.03

30.86

30.70

30.51

Cu9-ring, pz-3,5-H2

28.73

28.76

28.57

28.40

28.25

28.10

27.93

27.78

27.63

27.49

27.33

27.20

27.06

26.91

Cu8-ring, pz-4-H

30.16

30.18

30.19

30.19

30.19

30.16

30.12

30.08

30.04

29.99

29.93

29.85

29.79

29.72

Cu8-ring, pz-3,5-H2

26.83

26.86

26.88

26.88

26.88

26.86

26.83

26.78

26.74

26.69

26.63

26.57

26.51

26.44

Cu14-ring, pz-4-H

28.73

28.76

28.80

28.85

28.88

28.89

28.91

28.89

28.88

28.86

28.83

28.78

28.73

28.67

Cu14-ring, pz-3,5-H2

22.91

22.93

22.94

22.94

22.95

22.94

22.92

22.91

22.88

22.85

22.80

22.76

22.71

22.66

Cu14-ring, OH

−28.28

−28.02

−27.93

−27.95

−27.81

−27.76

−27.72

−27.63

−27.53

−27.53

−27.33

−27.23

−27.09

−26.97

Cu8-ring, OH

−

−

−36.50

−35.92

−35.72

−35.67

−35.61

−35.53

−35.47

−35.47

−35.27

−35.20

−35.06

−35.00

Cu9-ring, OH

−

−

−41.73

−40.19

−39.47

−38.89

−38.36

−37.85

−37.37

−36.92

−36.53

−36.16

−35.81

−35.41

6: Cu32 (8+14+10)
Cu10-ring, pz-4-H

39.69

39.52

39.12

38.73

38.33

37.93

~37.5

−

−

−

−

−

−

−

Cu10-ring, pz-3,5-H2

33.85

33.70

33.35

33.02

32.65

−

−

−

−

−

−

−

−

−

Cu8-ring, pz-4-H

35.82

35.72

35.37

35.23

34.97

34.70

34.43

34.16

33.91

33.66

33.40

33.15

~32.92

−

Cu8-ring, pz-3,5-H2

31.41

31.32

31.11

30.92

30.71

30.48

30.27

~30.0

29.82

29.62

29.41

29.20

~29.0

−

Cu14-ring, pz-4-H

29.15

29.18

29.21

29.23

29.24

29.24

29.24

29.21

29.18

29.15

29.11

29.06

~29.0

−

Cu14-ring, pz-3,5-H2

23.41

23.43

23.44

23.45

23.45

23.44

23.43

23.40

23.37

23.34

23.29

23.24

23.20

23.14

Cu8-ring, OH

−36.07

−35.99

−35.96

−35.84

−35.76

−35.64

~−35.5

−

−

−

−

−

−

−

Cu10-ring, OH

−42.21

−41.99

−41.73

−41.46

−41.09

−40.74

−40.39

~−40.0

~−39.6

~−39.2

~−38.8

~−38.4

~−38.1

~−37.7
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In fact, the signals of the Cu10-ring are the most paramagnetically shifted among all Cun-rings
observed within sulfate-incarcerating nanojars, and they display the strongest temperature
dependence (6, 5, and 12 ppm shift for the pyrazole 4- and 3,5-protons and OH proton,
respectively, upon going from 25 °C to 150 °C, compared to 5, 4, and 5 ppm, respectively, for the
Cu9-ring). The Cu6- and Cu12-ring signals in the Cu27- and Cu28-nanojars display a much smaller
shift with temperature (Cu6-ring: 1−2 and 2 ppm for the pyrazole and OH protons, respectively;
Cu12-ring: 0.2−0.4 and 0.5−3 ppm for the pyrazole and OH protons) (Figure 3.54).

Figure 3.54: Temperature-dependent variation of the chemical shift of different Cun-ring protons
in the Cu6+12+9CO3, Cu6+12+9SO4 and Cu6+12+10SO4 nanojars in DMSO-d6, illustrating the influence
of incarcerated anion and size of the ring on chemical shift (also see Figure 3.53). Reproduced
with permission, from reference 107.
The temperature-dependent variation of the chemical shift of different Cun-ring protons in the
various sulfate nanojars in DMSO-d6, illustrating not only the influence of the size of the ring on
chemical shift, but also the difference in chemical shift for the same Cun-ring in different nanojars,
is shown in Figure 3.53. As the Cu6+12+9/Cu6+12+10 nanojar mixture is heated in DMSO-d6, a gradual
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decrease of the Cu6+12+10 signals are observed, while new signals, corresponding to Cu8+13+8 and
Cu8+14+9 nanojars, appear. Upon cooling back to 25 °C, mixture of Cu6+12+9, Cu6+12+10, Cu7+13+9,
Cu8+13+8 and Cu8+14+9 nanojars is obtained, confirmed also by ESI-MS spectrometry (Figure 3.55).

Figure 3.55: ESI-MS(–) spectra (in CH3CN) of the nanojar fraction containing Cu28SO4 and small
amounts of Cu27SO4 before heating (A) and after heating to 150 ºC in DMSO-d6 (B). Reproduced
with permission, from reference 107.
Similarly to the carbonate analogues, two different Cu29-nanojars, Cu7+13+9SO4 and Cu8+13+8SO4
are obtained with sulfate (see Figure 3.51 and Figure 3.52, as well as Appendix C). In the assynthesized mixture at room temperature, Cu7+13+9SO4 is much more abundant than Cu8+13+8SO4.
Upon heating in DMSO-d6, however, the former transforms to the latter, which, in turn, transforms
to Cu8+14+9SO4 at even higher temperatures (greater than ∼100 °C). At 150 °C, the mixture that
initially contained mostly Cu7+13+9SO4 and Cu8+14+9SO4, and small amounts of Cu6+12+9SO4,
Cu6+12+10SO4, Cu8+13+8SO4, Cu8+14+10SO4 nanojars, displays only two sets of peaks, corresponding
to Cu8+14+9SO4 and a small amount of Cu8+13+8SO4 nanojars (Figure 3.56).
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Figure 3.56: ESI-MS(–) spectra (in CH3CN) of the nanojar fraction containing Cu29SO4 and
Cu31SO4 (and small amounts of Cu27SO4, Cu28SO4 and Cu32SO4) before heating (A) and after
heating to 150 ºC in DMSO-d6 (B). Reproduced with permission, from reference 107.
The Cu8- and Cu13-ring signals show much less variation with temperature than the Cu9- and Cu10ring signals, and are more similar to the Cu12-ring signals (Cu8-ring: 0.5 and 4 ppm for the pyrazole
and OH protons, respectively; Cu13-ring: 0.2−0.5 and 1.5 ppm for the pyrazole and OH protons,
respectively). In the Cu8+13+8 nanojar, the incarcerated anion has less influence than in the Cu6+12+9
nanojar: differences of 0.2−1 ppm (pyrazole protons) and 2−5 ppm (OH protons) are observed
between Cu8+13+8SO4 and Cu8+13+8CO3.105 Notably, the crystal structures of the two nanojars are
virtually identical (see sections 3.2.4.4.11 and 3.2.4.4.15).
As with the carbonate-incarcerating analogues, Cu8+14+9SO4 shows the broadest signals among the
nanojars of different sizes (see Figure 3.51 and Figure 3.52, as well as Appendix C). At room
temperature, the pyrazole proton signals of the Cu9-ring, as well as those of the OH protons of both
the Cu8- and Cu9-rings are too broad to be observed. In contrast to the carbonate analogue,
however, Cu8+14+9SO4 is stable at higher temperatures, and the corresponding signals appear much
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sharper at 150 °C. At this temperature, tiny amounts of Cu8+13+8SO4 decomposition product are
also observed as confirmed by ESI-MS as well (Figure 3.57).

Figure 3.57: ESI-MS (–) spectra (in CH3CN) of the nanojar fraction containing Cu31SO4 and small
amounts of Cu32SO4 before heating (A) and after heating to 150 ºC in DMSO-d6 (B). Reproduced
with permission, from reference 107.
Assignment of the NMR signals corresponding to protons in the pyrazole 4- and 3,5-positions was
easily done earlier on a pure Cu27CO3 sample at room temperature, as an integrated ratio of 1:2
was unambiguously obtained for distinct peaks. Although overlapping prevents the quantitative
integration of certain peaks in CunSO4 mixtures at a given temperature, the assignment of
individual peaks is possible thanks to the different temperature dependence of the chemical shift
of those peaks. Nevertheless, we verified the assignment of the 4- and 3,5-protons by substituting
the 4-position of the pyrazole ligands in Cu31SO4 with a methyl group. Thus, nanojars
(Bu4N)2[SO4Ì{Cu(OH)(4-Mepz)}31] were prepared using 4-methylpyrazole instead of pyrazole.
The 1H NMR peaks corresponding to the pyrazole 4-position are absent in the substituted nanojar
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(see Appendix C), while the peaks corresponding to the equivalent 3- and 5-positions have almost
identical chemical shifts to those in the unsubstituted nanojar (see Appendix C).
3.2.4.1.3

1

H NMR and mass spectrometry characterization of [Cu3(µ3-OH)(µ-pz)3(NO3)2
(H2O)] 69a and [Cu3(µ3-OH)(µ-pz)3(NO3)2(CH3CN)] 69b

The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,
55, 7717−7728.106 Copyright 2016 American Chemical Society.
In the ESI-MS(+) spectrum of 69a in CH3CN, the base peak observed at m/z 407.9 corresponds to
[Cu3O(pz)3]+ (due to loss of H2O, NO3− and HNO3 upon ionization); smaller peaks attributable to
[Cu4O2(pz)4]+ (m/z 553.8), [Cu5O2(pz)5]+ (m/z 683.8), [Cu6(OH)2(pz)6(NO3)3]+ (m/z 1003.7) and
[{Cu6(OH)2(pz)6(NO3)3}2(NO3)]+ (m/z 2069.4) are also present. In the ESI-MS(–), the base peak
observed at m/z 526.8 corresponds to [Cu3O(pz)2(NO3)3]–; a smaller peak attributable to
[Cu3(OH)3(pz)2(NO3)2]– (m/z 499.8), as well as traces of [Cu3(OH)4(pz)3]− (m/z 459.9),
[Cu3O(pz)3(NO3)2]– (m/z 531.9), [Cu4O2(pz)2(NO3)3]− (m/z 605.7), [Cu4O2(pz)4(NO3)2]– (m/z
677.8), [Cu6O2(pz)4(NO3)5]− (m/z 991.6) and [Cu6O2(pz)5(NO3)4]− (m/z 996.6) are also identified.
Importantly, no traces of nanojars could be detected in either negative or positive mode. The 1H
NMR spectrum of 69a shows two peaks in a 1:2 integrated ratio at 40.90 and 35.19 ppm in
(CD3)2CO at 25 °C, attributable to the pyrazolate protons in the 4 and 3,5 positions, respectively
(Figure 3.58).
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Figure 3.58: 1H NMR spectrum (400 MHz, (CD3)2CO, 25 °C) of [Cu3(µ3-OH)(µ-pz)3(NO3)2(H2O)]
69a. Reproduced with permission, from reference 106.
The observed signals are relatively sharp for a paramagnetic complex, suggesting strong
antiferromagnetic coupling between the Cu(II) centers.52,167 Similar values are obtained with
recrystallized 69b (40.99 and 35.13 ppm in (CD3)2CO at 25 °C). These results show that in contrast
to the solid-state structure, in solution the complex assumes 3-fold symmetry, as a result of fast
exchange of the nitrate ions with the water 69a or acetonitrile 69b moieties. Complex 69b retains
its 3-fold symmetry in (CD3)2CO solution down to −100 °C (Figure 3.59). 69a, however, partially
dimerizes in (CD3)2CO solution, as suggested by the appearance of a second set of peaks. The ratio
of dimer to trinuclear complex increases as the temperature is lowered (Figure 3.59). Dimerization
leads to a decrease of the unpaired electron density on the complex, resulting in the upfield shift
of the peaks, along with lowering the symmetry from C3v to C2h, resulting in a larger number of
peaks.
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Figure 3.59: Variable-temperature 1H NMR spectra of [Cu3(µ3-OH)(µ-pz)3(NO3)2(H2O)] (69a,
left) and [Cu3(µ3-OH)(µ-pz)3(NO3)2(CH3CN)] (69b, right) in (CD3)2CO. Peaks corresponding to
the trinuclear complexes are indicated in blue, those of the dimer in red, those of H2O in cyan, and
those of CH3CN in violet. Reproduced with permission, from reference 106.
The proposed structure of the dimer with bridging H2O molecules is shown in Figure 3.60. Similar
structures, with carboxylate bridges instead of water and carboxylate or pyrazole ligands instead
of nitrate, have been characterized crystallographically.53,69,169,170 The variable-temperature 1H
NMR studies also provide proof for the coordinated H2O or CH3CN molecules in 69a and 69b,
respectively: as the temperature is lowered, the corresponding peaks display increasing hyperfine
shifts and shorter relaxation times (evidenced by downfield shifts and broadening), similar to the
pyrazolate peaks.
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Figure 3.60: Proposed structure of the dimer formed by 69a in acetone solution. Color scheme:
Cu–blue; O–red; N–light blue; C–black (H atoms not shown). Reproduced with permission, from
reference 106.

3.2.4.2

1

H NMR spectroscopic and mass spectrometric studies of thermal stability of nanojars

The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,
55, 10666−10679.107 Copyright 2016 American Chemical Society.
As evidenced by the 1H NMR experiments in DMSO solution described in (section 3.2.4.1.2),
certain nanojars are more stable at high temperature than others. Thus, nanojars that are stable at
room temperature, such as Cu6+12+9SO4, Cu6+12+10SO4, Cu7+13+9SO4 and Cu8+14+10SO4, transform in
solution to more robust Cu8+13+8SO4 and Cu8+14+9SO4 nanojars upon increasing the temperature.
The higher stability of the latter two complexes could be attributed to a tighter accommodation of
the sulfate ion guest within the nanojar host, which will form at higher temperatures on the expense
of both smaller and larger nanojars. Similarly, the carbonate ion finds a better fit in the smaller
nanojars, as Cu6+12+9CO3 and Cu8+13+8CO3 are more resistant to heating than Cu7+13+9CO3 and
Cu8+14+9CO3.28 After refluxing a mixture of CunSO4 and CunCO3 in THF (b.p. 66 °C) for 24 h, only
Cu31SO4, Cu29SO4, Cu27CO3 and Cu29CO3 survive, as shown by ESI-MS (Figure 3.34B); 1H NMR
indicates that both Cu29 nanojars (Cu7+13+9 and Cu8+13+8) are still present, with both sulfate and
carbonate (Figure 3.61).
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Figure 3.61: 1H NMR spectrum (in DMSO-d6) of a mixture of sulfate- and carbonate-incarcerating
nanojars with a SO42−:CO32− molar ratio of 1:1 (all reagents soluble in the THF reaction medium),
after refluxing the THF solution for 24 hours (pyrazole signals in the 21–41 ppm window).
Reproduced with permission, from reference 107.
In contrast, all nanojars are considerably more stable at higher temperatures in the solid state: the
ESI-MS spectrum of a mixture of CunSO4 and CunCO3 is almost unchanged after heating at 140
°C for 24 h in an oven under air. Furthermore, thermogravimetric analysis shows that, regardless
of nanojar size or incarcerated anion (sulfate or carbonate), thermal decomposition accompanied
by weight loss does not occur up to 205−210 °C under N2 (see Appendix D).
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3.2.4.3

Mass-spectrometric study of carbonate- and sulfate-nanojars
The results discussed in this section were originally published in Chem. - Eur. J. 2016, 22,

5499−5503.105 Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
ESI-MS(–) of the as-prepared mixtures of (Bu4N)2[anionÌ{Cu (OH)(pz)}n] (anion = CO32−
or SO42−) nanojars (by the room temperature self-assembly of Cu2+, OH− and pyrazole, see Figure
3.26 and Figure 3.32) in CH3CN, at cone voltages no greater than 40 V, reveals in each case the
presence of multiple [anionÌ{Cu(OH)(pz)}n]2− nanojars (Figure 3.62).

Figure 3.62: ESI-MS(–) spectra of the as-synthesized CO32− (lower) and SO42− (upper) nanojar
mixtures at 40 V in CH3CN. Insets show shrunken daughter nanojars at 100 V (numbers indicate
parent nanojar). Reproduced with permission, from reference 105.
In the case of carbonate, dinegative Cu27 (m/z 2023), Cu29 (m/z 2171), Cu30 (m/z 2244) and Cu31
(m/z 2318) nanojars are observed, while with sulfate, Cu27 (m/z 2041), Cu28 (m/z 2115), Cu29 (m/z
2189) and Cu31 (m/z 2336) nanojars are detected. Accurate mass data, as well as predicted and
observed isotopic patterns are presented in the (Table 3.10 and Appendix B).
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Table 3.10: Accurate mass data for the carbonate- and sulfate-nanojars by ESI-MS(–). In each
case, the most abundant peak from the isotope pattern is used for comparing predicted and
observed m/z values. Reproduced with permission, from reference 105.
Nanojar
[CO3Ì{Cu(OH)(pz)}27]2−

Molecular formula
Cu27C82H108N54O30

Predicted m/z
2021.9646

Observed m/z
2021.9650

[CO3Ì{Cu(OH)(pz)}29]2−

Cu29C85H112N56O31

2169.9258

2169.9153

2−

[CO3Ì{Cu(OH)(pz)}30]

Cu30C88H116N58O32

2243.4070

2244.3972

[CO3Ì{Cu(OH)(pz)}31]2−

Cu31C94H124N62O34

2316.8879

2316.8809

[SO4Ì{Cu(OH)(pz)}27]2−

Cu27C81H108N54O31S

2039.9480

2039.9636

[SO4Ì{Cu(OH)(pz)}28]2−

Cu28C84H112N56O32S

2113.4290

2113.4290

[SO4Ì{Cu(OH)(pz)}29]2−

Cu29C87H116N58O33S

2186.9099

2186.9063

[SO4Ì{Cu(OH)(pz)}31]

Cu31C93H124N62O35S

2334.8713

2334.8789

2−

At sampling cone voltages higher than 40 V, the peaks corresponding to [CO3Ì{Cu(OH)(pz)}n]2–
nanojars in the m/z 2010−2330 window gradually disappear, while a peak at m/z 198, along with
a new group of peaks in the m/z 1550−2010 window appear. At 100 V, no parent nanojars, but
only daughter species are observed (Figure 3.62). Although the m/z = 198 peak could easily be
assigned to [CuI(pz)2]−, the origin of the peaks in the m/z 1550−2010 window was not readily
apparent. Tandem mass spectrometry experiments were carried out on each parent
[CO3Ì{Cu(OH)(pz)}n]2– peak (Appendix E). The results show that the nanojars shrink by losing
neutral Cu5(OH)10(Hpz)10−y(H2O)(n+y−20)/2 fragments (y = 4−12; y has the same parity as n). Thus,
four to five shrunken nanojars of the formula [Cun−5O(n−y)/2(pz)n+y−10CO3]2− were produced by each
parent nanojar (Table 3.11). The corresponding sulfate nanojars lose Cu3(OH)6(Hpz)8−y
(H2O)(n+y−14)/2 fragments (y = (−1)−8), and produce [Cun−3O(n−y+2)/2(pz)n+y−8SO4]2− daughter nanojars (Appendix E). In addition to these major peaks, minor peaks attributed to
[Cun−5O(n−y)/2(OH)(pz)n+y−11CO3]2− and [Cun−3O(n−y+2)/2(OH)(pz)n+y−9SO4]2−, respectively, are also
observed.
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Table 3.11: Carbonate- and sulfate-nanojar species observed by ESI-MS(–) at different cone
voltages (40 V – parent nanojar; 100 V – daughter nanojars). See also Appendix E. Reproduced
with permission, from reference 105.
Parent nanojar
(m/z)

[CO3Ì{Cu(OH)
(pz)}27]2−
(2022.93)

Daughter nanojars
(m/z)
[CO3ÌCu22O11(pz)22]2−
(1554.79)
[CO3ÌCu22O10(pz)24]2−
(1613.86)
[CO3ÌCu22O9(pz)26]2−
(1672.93)
[CO3ÌCu22O8(pz)28]2−
(1732.00)
[CO3ÌCu22O7(pz)30]2−
(1791.07)

[CO3Ì{Cu(OH)
(pz)}29]2−
(2170.55)

[CO3ÌCu24O12(pz)24]2−
(1693.40)
[CO3ÌCu24O11(pz)26]2−
(1752.47)
[CO3ÌCu24O10(pz)28]2−
(1811.55)
[CO3ÌCu24O9(pz)30]2−
(1870.62)

[CO3Ì{Cu(OH)
(pz)}30]2−
(2244.36)

[CO3ÌCu25O13(pz)24]2−
(1733.17)
[CO3ÌCu25O12(pz)26]2−
(1792.25)
[CO3ÌCu25O11(pz)28]2−
(1851.32)
[CO3ÌCu25O10(pz)30]2−
(1910.39)
[CO3ÌCu25O9(pz)32]2−
(1969.46)

Parent nanojar (m/z)

Daughter nanojars
(m/z)

[SO4Ì{Cu(OH)(pz)}27]2−
(2040.95)

[SO4ÌCu24O14(pz)20]2−
(1593.28)
[SO4ÌCu24O13(pz)22]2−
(1652.35)
[SO4ÌCu24O12(pz)24]2−
(1711.43)

[SO4Ì{Cu(OH)(pz)}28]2−
(2114.76)

[SO4ÌCu25O15(pz)20]2−
(1633.05)
[SO4ÌCu25O14(pz)22]2−
(1692.13)
[SO4ÌCu25O13(pz)24]2−
(1751.20)
[SO4ÌCu25O12(pz)26]2−
(1810.27)

[SO4Ì{Cu(OH)(pz)}29]2−
(2188.57)

[SO4ÌCu26O16(pz)20]2−
(1672.83)
[SO4ÌCu26O15(pz)22]2−
(1731.90)
[SO4ÌCu26O14(pz)24]2−
(1790.97)
[SO4ÌCu26O13(pz)26]2−
(1850.04)
[SO4ÌCu26O12(pz)28]2−
(1909.11)
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Table 3.11: Continued.
Parent nanojar
(m/z)

[CO3Ì{Cu(OH)
(pz)}31]2−
(2318.18)

3.2.4.4

Daughter nanojars
(m/z)
[CO3ÌCu26O13(pz)26]2−
(1832.02)
[CO3ÌCu26O12(pz)28]2−
(1891.09)
[CO3ÌCu26O11(pz)30]2−
(1950.16)
[CO3ÌCu26O10(pz)32]2−
(2009.23)

Parent nanojar (m/z)

Daughter nanojars
(m/z)

[SO4Ì{Cu(OH)(pz)}31]2−
(2336.20)

[SO4ÌCu28O17(pz)22]2−
(1811.44)
[SO4ÌCu28O16(pz)24]2−
(1870.52)
[SO4ÌCu28O15(pz)26]2−
(1929.59)
[SO4ÌCu28O14(pz)28]2−
(1988.66)
[SO4ÌCu28O13(pz)30]2−
(2047.73)

Crystallographic studies of organic compounds, nanojars and other copper complexes

3.2.4.4.1

1,6-Bis(pyrazol-3(5)-yl)hexane

The results discussed in this section were originally published in RSC Adv. 2015, 5, 24081–
24093,111 and are reproduced by permission of The Royal Society of Chemistry.
The unexpected insolubility of 1,6-bis(pyrazol-3(5)-yl)hexane in most common solvents, as well
as the difficulty in completely removing water from it, even after heating in high vacuum,
prompted us to carry out single-crystal X-ray diffraction studies to elucidate its solid state
structure. Crystals of 1,6-bis(pyrazol-3(5)-yl)hexane hydrate were grown by slow cooling of a hot
aqueous solution to which a small amount of methanol was added. Within the crystal lattice of 1,6bis(pyrazol-3(5)-yl)hexane, the bridging hexylene unit is fully extended and the two pyrazole
moieties are at a dihedral angle of 63.9(1)° (Figure 3.63).
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Figure 3.63: Crystal structure (thermal ellipsoid plot, 50% probability level) of 1,6-bis(pyrazol3(5)-yl)hexane hydrate. Reproduced with permission, from reference 111.

The pyrazole N–H hydrogen atoms are located on the N-atom adjacent to the bridging hexylene
unit, and are involved in hydrogen-bonding with the solvent water molecule (Table 3.12). The two
H-atoms of H2O, in turn, are involved in hydrogen- bonding to the other pyrazole N-atom. Besides
the hydrogen-bonded network within the resulting two-dimensional layer (Figure 3.64), edge-toface interactions are observed between neighboring pyrazole (pz) units, with closest contact of
2.961(3) Å (C11−H11···N2¢), C11−H11/centroid (pz) distance of 3.183(3) Å, centroid (pz)–
centroid (pz) distance of 5.262(2) Å, and pz–pz dihedral angle of 63.9(1)º.

Table 3.12: Summary of hydrogen bonding data for 1,6-bis(pyrazol-3(5)-yl)hexane hydrate (with
esds, except fixed/riding hydrogens). Reproduced with permission, from reference 111.
D−H
(Å)

H···A
(Å)

D···A
(Å)

O1−H2o···N1¢

0.86(2)
0.84(2)

1.95(2)
1.98(2)

2.807(3)
2.818(3)

D−H−A
(°)
175(2)
177(3)

N2−H2n···O1¢
N3−H3n···O1¢

0.86
0.86

1.97
1.98

2.826(2)
2.838(3)

171
175

D−H···A
O1−H1o···N4¢
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Symmetry operator for A
−x+1, −y+2, −z+1
−x, −y, −z+1
x, y−1, z
x+1, y, z

Figure 3.64: Hydrogen-bonding network (green dashed lines) within a layer of 1,6-bis(pyrazol3(5)-yl)hexane hydrate. Reproduced with permission, from reference 111.

Further edge-to-face pyrazole interactions are observed in-between the layers (Figure 3.65), with
closest contact of 2.901(4) Å (C2−H2···C12¢), C2−H2/centroid (pz) distance of 3.169(3) Å,
centroid (pz)–centroid(pz) distance of 5.159(2) Å, and pz–pz dihedral angle: 63.9(1)º. Such a 2D
layered structure is unusual for NH–pyrazoles with no additional donor atoms, which typically
self-assemble either into discrete cyclic motifs (dimers, trimers, tetramers, hexamers), or 1D
catemers, via intermolecular N–H/N hydrogen bonds.171
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Figure 3.65: View of the layered structure of 1,6-bis(pyrazol-3(5)-yl)hexane hydrate (H-bonds
shown by green dashed lines). Reproduced with permission, from reference 111.
1,6-Bis(pyrazol-3(5)-yl)hexane is only soluble in highly polar solvents, such as methanol, ethanol,
dimethylformamide, dimethylsulfoxide, nitromethane and nitrobenzene, and is slightly soluble in
cold water (solubility increases significantly in hot water). Its very poor solubility in other organic
solvents (isopropanol, acetonitrile, ethyl acetate, acetone, tetrahydrofuran, diethyl ether,
dichloromethane, chloroform, hydrocarbons), even at reflux temperatures, is surprising, given that
3(5)-propylpyrazole (half of the 1,6-bis(pyrazol-3(5)-yl)hexane molecule) is readily soluble in all
common solvents, including hexane. The water of crystallization provides increased lattice
enthalpy, by forming an extended hydrogen-bonded 2D network with the 1,6-bis(pyrazol-3(5)yl)hexane units, which concurs with the difficulty in drying 1,6-bis(pyrazol-3(5)-yl)hexane.
Furthermore, the extensive H-bonding interactions within the lattice are in accord with the poor
solubility of the compound in solvents of medium or low polarity. THP-protected 1,6-bis(pyrazol3(5)-yl)hexane, which lacks the N–H hydrogen bond donor, is readily soluble in common organic
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solvents (even in hexane, slightly), and similarly to all other 3(5)-alkylpyrazoles studied here, it
does not have affinity for water.
3.2.4.4.2

5-n-Hexadecyl-1-(tetrahydropyran-2-yl)pyrazole

The results discussed in this section were originally published in RSC Adv. 2015, 5, 24081–
24093,111 and are reproduced by permission of The Royal Society of Chemistry.
Crystals of 5-n-hexadecyl-1-(tetrahydropyran-2-yl)pyrazole were grown by slow evaporation of a
methanolic solution containing a small amount of water. Two crystallographically independent
molecules are found within the asymmetric unit of 5-n-hexadecyl-1-(tetrahydropyran-2yl)pyrazole (Figure 3.66).

Figure 3.66: Crystal structure (thermal ellipsoid plot, 50% probability level) of 5-n-hexadecyl-1(tetrahydropyran-2-yl)pyrazole, showing the two crystallographically independent molecules
(from different asymmetric units, for clarity). Reproduced with permission, from reference 111.
The C16 chains are fully extended, a common feature of crystal structures of molecules possessing
long hydrocarbon chains. An analysis of the Cambridge Structural Database reveals that it is the
ratio between the size/number of the aliphatic chains and the size of the polar part of the
molecule/structure that determines the conformation of the chain. When the size of the chain(s)
dominates, a fully extended conformation of the chain, which maximizes the London dispersion
forces between neighboring chains, provides a significant contribution to the overall crystal lattice
enthalpy. The result is a layered structure, wherein the nonpolar chains and the more polar part of
the molecule each aggregate separately to form alternating 2D layers (Figure 3.67). When the size
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of the polar part of the molecule (which might include counterions) dominates, the long
hydrophobic chains might not be fully extended and densely packed, but can assume different bent
conformations to fill the crystal lattice voids determined by the dominant polar interactions.172

Figure 3.67: Packing diagram of 5-n-hexadecyl-1-(tetrahydropyran-2-yl)pyrazole (view down the
b axis), showing a layered structure. Reproduced with permission, from reference 111.

3.2.4.4.3

Bis(3-amino-1H-pyrazol-4-yl)-1H-pyrazol-3-yl-methane (HpzCH(HpzNH2)2) 21

The results discussed in this section are reprinted with permission, from J. Org. Chem.
2017, 82, 10549−10562.112 Copyright 2017 American Chemical Society.
Single crystals of bis(3-amino-1H-pyrazol-4-yl)-1H-pyrazol-3-yl-methane 21 are grown by slow
evaporation of an ethanol/water solution. X-ray diffraction data are collected at room temperature
from a single-crystal mounted atop a glass fiber with cyanoacrylate glue. The high-quality
diffraction data collected allows for the unambiguous assignment of N− H hydrogen atoms in 21,
which is situated on a general position within the triclinic lattice (Figure 3.68). Thus, the position
of the N atoms and their protonation state as well as the connectivity between the pyrazole rings
are established unequivocally on the basis of the H-bond network formed by 21 with its
neighboring molecules (Figure 3.69). Hydrogen bonding data are summarized in Table 3.13.
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Figure 3.68: Thermal ellipsoid plot (50% probability level) of the crystal structure of bis(3-amino1H-pyrazol-4-yl)-1H-pyrazol-3-yl-methane 21. Reproduced with permission, from reference 112.
Table 3.13: Summary of the hydrogen-bonding data for bis(3-amino-1H-pyrazol-4-yl)-1Hpyrazol-3-yl-methane 21. Reproduced with permission, from reference 112.
D−H···A
N2−H2N···N3#
N3−H3B···N1#
N5−H5N···N6#
N6−H6A···N7#
N8−H8N···N4#

D−H (Å)
0.858(15)
0.885(15)
0.901(15)
0.893(15)
0.873(14)

H···A (Å)
2.090(16)
2.201(16)
2.036(16)
2.143(16)
2.102(15)

D···A (Å)
2.923(2)
3.061(2)
2.936 (2)
3.006(2)
2.939(2)
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D−H−A (°)
164(2)
164(2)
177(2)
162(2)
161(2)

Symmetry operator for A
−x, −y, −z
x+1, y, z
−x, −y, −z+1
−x, −y+1, −z+1
x−1, y+1, z

Figure 3.69: Packing diagram showing the H-bonding interactions between neighboring molecules
of bis(3-amino-1H-pyrazol-4-yl)-1H-pyrazol-3-yl-methane 21. Reproduced with permission, from
reference 112.

3.2.4.4.4

(1E,7E)-1,8-bis(dimethylamino)octa-1,7-diene-3,6-dione ((CH3)2NCHCHCOCH2)2

The results discussed in this section through section 3.2.4.4.7 were originally published in
Chem. Commun. 2017, 53, 1029−1032,108 and are reproduced by permission of The Royal Society
of Chemistry.
X-ray quality single-crystals of (1E, 7E)-1,8-bis(dimethylamino)octa-1,7-diene-3,6-dione are
grown from an ethyl acetate solution by hexane vapor diffusion (Figure 3.70).
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Figure 3.70: Thermal ellipsoid plot (50%) of the crystal structure of (1E, 7E)-1,8-bis(dimethylamino)octa-1,7-diene-3,6-dione. Bond lengths (Å): C1−N1: 1.447(1); C2−N1: 1.449(2); C3−N1:
1.335(1); C3−C4: 1.363(1); C4−C5: 1.442(2); C5−O1: 1.229(1); C5−C6: 1.517(1); C6−C6*:
1.498(2). Symmetry operator (*): −x+1, −y, −z+1. Reproduced with permission, from reference
108.

3.2.4.4.5

1,2-Bis(1H-pyrazole-3-yl)ethane

Single-crystals of 1,2-bis(1H-pyrazole-3-yl)ethane are obtained by slow evaporation of an
EtOH/H2O solution (Figure 3.71 and Figure 3.72).

Figure 3.71: Thermal ellipsoid plot (50%) of the crystal structure of 1,2-bis(1H-pyrazole-3yl)ethane. Bond lengths (Å): N1−N2: 1.356(1); N2−C1: 1.333(2); C1−C2: 1.369(2); C2−C3:
1.399(2); C3−N1: 1.333(2); C3−C4: 1.497(2); C4−C4*: 1.528(2). Symmetry operator (*): −x,
y−1/2, −z+1/2. Reproduced with permission, from reference 108.
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Figure 3.72: Crystal packing diagram of 1,2-bis(1H-pyrazole-3-yl)ethane. Hydrogen bonding:
N2···N1*: 2.923(1) Å; N2−H2N: 0.88(1) Å; H2N···N1*: 2.08(1) Å; N2−H2N···N1*: 159(1)º.
Symmetry operator (*): −x, y−1/2, −z+1/2. Reproduced with permission, from reference 108.

3.2.4.4.6

Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2(C5H5N)5 66

Single-crystals of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2(py)5 are obtained by iPr2O vapor
diffusion to a pyridine solution of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2(H2O)2(THF) 66. A
prelimary X-ray crystal structure from the poorly diffracted crystal is described here (see), which
unambiguously establishes the molecular structure of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2 (NO3)2(py)5.
The molecule is comprised of two Cu3 triangles sharing an edge at a dihedral angle of 135.05(8)º
(Figure 3.73). The resulting bent-rhombus shaped Cu4-core is held together by two µ3-OH groups
(located 0.667(10) and 0.700(12) Å above the Cu3 mean-planes, respectively; average Cu–O bond
length: 1.980(11) Å) and two µ3-bridging pzCH2CH2pz ligands (average Cu–N bond length:
1.963(15) Å).
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Figure 3.73: Crystal structure of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2(py)5 66. Weak Cu−O
bonds and H-bonds are shown with dashed lines. Reproduced with permission, from reference
108.
The Cu···Cu separations along the outer edges of the Cu4 core average 3.308(3) Å, whereas the
central Cu···Cu distance along the common edge is significantly shorter (3.003(3) Å). The two
central Cu atoms have a distorted square planar geometry with pyridine ligands in the axial
positions. The two outer Cu atoms both have a pyridine ligand in their basal/equatorial plane, and
nitrate O atom in their axial position. One of these two Cu atoms displays slightly distorted squarepyramidal coordination geometry, whereas the other Cu atom has an additional, weakly
coordinating pyridine ligand and is therefore hexacoordinate, with an elongated, distorted
octahedral geometry. The two nitrate ions form H-bonds to the two µ3-OH groups. A complex with
a related Cu4(µ3-OH)2(µ4-Cl) core is known.173
3.2.4.4.7

Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4] 67

Two crystallographically independent molecules are found in the solid-state structure of
Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4] (crystallized by Et2O vapor diffusion to a CH2Cl2 solution),
each located on an inversion center, which gives rise to crystallographically imposed planar
Cu4(µ4-OH) cores. The ligands pzCH2CH2pz of one of the two units are disordered over two
positions about the inversion center (Figure 3.74).
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Figure 3.74: Thermal ellipsoid plot (50% probability) of Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4] 67.
Reproduced with permission, from reference 108.
Structural description is based on the non-disordered unit (Figure 3.75). The four Cu atoms form
a slightly distorted square (Cu···Cu distances: 3.170(1) and 3.220(1) Å; Cu–Cu–Cu angles:
91.46(3) and 88.54(3)º). Two pairs of ligand pzCH2CH2pz are bound on each side of the Cu4(µ4OH) core. The pyrazole moieties form angles of 52.2(2)–59.6(2)1 with the Cu4(µ4-OH) core
(average: 55.1(2)º). The Cu centers are square-pyramidal, with four pyrazole N atoms in the basal
positions and a hydroxide O atom in the axial positions. The Cu atom chelated by two pzCH2CH2pz
ligands has slightly shorter bond lengths (average Cu2–N: 1.981(6) Å; Cu2–O1: 2.2304(8) Å) than
the Cu atom coordinated by the terminal pyrazole N atoms (average Cu1–N: 2.018(6) Å; Cu1–O1:
2.2879(9) Å).
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Figure 3.75: Crystal structure of Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4] 67. Only one of the two
crystallographically independent moieties of Bu4N[Cu4(µ4-OH)(µ3-pzCH2CH2pz)4], and no
counterion or H-atoms are shown for clarity. Reproduced with permission, from reference 108.

3.2.4.4.8

[Cu3(µ3-OH)( µ-pz)3(NO3)2(CH3CN)] 69b

The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,
55, 7717−7728.106 Copyright 2016 American Chemical Society.
The crystal structure of the trinuclear complex [Cu3(µ3-OH)(µ-pz)3(NO3)2(CH3CN)] 69b, obtained
by diethyl ether vapor diffusion into an acetonitrile solution of [Cu3(µ3-OH)(µ-pz)3(NO3)2(H2Ο)]
69a, is shown in Figure 3.76 (see Appendix D for thermogravimetric analysis of 69b). The
complex, crystallized in the chiral space group P43212, is located on a C2 axis running through the
linear CH3CN molecule and symmetrically bisecting the pyrazolate moiety on the opposite side of
the trinuclear unit. The Cu3(µ-pz)3 framework is nearly planar, with the pyrazolate moieties twisted
by 3.8(1)° and 7.2(2)° relative to the Cu3(pz)3 mean plane. The µ3-OH unit is located 0.509(4) Å
above this mean plane and is disordered (50/50) about the C2 axis. The nitrate ion, located on a
general position, is also disordered over two positions (50/50). To date, only one of the structurally
characterized Cu3(µ-pz)3 frameworks has nitrate as sole terminal ligand for the Cu centers;174 all
others contain pyrazole167,175,176,177 or pyridine178 ligands in addition to the nitrate ions. In [Cu3(µ3OH)(µ-pz)3(NO3)2(CH3CN)], the coordinating O atom of the nitrate ion forms a longer, axial bond
to the CH3CN bound Cu atom of an adjacent trinuclear unit (O2−Cu1′, 2.403(12) Å), whereas
another O atom of the same nitrate ion forms a hydrogen bond with the µ3-OH group of the same
adjacent trinuclear unit (O3···O1′, 1.967(10) Å). Interatomic distances are similar to related
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trinuclear copper pyrazolate complexes.167,174,175,176,177,178 Within the crystal lattice, the trinuclear
units are found in a helical arrangement around the 43 screw axis (Figure 3.76).

Figure 3.76: (Left) Crystal structure of Cu3(µ3-OH)(µ-pz)3(NO3)2(CH3CN) 69b. Only one position
of the disordered nitrate (50/50) and hydroxide ions (50/50) is shown for clarity. Symmetry code:
(a) y, x, –z. Bond lengths (Å): Cu1−O1, 2.011(4); Cu1−N1, 1.952(3); Cu1−N5, 2.027(4); Cu2−O1,
2.042(5); Cu2−N2, 1.919(3); Cu2−N3, 1.927(3); Cu2−O2, 1.922(12). (Right): helical arrangement
of the trinuclear units around the crystallographic 43 screw axis (C−H hydrogens, nitrate and
acetonitrile units not shown). Reproduced with permission, from referenc 106.

3.2.4.4.9

(Bu4N)2[CO3{Cu(OH)(pz)}6+12+9](C7H8)(C6H12)5

The results discussed in this section through section 3.2.4.4.11 were originally published
in Chem. - Eur. J. 2016, 22, 5499−5503.105 Copyright Wiley-VCH Verlag GmbH & Co. KGaA.
Reproduced with permission.
Single crystals were grown by hexane or cyclohexane vapor diffusion into a toluene solution of
the nanojars. One of the two Bu4N+ counterion molecules is completely disordered over two
positions (50/50). Four of the five cyclohexane solvent molecules are disordered over two
positions (50/50); the toluene solvent molecule is also disordered over two positions (67/33). The
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nanojar crystallizes in a triclinic (Pī) lattice with one toluene and five cyclohexane solvent
molecules.179 The nanojar, located on a general position, consists of three [Cu(OH)(pz)]x rings
(Cu6, x = 6; Cu12, x = 12; Cu9, x = 9) surrounding a CO32− ion, and has pseudo-C3v symmetry
(Figure 3.77 and Figure 3.78).

Figure 3.77: Top- and side-views of the crystal structures of (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9],
(Cu6–cyan; Cu9–red; Cu12–violet; Carbonate is orange; H-bonds and weak Cu···O interactions are
illustrated with green and black dashed lines, respectively). Reproduced with permission, from
reference 105.

The Cu6 and Cu9 rings form three shorter (average O···O 2.754(5) Å) and nine longer (average
O···O 2.872(5) Å) hydrogen bonds, respectively, with the incarcerated CO32− ion (Table 3.14 and
Figure 3.79 – Figure 3.82). Thus, the neutral nanojar binds the CO32− ion by twelve hydrogen
bonds (O···O 2.746(5)– 2.915(5) Å; average 2.842(5) Å), four to each of the three carbonate O
atoms (Figure 3.83). The OH groups of the Cu12 ring, in turn, form alternating H bonds with the
two smaller rings (average O···O 2.761(5) Å), so that the Cu6 and Cu9 rings each accept six H
bonds from the Cu12 ring (Cu6 2.716(5)–2.772(5) Å, average O···O 2.742(5) Å; Cu9 2.754(6)–
2.824(5) Å, average 2. 780(5) Å) (Figure 3.84 and Figure 3.85).
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Figure 3.78: Ball-and-stick representation (top- and side-views) of (Bu4N)2[CO3{Cu(OH)
(pz)}6+12+9]. C−H hydrogen atoms are omitted for clarity. Color code: Cu−dark blue; O−red;
N−light blue; C−black; H−pink. Reproduced with permission, from reference 105.
The overall H bonding pattern in (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9] is shown in Figure 3.86.
Although all six Cu atoms of the Cu6 ring of the nanojar form axial Cu–O interactions with the
Cu12 ring (Cu···O 2.375(4)–2.487(4) Å; average 2.414(4) Å), only six Cu atoms of the Cu9 ring
are involved in Cu···O contacts less than 3.00(8) Å (Cu···O 2.352(4)– 3.068(4) Å; average
2.713(4) Å). The other three Cu atoms of the Cu9 ring are at distances of over 3.176(4) Å from O
atoms of the Cu12 ring, and are not considered to contribute significantly to bonding.180 Likewise,
none of the Cu atoms of the Cu12 ring have nearby O atoms to interact with. Overall, there are
twelve Cu···O distances < 3.00(8) Å in-between Cux rings, with an average of 2.564(4) Å.
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Table 3.14: Summary of hydrogen bonding (H···A < r(A) + 2.00 Å and <DHA > 110º) in
(Bu4N)2[CO3{Cu(OH)(pz)}6+12+9] (with esd’s except fixed and riding H). O1−O6: 6-membered
ring; O7−O18: 12-membered ring; O19−O27: 9-membered ring; O28−O30: carbonate.
Reproduced with permission, from reference 105.
D−H···A
O1−H1o···O29
O2−H2o···O28
O3−H3o···O28
O3−H3o···O30
O4−H4o···O30
O5−H5o···O29
O5−H5o···O30
O6−H6o···O29
O7−H7o···O19
O8−H8o···O6
O9−H9o···O21
O10−H10o···O1
O11−H11o···O22
O12−H12o···O2
O13−H13o···O24
O14−H14o···O3
O15−H15o···O25
O16−H16o···O4
O17−H17o···O27
O18−H18o···O5
O19−H19o···O29
O20−H20o···O29
O21−H21o···O29
O22−H22o···O28
O23−H23o···O28
O24−H24o···O28
O25−H25o···O30
O26−H26o···O30
O27−H27o···O30

D−H (Å)
0.81(2)
0.81(2)
0.80(2)
0.80(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.82(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.82(2)
0.81(2)
0.81(2)
0.81(2)
0.82(2)
0.80(2)
0.81(2)
0.81(2)
0.82(2)

H···A (Å) D···A (Å)
2.61(3)
3.356(5)
1.98(3)
2.760(5)
2.59(3)
3.344(5)
2.59(3)
3.317(5)
1.97(2)
2.755(5)
2.55(3)
3.316(5)
2.62(3)
3.341(5)
1.94(2)
2.746(5)
2.00(2)
2.801(6)
1.94(2)
2.746(5)
1.96(3)
2.754(5)
1.91(2)
2.716(5)
1.95(2)
2.775(5)
1.92(2)
2.729(5)
1.96(2)
2.764(5)
1.94(2)
2.742(5)
2.03(2)
2.824(5)
1.97(2)
2.772(5)
1.95(2)
2.763(6)
1.94(2)
2.746(5)
2.11(2)
2.915(5)
2.09(3)
2.864(5)
2.11(3)
2.886(5)
2.11(3)
2.889(5)
2.07(3)
2.852(6)
2.08(3)
2.844(5)
2.09(3)
2.875(5)
2.03(2)
2.816(5)
2.13(2)
2.905(5)
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D−H−A (º)
154(5)
161(6)
157(5)
152(5)
165(6)
160(6)
149(5)
170(6)
172(6)
147(7)
163(6)
175(6)
177(6)
176(6)
170(6)
175(6)
166(6)
173(6)
176(6)
174(6)
167(6)
161(6)
161(6)
161(6)
159(6)
160(6)
164(6)
164(6)
158(6)

Figure 3.79: Top- and side-views of the 6-membered ring in (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9],
showing hydrogen-bonding (green dashed lines) to the carbonate ion. C−H hydrogen atoms are
omitted for clarity. Reproduced with permission, from reference 105.

Figure 3.80: Top- and side-views of the 9-membered ring in (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9],
showing hydrogen-bonding (green dashed lines) to the carbonate ion. C−H hydrogen atoms are
omitted for clarity. Reproduced with permission, from reference 105.
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Figure 3.81: Top-views of the 12-membered ring in (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9]. C−H
hydrogen atoms are omitted for clarity. Reproduced with permission, from reference 105.

Figure 3.82: Top- and side-views of the 6- and 9-membered rings in (Bu4N)2[CO3{Cu(OH)
(pz)}6+12+9] hydrogen-bonding (green dashed lines) to the carbonate ion. C−H hydrogen atoms are
omitted for clarity. Color code: Cu−dark blue; O−red; N−light blue; C−black; H−pink.
Reproduced with permission, from reference 105.
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Figure 3.83: Top- and side-views of the hydrogen-bonding pattern (green dashed lines) to the
carbonate ion in (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9]. C– H hydrogen atoms are omitted for clarity.
Reproduced with permission, from reference 105.

Figure 3.84: Top- and side-views of the 6- and 12-membered rings in (Bu4N)2[CO3{Cu(OH)
(pz)}6+12+9], showing hydrogen-bonding (green dashed lines) and axial Cu-O interactions (black
dashed lines for Cu···O distances <2.50 Å) between the two. C−H hydrogen atoms are omitted for
clarity. Color code: Cu−dark blue; O−red; N−light blue; C−black; H−pink. Reproduced with
permission, from reference 105.
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Figure 3.85: Top- and side-views of the 9- and 12-membered rings in (Bu4N)2[CO3{Cu(OH)
(pz)}6+12+9], showing hydrogen-bonding (green dashed lines) and axial Cu-O interactions (black
dashed lines for Cu···O distances <2.50 Å: Cu19···O18, Cu22···O10, Cu25···O14) between the
two. C−H hydrogen atoms are omitted for clarity. Color code: Cu−dark blue; O−red; N−light blue;
C−black; H−pink. Reproduced with permission, from reference 105.

Figure 3.86: Top- and side-views of the overall hydrogen-bonding pattern (green dashed lines) in
(Bu4N)2[CO3{Cu(OH)(pz)}6+12+9], converging at the central carbonate ion. Reproduced with
permission, from reference 105.
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3.2.4.4.10

(Bu4N)2[CO3{Cu(OH)(pz)}7+13+9] (C7H8)4(C6H14)

Single crystals were grown by hexane or cyclohexane vapor diffusion into a toluene
solution of the nanojars. In the nanojar, a terminal CH3 group of each of the two Bu4N+ counterions
is disordered over two positions (70/30). Two toluene solvent molecules are disordered over two
positions (50/50), and another two are disordered with a hexane solvent molecule (50/50). Within
the monoclinic (P21/n) lattice of (Bu4N)2[CO3Ì{Cu(OH)(pz)} 7+13+9], the nanojar consisting of
Cu7, Cu13, and Cu9 rings is crystallized with one hexane and four toluene solvent molecules, and
is located on a general position (Figure 3.87 and Figure 3.88).

Figure 3.87: Top- and side-views of the crystal structures of (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9],
(Cux rings: Cu7–olive; Cu9–red; Cu13–blue; carbonate is orange; H-bonds and weak Cu···O
interactions are illustrated with green and black dashed lines, respectively). Reproduced with
permission, from reference 105.
The Cu7 ring forms six H bonds (O···O 2.843(5)–2.956(5) ; average 2.897(5) ), whereas the Cu9
ring forms three shorter (O···O 2.753(5)–2.894(5) Å; average 2.809(5) Å) and five longer (O···O
2.961(6)–3.140(5) Å; average 3.054(5) Å) H bonds with the incarcerated CO32– ion (Table 3.15,
Figure 3.89 – Figure 3.92).
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Figure 3.88: Ball-and-stick representation (top- and side-views) of (Bu4N)2[CO3{Cu(OH)
(pz)}7+13+9]. C−H hydrogen atoms are omitted for clarity. Color code: Cu−dark blue; O−red;
N−light blue; C−black; H−pink. Reproduced with permission, from reference 105.
Thus, in (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9], only eight of the fourteen H bonds formed by the
neutral nanojar with the CO32– ion are within an O···O distance range of 2.75(1)–2.92(1) Å (Figure
3.93), in contrast to (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9], in which all twelve H bonds are within that
range. As a result, the average H-bonding distance to carbonate in (Bu4N)2[CO3
{Cu(OH)(pz)}7+13+9] (O···O: 2.934(5) Å) is significantly longer than in (Bu4N)2[CO3{Cu(OH)
(pz)}6+12+9] (O···O: 2.842(5) Å). The central Cu13 ring forms six H bonds to the Cu7 ring (O···O
2.692(5)–2.918(5) Å; average 2.808(5) Å) and seven H bonds to the Cu9 ring (O···O 2.708(5)–
3.051(5) Å; average 2.828(5) Å) (Figure 3.94 and Figure 3.95). The overall H-bonding pattern in
(Bu4N)2[CO3{Cu(OH)(pz)}7+13+9] is shown in Figure 3.96.
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Table 3.15: Summary of hydrogen bonding (H···A < r(A) + 2.00 Å and <DHA > 110º) in
(Bu4N)2[CO3{Cu(OH)(pz)}7+13+9] (with esds except fixed and riding H). O1−O7: 7-membered
ring; O8−O20: 13-membered ring; O21−O29: 9-membered ring; O30−O32: carbonate.
Reproduced with permission, from reference 105.
D−H···A
O1−H1o···O31
O2−H2o···O30
O3−H3o···O30
O4−H4o···O32
O5−H5o···O32
O6−H6o···O32
O7−H7o···O31
O8−H8o···O7
O9−H9o···O22
O10−H10o···O1
O11−H11o···O24
O12−H12o···O2
O13−H13o···O25
O14−H14o···O3
O15−H15o···O26
O16−H16o···O4
O17−H17o···O28
O18−H18o···O5
O19−H19o···O29
O20−H20o···O21
O21−H21o···O31
O22−H22o···O31
O23−H23o···O31
O24−H24o···O30
O25−H25o···O30
O26−H26o···O30
O28−H28o···O32
O29−H29o···O32

D−H (Å)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.82(2)
0.83(2)
0.83(2)
0.83(2)
0.84(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.84(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.83(2)
0.82(2)
0.84(2)

H···A (Å)
2.08(3)
2.17(3)
2.11(3)
2.15(3)
2.04(3)
2.64(3)
2.07(3)
1.89(3)
1.90(2)
1.97(3)
2.03(2)
2.10(2)
1.92(2)
2.10(2)
2.05(2)
2.02(2)
1.90(3)
1.87(2)
2.27(3)
2.04(3)
2.31(3)
1.93(2)
2.33(3)
2.26(4)
2.07(3)
2.28(2)
1.97(2)
2.19(4)
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D···A (Å)
2.887(5)
2.956(5)
2.904(5)
2.920(5)
2.843(5)
3.398(5)
2.874(5)
2.698(5)
2.723(6)
2.775(5)
2.851(5)
2.912(5)
2.751(5)
2.918(5)
2.849(5)
2.855(5)
2.708(5)
2.692(5)
3.051(6)
2.861(6)
3.107(5)
2.752(5)
3.140(5)
3.019(5)
2.894(5)
3.042(5)
2.780(5)
2.960(6)

D−H−A (º)
164(6)
158(6)
159(6)
155(6)
163(6)
152(6)
165(6)
166(6)
169(6)
166(6)
166(6)
174(6)
174(6)
166(6)
161(6)
179(7)
165(6)
168(6)
157(6)
169(6)
160(6)
171(6)
166(6)
152(6)
175(6)
154(6)
168(6)
152(7)

The Cu7 and Cu9 rings of (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9] form seven and six Cu···O contacts <
3.00(8) Å, respectively, with O atoms of the Cu13 ring (Cu7 ring, Cu···O 2.351(4)–2.836(4) Å,
average 2.543(4) Å; Cu9 ring, Cu···O 2.325(4)– 2.891(4) Å; average 2.553(4) Å). All other Cu
atoms, including the ones of the Cu13 ring, are at distances larger than 3.188(4) Å from the closest
non-bonding O atoms. Overall, there are thirteen Cu···O distances < 3.00(8) Å in-between the Cux
rings, with an average of 2.548(4) Å.

Figure 3.89: Top- and side-views of the 7-membered ring in (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9],
showing hydrogen-bonding (green dashed lines) to the carbonate ion. C−H hydrogen atoms are
omitted for clarity. Reproduced with permission, from reference 105.
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Figure 3.90: Top- and side-views of the 13-membered ring in (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9].
C−H hydrogen atoms are omitted for clarity. Reproduced with permission, from reference 105.

Figure 3.91: Top- and side-views of the 9-membered ring in (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9],
showing H-bonding (green dashed lines for O···O distances <3.00(5) Å, grey dashed lines for
O···O distances 3.00(5)−3.20(5) Å) to the carbonate ion. C−H hydrogen atoms omitted for clarity.
Reproduced with permission, from reference 105.
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Figure 3.92: Top- and side-views of the 7- and 9-membered rings in (Bu4N)2[CO3{Cu(OH)
(pz)}7+13+9] hydrogen-bonding (green dashed lines for O···O distances <3.00(5) Å, grey dashed
lines for O···O distances 3.00(5)−3.20(5) Å) to the carbonate ion. C−H hydrogen atoms are
omitted for clarity. Color code: Cu−dark blue; O−red; N−light blue; C−black; H−pink.
Reproduced with permission, from reference 105.

Figure 3.93: Top- and side-views of the hydrogen-bonding pattern (green dashed lines for O···O
distances 3.00(5)−3.20(5) Å) to the carbonate ion in (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9].
Reproduced with permission, from reference 105.
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Figure 3.94: Top- and side-views of the 7- and 13-membered rings in (Bu4N)2[CO3{Cu(OH)
(pz)}7+13+9], showing hydrogen-bonding(green dashed lines for O···O distances <3.00(5) Å, grey
dashed lines for O···O distances 3.00(5)−3.20(5) Å) and axial Cu-O interactions (black dashed
lines for Cu···O distances <2.50 Å) between the two. C−H hydrogen atoms are omitted for clarity.
Color code: Cu−dark blue; O−red; N−light blue; C−black; H−pink. Reproduced with permission,
from reference 105.

Figure 3.95: Top- and side-views of the 9- and 13-membered rings in (Bu4N)2[CO3{Cu(OH)
(pz)}7+13+9], showing hydrogen-bonding (green dashed lines for O···O distances <3.00(5) Å, grey
dashed lines for O···O distances 3.00(5)−3.20(5) Å) and axial Cu-O interactions (black dashed
lines) between the two. C−H hydrogen atoms are omitted for clarity. Color code: Cu−dark blue;
O−red; N−light blue; C−black; H−pink. Reproduced with permission, from reference 105.
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Figure 3.96: Top- and side-views of the overall hydrogen-bonding pattern (green dashed lines for
O···O distances 3.00(5)−3.20(5) Å) in (Bu4N)2[CO3{Cu(OH)(pz)}7+13+9], converging at the central
carbonate ion. Reproduced with permission, from reference 105.

3.2.4.4.11

(Bu4N)2[CO3{Cu(OH)(pz)}8+13+8] (C7H8)(C6H14)

Single crystals were grown by hexane or cyclohexane vapor diffusion into a toluene
solution of the nanojars. In the nanojar, a terminal CH3 group of the symmetry-related Bu4N+
counterions is disordered over two positions (50/50). The toluene solvent molecules are disordered
with hexane solvent molecules (50/50). Nanojar (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8] crystallizes
in a monoclinic (C2/c) lattice with one hexane and one toluene solvent molecule, and consists of
one Cu13- and two Cu8 rings (Figure 3.97 and Figure 3.98). The nanojar is located on a twofold
rotation axis (C2), which runs through the C atom of the incarcerated carbonate ion, symmetrically
bisecting the latter. Each Cu8 ring forms six H bonds to the carbonate ion (O···O 2.792(7)–3.072(7)
Å; average 2.905(7) Å); only eight of the twelve H bonds have O···O distances<2.92(1) Å
(compared to twelve in (Bu4N)2[CO3{Cu(OH)(pz)}6+12+9]; Table 3.16, Figure 3.99–Figure 3.102).
The average H bonding distance to carbonate in (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8] is 2.90(1) Å.
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Figure 3.97: Top- and side-views of the crystal structures of (Bu4N)2[CO3{Cu(OH)(pz)}8+13+8]
(Cux rings: Cu8–magenta; Cu13–blue; Carbonate is orange; H-bonds and weak Cu···O interactions
are illustrated with green and black dashed lines, respectively). Reproduced with permission, from
reference 105.

Figure 3.98: Ball-and-stick representation (top- and side-views) of (Bu4N)2[CO3Ì{Cu(OH)
(pz)}8+13+8]. C−H hydrogen atoms are omitted for clarity. Color code: Cu−dark blue; O−red;
N−light blue; C−black; H−pink. Reproduced with permission, from reference 105.
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Table 3.16: Summary of hydrogen bonding (H···A < r(A) + 2.00 Å and <DHA > 110º) in
(Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8] (with esds except fixed and riding H). O1−O5 and O13−O15:
8-membered ring; O6−O12: 13-membered ring; O16−O17: carbonate. Symmetry operator for O5':
−x, y, −z+3/2. Reproduced with permission, from reference 105.
D−H···A
O1−H1o···O16
O2−H2o···O16
O3−H3o···O30
O4−H4o···O17
O5−H5o···O17
O7−H7o···O13
O8−H8o···O2
O9−H9o···O14
O10−H10o···O3
O11−H11o···O4
O12−H12o···O5'
O13−H13o···O16
O14−H14o···O16
O15−H15o···O16
O15−H15o···O17

D−H (Å)
0.81(2)
0.81(2)
0.81(2)
0.80(2)
0.80(2)
0.80(2)
0.81(2)
0.82(2)
0.80(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)
0.81(2)

H···A (Å)
2.28(3)
2.04(2)
2.53(4)
2.27(4)
2.03(3)
2.01(2)
1.93(2)
1.96(2)
2.01(2)
2.36(4)
1.91(2)
2.07(3)
2.08(3)
2.66(4)
2.66(4)

D···A (Å)
3.072(7)
2.837(6)
3.213(6)
3.017(6)
2.792(7)
2.807(6)
2.727(6)
2.773(6)
2.811(6)
3.109(7)
2.710(6)
2.866(7)
2.841(6)
3.400(6)
3.336(4)

D−H−A (º)
166(7)
168(7)
144(6)
155(7)
161(7)
170(7)
168(7)
172(6)
172(7)
154(6)
174(7)
166(7)
157(6)
153(7)
143(6)

The central Cu13 ring forms five H bonds to each Cu8 ring (average O···O 2.766(6) Å; Figure
3.103). The overall H-bonding pattern is shown in Figure 3.104. In compound (Bu4N)2[CO3Ì{Cu
(OH)(pz)}8+13+8], seven Cu atoms of each Cu8 ring form axial Cu–O interactions shorter than
3.00(5) with the Cu13 ring (Cu···O 2.340(4)–2.993(4) Å, average 2.573(4) Å). The other Cu atoms,
including the ones of the Cu13 ring, are at distances larger than 3.201(4) from the closest nonbonding O atoms. Overall, there are fourteen Cu···O distances < 3.00(5) Å, with an average of
2.574(4) Å.
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Figure 3.99: Top- and side-views of the 8-membered ring in (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8],
showing hydrogen-bonding (green dashed lines for O···O distances <3.00(5) Å, grey dashed lines
for O···O distances 3.00(5)−3.20(5) Å) to the carbonate ion. C−H hydrogen atoms are omitted for
clarity. Reproduced with permission, from reference 105.

Figure 3.100: Top- and side-views of the 13-membered ring in (Bu4N)2[CO3Ì{Cu(OH)
(pz)}8+13+8], with the carbonate ion at the center. C−H hydrogen atoms are omitted for clarity.
Reproduced with permission, from reference 105.
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Figure 3.101: Top- and side-views of the two 8-membered rings in (Bu4N)2[CO3Ì{Cu(OH)
(pz)}8+13+8] hydrogen-bonding (green dashed lines for O···O distances <3.00(5) Å, grey dashed
lines for O···O distances 3.00(5)−3.20(5) Å) to the carbonate ion. C−H hydrogen atoms are
omitted for clarity. Color code: Cu−dark blue; O−red; N−light blue; C−black; H−pink.
Reproduced with permission, from reference 105.

Figure 3.102: Top- and side-views of the hydrogen-bonding pattern (green dashed lines) to the
carbonate ion in (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8]. Reproduced with permission, from reference
105.
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Figure 3.103: Top- and side-views of the 8- and 13-membered rings in (Bu4N)2[CO3Ì{Cu(OH)
(pz)}8+13+8], showing hydrogen-bonding(green dashed lines for O···O distances <3.00(5) Å, grey
dashed lines for O···O distances 3.00(5)−3.20(5) Å) and axial Cu-O interactions (black dashed
lines for Cu···O distances <2.50 Å: Cu3···O9, Cu5···O12, Cu14···O8) between the two. C−H
hydrogen atoms are omitted for clarity. Color code: Cu−dark blue; O−red; N−light blue; C−black;
H−pink. Reproduced with permission, from reference 105.

Figure 3.104: Top- and side-views of the overall hydrogen-bonding pattern (green dashed lines)
in (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8], converging at the central carbonate ion. Reproduced with
permission, from reference 105.
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3.2.4.4.12

(Et4N)2[CO3Ì{Cu(OH)(pz)}29(H2O)2]

The results discussed in this section through section 3.2.4.4.14 were originally published
in Dalton Trans. 2016, 45, 8327−8339,104 and are reproduced by permission of The Royal Society
of Chemistry.
The nanojar in (Et4N)2[CO3Ì{Cu(OH)(pz)}29(H2O)2], which consists of three [Cu(OH)(pz)]x rings
with x = 8, 13 and 8, is similar to the one found in (Bu4N)2[CO3Ì{Cu(OH)(pz)}29];105 however,
the difference in counterion size (Et4N+ vs. Bu4N+) does induce significant changes in the
molecular structure of the nanojar (Figure 3.105). Furthermore, despite a seemingly very similar
overall crystal packing, the position of the nanojars relative to the crystal’s symmetry elements is
altered in (Et4N)2[CO3Ì{Cu(OH)(pz)}29] compared to (Bu4N)2[CO3Ì{Cu(OH)(pz)}29]. In
(Bu4N)2[CO3Ì{Cu(OH)(pz)}29], the nanojar is located on a two-fold rotation axis (C2), which runs
through the C-atom of the incarcerated carbonate ion, symmetrically bisecting the latter. In
(Et4N)2[CO3Ì{Cu(OH)(pz)}29], the nanojar is also located on a two-fold rotation axis, but unlike
in (Bu4N)2[CO3Ì{Cu(OH)(pz)}29], the C2 axis does not bisect the carbonate ion symmetrically,
although it still runs through its central C-atom. As a result, the incarcerated carbonate ion in
(Et4N)2[CO3Ì{Cu(OH)(pz)}29] is disordered over two positions (50/50). Similarly to (Bu4N)2
[CO3Ì{Cu(OH)(pz)}29],105 in (Et4N)2[CO3Ì{Cu(OH)(pz)}29] each Cu8 ring forms six H-bonds to
the carbonate ion (for one Cu8 ring, O⋯O: 2.81(1)–3.12(1) Å; average: 2.90(1) Å; for the other
Cu8 ring, O⋯O: 2.68(1)–3.01(1) Å; average: 2.90(1) Å). As in (Bu4N)2[CO3Ì{Cu(OH) (pz)}29],
only eight of the twelve H-bonds to carbonate in (Et4N)2[CO3Ì{Cu(OH)(pz)}29] have O⋯O
distances <2.92(1) Å. The average H-bonding distance to carbonate is identical in
(Bu4N)2[CO3Ì{Cu(OH)(pz)}29] and (Et4N)2[CO3Ì{Cu(OH)(pz)}29] (2.90(1) Å). The central Cu13
ring forms five H-bonds to each Cu8 ring (average O⋯O: 2.752(6) Å in (Et4N)2[CO3Ì{Cu(OH)
(pz)}29], 2.766(6) Å in (Bu4N)2[CO3Ì{Cu(OH)(pz)}29]). The presence of two water molecules
(symmetry-related) in (Et4N)2[CO3Ì{Cu(OH)(pz)}29] has significant consequences on the
structure of the nanojar (no water is found in (Bu4N)2[CO3Ì{Cu(OH)(pz)}29]). Each H2O molecule
is hydrogen-bonded to two OH groups across the Cu8 ring (O19⋯O5: 2.851(6), O19⋯O2:
3.039(7) Å).
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Figure 3.105: Comparison (top- and side-views) of the near-identical structures of
(Bu4N)2[CO3Ì{Cu(OH)(pz)}29] (left) and (Et4N)2[CO3Ì{Cu(OH)(pz)}29(H2O)2] (right; only one
position of the disordered pyrazole and carbonate units is shown). Reproduced with permission,
from reference 104.
As a result, those two OH groups are pulled closer to each other (O2⋯O5: 4.981(6) Å), compared
to the corresponding distance in (Bu4N)2[CO3Ì{Cu(OH)(pz)}29]) (O⋯O: 5.596(6) Å), which lacks
the bridging H2O molecules. In fact, O2 and O5 are indeed the two most likely O-atoms to bind a
bridging H2O molecule, since those two O-atoms are not involved in significant H-bonding with
the Cu13 ring (O⋯O: 3.326(6) and 3.317(6) Å in (Et4N)2[CO3Ì{Cu(OH)(pz)}29]; 3.245(6) and
3.324(6) Å in (Bu4N)2[CO3Ì{Cu(OH)(pz)}29]). The distance between the two bonded Cu atoms

236

across the ring also decreases from 8.254(1) Å in (Bu4N)2[CO3Ì{Cu(OH)(pz)}29] to 7.846(1) Å
in (Et4N)2[CO3Ì{Cu(OH)(pz)}29].
In both (Et4N)2[CO3Ì{Cu(OH)(pz)}29] and (Bu4N)2[CO3Ì{Cu(OH)(pz)}29], seven Cuatoms of each Cu8 ring form axial Cu–O interactions shorter than 3.00(5) Å with the Cu13 ring
((Et4N)2[CO3Ì{Cu(OH)(pz)}29], Cu⋯O: 2.367(5)–3.041(5) Å, average: 2.575(4) Å; (Bu4N)2
[CO3Ì{Cu(OH)(pz)}29], Cu⋯O: 2.340(4)–2.993(4) Å, average: 2.573(4) Å). The other Cu atoms,
including the ones of the Cu13 ring, are at distances larger than 3.201(4) Å from the closest nonbonding O-atoms. Overall, there are fourteen Cu⋯O distances <3.00(5) Å in each nanojar, with
an average of 2.574(4) Å.
3.2.4.4.13

(Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5-Me2pz)15(H2O)}]

Within the triclinic (Pī) crystal lattice of (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5-Me2pz)15
(H2O)}], the nanojar is located on a general position (with pseudo-mirror symmetry) and consists
of three rings, [Cu(OH)(pz)]7, [Cu(OH)(3,5-Me2pz)]14 and [Cu9(OH)9(pz)8(3,5-Me2pz)(H2O)]
(Figure 3.106–Figure 3.116). The encapsulated carbonate ion is found disordered over three
positions (55/28/17), around the axis perpendicular to the central carbon atom. In each orientation,
the carbonate ion is bound by twelve hydrogen bonds (average O⋯O: 2.90(2) Å), six each from
the Cu7 and Cu9 rings, four to each of the three carbonate O-atoms.
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Figure 3.106: Top- and side-views of the crystal structure of (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15
(3,5-Me2pz)15(H2O)}]. Color scheme: Cu7 olive; Cu9 red; Cu14 orange; CO32− lime-green; H bonds
and weak Cu⋯O interactions green and black dashed lines, respectively; Cu–O bonds to the
coordinated H2O molecule red/white stripes. Only the major component of the disordered units,
and no C–H and H2O hydrogens, counterions or solvent molecules are shown. Reproduced with
permission, from reference 104.
The Cu7 and Cu9 rings each accept seven H-bonds from the Cu14 ring (Cu7 ring, O⋯O: 2.787(5)–
3.123(5) Å, average: 2.976(5) Å; Cu9 ring, O⋯O: 2.750(5)–3.050(5) Å, average: 2.910(5) Å).
Thus, the fourteen OH groups of the Cu14 ring form alternating H-bonds with the Cu7 and Cu9
rings (average O⋯O: 2.943(5) Å). The presence of a water molecule within the nanojar is
apparently the consequence of the steric hindrance caused by the methyl groups of the 3,5-Me2pz
unit within the Cu9 ring. Thus, the H2O molecule fills the void created between the Cu9 and Cu14
rings, as the Cu2(µ-3,5-Me2pz) moiety moves away from the two neighboring pyrazole units of the
Cu9 ring (Figure 3.106, right). This H2O molecule bridges the pair of Cu-atoms linked by the only
3,5-Me2pz unit of the Cu9 ring (Cu28⋯O31: 2.431(6), Cu29⋯O31: 2.450(7) Å), and donates a
very short hydrogen bond to an adjacent OH-group of the Cu14 ring (O16–H16o⋯O31: 2.482(9)
Å). The overall H-bonding pattern in (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5-Me2pz)15(H2O)}] is
shown in Figure 3.115.
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The Cu7 and Cu9 rings form seven and six Cu⋯O contacts <3.000(1) Å, respectively, with Oatoms of the Cu14 ring (Cu7-ring, Cu⋯O: 2.516(4)–2.809(4) Å, average: 2.618(4) Å; Cu9 ring,
Cu⋯O: 2.407(4)–2.984(5) Å; average: 2.541(4) Å). Two Cu-atoms of the Cu9 ring (bridged by the
3,5-Me2pz ligand) bind the bridging H2O molecule, which donates a H-bond to the Cu14 ring. All
other Cu atoms, including the ones of the Cu14 ring, are at distances larger than 3.545(4) Å from
the closest non-bonding O atoms. Overall, there are thirteen Cu⋯O distances <3.000(1) Å inbetween Cux-rings, with an average of 2.548(4) Å.

Figure 3.107: Top- and side-views of (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5-Me2pz)15(H2O)}] (for
clarity, only the major component of the disordered units is shown). H-bonds are shown as green
dashed lines, and weak Cu−O bonds as black dashed lines. Reproduced with permission, from
reference 104.
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Figure 3.108: Top- and side-views of the Cu7 ring in (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5Me2pz)15(H2O)}], showing hydrogen-bonding (green dashed lines for O···O distances <3.00(5) Å,
grey dashed lines for O···O distances 3.00(5)−3.20(5) Å) to the carbonate ion (only the major
component of the disordered units is shown). Reproduced with permission, from reference 104.

Figure 3.109: Top- and side-views of the Cu14 ring in (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5Me2pz)15(H2O)}], with the carbonate ion at the center (only the major component of the disordered
units is shown). Reproduced with permission, from reference 104.
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Figure 3.110: Top- and side-views of the Cu9 ring in (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5Me2pz)15(H2O)}], showing hydrogen-bonding (green dashed lines for O···O distances <3.00(5) Å,
grey dashed lines for O···O distances 3.00(5)−3.20(5) Å) to the carbonate ion (only the major
component of the disordered units is shown). Cu−O bonds to the H2O molecule are shown with
black dashed lines. Reproduced with permission, from reference 104.

Figure 3.111: Top- and side-views of the Cu7 and Cu9 rings in (Bu4N)2[CO3Ì{Cu30(OH)30
(pz)15(3,5-Me2pz)15(H2O)}], showing hydrogen-bonding (green dashed lines for O···O distances
<3.00(5) Å, grey dashed lines for O···O distances 3.00(5)−3.20(5) Å) to the carbonate ion (only
the major component of the disordered units is shown). Cu−O bonds to the H2O molecule are
shown with black dashed lines. Reproduced with permission, from reference 104.
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Figure 3.112: Top- and side-views of the Cu7 and Cu14 rings in (Bu4N)2[CO3Ì{Cu30(OH)30
(pz)15(3,5-Me2pz)15(H2O)}], showing hydrogen-bonding (green dashed lines for O···O distances
<3.00(5) Å, grey dashed lines for O···O distances 3.00(5)−3.20(5) Å) and axial Cu-O interactions
(black dashed lines for Cu···O distances <2.50 Å) (only the major component of the disordered
units is shown). Reproduced with permission, from reference 104.

Figure 3.113: Top- and side-views of the Cu9 and Cu14 rings in (Bu4N)2[CO3Ì{Cu30(OH)30
(pz)15(3,5-Me2pz)15(H2O)}], showing hydrogen-bonding (green dashed lines for O···O distances
<3.00(5) Å, grey dashed lines for O···O distances 3.00(5)−3.20(5) Å) and axial Cu-O interactions
(black dashed lines for Cu···O distances <2.50 Å) between the two (only the major component of
the disordered units is shown). Reproduced with permission, from reference 104.
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Figure 3.114: Top- and side-views of the hydrogen-bonding pattern (green dashed lines for O···O
distances<3.00(5) Å, grey dashed lines for O···O distances 3.00(5)−3.20(5) Å) to the carbonate
ion in (Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5-Me2pz)15(H2O)}] (only the major component of the
disordered carbonate ion is shown). Reproduced with permission, from reference 104.

Figure 3.115: Top- and side-views of the overall hydrogen-bonding pattern (green dashed lines for
O···O distances <3.00(5) Å, grey dashed lines for O···O distances 3.00(5)−3.20(5) Å) in
(Bu4N)2[CO3Ì{Cu30(OH)30(pz)15(3,5-Me2pz)15(H2O)}], converging at the central carbonate ion
(only the major component of the disordered carbonate ion is shown). Reproduced with
permission, from reference 104.
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Figure 3.116: Space-filling representations (two different top- and side-views) of (Bu4N)2[CO3Ì
{Cu30(OH)30(pz)15(3,5-Me2pz)15(H2O)}] (only the major component of the disordered units is
shown). Reproduced with permission, from reference 104.

3.2.4.4.14

(Bu4N)2[CO3⊂{Cu30(OH)30(pz)16(3,5-Me2pz)14}]

Only very small crystals of (Bu4N)2[CO3⊂{Cu30(µ-OH)30(µ-pz)16(µ-3,5-Me2pz)14}] could
be obtained, which diffracted poorly; therefore, only preliminary data are presented here
(monoclinic, P2/n, a = 23.864(4) Å, b = 14.830(2) Å, c = 31.070(4) Å, β = 95.138(10), V =
10952(3) Å3, Z = 2). Although the severely disordered solvent molecules and Bu4N+ counterions
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are not modeled, the identity of the nanojar is established unambiguously, and all Cu-atoms are
refined anisotropically (R1 = 16%, Rw = 20%). The nanojar (Bu4N)2[CO3⊂{Cu30(µ-OH)30(µpz)16(µ-3,5-Me2pz)14}], (Figure 3.117) consisting of one [Cu(OH)(3,5-Me2pz)]14 and two
[Cu(OH)(pz)]8 rings, is located on a two-fold rotation axis (C2), which runs perpendicular to the
encapsulated carbonate ion, disordered accordingly over two positions (50/50). The position of the
nanojar and encapsulated carbonate ion relative to the C2 axis is clearly different than in
(Et4N)2[CO3Ì{Cu(OH)(pz)}8+13+8] and (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8], in which the C2 axis
is located in the plane of the carbonate ion. The central Cu14 ring is made up by 3,5-dimethylpyrazolate ligands, while the two Cu8 side rings contain only non-substituted pyrazole ligands.

Figure 3.117: Top- and side-views of the crystal structure of (Bu4N)2[CO3⊂{Cu30 (µ-OH)30(µpz)16(µ-3,5-Me2pz)14}]. Color scheme: Cu8–magenta; Cu13–orange; CO32− lime-green (only one
position of the disordered carbonate, and no H atoms, counterions or solvent molecules are shown).
Reproduced with permission, from reference 104.
The CO32– ion is bound by a total of nine H bonds in each disordered position (O⋯O: 2.63(9)–
2.97(9) Å, average: 2.87(8) Å), four from one Cu8 ring and five from the other, with each O atom
having three H bonds. Each Cu8 ring forms six H bonds with the Cu14 ring (O⋯O: 2.73(5)–2.96(5)
Å, average: 2.87(5) Å). The two Cu8 rings form six and eight Cu⋯O contacts <3.00(7) Å,
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respectively, with O-atoms of the Cu14 ring (one Cu8 ring, Cu⋯O: 2.52(3)–2.76(3) Å, average:
2.56(3) Å; other Cu8 ring, Cu⋯O: 2.43(3)–3.10(3) Å; average: 2.67(3) Å). All other Cu atoms,
including the ones of the Cu14 ring, are at distances larger than 3.13(3) Å from the closest nonbonding O atoms. Overall, there are fourteen Cu⋯O distances <3.00(7) Å, with an average of
2.61(3) Å.
3.2.4.4.15

(Bu4N)2[SO42–Ì{Cu(OH)(pz)}8+13+8]·2C4H8O2

The results discussed in this section are reprinted with permission, from Inorg. Chem. 2016,
55, 10666−10679.107 Copyright 2016 American Chemical Society.
Single crystals of (Bu4N)2[SO42–Ì{Cu(OH)(µ-pz)}8+13+8]·2C4H8O2 are grown by hexane vapor
diffusion to an ethyl acetate (C4H8O2) solution of a sulfate-incarcerating nanojar mixture. Once
removed from the mother liquor, the crystals are extremely sensitive to solvent loss under ambient
conditions and are quickly mounted under a cryostream (100 K) to prevent decomposition.
(Cu29SO4) crystallizes in a monoclinic (C2/c) lattice with two ethyl acetate solvent molecules, and
consists of one Cu13 ring and two Cu8 rings (see Figure 3.118 and Figure 3.119). The nanojar is
located around a two-fold rotation axis (C2), which runs through the S atom of the incarcerated
sulfate ion, from the side of the nanojar. The SO42− ion is severely disordered about the special
position (only the disorder about the C2 axis was modeled). The OH protons of the two Cu8 rings
form a multitude of hydrogen bonds with the incarcerated, disordered sulfate ion, with O···O
distances ranging from 2.624(15) Å to 3.023(16) Å, while the OH protons of the central Cu13 ring
form five hydrogen bonds with each of the two Cu8 rings (O···O: 2.715(4)−2.834(5) Å; average:
2.774(5) Å). Seven Cu atoms of each Cu8 ring form axial Cu···O interactions shorter than 3.00(5)
Å with the Cu13 ring (Cu···O: 2.348(4)−3.024(3) Å). The other Cu atoms, including those of the
Cu13 ring, are at distances larger than 3.186(3) Å from the closest nonbonding O atoms. Overall,
there are 14 Cu···O distances of <3.00(5) Å, with an average of 2.582(3) Å. The structure of
Cu8+13+8SO4 closely resembles that of the analogous Cu8+13+8CO3, as illustrated in Figure 3.97.
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Figure 3.118: Top and side views of the crystal structure of (Bu4N)2[SO42–Ì{Cu(OH)(pz)}8+13+8].
(Color scheme: Cu8–magenta; Cu13–blue; S yellow; O–red. C−H hydrogen atoms, counterions and
solvent molecules are not shown) Reproduced with permission, from reference 107.

Figure 3.119: Space-filling representation of [SO42–Ì{Cu(OH)(pz)}8+13+8]2–. Reproduced with
permission, from reference 107.
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CHAPTER 4

4

CONCLUSIONS AND FUTURE WORK

Solvent- and catalyst-free, green protection methodology we have developed, showed that
a variety of functional groups, including –OH, –SH, –COOH, –CONH2 and heterocyclic
polyamines, can be quantitatively protected with the inexpensive 3,4-dihydro-2H-pyran (DHP).
The conversion of the protecting reaction was found to be influenced by the following variables:
acidity of the substrate, miscibility of substrate and DHP, amount of DHP employed,
nucleophilicity of the atom to be protected, steric hindrance, reaction time and reaction
temperature.
One-pot telescoping synthesis methodology of mono- and dialkylpyrazoles, provides high
overall yields of pyrazole derivatives, in addition to many other advantages such as minimizing of
the use of solvents/reagents, greatly diminishing waste production, eliminating the use of highly
toxic or explosive materials, easily scalable and versatility to allow for the synthesis of various
other 3,5-disubstituted pyrazoles (symmetrical and unsymmetrical) such as alkyl, halogen,
hydroxyl, amino, azido, carbonyl, and organo-element substituents.
Study of the intriguing reactivity of amino- and hydroxypyrazole derivatives toward
aldehydes and ketones under either neutral or acidic conditions, provided not only an understanding
of the mechanism of the reactions, but also a variety of novel bis- and non-scorpionate
tris(pyrazolyl) methane ligands. The study showed that the conversion and outcome of the reaction
can be affected by different factors, such as presence or absence of the acid catalyst, ratios between
aldehydes/ketones and amines, aldehydes vs ketones, effect of the aliphatic vs aromatic substituents,
and effect of the steric hindrance.
The selective C-4 deuteration of the pyrazole nucleus activated by NH2 or OH groups at the
C-3(5) position by D2O was studied, either in the presence or absence of an acid catalyst or with
heat, and a convenient procedure for large-scale deuteration was developed. The study showed that
both the reaction conditions and the substituents of the pyrazole substrates influence the rate of the
deuteration reaction.
248

Computational studies showed that in contrast to the methyl-substituted, six-membered
aromatic molecules, which deprotonate at the substituted methyl group and produces exocyclic
benzylic carbanions stabilized by π-conjugation, methyl-substituted, five-membered aromatic
rings deprotonate at an endocyclic CH group. Diminished π-conjugation, reduced bond angles and
strengthened induction of Csp2 versus Csp3 in five-membered ring are collectively responsible for
deprotonation of an endocyclic carbon rather than of the ‘benzylic’ position.
It has also been shown that the resistance of 5-alkyl-1-(tetrahydropyran-2-yl)-1H-pyrazole
isomer to deprotonation by nBuLi, previously attributed to the “adjacent lone pair effect”, is mainly
due not to electron pair repulsion, but rather to reduced π-resonance and weaker electrostatic
interactions within the pyrazole ring.
The stability of nanojars is determined by the size match between nanojar host and the
anion guest: the smaller carbonate ion fits best inside the smallest nanojar (Cu27), whereas the
larger sulfate ion prefers the largest nanojar (Cu31). Therefore, the less stable sulfate and carbonate
nanojars in the [anionÌ{Cu(OH)(pz)}n]2– (n = 27 – 31) series selectively break down in the
presence of pyridine or NH3, and self-assemble back into the more stable ones under the given
conditions. For instance, NH3 leads to the most stable pure [CO32–Ì{Cu(OH)(pz)}27] and [SO42–
Ì{Cu(OH)(pz)}31] nanojars, whereas pyridine provides a mixture of [CO32–Ì{Cu(OH)(pz)}27]
and [CO32–Ì{Cu(OH)(pz)}29]. Furthermore, Pb(NO3)2, which provides acidity because of
hydrolysis during the nanojar-forming reaction, leads to the most stable pure [SO42Ì{Cu(OH)
(pz)}31].
Further knowledge of the stability of various nanojars with different anions is made
available by anion exchange studies. Cu27SO4 is the only nanojar that exchanges its incarcerated
SO42− anion with CO32− in THF solution (molar ratio of anions is 1:1). In contrast, only Cu31CO3
exchanges CO32− to SO42− under identical conditions. It can be concluded that, although sulfate or
carbonate may be thermodynamically preferred by nanojars of certain sizes (SO42− bound most
strongly by the large Cu31 nanojar and most weakly by the small Cu27 nanojar, and vice versa for
CO32−), there is a considerable kinetic barrier for exchanging an already incarcerated anion.
In contrast to the unprecedented stability of nanojars to highly alkaline media such as 10
M NaOH, nanojars are unstable under acidic pH, and even very weak acids break down nanojars
249

to trinuclear copper pyrazolate complexes and ultimately to its original components, copper ions
and pyrazole. These properties are ideal for recycling the nanojars as extracting agents of anions
with large hydration energies from alkaline aqueous media. The extracted anion is conveniently
recovered under slightly acidic conditions, and the nanojars are then fully reassembled when the
pH is made alkaline again.
The mechanism of self-assembly of nanojars from pyrazole, Cu(NO3)2 and NaOH in the
presence of Na2CO3 is proposed based on mass spectrometric, UV–vis and NMR spectroscopic,
pH titration and crystallographic studies. When the reaction is carried out in THF, the insoluble
NaOH and Na2CO3 will gradually react with the copper pyrazolate trinuclear intermediate [Cu3(µ3OH)(µ-pz)3(NO3)2(H2O)], which forms first. As more NaOH reacts, the nitrate ions are gradually
replaced by hydroxide ions. The resulting [Cu3(µ3-OH)(µ-pz)3(OH)x(NO3)3-x]− (x = 1−3)
intermediates, which have unstable terminal Cu−OH groups, react with each other to form OHbridged units, [Cu3(µ3-OH)(µ-pz)3(NO3)2]2(µ-OH) and then [{Cu3(µ3-OH)(µ-pz)3(µ-OH)2}x
(NaNO3)y(Na2CO3)z] oligomers. In these oligomers, the Cu3(OH)3(pz)3 repeating units have the
same composition as the [Cu(OH)(pz)]n (n = 3x) nanojars and are rearranged to the final products,
Na2[CO3{Cu(µ-OH)(µ-pz)}n] (n = 27, 29, 31), while eliminating the last amounts of NaNO3. When
carried out in water, in which all reactants are soluble, the reaction is very fast and an insoluble,
polymeric [{Cu3(OH)3(pz)3}x(NaNO3)y(Na2CO3)z]∞ intermediate forms instantly. If it is further
stirred in water, the intermediate slowly transforms into intractable [trans-Cu(µ-OH)(µ-pz)]∞ and
eliminates NaNO3 and Na2CO3.
The formation of the trinuclear intermediate at a Cu:Hpz:NaOH molar ratio of 3:3:4 also
confirmed by pH titration and UV–vis monitoring of the accompanying absorbance changes. This
intermediate transform cleanly into nanojars upon addition of two more equivalents of NaOH (at
a Cu:Hpz:NaOH molar ratio of 3:3:6).
We have shown that if pairs of pyrazole ligands are locked together by an ethylene tether,
a variety of novel coordination architectures which are inaccessible with a given ligand, can be
obtained. For example, when the ligand 1,2-bis(1H-pyrazol-3-yl)ethane (H2L), is employed, the
tetranuclear complexes Cu4(µ3-OH)2(µ3-L)2(NO3)2 and Bu4N[Cu4(µ4-OH)( µ3-L)4] are obtained. In
contrast, the trinuclear complex Cu3(µ3-OH)2(µ-pz)2(NO3)2(H2O) or the polymeric complex [Cu(µ250

pz)2]∞ are produced when the simple, non-tethered pyrazole is the ligand. In addition, using H2L
in the synthesis of nanojars provides total selectivity for carbonate over sulfate anions.
In the future, in order to achieve high selectivity for different anions, we need to obtain
rigidified oligopyrazole ligands, and use them to prepare nanojars. Such nanojars, are expected to
provide hydrogen bonds with specific lengths and orientations, and to optimally fit the geometry
of the targeted oxoanions (i.e. lengths and orientations of the element-oxygen bonds within those
anions).
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A. Appendix A
1

H NMR and 13C NMR spectral data of selected compounds
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H NMR spectrum of bis(3(5)-aminopyrazol-4-yl)-pyrazol-3(5)-yl-methane 21 in DMSO-d6.
Reproduced with permission, from reference 112.
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C NMR of bis(3(5)-aminopyrazol-4-yl)-pyrazol-3(5)-yl-methane 21 in DMSO-d6. Reproduced
with permission, from reference 112.
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1

H NMR of N-(4-((1H-Pyrazol-3-yl)methylene)-4H-pyrazol-3-yl)-1-(1H-pyrazol-3-yl)methanimine 19 in DMSO-d6. Reproduced with permission, from reference 112.

13

C NMR of N-(4-((1H-Pyrazol-3-yl)methylene)-4H-pyrazol-3-yl)-1-(1H-pyrazol-3-yl)methanimine 19 in DMSO-d6. Reproduced with permission, from reference 112.
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NMR of 3(5)-aminopyrazole-d4 in D2O. Reproduced with permission, from reference 114.
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NMR spectrum of 3(5)-aminopyrazole-d4 in D2O. Reproduced with permission, from
reference 114.
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1

H NMR monitoring of the deuteration of 5-amino-1-methylpyrazole 55 in D2O with 100 mol %

DCl at 25 °C. Reproduced with permission, from reference 114.

1

H NMR monitoring of the deuteration of 3(5)-amino-5(3)-phenylpyrazole 60 in CD3OD with 100

mol % DCl at 25 °C. Reproduced with permission, from reference 114.
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1

H NMR spectrum (400 MHz, DMSO-d6, 150 ºC) of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2(H2O)2
(THF) 66, showing the 1:1 stoichiometry between complex 66 and THF. Reproduced with
permission, from reference 108.
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B. Appendix B
Predicted and observed isotopic patterns of selected compounds

270

Predicted (blue) and observed (red) isotopic patterns for [(Bu4N)Cu2(pz)2(CO3)2]− (A),
[(Bu4N)Cu2(pz)2(CO3)(SO4)]− (B), [(Bu4N)Cu2(pz)2(SO4)2]− (C), [SO4⊂{Cu(OH)(pz)}30]2− (D),
[SO4⊂{Cu(OH)(pz)}32]2− (E) and [SO4⊂{Cu(OH)(pz)}33]2− (F). Reproduced with permission,
from reference 107.
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A)

D)

B)

E)

C)

F)

Predicted (blue) and observed (red) isotopic patterns for [Cu4O(OH)( pzCH2CH2pz)2(NO3)2]– (A),
[Cu4O(OH)(pzCH2CH2pz)2]+ (B), [Cu4(OH)(pzCH2CH2pz)4]– (C), [Cu26(OH)26(pzCH2CH2pz)13
(CO3)]2– (D), [Cu28(OH)28(pzCH2CH2pz)14(CO3)]2– (E) and [Cu30(OH)30(pzCH2CH2pz)15(CO3)]2–
(F). Reproduced with permission, from reference 108.
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A)

E)

B)

F)

C)

G)

D)

H)

Predicted (green) and observed (red) isotopic pattern for [CO3⊂{Cu(OH)(pz)}27]2- (A);
[CO3⊂{Cu(OH)(pz)}7+13+9]2- and [CO3⊂{Cu(OH)(pz)}8+13+8]2- (B); [CO3⊂{Cu(OH)(pz)}30]2(C); [CO3⊂{Cu(OH)(pz)}31]2- (D); [SO4⊂{Cu(OH)(pz)}27]2- (E); [SO4⊂{Cu(OH)(pz)}28]2- (F);
[SO4⊂{Cu(OH)(pz)}29]2- (G); [SO4⊂{Cu(OH)(pz)}31]2- (H). Reproduced with permission, from
reference 105.
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C. Appendix C
Variable-temperature 1H NMR spectroscopy of selected compounds
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Variable-temperature 1H NMR spectra (in DMSO-d6) of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2
(NO3)2(H2O)2(THF) 66. Only the regions between 125−175 ppm (OH proton), 35−55 pm (pz
protons) and (−3)−1 ppm (CH2CH2 protons) are shown for clarity. Reproduced with permission,
from reference 108.

275

Variable-temperature 1H NMR spectra (in DMSO-d6) of the mixture of nanojars (Bu4N)2
[Cun(OH)n(pzCH2CH2pz)n/2(CO3)] (n = 26, 28, 30) 68 (pyrazole signals in the 21−45 ppm
window). Reproduced with permission, from reference 108.
276

Variable-temperature 1H NMR spectra (in DMSO-d6) of the mixture of nanojars (Bu4N)2[Cun
(OH)n(L)n/2(CO3)] (n = 26, 28, 30) 68 (OH signals in the (−28)−(−70) ppm window). Reproduced
with permission, from reference 108.
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Variable-temperature 1H NMR spectra of (Bu4N)2[SO4Ì{Cu(OH)(pz)}28] with small amounts of
(Bu4N)2[SO4Ì{Cu(OH)(pz)}27] in DMSO-d6 (pyrazole signals in the 21−41 ppm window).
Reproduced with permission, from reference 107.
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Variable-temperature 1H NMR spectra of (Bu4N)2[SO4Ì{Cu(OH)(pz)}28] with small amounts of
(Bu4N)2[SO4Ì{Cu(OH)(pz)}27] in DMSO-d6 (OH signals in the (–25)−(–59) ppm window).
Reproduced with permission, from reference 107.
279

Variable-temperature 1H NMR spectra of (Bu4N)2[SO4Ì{Cu(OH)(pz)}29] and (Bu4N)2[SO4Ì
{Cu(OH)(pz)}31], with small amounts of Cu27SO4, Cu28SO4 and Cu32SO4 in DMSO-d6 (pyrazole
signals in the 21−41 ppm window). Reproduced with permission, from reference 107.
280

Variable-temperature 1H NMR spectra of (Bu4N)2[SO4Ì{Cu(OH)(pz)}29] and (Bu4N)2[SO4Ì
{Cu(OH)(pz)}31], with small amounts of Cu27SO4, Cu28SO4 and Cu32SO4 in DMSO-d6 (OH signals
in the (–25)−(–59) ppm window). Reproduced with permission, from reference 107.
281

Variable-temperature 1H NMR spectra of (Bu4N)2[SO4Ì{Cu(OH)(pz)}31] with small amounts of
(Bu4N)2[SO4Ì{Cu(OH)(pz)}32] in DMSO-d6 (pyrazole signals in the 21−41 ppm window).
Reproduced with permission, from reference 107.
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Variable-temperature 1H NMR spectra of (Bu4N)2[SO4Ì{Cu(OH)(pz)}31] with small amounts of
(Bu4N)2[SO4Ì{Cu(OH)(pz)}32] in DMSO-d6 (OH signals in the (–25)−(–59) ppm window).
Reproduced with permission, from reference 107.
283

H NMR spectra of pure (Bu4N)2[SO4Ì{Cu(OH)(pz)}31] in DMSO-d6 at 25 °C and 100 °C,
showing pyrazole proton signals in the 21−35 ppm window. Insets show the corresponding OH
proton signals. Small peaks corresponding to Cu8+13+8SO4 decomposition product are observed at
high temperature. Reproduced with permission, from reference 107.
1

284

Variable-temperature 1H NMR spectra of (Bu4N)2[SO4Ì{Cu(OH)(4-Mepz)}31] with small
amounts of (Bu4N)2[SO4Ì{Cu(OH)(4-Mepz)}32] in DMSO-d6 (pyrazole signals in the 21−41 ppm
window). Reproduced with permission, from reference 107.
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Variable-temperature 1H NMR spectra of (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9] in toluene-d8 (left:
pyrazole protons; right: OH protons; red–Cu9 ring; cyan–Cu6 ring; violet –Cu12 ring). Reproduced
with permission, from reference 105.

286

Variable-temperature 1H NMR spectra of (Bu4N)2[CO3Ì{Cu(OH)(pz)}6+12+9] in DMSO-d6 (red –
Cu9 ring; cyan–Cu6 ring; violet–Cu12 ring; magenta–Cu13 ring; blue–Cu8 ring). Peaks
corresponding to (Bu4N)2[CO3Ì{Cu(OH)(pz)}8+13+8] are observed at temperatures above 110 °C,
indicating that (Cu6+12+9) converts to (Cu8+13+8) at high temperatures. Reproduced with permission,
from reference 105.
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Variable-temperature 1H NMR spectra of the as-synthesized mixture of CO3 nanojars in DMSOd6, evidencing the otherwise hard to observe, broad peaks of the Cu31 nanojar. These peaks sharpen
as the temperature increases, but then diminish above ~60 °C, as the Cu8+14+9 nanojar breaks down
to the Cu8+13+8 nanojar. Reproduced with permission, from reference 105.
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D. Appendix D
Thermogravimetric analysis of selected compounds
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Thermogravimetric curve of Cu3(µ3-OH)(µ-pz)3(NO3)2(CH3CN) 69b (Figure 3.76), heated at 5
°C/min under N2. Calculated loss of the CH3CN molecule: 7.15%; observed: 7.2%. Reproduced
with permission, from reference 106.
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Thermogravimetric curve of Cu3(µ3-OH)(µ-pz)3(NO3)2(H2O) 69a, heated at 5 °C/min under N2.
Calculated loss of the H2O molecule: 3.27%; observed loss by the same temperature as in the case
of 69b (135 °C): 7.4%. Reproduced with permission, from reference 106.
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Thermogravimetric curves for the Cu27CO3, Cu28SO4 (with small amounts of Cu27SO4) and
Cu31SO4 (with small amounts of Cu32SO4) heated at a rate of 5 °C/min under N2. Cu28SO4 retains
a toluene solvent molecule at room temperature under vacuum, which is lost on heating above ~50
°C (1.9%). Reproduced with permission, from reference 107.

Thermogravimetric curve of Cu4(µ3-OH)2(µ3-pzCH2CH2pz)2(NO3)2(H2O)2(THF) 66, heated at 3
ºC/min under N2. Calculated loss of the THF molecule: 8.58%; observed: 8.6%. Calculated loss of
the THF and the two H2O molecules: 12.86%; observed: 12.9%. Reproduced with permission,
from reference 108.
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E. Appendix E
Tandem mass spectrometry of nanojars
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A)

E)

E)

F)

C)

G)

G)

H)

Tandem mass spectrum of [CO3⊂{Cu(OH)(pz)}27]2- (A); [CO3⊂{Cu(OH)(pz)}7+13+9]2- and
[CO3⊂{Cu(OH)(pz)}8+13+8]2- (B); [CO3⊂{Cu(OH)(pz)}30]2- (C); [CO3⊂{Cu(OH)(pz)}31]2- (D);
[SO4⊂{Cu(OH)(pz)}27]2- (E); [SO4⊂{Cu(OH)(pz)}28]2- (F); [SO4⊂{Cu(OH)(pz)}29]2- (G);
[SO4⊂{Cu(OH)(pz)}31]2- (H). Reproduced with permission, from reference 105.
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